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Summary 
 The gastrointestinal tract of mice and men harbors a highly diverse microbiota that confers 
protection to the host against infections with enteric pathogens such as Salmonella enterica serovar 
Typhimurium (S. Tm). This phenomenon is termed as colonization resistance (CR). The tremendous 
complexity of the intestinal ecosystem precludes investigating the contribution of individual strains to 
host-bacterial interactions as well as studying their individual role in CR. Therefore, we established a 
gnotobiotic mouse model which harbors a defined consortium of mouse-derived bacteria able to confer 
CR against S. Tm. This bacterial consortium was named as the Oligo-Mouse Microbiota (Oligo-MM) and 
comprises twelve isolates abundant in the mouse intestine which are assigned to five major eubacterial 
phyla (Firmicutes, Bacteroidetes, Actinobacteria, Verrucomicrobia and Proteobacteria). Firstly, this work 
presents isolation and characterization of the individual members of the consortium and the generation of 
a gnotobiotic mouse line stably colonized with the Oligo-MM. Secondly, the establishment of Oligo-MM 
specific molecular tools including a qPCR assay and probes for fluorescence in situ hybridization (FISH) 
is reported. Furthermore, draft genome sequences were generated for all strains and enabled functional 
metagenomic analysis. All strains were deposited at the German Type Culture collections (DSMZ). 
Finally, an innovative approach which combines mouse infection experiments and comparative 
metagenomics was employed to identify bacterial mechanisms potentially involved in CR against S. Tm. 
In conclusion, the Oligo-MM consortium will be a useful tool to understand the role of single species in a 
complex microbial ecosystem and decipher molecular mechanisms underlying host-microbiota pathogen 
interaction. 
 Gut inflammation and disease induced by S. Tm is the result of the interplay between S. Tm 
virulence factors, the mucosal immune system, physical barriers and the microbiota. The intestinal mucus 
layer is known to provide protection against enteric infections and mucus-deficient mice have been shown 
to be more susceptible to infection with enteric pathogens such as S. Tm when compared to control mice. 
Anterior gradient homolog 2 (AGR2) is a member of the protein disulfide isomerase family involved in 
correct folding and export of the major component of the colonic mucus layer, MUC2. In the second part 
of this thesis, AGR2ko mice deficient in mucus secretion were employed to investigate the role of the 
intestinal mucus layer and the microbiota in S. Tm infection using the antibiotic-treated Salmonella colitis 
model. Surprisingly, streptomycin (sm)-treated AGR2ko mice were shown to be protected to early S. Tm-
induced colitis in contrast to their heterozygous littermate controls (AGR2het). This effect was not seen in 
mice pretreated with a different antibiotic, ampicillin. Microbiota composition analysis combined with 
indicator taxa analysis identified bacterial members assigned to the Deferribacteres phylum as candidates
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 of protective microbiota in sm-treated AGR2ko mice. Additionally, expression of the S. Tm type III 
secretion system 1 (T3SS-1) was found to be downregulated in sm-treated AGR2ko mice. This reveals 
microbiota-mediated regulation of T3SS-1 as novel potential mechanism involved in reduced symptoms 
of S. Tm-induced colitis. Finally, germfree rederivation of AGR2ko and AGR2het mice and generation of 
isobiotic mice using the Oligo-MM consortium will serve as toolbox to disentangle the mechanisms 
involved in protection against S. Tm in mucin-deficient mice. 
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Zusammenfassung  
 Der gastrointestinale Trakt von Menschen und Mäusen wird jeweils von einer höchst diversen 
mikrobiellen Gemeinschaft, genannt Mikrobiota, besiedelt, welche den Wirt vor Infektionen durch 
enterische Pathogene wie Salmonella enterica serovar Typhimurium (S. Tm) schützt. Dieses Phänomen 
wird als Kolonisationsresistenz (KR) bezeichnet. Die enorme Komplexität des intestinalen Ökosystems 
erschwert die genaue Untersuchung der individuellen Bakterien in Bezug auf ihre Interaktion mit dem 
Wirt, sowie ihre individuelle Rolle bei der KR. In dieser Arbeit wurde ein definiertes Konsortium von 
mausstämmigen Bakterien etabliert, welches KR gegenüber S. Tm im gnotobiotischen Mausmodell 
vermittelt. Dieses bakterielle Konsortium wird als die Oligo-Maus Mikrobiota (Oligo-MM) bezeichnet 
und enthält zwölf dem Mausdarm entstammende Isolate, welche fünf eubakterielle Hauptphyla 
(Firmicutes, Bacteroidetes, Actinobacteria, Verrucomicrobia und Proteobacteria) repräsentieren. Diese 
Studie beschreibt erstens die Isolierung und Charakterisierung der individuellen Stämme des Konsortiums 
und die Erstellung einer gnotobiotischen Mauslinie, die stabil mit Oligo-MM kolonisiert wird. Zweitens 
wird die Entwicklung von Oligo-MM-spezifischen molekularen Werkzeugen wie einem spezifischen 
quantitativen PCR-Assay sowie von Sonden für die Fluoreszenz in situ Hybridisierung (FISH) 
beschrieben. Des Weiteren wurden Genomsequenzen für alle Stämme generiert, welches die funktionelle 
metagenomische Analyse ermöglichte. Alle Stämme wurden im Deutschen Zentrum für Mikroorganismen 
und Zellkulturen (DSMZ) hinterlegt. Letztendlich wurde ein innovatives Vorgehen angewandt, welches 
Mausinfektionsexperimente und vergleichenden Metagenomanalysen kombiniert, um bakterielle 
Mechanismen zu identifizieren, die möglicherweise eine Rolle bei der KR gegen S. Tm spielen. 
Zusammenfassend wird das Oligo-MM Konsortium zum molekularen Verständnis der Rolle einzelner 
Bakterien im komplexen mikrobiellen Ökosystem beitragen und die molekularen Mechanismen der 
Erreger-Wirtsinteraktion entschlüsseln.  
 Durch S. Tm hervorgerufene Darmentzündungen und Infektion sind das Ergebnis des 
Zusammenspiels von S. Tm Virulenzfaktoren, dem mukosalen Immunsystem, physischen Barrieren und 
der Mikrobiota. Der Darmschleimhaut bietet Schutz gegen Darminfektionen. Im Vergleich zu 
Kontrollmäusen sind Muzin-defiziente Mäuse anfälliger für Infektionen durch Erreger wie S. Tm. 
Anterior gradient homolog 2 (AGR2) ist ein Mitglied der Proteindisulfidisomerase Familie, welche für die 
korrekte Faltung und den Export der Hauptkomponente der Darmschleimhautschicht, MUC2 
verantwortlich ist. Im zweiten Teil dieser Arbeit wurden AGR2ko Mäuse mit defekter Muzinsekretion 
verwendet, um die Rolle der intestinalen Muzinschicht und der Mikrobiota bei der S. Tm Infektion im 
antibiotika-behandelten Salmonella Kolitismodell zu untersuchen. Überraschenderweise waren 
Streptomycin (Sm)-behandelte AGR2ko-Mäuse geschützt gegen frühzeitige S. Tm-induzierte Kolitis im
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Vergleich zu ihren heterozygoten Wurfgeschwistern (AGR2het). Dieser Effekt wurde nicht bei Mäusen 
beobachtet, welche mit einem anderen Antibiotikum, Ampicillin, vorbehandelt wurden. Die Analyse der 
Mikrobiota-Zusammensetzung in Kombination mit einer Indikator-taxa-Analyse konnte bakterielle 
Vertreter des Phylums Deferribacteres als Kandidaten der protektiven Mikrobiota in Sm-behandelten 
AGRko-Mäusen identifizieren. Zudem war die Expression des S. Tm Typ III Sekretionssystems (T3SS-1) 
in Sm-behandelten AGR2ko-Mäusen deutlich herunterreguliert. Dieses Resultat identifiziert die 
Mikrobiota-gesteuerte Regulation des T3SS-1 als neuen potentiellen Mechanismus bei der Pathogenese 
der S. Tm-Infektionen. Schlussendlich wird die Rederivierung keimfreier AGR2ko- und AGR2het-Mäuse 
und die Züchtung von isobiotischen Mäusen unter Verwendung vom Oligo-MM Konsortiums zur 
Aufklärung der genauen Mechanismen beitragen, die in Mucin-defizienten zum Schutz gegen S. Tm 
beitragen. 
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 Introduction 1.
 The gut harbors the most dense and complex microbial ecosystem within the human body, termed 
as microbiota (Ley, Lozupone et al. 2008). This thesis focuses at the role of the gut microbiota in enteric 
infections. The first part of the introduction takes a glance at the complexity of the gut microbiota, its 
various functions and the challenge to study the interactions between the gut microbiota, the host and the 
enteric pathogens such as Salmonella enterica serovar Typhimurium (S. Tm) in experimental animal 
models. The second part introduces the techniques to analyze the gut microbiota composition. In the third 
part, the human enteropathogen S. Tm is introduced. The fourth part gives an overview on colonization 
resistance against enteric pathogens and experimental animal models developed to study it. Finally, the 
last part introduces the intestinal mucus layer, its protective role towards the host and its various 
interactions with the gut microbiota. 
 
  The mammalian gut microbiota 1.1.
 Composition of the microbiota in humans and mice  1.1.1.
 The gastrointestinal tract is inhabited by approximately 1000 bacterial species, making up 1012 
cells per gram of large intestinal content (Marchesi and Shanahan 2007). In order to study the functions of 
the gut microbiota and its role in health and disease, most of the in vivo studies have so far employed a 
well-defined model organism: the laboratory mouse (mus musculus).  
 The composition of the gut microbiota of humans and mice is rather similar at the taxonomic 
phylum level. The microbiota of both is dominated by anaerobic bacteria belonging to the Firmicutes and 
the Bacteroidetes making up 90 %. The Actinobacteria, the Proteobacteria, the TM7 and the 
Verrucomicrobia are present at a lower abundance (Figure 1A) (Eckburg, Bik et al. 2005, Ley, Backhed et 
al. 2005). However, at the taxonomic genus level, the gut microbiota of humans and mice is rather 
different. Opposite to the mouse microbiota, the gut microbiota of humans harbors more Prevotella, 
Faecalibacterium and Ruminococcus genera. On the other side, the gut microbiota of mice harbors more 
Lactobacillus, Alistipes, Turicibacter and Mucispirillum genera than the human microbiota (Krych, 
Hansen et al. 2013, Nguyen, Vieira-Silva et al. 2015) (Figure 1B). Such differences were also shown at 
the taxonomic family level (Seedorf, Griffin et al. 2014) and may hamper direct translation of data 
obtained from mouse experiments to the human system. 
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Figure 1. Phylogenetic comparison of the intestinal microbiota composition of humans and mice. 
(A) Intestinal microbiota composition of humans and mice is very similar at the taxonomic phylum level. Divisions 
detected in mouse cecum and in human colonic microbiota are indicated by the mouse symbol (Ley, Backhed et al. 
2005) and the human-head symbol (Eckburg, Bik et al. 2005), respectively. “H” denotes additional divisions 
represented in the human fecal microbiota, as determined from GenBank entries. Divisions dominant in mice and 
humans are colored red, rarer divisions are blue, and undetected divisions are black. The bar indicates changes per 
nucleotide. Taken from (Ley, Backhed et al. 2005) with permission. Copyright 2015 National Academy of Sciences, 
U.S.A. (B) Similarities and discrepancies of both microbial ecosystems at the taxonomic genus level in feces using 
four human datasets and five mouse datasets. Genera with significant differences (P<0.05) between human and 
mouse microbiota are annotated with an asterisk. Taken from (Nguyen, Vieira-Silva et al. 2015) under the terms of 
the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0). 
 
 The effects of the microbiota on its host 1.1.2.
 The enormous amount of microorganisms which are directly adjacent to the single-layered 
intestinal epithelial border requires that host and commensal microbiota develop strategies to coexist. In 
most cases, the interactions appear to be of mutual benefit for both the gut microbiota and its host. It is 
well known that the gut microbiota inflicts beneficial effects on its natural host. However, in some cases, 
the gut microbiota can also be deleterious for the host. 
 
 Education of the immune system  1.1.2.1.
 Starting right after birth, the gut microbiota educates the immune system (Lotz, Gutle et al. 2006). 
This phenomenon has been intensively studied in humans, where newborns encounter the first bacterial 
invaders while passing through the maternal vagina. Controversially, another study detected bacteria even 
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in the placenta, suggesting that bacterial colonization could occur before birth (Aagaard, Ma et al. 2014). 
However, these results are highly discussed in the field (Aagaard 2014). Thus, members of the vaginal 
microbiota constitute the first microbial community established in the gut and some members of this 
microbiota stably colonize. Further on, once in the gut, these pioneer colonizers enter in contact with the 
epithelial border (Dominguez-Bello, Costello et al. 2010). This first contact is essential for educating the 
immune system of newborns (Lotz, Gutle et al. 2006), participating in milk digestion (Gagnon, Savard et 
al. 2015) and aiding other commensals to colonize the gastrointestinal tract (Penders, Thijs et al. 2006). It 
is known that when the first microbial community differs from the community of vaginal microbiota (e.g. 
babies born by caesarian), newborns harbor another gut microbiota in their early age. This correlates with 
the risk of developing asthma and multiple allergies later in life, in humans (Kero, Gissler et al. 2002). 
Moreover, germfree mice colonized with bacterial strains isolated from humans have an impaired immune 
system compared to animals colonized with murine isolates (Chung, Pamp et al. 2012). Therefore, both 
the microbiota composition and its adaptation to its host are important to educate the immune system. 
 In adult mice, it is well documented that the members of the gut microbiota can influence the 
intestinal immune system and the barrier function. They can influence the innate immune system by 
inducing the production of antimicrobial peptides (e.g. REGIIIβ, REGIIIγ) (Vaishnava, Behrendt et al. 
2008) and by maturating lymphoid tissues via their recognition by host pattern recognition receptors 
(PRR) (Bouskra, Brezillon et al. 2008). Moreover, they can influence the adaptive immune system by 
inducing regulatory immune responses (Atarashi, Tanoue et al. 2013), by promoting the differentiation of 
T helper cell (Th17) (Atarashi, Nishimura et al. 2008) and by inducing the production of secretory 
immunoglobulin A (Macpherson and Uhr 2004). Finally, the gut microbiota can influence the barrier 
function by modulating the structure of mucus layers (Johansson, Jakobsson et al. 2015) and regulating 
intestinal epithelial permeability (Stefka, Feehley et al. 2014). 
 
 Influence of the gut microbiota on gut morphology and nutrition 1.1.2.2.
 Besides, the gut microbiota is known to influence the intestinal morphology, physiology and 
motility (Berg 1996). Using germfree animals, it was shown that commensals increase the number of 
goblet cells (Stefka, Feehley et al. 2014) and the production of mucus (Jakobsson, Rodriguez-Pineiro et al. 
2015). They also participate to microvilli formation, increase the rate of the epithelial cell turnover, and 
contribute to the development of the gut-associated lymphoid tissues, the Peyer´s patches and the 
mesenteric lymph nodes (Falk, Hooper et al. 1998, Round and Mazmanian 2009, Ohland and Jobin 2015). 
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 Furthermore, the gut microbiota fulfills a variety of metabolic functions, which can contribute to 
nutrition and is therefore beneficial for the host (Nicholson, Holmes et al. 2012). The metabolites shaped 
and modified by the gut microbiota are termed metabolome. The microbiota can promote glucose 
absorption as well as catabolize host dietary nutrients (Backhed, Ding et al. 2004) and mucus glycans 
(Johansson, Jakobsson et al. 2015). Additionally, bacterial metabolites such as amino acids (Zheng, Xie et 
al. 2011), carbohydrates (Flint, Scott et al. 2012) or vitamins (Koenig, Spor et al. 2011) can have also 
beneficial effects on the host. Finally, the microbiota ferment dietary fibers and complex-carbohydrates 
into short-chain fatty acids (SCFA) such as butyrate (Donohoe, Holley et al. 2014), propionate and acetate 
(Caspari and Macy 1983). The SCFA, in particular butyrate, are known to influence epithelial cell 
proliferation (Donohoe, Collins et al. 2012), mucosal immune response and mucus secretion (Vanhoutvin, 
Troost et al. 2009). However, these effects are controversial and highly discussed in the field (Hamer, 
Jonkers et al. 2010, Bultman and Jobin 2014). 
 
 Environmental and host factors influencing the intestinal microbiota 1.1.3.
composition 
 Under healthy conditions, the composition of the gut microbiota differs largely within and 
between individuals depending on different factors such as aging and ethnic group (Yatsunenko, Rey et al. 
2012), intestinal location (Zhang, Geng et al. 2014), lifestyle habit (Ley, Hamady et al. 2008), foregoing 
infection (Gradel, Nielsen et al. 2009), diet (Carmody, Gerber et al. 2015), pregnancy (Koren, Goodrich et 
al. 2012), previous antibiotic therapy (Liou and Turnbaugh 2012), atmospheric pressure (Adak, Maity et 
al. 2014) and housing conditions in case of experimental animals (Ma, Bokulich et al. 2012, Rogers, 
Kozlowska et al. 2014). Severe changes in the composition of the gut microbiota, termed as dysbiosis, 
have further been associated with various diseases. In this section, some factors involved in dysbiosis are 
described in more details. 
 
 Diet 1.1.3.1.
 The diet can promote dysbiosis (Goodman, Kallstrom, 2011). Dietary habits such as herbivore, 
carnivore or insectivore lifestyles are known to influence the gut microbiota in humans and in other 
organisms (Ley, Hamady et al. 2008, Ley, Lozupone et al. 2008). Nutrient sources such as high fat and 
high sugar diets (Carmody, Gerber et al. 2015), carbohydrates (Aguirre, Eck et al. 2015), artificial 
sweeteners (Suez, Korem et al. 2014) or vitamins (e.g. vitamins A and B12) (Cha, Chang et al. 2010, 
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Degnan, Barry et al. 2014) can also affect the composition of the gut microbiota. For example, the 
artificial sweeteners increase the Bacteroidales and decrease the Clostridiales. This dysbiosis can lead to 
an increase of glucose intolerance and metabolic disorders (Suez, Korem et al. 2014). Furthermore, Faith 
et al. developed a modeling approach to predict the reaction of microbiota after a change of diet, based on 
the diet composition. This model could allow the manipulation of the microbiota to improve global human 
health and prevent or treat various diseases (Faith, McNulty et al. 2011).    
 
 Antibiotic treatment 1.1.3.2.
 Antibiotic treatment promotes severe dysbiosis, despite the high abundance of antibiotic 
resistances in the microbiome (Sommer, Dantas et al. 2009, Maurice, Haiser et al. 2013). Dysbiosis can 
have deleterious effects on the host. Antibiotic-induced dysbiosis is associated with an increased adiposity 
suggesting that a dysbiotic microbiota is more efficient in extracting energy from the diet than a 
conventional microbiota (Flint 2012, Liou and Turnbaugh 2012). Moreover, antibiotic-induced dysbiosis 
can facilitate enteric infections by both genuine and opportunistic pathogens (e.g. Clostridium difficile, 
vancomycin-resistant Enterococcus and Salmonella enterica serovar Typhimurium) and inhibit immune 
responses (e.g. production of the antibacterial lectin RegIIIγ) (Brandl, Plitas et al. 2008, Ng, Ferreyra et al. 
2013). Further, long-term disturbances triggered by antibiotic treatment are associated with several 
pathologies such as colitis, diarrhea and allergies (Hill, Siracusa et al. 2012, Varughese, Vakil et al. 2013, 
Satokari, Fuentes et al. 2014). Additionally, in a dose-dependent manner, antibiotics are also known to 
influence the quorum-sensing systems of the gut bacteria (Struss, Pasini et al. 2012). 
 
 Inflammation and infection 1.1.3.3.
 Chronic and acute intestinal inflammation in humans and mice are associated with severe 
dysbiosis. In particular, in chronic inflammatory disease, relative abundance of Firmicutes and 
Bacteroidetes was shown as shifted and relative abundance of Deferribacteres and Proteobacteria was 
observed as increased (Morgan, Tickle et al. 2012, Schwab, Berry et al. 2014). However, it is unclear 
whether this dysbiosis is responsible for inflammation or occurs consequently. During infection, 
enteropathogens trigger inflammatory responses using different virulence factors such as flagella and type 
three secretion systems (T3SS). This leads to dysbiosis (Belzer, Gerber et al. 2014) as well as drastic 
changes in the gut ecosystem such as increased hypoxia (i.e. diminished availability of oxygen) (Harris, 
Carter et al. 2011), increased mucus secretion (Xue, Zhang et al. 2014) and massive induction of immune 
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response  (e.g. cytokines, IL-1β, interferon-γ) (Rhee, Walker et al. 2005, Muller, Hoffmann et al. 2009) 
(also reviewed in (Kaiser, Diard et al. 2012)). 
 
 Host genotype 1.1.3.4.
 For both humans and mice, it is known that host genotype shapes the gut microbiota. In humans, 
this was shown by a study on monozygotic and dizygotic twin pairs (Goodrich, Waters et al. 2014). In 
mice, evidence comes from genetically modified mouse models (Ley, Backhed et al. 2005, Krych, Hansen 
et al. 2013). However, it remains unclear whether genetic mutations have direct or indirect effects on 
microbiota composition. For example, the major component of the intestinal mucus layer is mucin 2 
(MUC2). MUC2-deficient mice were shown to harbor a different microbiota as compared to wild-type 
(WT) mice (Sovran, Loonen et al. 2015). However, it is unclear whether this difference is due to their lack 
of intestinal mucus layer (Van der Sluis, De Koning et al. 2006), their different profile of gene expression 
compared to their WT littermates (e.g. for genes involved in immune response, lipid metabolism pathways 
and cell-cycle control) (Sovran, Loonen et al. 2015) or other consequences of muc2 mutation. Therefore, 
various strategies aim to decrease variations in microbiota composition such as cohousing WT and mutant 
mice, using littermates as reference group, standardizing diet, minimizing stress factors, and so on 
(Laukens, Brinkman et al. 2015). 
 
 In conclusion, regarding the high complexity of the interactions between the gut microbiota and 
its host, it is challenging to understand host-microbiota relationships at a molecular level. Therefore, one 
of the strategies to study these interactions is to simplify the system by using well-characterized animal 
models in combination with well-defined microbiota and specific-analytical methods. 
 
  Analytical tools to study the gut microbiota composition and function 1.2.
 A variety of different analysis tools has been developed to analyze the composition and the 
localization of the gut microbiota. While methods based on counting of 16S rRNA gene copies as well as 
bacterial culture methods can be used to study relative abundance of individual microbial taxa, 
fluorescence in situ hybridization (FISH) allows the localization and the quantification of single cells in 
situ. We used three different analysis methods to compensate the bias of each of the single methods. The 
strengths and limitations of each method are outlined below. 
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 High-throughput amplicon sequencing and quantitative PCR of bacterial 1.2.1.
16S rRNA genes 
 High-throughput 16S rRNA amplicon sequencing is one of the most powerful approaches to study 
microbiota composition (Sogin, Morrison et al. 2006). It provides a relatively cheap and high-throughput 
dataset of sequences, which can be used to describe the gut microbiota composition to a low taxonomic 
level, and offers the parallel analysis of a large amount of samples in a short time scale. However, results 
vary depending on the analysis platform, the amplified 16S rRNA gene region (i.e. primer bias), the 
sequencing depth, the 16S rRNA gene used for taxonomic assignment and the bioinformatics analysis 
pipeline used (Koren, Knights et al. 2013, Schmidt, Matias Rodrigues et al. 2015). Furthermore, chimera 
generated during PCR amplification constitute another source for errors (Edgar, Haas et al. 2011). 
 The quantitative polymerase chain reaction (qPCR) assay provides more sensitive and specific 
detection of bacterial strains than other gDNA-based methods. It is currently also cheaper than the 
amplicon sequencing technique. However, it does not allow the detection of bacterial contaminants as it 
only detects targeted bacterial strains. 
 
 Meta-omics analyses 1.2.2.
 While metagenomics is used to predict the functional capacity of the entire gut microbiota 
community using genomic DNA (gDNA) sequencing, metatranscriptomics is used to get an overview on 
the transcriptional activity using RNA sequencing (Gill, Pop et al. 2006, Xiong, Frank et al. 2012). 
Importantly, two subjects with similar metagenomic profiles can have different metatranscriptomic 
activities (Franzosa, Morgan et al. 2014). This can be because metabolic pathways predicted to be in the 
same microbiota can be in different bacteria. Moreover, functional analyses are biased regarding how 
genes are related to the reference proteins. 
 Recently, metaproteomics and metabolomics analyses have been used to identify the functional 
activity of a microbial community in more details (Nicholson, Holmes et al. 2005, Verberkmoes, Russell 
et al. 2009). 
 
 In conclusion, gDNA-based methods are powerful tools to study microbiota composition and 
functionome. However, they can bias the data due to gDNA extraction efficiency as Gram-negative and 
Gram-positive bacteria have different cell walls, which exhibit different susceptibility to lysis methods 
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(Salonen, Nikkila et al. 2010, Maukonen, Simoes et al. 2012). This leads to a bias in favor of Gram-
negative bacteria, which are easier to lyse. Bacterial genomes can harbor one to several copies of the same 
16S rRNA gene, which can be either identical or different. This also leads to misestimation of the relative 
abundance of bacterial strains and can complicate the taxonomic assignment (Watanabe, Kojima et al. 
2013). 
 
 Fluorescence in situ hybridization  1.2.3.
 Fluorescence in situ hybridization (FISH) uses probes targeting the 16S rRNA. FISH probes are 
fluorescently labelled to specifically detect bacterial communities at the single-cell level, study ecological 
niches in tissue sections and determine the relative abundance of individual microbial community 
members using image analysis software such as the digital image analysis in microbial ecology software 
(DAIME) or BacSpace (Daims, Lucker et al. 2006, Earle, Billings et al. 2015). It can also be combined 
with other techniques such as high-resolution secondary ion mass spectrometry (NanoSIMS) to visualize 
bacterial metabolic activities in vivo (Berry, Stecher et al. 2013). However, despite the efforts made to 
optimize the FISH protocols, the fluorescent signal intensity, the microscopic resolution and the image 
analysis, it is challenging to establish a specific FISH protocol for gut tissues. This is mainly due to the 
high bacterial density in the gut and the auto-fluorescence of the gut tissue and plant fibers. 
 
 Bacterial isolation and culture 1.2.4.
 Bacterial isolation and culture is essential to characterize the physiological properties of bacterial 
strains in vitro, determine its genome sequence and perform proof of experimental concept. The genome 
sequence allows gaining insights into function and metabolic pathways of the organism and facilitating the 
development of specific analytical tools. Eventually, strategies for genetic manipulation can also be 
developed based on the genomic information. However, despite 52 phyla identified in the domain 
Bacteria, only half of them have cultured representative strains (nicely reviewed in (Rappe and 
Giovannoni 2003)). Therefore, efforts are made to circumvent technical problems (e.g. working under 
anaerobic atmosphere) and to develop new cultivating methods such as enrichment culture (Clavel, 
Henderson et al. 2006), high-throughput methods (Connon and Giovannoni 2002), gel microdroplet 
approach (Zengler, Toledo et al. 2002) or synergistic bacterial growth (Kaeberlein, Lewis et al. 2002). 
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  Salmonella enterica serovar Typhimurium - a model human 1.3.
pathogen to study microbiota-pathogen interaction in the gut 
 Salmonella enterica serovar Typhimurium (S. Tm) is a facultative anaerobic, non-spore-forming, 
Gram-negative bacterium, which is taxonomically assigned to the Enterobacteriaceae family. In humans, 
food-borne infections with nontyphoidal Salmonella strains (e.g. S. Tm) lead usually to self-limiting 
diarrhea and can, in some cases, also cause bacteremia (e.g. young children and immunocompromised 
patients) (Fabrega and Vila 2013). To infect successfully its host, S. Tm harbors a tremendous amount of 
virulence factors encoded within five Salmonella pathogenicity islands (SPI) in the chromosome and a 
virulence plasmid (pSLT). Initiation and amplification of the pro-inflammatory signals by S. Tm results in 
activation of macrophages and dendritic cells (Rydstrom and Wick 2007), granulocyte transmigration in 
the gut lumen, mucosal edema, epithelial damage, reduced numbers of mucus-loaded goblet cells (Barthel, 
Hapfelmeier et al. 2003) and mucin secretion (Day, Mandal et al. 1978). Moreover, S. Tm has to compete 
with the gut microbiota and deal with the inflammatory milieu in the gut. Here, the pathogenesis of S. Tm 
is reviewed with its most relevant virulence factors, followed by S. Tm interaction with the gut microbiota 
in the healthy and inflamed gut. 
 
 Mechanisms of Salmonella Typhimurium pathogenesis 1.3.1.
 The majority of studies have been performed in a mouse model for S. Tm-induced colitis, the 
streptomycin-treated (sm-treated) mouse colitis model (Barthel, Hapfelmeier et al. 2003). S. Tm 
pathogenesis is schematized below (Figure 2).  
 After infection of sm-treated mice, S. Tm reaches the intestine and crosses the mucus layer in 
order to reach the epithelial border using chemotactic flagella-mediated motility (Stecher, Hapfelmeier et 
al. 2004). Using different adhesins, S. Tm attaches to the enterocytes in the small intestine preferentially, 
where M cells of the Peyer’s patches are infected (Gerlach, Jackel et al. 2007). 
 So far, three mechanisms for S. Tm entry into host cells have been described. (1) After its 
adhesion to epithelial cells, S. Tm employs a type three secretion system (T3SS) termed as T3SS-1 and 
encoded on Salmonella pathogenicity island 1 (SPI-1). Using a needle complex and a translocon 
machinery, T3SS-1 injects at least fourteen different effector proteins into the host cell (Kaiser, Diard et al. 
2012). This leads to actin cytoskeletal rearrangement, internalization of S. Tm via a Trigger-like 
mechanism, and initiation of gut inflammation through the induction of pro-inflammatory cytokines (e.g. 
IFNγ, IL-1β and MIP2) (Hapfelmeier, Ehrbar et al. 2004, Patel and Galan 2005). (2) After its adhesion to 
Introduction 
 
 
10 
 
epithelial cells, S. Tm uses an outer membrane protein (OMP) termed the Rck, which is encoded on pSLT, 
to enter epithelial cells via a Zipper-like mechanism. Rck interacts with its host receptor (still unknown) to 
manipulate the host signaling and trigger S. Tm internalization. S. Tm is the first pathogen to be described 
as able to induce both Zipper and Trigger mechanisms for host cell invasion (Velge, Wiedemann et al. 
2012). (3) S. Tm is directly sampled from the gut lumen by dendritic cells, which open the tight junctions 
and send dendrites to the lumen (Rescigno, Rotta et al. 2001). 
 Once inside the phagocytic or non-phagocytic cells, S. Tm is contained in a Salmonella-containing 
vacuole (SCV) (Garcia-del Portillo, Foster et al. 1992). In order to survive and replicate intracellularly, S. 
Tm expresses a second T3SS, termed as T3SS-2 and encoded on SPI-2, as well as corresponding effectors 
proteins (Figueira and Holden 2012). Among other, the SPI-2-encoded effector proteins are reported to 
block fusion of the SCV with lysosomes (Uchiya, Barbieri et al. 1999), to manipulate the vesicular 
trafficking pathway (e.g. transcytosis of the SCV to the basolateral membrane) (Garvis, Beuzon et al. 
2001) and to induce the formation of Salmonella-induced filaments (Garcia-del Portillo, Zwick et al. 
1993). Eventually, T3SS-2 activity enables intracellular replication, induction of profound inflammation 
and systemic spread (Hapfelmeier and Hardt 2005). 
 Effector proteins encoded by T3SS-1 and T3SS-2 can also induce systemic dissemination of S. 
Tm to other organs such as mesenteric lymph nodes, liver, spleen and gallbladder (Lawley, Chan et al. 
2006). To favor dissemination, S. Tm can induce epithelial and macrophage cell death (Monack, Raupach 
et al. 1996, Paesold, Guiney et al. 2002). These events trigger acute and chronic inflammatory responses 
through the activation of cytokines such as IFNγ (Monack, Bouley et al. 2004). Moreover, S. Tm has 
several mechanisms to promote its survival in the host such as turning into non-replicating persisters 
within macrophages or inducing biofilm formation (Papavasileiou, Papavasileiou et al. 2010, Helaine, 
Cheverton et al. 2014). During persistent infection, S. Tm can be transmitted to a new host using fecal 
shedding (Lam and Monack 2014). 
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Figure 2. Schematic representation of Salmonella Typhimurium pathogenesis. 
1. Adhesion: After ingestion, S. Tm swims towards the gut epithelium along chemotactic gradients. After penetrating 
the mucus layer, it adheres to the epithelial surface using diverse adhesins. 2. Host cell invasion: In order to invade 
into epithelial cells, S. Tm can use two mechanisms. Firstly, S. Tm can use its T3SS-1 to inject several effector 
proteins into the cellular cytoplasm. T3SS-1 effectors are also known to induce the expression of pro-inflammatory 
cytokines. Secondly, S. Tm uses its Rck invasin to interact with the epithelial cell. In both cases, it triggers actin 
rearrangement and lead to the engulfment of S. Tm into the epithelial cell. The host receptor of Rck invasion remains 
unknown. Finally, S. Tm can also be sampled by dendritic cells directly from the gut lumen. 3. Intracellular 
survival and replication: Once inside the host cells, S. Tm uses its T3SS-2 to inject effector proteins into the cell 
cytoplasm. Thereby, it manipulates the host cell (e.g. vesicular trafficking pathways) in order to survive and replicate 
into the Salmonella-containing vacuole (SCV). T3SS-2 effectors are also known to cause tissue-wide inflammation. 
Moreover, macrophages are able to phagocytose S. Tm, which can survive intracellularly and replicate. 4. 
Dissemination: In order to disseminate, S. Tm uses different mechanisms, which remain unclear. For example, S. 
Tm can induce epithelial cell apoptosis and dendritic cell pyroptosis. 
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 Salmonella Typhimurium outcompetes the gut microbiota and benefits 1.3.2.
from the gut inflammation 
 Upon infection, S. Tm encounters a dense and autochthonous microbiota that prevents S. Tm 
infection. In order to successfully colonize and infect its host, S. Tm has developed several strategies to 
outcompete the microbiota (Figure 3). 
 The ability of S. Tm to colonize the gut correlates with the presence of close related species 
(Stecher, Chaffron et al. 2010). S. Tm can also exploit hydrogen and sugars (e.g. sialic acid), which are 
microbiota-derived to colonize the gut (Maier, Vyas et al. 2013, Ng, Ferreyra et al. 2013). Using flagella 
and chemotaxis, S. Tm follows the gradient of high-energy nutrients (e.g. mucin-derived sugars and 
electron acceptors) and reaches the epithelial cells to initiate inflammation (Stecher, Hapfelmeier et al. 
2004). Moreover, S. Tm can exploit inflammation to outcompete the microbiota. Indeed, the mucosal 
inflammation increases the release of mucins and other glycoconjugate nutrients, which favors S. Tm 
colonization and helps the remaining pathogens in the lumen to sense the epithelial border (Stecher, 
Barthel et al. 2008). Moreover, during inflammation, polymorphonuclear neutrophils (PMN) that 
transmigrate into the intestinal lumen release reactive oxygen species (ROS) and reactive nitrogen species 
(RNS) to kill S. Tm (Loetscher, Wieser et al. 2012). The by-products of releasing ROS and RNS are 
tetrathionate and nitrate, respectively, which are used by S. Tm as respiratory electron acceptors (Winter, 
Thiennimitr et al. 2010, Rivera-Chavez, Winter et al. 2013). This ability to perform anaerobic respiration 
boosts S. Tm growth and enables it to outcompete obligate anaerobic commensals (Rivera-Chavez, Winter 
et al. 2013). Furthermore, to survive inflammatory responses, S. Tm developed resistances against some 
anti-microbial peptides (e.g. RegIIIβ) (Stelter, Kappeli et al. 2011). Other antimicrobials are released to 
enable the acquisition of essential micronutrients. It is the case for the acquisition of iron against which 
the mucosa excretes the enterochelin-sequestering protein lipocalin-2 (Lcn2) to limit iron availability. S. 
Tm bypasses this host-defense by producing the salmochelin, which is an Lcn2-resistant glycosylated 
enterochelin derivative (Raffatellu, George et al. 2009). Similarly, calprotectin is released by PMNs to 
sequester zinc in the inflamed gut. S. Tm overcomes this calprotectin-mediated zinc chelation by 
expressing a zinc transporter (ZnuABC), which is known to enhance S. Tm growth and allow S. Tm to 
overgrow the gut microbiota (Liu, Jellbauer et al. 2012). 
 In conclusion, in order to infect its host successfully, S. Tm developed strategies to overgrow the 
gut microbiota, to benefit from mucosal inflammation and to resist host-defense mechanisms. All together, 
these mechanisms negatively affect gut microbiota in particular the anaerobic commensals, which are 
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presumably more sensitive to inflammation and to antimicrobials (Stecher, Robbiani et al. 2007). 
However, the gut microbiota can also play a protective role during S. Tm infection. 
 
 
Figure 3. Schematic representation of S. Tm growth within the normal and the inflamed gut. 
Upon entering the intestinal tract, S. Tm encounters the gut microbiota, which is already established and well-
adapted to the gut ecosystem. To successfully colonize and invade the gut, S. Tm uses different mechanisms. 1. S. 
Tm utilizes the microbiota-derived products (e.g. H2). 2. S. Tm uses mucus-derived carbohydrates, which are 
degraded by mucolytic bacteria (e.g. sialic acid). 3. S. Tm uses chemotaxis and motility to penetrate the mucus layer 
and reach the epithelial border. Moreover, S. Tm benefits from inflammation as it 4. senses the chemotactic gradient 
emanating from the mucus layer, which is increased by inflammation. 5. S. Tm uses tetrathionate and nitrate, which 
result from inflammation, as anaerobic electron acceptor. 6. S. Tm resists antimicrobials such as lipocalin and 
calprotectin. 
 
  Colonization resistance 1.4.
 Previous studies have shown that antibiotic treatment (e.g. with streptomycin) enhanced infections 
by enteropathogens such as Salmonella spp. (Miller, Bohnhoff et al. 1956), E. coli, Klebsiella pneumonia 
and Pseudomonas aeruginosa in mice (van der Waaij, Berghuis-de Vries et al. 1971). Similar observations 
were also reported for other enteropathogens such as Shigella sonnei (Pongpech, Hentges et al. 1989), 
Clostridium difficile (Reeves, Koenigsknecht et al. 2012), Enterococcus faecium (Ubeda, Bucci et al. 
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2013) and S. Tm (Stecher, Robbiani et al. 2007). These studies highlight the protective role of the gut 
microbiota for its host against enteric pathogens. This is termed as colonization resistance (CR). Here, I 
first review the direct and indirect CR effects mediated by the gut microbiota on enteropathogens, and 
then the animal models used to study CR in vivo. 
 
 Direct effects of the gut microbiota on the enteric pathogens 1.4.1.
 The gut microbiota can interfere with pathogen growth and inhibit enteric infections in many 
ways. One potential mechanism is the competition for nutrients or micronutrient. This has been postulated 
as the Freter’s nutrient-niche hypothesis. It states that a bacterium cannot invade a resident microbiota if 
its metabolic niche is already occupied by other strains (Freter, Brickner et al. 1983). Competition 
mechanisms include nutrients such as amino acid and sugars as well as micronutrients like iron and H2 
(Deriu, Liu et al. 2013, Maier, Vyas et al. 2013, Sassone-Corsi and Raffatellu 2015). Supporting this idea, 
microbiota complexity positively correlates with CR against enteric pathogens in many cases (e.g. S. Tm) 
(Stecher, Chaffron et al. 2010). Another mechanism of CR is the production of antimicrobial compounds 
and toxins by the microbiota. Some commensals are known to secrete antimicrobial peptides called 
microcins or bacteriocins, which kill bacterial competitors including pathogens (e.g. E. coli Nissle, 
Clostridium difficile, Bifidobacterium spp. and Lactobacillus spp.) (Allison, Fremaux et al. 1994, 
Nedialkova, Denzler et al. 2014, Buffie, Bucci et al. 2015). Moreover, fermentation of carbohydrates leads 
to production of short chain fatty acids (SCFA) such as acetate, propionate and butyrate. Acetate is known 
to prevent the release of Shiga toxin during infection with enterohaemorrhagic E.coli (EHEC) and to 
modulate the expression of invasion genes of S. Tm in the large intestine (Durant, Corrier et al. 2000, 
Lawhon, Maurer et al. 2002, Fukuda, Toh et al. 2011). Propionate and butyrate are known to repress 
virulence (e.g. S. Tm) (Lawhon, Maurer et al. 2002). Furthermore, commensals (e.g. strains belonging to 
the Bacteroidetes phylum) can secrete antibacterial toxins using the type VI secretion system (T6SS) in a 
contact-dependent manner (Russell, Wexler et al. 2014). Finally, another mechanism of CR is the 
competition between commensals and enteropathogens for adhesion to the host epithelium. However, this 
was shown in cell cultures only (Alemka, Clyne et al. 2010, Ren, Li et al. 2012) and mechanisms by 
which adherent commensals inhibit attachment and virulence of enteropathogens remain unclear (Greene 
and Klaenhammer 1994). 
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 Indirect effects on pathogen colonization 1.4.2.
 Studies using germfree mice clearly demonstrate the essential role of the microbiota for educating 
the gut immune system and inducing maturation of the epithelial border (Backhed 2012). One potential 
mechanism is the effect on the innate immune system. Microbial colonization is associated with the 
induction of innate immune responses such as expression of antimicrobial peptides (e.g. C-type lectins and 
α-defensins) (Cash, Whitham et al. 2006, Vaishnava, Behrendt et al. 2008), cytokines (e.g. IL-1β and IL-
22) (Satoh-Takayama, Vosshenrich et al. 2008, Hasegawa, Kamada et al. 2012) and inducible nitric oxide 
synthase (Allen, Lafuse et al. 2012). Additionally, the gut microbiota can also trigger adaptive immune 
responses and interfere with the differentiation of T cell subpopulations such as Th17 cells, which are 
involved in pro-inflammatory responses and regulatory T cells, which play a role in the anti-inflammatory 
immune responses and tolerance (Atarashi, Tanoue et al. 2011). The microbiota also promotes 
differentiation and activation of B cells, as well as secretion of Immunoglobulin A (Hapfelmeier, Lawson 
et al. 2010). This plays an important role in maintaining the gut homeostasis. Thirdly, by interacting with 
epithelial cells, commensal bacteria can also protect from enteric infections. Microbiota-released SCFA 
can provide nutrition for colonocytes, modulate host signaling pathways, suppress inflammation and 
increase the mucosal barrier function by promoting the formation of tight junctions (reviewed in (Ploger, 
Stumpff et al. 2012)). Butyrate was also shown to stimulate mucus expression and secretion 
(Shimotoyodome, Meguro et al. 2000, Gaudier, Rival et al. 2009). 
 
 Mouse models developed to study the colonization resistance and the 1.4.3.
underlined mechanisms 
 It is well-established that conventional mice are more resistant to enteric infections (e.g. S. Tm 
and Citrobacter rodentium) as compared to germ-free mice (Kamada, Kim et al. 2012). However, the 
conventional microbiota harbors approximately 1000 bacterial species, making up 1012 cells per gram of 
large intestinal content  (Marchesi and Shanahan 2007). Therefore, mice which harbor a simplified and 
well-defined gut microbiota (i.e. gnotobiotic mice) have been developed to study the contribution of single 
bacterial strain to CR. Numerous studies have used mice harboring bacteria derived from humans 
(Fukuda, Toh et al. 2011, Ganesh, Klopfleisch et al. 2013, Lee, Donaldson et al. 2013, Faith, Ahern et al. 
2014, Slezak, Krupova et al. 2014). However, human microbiota colonized mice were shown to exhibit an 
impaired immune system and an increased susceptibility to Salmonella infection, as compared to mice 
colonized with a murine microbiota (Chung, Pamp et al. 2012). Moreover, Seedorf et al., provided 
evidence that a mouse-adapted microbiota better invades and colonizes the mouse gut than 
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xenomicrobiota (Seedorf, Griffin et al. 2014). Therefore, mice harboring a limited mouse-adapted 
microbiota were developed (Itoh and Mitsuoka 1985, Reeves, Koenigsknecht et al. 2012). As an example, 
the altered Schaedler flora (ASF) harbors eight strains and has been widely used (Dewhirst, Chien et al. 
1999). However, mice colonized with the ASF strains were shown to exhibit large cecal size (Wymore 
Brand, Wannemuehler et al. 2015), abnormal T cell repertoire (Geuking, Cahenzli et al. 2011), lack of 
colonization resistance (Stecher, Chaffron et al. 2010) and abnormal metabolic capacity (Norin and 
Midtvedt 2010, Berry, Stecher et al. 2013). These observations highlight the importance of improving 
current gnotobiotic mouse models based on murine isolates to study CR mechanisms. 
 
  The intestinal mucus layer 1.5.
 Composition of the mucus layer 1.5.1.
 The mucus layer represents one of the first physical barriers encountered by the gut microbiota 
and the enteropathogens. In the large intestine, the mucus layer is mainly composed of a secreted gel-
forming mucin named MUC2 (Gum, Hicks et al. 1994). MUC2 forms a network composed of a core 
protein, rich in the amino acids proline, threonine and serine (PTS), which are repeated in tandem and 
constitute the PTS domain. In the endoplasmic reticulum (ER), the core protein is dimerized at the C-
termini and trimerized at the N-termini via disulfide bonds (Figure 4A) (Asker, Axelsson et al. 1998, 
Godl, Johansson et al. 2002). The polymer is then conveyed to the Golgi apparatus where the PTS domain 
is heavily O-glycosylated, becoming the mucin domain. This resulting mature mucin is finally condensed 
into granulae before being secreted by specialized cells termed goblet cells (Johansson, Gustafsson et al. 
2010). When released on the apical side of the intestinal epithelium, MUC2 expands and divides into 2 
layers: the inner mucus layer, which is firmly adherent and close to the epithelial border, and the outer 
mucus layer, which is loose and closer to the gut lumen (Figure 4B). In healthy conditions, the inner layer 
is devoid of bacteria, while the outer layer can be colonized (Figure 4C) (Johansson, Phillipson et al. 
2008). Proteomic analysis suggests that the loose property of the second mucus layer results from 
proteolytic cleavage of the firm mucus layer by host endogenous proteases (Johansson, Thomsson et al. 
2009). However, the role of mucin-degrading bacteria cannot be entirely excluded (e.g. Bifidobacterium 
spp., Ruminococcus spp., Akkermansia muciniphila) (Hoskins, Agustines et al. 1985, Png, Linden et al. 
2010, Subramani, Johansson et al. 2010). 
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Figure 4. Structure and organization of the intestinal mucus layer. 
(A) MUC2 contains cysteine-rich N- and C-terminal parts, four complete von Willebrand D domains (D1-D4) and 
PTS domains, which are rich in proline, threonine and serine. In the endoplasmic reticulum, MUC2 is dimerized at 
the C-termini and trimerized at the N-termini. In the Golgi apparatus, PTS domains are heavily O-glycosylated and 
become the mucin domain. Finally, mucin is condensed and stored into granulae in goblet cells before being 
secreted. (B) The secreted mucus is organized into two layers: the inner mucus layer, which is firmly adherent and 
close to the epithelial border (Firm) and the outer mucus layer, which is a nonattached, soluble mucus layer (Loose). 
(A-B) Taken from (Johansson, Larsson et al. 2011) with permission. (C) MUC2 immunostaining (green) revealed 
MUC2-positive goblet cells and mucus layers in distal colon. Bacteria (red) were detected by FISH using a general 
bacterial probe (Eub338). The inner mucus layer (s) is devoid of bacteria, which are only detected in the outer mucus 
layer. Scale bar: 20 µm. Taken from (Johansson, Phillipson et al. 2008) with permission. Copyright (2005) National 
Academy of Sciences, U.S.A.  
 
 Interactions of the mucus layer with the gut microbiota and the 1.5.2.
enteropathogens 
 The mucus layer represents an essential and dynamic platform of interactions between the host 
and the gut bacteria. 
 Firstly, the mucus layer is an ecological niche. Indeed, the outer mucus layer harbors a different 
microbial composition as compared to the gut lumen (Li, Limenitakis et al. 2015). The bacterial strains 
hosted by the mucus layer can degrade and feed on the mucus layer. They are termed mucolytic bacteria 
(e.g. Bacteroides acidifaciens and Akkermansia muciniphila) (Berry, Stecher et al. 2013, Marcobal, 
Southwick et al. 2013). Furthermore, bacteria hosted by the mucus layer can benefit from bacterial- or 
host-derived substrates others than mucin. For example, E.coli can use fucose released from mucin by 
Bacteroides thetaiotaomicron and host-derived phospholipids enclosed in the outer mucus layer (Pacheco, 
Curtis et al. 2012, Li, Limenitakis et al. 2015). Finally, bacteria can also bind to the mucus layer. This can 
affect pathogen invasion and virulence (e.g. S. Tm), as well as allow bacteria to adhere to the mucus layer 
and avoid regular shedding (Cheng and Bjerknes 1983, Huang, Lee et al. 2011, Hansson 2012, Zarepour, 
Bhullar et al. 2013). 
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 Besides being a nutrient source for bacteria, the mucus layer represents a physical and a chemical 
barrier. First, it has a protective role against enteric pathogens (e.g. Yersinia enterocolitica, Citrobacter 
rodentium and S. Tm) as well as commensal bacteria (Johansson, Phillipson et al. 2008, Zarepour, Bhullar 
et al. 2013). Second, it represents also a chemical barrier, as it binds numerous antimicrobial compounds 
targeting pathogens and commensals (Vaishnava, Behrendt et al. 2008). This limits bacterial contact from 
the mucosal epithelium and thus, contributes to maintain the gut homeostasis. 
 Finally, mucus layer benefits from commensals. Among others abnormalities, germfree mice 
exhibit a thinner mucus layer compared to conventional mice (Johansson, Phillipson et al. 2008). This 
suggests that the microbiota has beneficial effects on maturation of the mucus layer. For examples, 
Bacteroides thetaiotaomicron can use fucose as an energy source to generate a microbial signal that 
induces host fucosylated glycan synthesis (Hooper, Xu et al. 1999). Then, fucosylated glycans can be 
cleaved by commensals such as B. thetaiotaomicron that release fucose, which was shown to repress 
virulence gene expression of EHEC (Keeney and Finlay 2013). Moreover, B. thetaiotaomicron can release 
acetate, which also modulates the expression of genes involved in synthesis and glycosylation of mucin. 
Consequently, this leads to an increase in the number of goblet cells of the colonic epithelium (Wrzosek, 
Miquel et al. 2013). Finally, acetate can be used by Faecalibacterium prausnitzii to produce another 
SCFA, such as butyrate (Wrzosek, Miquel et al. 2013). SCFA are known to be beneficial for the epithelial 
border and modulate mucin gene expression (Gaudier, Jarry et al. 2004, Bultman and Jobin 2014). 
 
 Mouse models developed to study the role of the mucus layer 1.5.3.
 Mouse models harboring defective or altered mucus layer exhibit different phenotypes. In MUC2-
deficient mice, intestinal bacteria penetrate the inner mucus layer and enter in direct contact with intestinal 
epithelial cells (Johansson, Ambort et al. 2011). In consequence, MUC2ko mice develop spontaneous and 
severe colitis as well as tumors, depending on their genetic background (e.g. MUC2ko, Winnie and Eeyore 
mice) and hygiene conditions (Heazlewood, Cook et al. 2008, Bao, Guo et al. 2014). Moreover, these mice 
are known to be more susceptible to enteric infections and chemically induced colitis (Heazlewood, Cook 
et al. 2008, Bergstrom, Kissoon-Singh et al. 2010). Their histopathology is characterized by epithelial cell 
dysfunction, abnormal number and morphology of goblet cells, and endoplasmic reticulum stress 
(Heazlewood, Cook et al. 2008). 
 Mice lacking TMF/ARA160, a Golgi-associated protein expressed in colonic enterocytes, and 
mice exhibiting defective core 1-derived O-glycans in intestinal epithelial cells (TM-IEC C1galtko mice) 
harbor an altered mucosal architecture (e.g. thicker mucus or abnormal glycosylation) (Bel, Elkis et al. 
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2014, Sommer, Adam et al. 2014). These mice are more resistant to chemically induced colitis and do not 
develop spontaneous colitis (Bel, Elkis et al. 2014, Sommer, Adam et al. 2014). Moreover, studies showed 
that abnormal mucus layer affects the gut microbiota composition (Sommer, Adam et al. 2014) and that 
the colitis phenotype can be transmissible by fecal transplantation (Bel, Elkis et al. 2014). Furthermore, 
mice lacking the blood group glycosyltransferase β-1,4-N-acetylgalactosaminyltransferase 2 (B4galnt2) 
exhibit also an altered mucin structure. B4galnt2-deficient mice show different microbiota composition 
and lower susceptibility to S. Tm-induced inflammation, as compared to mice expressing B4galnt2 
(Rausch, Steck et al. 2015). 
 
 The protein disulfide isomerase AGR2 and its functions 1.5.4.
 Anterior gradient homolog 2 (AGR2) is a member of the protein disulfide isomerase family 
(Persson, Rosenquist et al. 2005), which is expressed in several cell types such as mucus-containing 
goblet, Paneth and enteroendocrine cells (Wang, Hao et al. 2008). AGR2 localizes to the ER lumen and is 
indirectly associated with ER membrane-bound ribosomes (Higa, Mulot et al. 2011). It was shown to be 
essential for correct folding and export of MUC2 (Park, Zhen et al. 2009), and to be involved in 
maintenance of ER homeostasis (Zhao, Edwards et al. 2010). AGR2 was also found to be secreted in 
intestinal mucus layer (Bergstrom, Berg et al. 2014). However, the extracellular functions of AGR2 remain 
unknown. Finally, AGR2 can be used as diagnostic marker for cancers (Kovalev, Shishkin et al. 2006), as 
dysregulation of AGR2 gene expression has been associated with tumor growth and metastasis in several 
cancers such as brain (Hong, Wang et al. 2013), ovarian (Sung, Choi et al. 2014) and pancreatic cancers 
(Ramachandran, Arumugam et al. 2008). 
 In order to study the role of AGR2 in vivo, AGR2ko mice were generated using different targeting 
constructs and promoters for the expression of Cre recombinase (Park, Zhen et al. 2009, Zhao, Edwards et 
al. 2010, Gupta, Wodziak et al. 2013). Compared to AGR2wt mice, all AGR2ko mice show a decrease 
secretion of heavily glycosylated proteins (e.g. mucins), loss of intestinal goblet cells, none or few MUC2 
protein detectable, body weight loss and morphologic abnormalities (e.g. enlarged stomach, small and 
large intestine). AGR2ko mice can also show dysregulation of immune response (e.g. increased expression 
of several pro-inflammatory cytokines), increased neutrophil infiltration and increased ER stress response. 
Moreover, premature death was observed and associated to intestinal obstruction (Gupta, Wodziak et al. 
2013) and severe spontaneous terminal ileitis and colitis (Park, Zhen et al. 2009, Zhao, Edwards et al. 
2010). It has been suggested that severity of spontaneous colitis could be due to mouse genetic 
background and housing conditions (e.g. in gnotobiotic facility). 
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 In this study, I used AGR2 mouse model from Park et al. In these AGR2ko mice, MUC2 core 
protein is undetectable in colon and mice show only mild spontaneous colitis in healthy conditions 
(Figure 5A,B). Finally, AGR2ko mice are more susceptible to colitis (e.g. dextran sodium sulfate (DSS)-
induced colitis) than their AGR2wt littermates (Figure 5C,D) (Park, Zhen et al. 2009). 
 
 
Figure 5. Presentation of the AGR2 mouse model from Park et al. 
(A) Immunohistochemical detection of MUC2 (brown) in colon shows that AGR2ko (AGR2-/-) mice are devoid of 
intestinal mucus layer. (B) Hematoxylin and eosin (H&E) staining of colon from AGR2ko and AGR2wt (AGR2+/+) 
mice. AGR2ko mice show loss of colonic goblet cells and enlarged colon. (C-D) AGR2ko and AGR2wt mice were 
exposed to DSS (1.5 % in drinking water) for 7-8 days. (C) H&E staining of colon from DSS-exposed mice. AGR2ko 
mice show severe epithelial damage compared to AGR2wt mice. (D) Percentage of AGR2ko (empty circle) and 
AGR2wt (full circle) mice that develop bloody stools during DSS exposure. AGR2ko mice are more susceptible to 
DSS-induced colitis than AGR2wt mice. Scale bars: 50 µm. Taken from (Park, Zhen et al. 2009) with permission.
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 Objectives 2.
 The conventional gut microbiota confers colonization resistance (CR) to infection with 
enteropathogens, including S. Tm. CR is absent in mice harboring a low complexity microbiota (LCM). 
However, CR is restored by cohousing of LCM mice with a conventional donor animal (Stecher, Chaffron 
et al. 2010). This observation underlines the importance of a complex gut microbiota in establishing 
normal CR. The mammalian gut is inhabited by 500-1,000 bacterial species (Marchesi and Shanahan 
2007). So far, the identity of CR mediating bacteria has remained unknown. Furthermore, it is unclear if a 
reduced and defined number of bacteria might be able to restore CR in gnotobiotic mice. For identifying 
and characterizing potentially protective members of the microbiota and eventually study CR in a 
mechanistic manner, I aimed to generate a gnotobiotic mouse model. A number of gnotobiotic mouse 
models, most of them based on humanized microbiota have been established in the past. To my 
knowledge, none of these models was shown to restore CR against S. Tm. 
 In the first part of this thesis, I aimed to establish a defined consortium of murine commensal 
bacteria and test for their ability to restore CR against S. Tm in gnotobiotic mice. To this end, I planned to 
optimize methods for bacterial cultivation and develop analytical tools to characterize and specifically 
detect each strain in vivo and test their ability to provide CR against S. Tm. 
 Salmonella Typhimurium uses chemotaxis and motility to reach the epithelial border and to 
induce colitis (Stecher, Hapfelmeier et al. 2004). The intestinal mucus layer consisting of highly 
glycosylated mucins forms a tight physical barrier and prevents access of both commensals and pathogens 
from the single-layered epithelial border. Several commensals can breakdown mucin glycoproteins and 
thereby release carbon sources (e.g. fucose), which can be used as nutrient source by other non-mucolytic 
bacteria and pathogens (Pacheco, Curtis et al. 2012, Berry, Stecher et al. 2013, Ng, Ferreyra et al. 2013). 
Therefore, the mucus layer takes a two-sided role in bacterial infections, which has hitherto been only 
poorly studied. 
 In the second part of my thesis, I aimed to investigate the role of the mucus layer during S. Tm 
infection, using mucin-deficient mice. As mice lacking the major intestinal mucin MUC2 develop 
spontaneous colitis at early age (Van der Sluis, De Koning et al. 2006) and thus cannot be used to study S. 
Tm pathogenesis, we used mice deficient in anterior gradient homolog 2 (AGR2). AGR2-deficient mice 
show absent MUC2 secretion but do not develop spontaneous colitis at young age (Park, Zhen et al. 
2009). Therefore, I used the AGR2-deficient mouse model to investigate the role of the mucus layer 
during S. Tm infection. 
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 Materials and Methods 3.
 Materials 3.1.
 Chemicals, Consumables and Instruments 3.1.1.
Table 1. Chemicals, kits and reagents 
Item Supplier 
ABTS Biozol (Eching) 
Acetic acid Roth (Karlsruhe) 
Agar BactoTM Becton Dickinson (New Jersey, US) 
Agarose Sigma-Aldrich Chemie (Munich) 
Bovine serum albumin GE Healthcare Life Sciences (Freiburg) 
Brain Heart Infusion Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Chloroform Roth (Karlsruhe) 
CloneJETTM PCR Cloning kit Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Cysteine (-L) Hydrochloride Monohydrate Sigma-Aldrich Chemie (Munich) 
Cystine (-L) Sigma-Aldrich Chemie (Munich) 
4',6-diamidino-2-phenylindole (DAPI) Roth (Karlsruhe) 
ddH2O  Ampuwa 
Defibrinated horse blood Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Defibrinated sheep blood Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
D-glucose Roth (Karlsruhe) 
DirectPCR-Tail Peqlab, VWR (Erlangen) 
DreamTaq PCR Master Mix (2x) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
EDTA Roth (Karlsruhe) 
Ethanol Roth (Karlsruhe) 
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Item Supplier 
FastStart Essential DNA Probes Master Roche (Rotkreuz) 
GeneRuler 1kb DNA Ladder Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Glycerol Rothipuran Roth (Karlsruhe) 
Hemin Sigma-Aldrich Chemie (Munich) 
Hexadecyltrimethyl ammonium bromide 
(CTAB) Roth (Karlsruhe) 
HRP-streptavidin Biozol (Eching) 
Isopropanol Roth (Karlsruhe) 
K2HPO4 Roth (Karlsruhe) 
KCl Fluka, Sigma-Aldrich Chemie (Munich) 
KH2PO4 Roth (Karlsruhe) 
Lipocalin-2/NGAL DuoSet (Mouse) R&D Systems (Minneapolis, US) 
Lysozyme from hen egg Sigma-Aldrich Chemie (Munich) 
MacConkey agar Roth (Karlsruhe) 
Menadione Sigma-Aldrich Chemie (Munich) 
Mucin from porcine stomach Sigma-Aldrich Chemie (Munich) 
NaCl Roth (Karlsruhe) 
Na2HPO4 unhydrated  Roth (Karlsruhe) 
Na2CO3 Merck Chemicals (Schwalbach) 
Na2S.9H2O Sigma-Aldrich Chemie (Munich) 
Normal goat serum Biozol (Eching) 
Tissue-Tek Optimal Cutting Temperature 
(O.C.T.) compound Sakura Finetek, (Torrance) 
Tween-20 Roth (Karlsruhe) 
Palladium chloride Sigma-Aldrich Chemie (Munich) 
Pancreatic digest of casein Becton Dickinson (New Jersey, US) 
Paraffin, Paraplast Plus Roth (Karlsruhe) 
Paraformaldehyde Roth (Karlsruhe) 
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Item Supplier 
Phalloidin FluoProbes® 647 Interchim (Montluçon) 
Phenol/chloroform/isoamylalcohol Roth (Karlsruhe) 
Primer and probe synthesis  Metabion (Martinsried) 
Proteinase K Roth (Karlsruhe) 
Proteose peptone No 3 Becton Dickinson (New Jersey, US) 
Sodium acetate Roth (Karlsruhe) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg) 
Sucrose (D-Saccharose) Roth (Karlsruhe) 
Sytox green nucleic acid stain Invitrogen, Thermo Fisher Scientific biosciences (St. Leon-Rot)  
Tris MP Biomedicals (Eschwege) 
Tryptone  Roth (Karlsruhe) 
Trypticase soy broth Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Vectashield mounting medium Biozol (Eching) 
Xylol Roth (Karlsruhe) 
Yeast extract  MP Biomedicals (Eschwege) 
Yeast t-RNA Roche (Rotkreuz) 
 
Table 2. Antibiotics used in this study 
Antibiotic Supplier Final concentration 
Ampicillin Roth (Karlsruhe) 100 µg/ml 
Chloramphenicol Roth (Karlsruhe) 30 µg/ml 
Kanamycin sulfate Roth (Karlsruhe) 30 µg/ml 
Streptomycin sulfate Roth (Karlsruhe) 50 µg/ml 
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Table 3. Specific instruments and materials 
Item Supplier 
Agencourt AMPure XP kit Beckman Coulter (USA) 
Aluminum crimp seals (diam. 11 mm) Sigma-Aldrich (Munich) 
Aluminum crimp seals (diam. 20 mm) Sigma-Aldrich (Munich) 
Blank antimicrobial susceptibility disks Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Bottle-Top-Filter (0.2 µm) A.Hartenstein (Wuerzburg) 
Butyl-rubber stoppers (diam. 11 mm) Sigma-Aldrich (Munich) 
Butyl-rubber stoppers (diam. 20 mm) Geo-Mocrobial Technologies 
Crimper (diam. 11 mm) Sigma-Aldrich (Munich) 
Crimper (diam. 20 mm) VWR (Erlangen) 
Cryotome CM1950 (Leica, Wetzlar) 
Cryotubes Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Decrimper (diam. 20 mm) VWR (Erlangen) 
Diagnostic slides (10 wells, 76 x 25 x 1 
mm) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Electroporation cuvette (1mm) Eppendorf (Wesseling-Berzdorf) 
Filter Millex (0.22 µm) Merck Chemicals (Schwalbach) 
Flexible vinyl Anaerobic Airlock chamber Type B Coy laboratory products 
Flexible film isolator Harlan (Rossdorf) 
Glass beads (0.5-0.75 mm) Schieritz & Hauenstein 
Glass beads (<106 µm) Sigma-Aldrich (Munich) 
Gnotocages Han, Bioscape (Emmendingen) 
LightCycler480 Multiwell Plate 96, white Roche (Rotkreuz) 
LightCycler96 Roche (Rotkreuz) 
Nanodrop Thermo Fisher Scientific biosciences (St. Leon-Rot) 
NucleoSipn Gel and PCR Clean-up kit Macherey-Nagel (Düren) 
NucleoSipn Plasmid kit Macherey-Nagel (Düren) 
Plasmid Plus Midi Kit Qiagen (Hilden) 
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Item Supplier 
QIAamp DNA Stool Mini Kit Qiagen (Hilden) 
Superfrost Plus slides (75 x 25 x 1 mm) A.Hartenstein (Wuerzburg) 
Wheaton glass serum bottles (1.5 ml) Sigma-Aldrich (Munich) 
Wheaton glass serum bottles (100 ml) Sigma-Aldrich (Munich) 
 
 
 Oligonucleotides, probes and antibodies 3.1.2.
Table 4. Oligonucleotides and probes 
Designation Sequence (5´ - 3´) Specificity Reference 
16S rRNA gene amplification, cloning and sequencing 
fD1 CGATATCTCTAGAAGAGTTTGATCCTGGCTCAG All bacteria* 
Adapted from (Weisburg, 
Barns et al. 1991) 
fD2 CGATATCTCTAGAAGAGTTTGATCATGGCTCAG All bacteria* 
Adapted from (Weisburg, 
Barns et al. 1991) 
rP1 GATATCGGATCCACGGTTACCTTGTTACGACTT All bacteria* 
Adapted from (Weisburg, 
Barns et al. 1991) 
fD1-EcoRV-
XbaI 
CCGATATCTCTAGAAGAGTTTGA
TCCTGGCTCAG All bacteria* 
Adapted from (Weisburg, 
Barns et al. 1991) 
fD2-EcoRV-
XbaI 
CCGATATCTCTAGAAGAGTTTGA
TCATGGCTCAG All bacteria* 
Adapted from (Weisburg, 
Barns et al. 1991) 
rP1-EcoRV-
BamHI 
CCGATATCGGATCCACGGTTACC
TTGTTACGACTT All bacteria* 
Adapted from (Weisburg, 
Barns et al. 1991) 
16S-27f AGAGTTTGATCMTGGCTCAG All bacteria* (Lane, Stackebrandt et al. 1991) 
pJet1-FP ACTACTCGATGAGTTTTCGG pJET 1.2 Fermentas 
pJet1-RP TGAGGTGGTTAGCATAGTTC pJET 1.2 Fermentas 
338F-M13 GTAAACGACGGCCAGTGCTCCTACGGGWGGCAGCAGT All bacteria* 
(Gronbach, Flade et al. 
2014) 
1044R-rM13 GGAAACAGCTATGACCATGACTACGAGCTGACGACARCCATG All bacteria* 
(Gronbach, Flade et al. 
2014) 
A-M13 
CCATCTCATCCCTGCGTGTCTCC
GACTCAG/MID 
sequence/GTAAACGACGGCCAGT
G 
All bacteria* (Gronbach, Flade et al. 2014) 
B-rM13 
CCTATCCCCTGTGTGCCTTGGCA
GTCTCAGGGAAACAGCTATGAC
CATGA 
All bacteria* (Gronbach, Flade et al. 2014) 
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Designation Sequence (5´ - 3´) Specificity Reference 
M13_F GTAAAACGACGGCCAG pCR®2.1-TOPO® Invitrogen 
M13_R CAGGAAACAGCTATGAC pCR®2.1-TOPO® Invitrogen 
AGR2 gene specific primers 
AGR2-KO-
fwd ACCTACATGGCCTTCCTTCC Agr2
ko-specific (Park, Zhen et al. 2009) 
AGR2-wt-
fwd TATCCAGGCTCAGCAGGTTT Agr2
wt-specific (Park, Zhen et al. 2009) 
AGR2-rev ACCATCAAGGGTCTGTTGCT Agr2ko and Agr2wt (Park, Zhen et al. 2009) 
16S rRNA specific FISH probes 
YL2_180 CACCATGCGGTGGGGCGGAGCA YL2 Unpublished 
YL27_180 AGATGCCTCCCCTCGGCCACA YL27 Unpublished 
YL31_180 CCATGCGACCCAACTGCATCA YL31 Unpublished 
YL32_180 CCATGCGGCACTGTGCGCTTA YL32 Unpublished 
Muc1437 CCTTGCGGTTGGCTTCAGAT YL44 (Derrien, Collado et al. 2008) 
BET940 TTAATCCACATCATCCACCG YL45 (Demaneche, Sanguin et al. 2008) 
YL58_180 CCATGCAGCCCTGTGCGCTTA YL58 Unpublished 
YL58_180_
negctrl TAAGCGCACAGGGCTGCATGG 
None of the    
Oligo-MM strains Unpublished 
I46_180 AGTATGCGCTCTGTATACCTA I46 Unpublished 
I48_180 TCATGCGATCTTGATATCCTA I48 Unpublished 
I49_180 GCCATGTGGCTTTTGTTGTTA I49 Unpublished 
KB1_180 GCCATGCGGCATAAACTGTTA KB1 Unpublished 
KB18_180 CCATGCGATAAGATAATGTCA KB18 Unpublished 
EUB338 I GCT GCC TCC CGT AGG AGT Most bacteria (Amann, Binder et al. 1990) 
EUB338 III GCT GCC ACC CGT AGG TGT Verrucomicrobiales (Daims, Bruhl et al. 1999) 
Designations of unpublished FISH probes were followed by the starting position (e.g. xxx_180) of the probe when 
aligned to the 16S rRNA gene of E. coli. * targeting the 16S rRNA of most of the bacteria. 
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Table 5. MID barcodes for 454 multiplexing 
Designation MID sequence 
MID1 ACGAGTGCGT 
MID2 ACGCTCGACA 
MID3 AGACGCACTC 
MID4 AGCACTGTAG 
MID5 ATCAGACACG 
MID6 ATATCGCGAG 
MID7 CGTGTCTCTA 
MID8 CTCGCGTGTC 
MID9 TAGTATCAGC 
MID10 TCTCTATGCG 
MID11 TGATACGTCT 
MID12 TACTGAGCTA 
MID13 CATAGTAGTG 
MID14 CGAGAGATAC 
MID15 ATACGACGTA 
MID16 TCACGTACTA 
MID17 TCGATCGAGT 
MID18 CAGTCAGTAG 
MID19 ACACTGACAC 
MID20 GTACGATCGT 
Designation MID sequence 
MID21 TGCGTGAGCA 
MID22 ACAGCTCGCA 
MID23 CTCACGCAGA 
MID24 GATGTCACGA 
MID25 GCACAGACTA 
MID26 GAGCGCTATA 
MID27 ATCTCTGTGC 
MID28 CTGTGCGCTC 
MID29 CGACTATGAT 
MID30 GCGTATCTCT 
MID31 TCTGCATAGT 
MID32 ATCGAGTCAT 
MID33 GTGATGATAC 
MID34 CATAGAGAGC 
MID35 ATGCAGCATA 
MID36 ATCATGCACT 
MID37 TGAGCTAGCT 
MID38 GATGACTGAC 
MID39 CACAGTCACA 
MID40 TGCTAGCATG 
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Table 6. 16S rRNA gene specific primers and hydrolysis probes for qPCR assay 
Designation Sequence (5´ - 3´) Specificity 
Isol46_Exonucl._fwd ACGGTAGCTAAAACCGGATAGGT  
Isol46_Exonucl._rev GCCTTGATGGGCGCTTTAA I46 
Probe_Isol46 FAM-TACAGAGCGCATACTCAGT-BHQ1  
Isol49_Exonucl._fwd GCACTGGCTCAACTGATTGATG  
Isol49_Exonucl._rev CCGCCACTCACTGGTGATC I49 
Probe_Isol49 HEX-CTTGCACCTGATTGACGA-BHQ1  
YL58_Exonucl._fwd GAAGAGCAAGTCTGATGTGAAAGG  
YL58_Exonucl._rev CGGCACTCTAGAAAAACAGTTTCC YL58 
Probe_YL58 FAM-TAACCCCAGGACTGCAT-BHQ1  
YL27_Exonucl.2_fwd TCAAGTCAGCGGTAAAAATTCG  
YL27_Exonucl.2_rev CCCACTCAAGAACATCAGTTTCAA YL27 
Probe2_YL27 HEX-CAACCCCGTCGTGCC-BHQ1  
YL31_Exonucl.2_fwd AGGCGGGATTGCAAGTCA  
YL31_Exonucl.3_rev CCAGCACTCAAGAACTACAGTTTCA YL31 
Probe2_YL31 FAM-CAACCTCCAGCCTGC-BHQ1  
YL32_Exonucl.2_fwd AATACCGCATAAGCGCACAGT  
YL32_Exonucl.2_rev CCATCTCACACCACCAAAGTTTT YL32 
Probe2_YL32 HEX-CGCATGGCAGTGTGT-BHQ1  
KB1_Exonucl._fwd CTTCTTTCCTCCCGAGTGCTT  
KB1_Exonucl._rev CCCCTCTGATGGGTAGGTTACC KB1 
Probe_KB1 FAM-CACTCAATTGGAAAGAGGAG-BHQ1  
YL2_Exonucl._fwd GGGTGAGTAATGCGTGACCAA  
YL2_Exonucl._rev CGGAGCATCCGGTATTACCA YL2 
Probe_YL2 HEX-CGGAATAGCTCCTGGAAA-BHQ1 YL2 
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Designation Sequence (5´ - 3´) Specificity 
KB18_Exonucl.2_fwd TGGCAAGTCAGTAGTGAAATCCA  
KB18_Exonucl.2_rev TCACTCAAGCTCGACAGTTTCAA KB18 
Probe2_KB18 FAM-CTTAACCCATGAACTGC-BHQ1  
YL44_Exonucl._fwd CGGGATAGCCCTGGGAAA  
YL44_Exonucl._rev GCGCATTGCTGCTTTAATCTTT YL44 
Probe_YL44 HEX-TGGGATTAATACCGCATAGTA-BHQ1  
YL45_Exonucl._fwd AGACGGCCTTCGGGTTGTA  
YL45_Exonucl._rev CGTCATCGTCTATCGGTATTATCAA YL45 
Probe_YL45 FAM-ACCACTTTTGTAGAGAACGA-BHQ1  
Isol48_Exonucl._fwd GGCAGCATGGGAGTTTGCT  
Isol48_Exonucl._rev TTATCGGCAGGTTGGATACGT I48 
Probe_Isol48 HEX-CAAACTTCCGATGGCGAC-BHQ1  
ASF356_Exonucl.2_fwd CGGCAAGGTAAGCGATATGTG  
ASF356_Exonucl.2_rev CGCTTTCCTCTCCTGTACTCTAGCT ASF356 
Probe2_ASF356 FAM-TAACTTAAGGATAGCATAACGAACT-BHQ1  
ASF360_Exonucl.4_fwd TGAGTGCTAAGTGTTGGGAGGTT  
ASF360_Exonucl.4_rev CGGAGTGCTTAATGCGTTAGCT ASF360 
Probe4_ASF360 FAM-CCGCCTCTCAGTGCT-BHQ1  
ASF361_Exonucl._fwd TCGGATCGTAAAACCCTGTTG  
ASF361_Exonucl._rev ACCGTCGAAACGTGAACAGTT ASF361 
Probe_ASF361 HEX-TAGAGAAGAAAGTGCGTGAGAG-BHQ1  
ASF457_Exonucl._fwd GACTGGAACAACTTACCGAAAGGT  
ASF457_Exonucl._rev CAGGTCTCCCCAACTTTTCCT ASF457 
Probe_ASF457 FAM-TAATGCCGGATGAGTTATA-BHQ1 ASF457 
ASF500_Exonucl._fwd AGGCGGGACTGCAAGTCA  
Materials and Methods 
 
31 
 
Designation Sequence (5´ - 3´) Specificity 
ASF500_Exonucl._rev CAAATGCAGGCCACAGGTT ASF500 
Probe_ASF500 HEX-ATGTGAAAACCACGGGC-BHQ1  
ASF502_Exonucl.3_fwd GACCCCAGTACCGCATGGTA  
ASF502_Exonucl.3_rev TCAGACGCGGGCCTATCTTA ASF502 
Probe3_ASF502(SB2) HEX-AGAGGTAAAAACTGAGGTGGT-BHQ1  
ASF519_Exonucl._fwd TGTGGCTCAACCATAAAATTGC  
ASF519_Exonucl._rev GCATTCCGCCTACCTCAAATAT ASF519 
Probe_ASF519 HEX-TTGAAACTGGTTGACTTGAG-BHQ1  
Salmo_Exonucl._fwd TGGGAAACTGCCTGATGGA  
Salmo_Exonucl._rev CTTGCGACGTTATGCGGTATT S. Typhimurium 
Probe_Salmo FAM-ATAACTACTGGAAACGGTGGC-BHQ1  
Univ_Exonucl.2_fwd TGCATGGYYGTCGTCAGC  
Univ_Exonucl.2_rev CRTCRTCCCCRCCTTCCTC All strains 
Probe2_Univ. HEX-AACGAGCGCAACCC-BHQ1  
All primers and probes were designed by Markus Beutler and are unpublished. Identity of Oligo-MM strains are 
indicated in blue, identity of ASF strains are in orange. Salmo: targets S. Typhimurium; Univ: targets all strains. 
Fwd: forward primer; Rev: reverse primer; Probe: hydrolysis probe labelled at the 5’ end either with FAM (6-
carboxyfluorescein) or HEX (6-carboxyhexafluorescein) and conjugated at the 3’ end with BHQ1 (black hole 
quencher 1). 
 
Table 7. Primary antibodies 
Antibody Origin Supplier Final concentration 
α-Salmonella B test serum 
anti-O Rabbit 
Becton Dickinson (New 
Jersey, US) 1:400 
α-MUC2 H-300 Rabbit Santa cruz (Heidelberg) 1:200 
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Table 8. Secondary antibodies 
Antibody Origin Supplier Final concentration 
α-rabbit IgG dylight 549 Goat Jackson ImmunoResearch (Baltimore, US) 1:400 
 
 Plasmids and strains 3.1.3.
Table 9. Plasmids in S. Tm 
Plasmid Genotype Reference 
pM973 T3SS-2 (SPI-2) promotor ssaG coupled with GFPmut2 coding sequence 
(Hapfelmeier, Stecher et al. 
2005) 
pM974 T3SS-1 (SPI-1) promotor of the sicAsipBCDA operon coupled with GFPmut2 coding sequence 
(Ackermann, Stecher et al. 
2008) 
pM979 Constitutively expressed GFPmut2 coding sequence (ribosomal rpsM promoter) 
(Stecher, Hapfelmeier et al. 
2004) 
pWKS30 Ampicillin resistance cassette (Wang and Kushner 1991) 
 
Table 10. Plasmids generated to sequence the full 16S rRNA genes of the Oligo-MM and ASF strains 
Plasmid Backbone Origin of the insert Restriction enzymes Reference 
pSAB3 pJET 1.2 YL27 NotI Unpublished 
pSAB4 pJET 1.2 YL58 HindIII Unpublished 
pSAB6 pJET 1.2 I46 NotI Unpublished 
pSAB7 pJET 1.2 I48 HindIII Unpublished 
pSAB8 pJET 1.2 I49 HindIII Unpublished 
pSAB9 pJET 1.2 KB1 NotI Unpublished 
pSAB10 pJET 1.2 ASF502 NotI Unpublished 
pSAB12 pJET 1.2 KB18 HindIII Unpublished 
pSAB13 pJET 1.2 ASF500 NotI Unpublished 
pMB1 pJET 1.2 S. Tm M557 HindIII Unpublished 
pM1452 pCR®2.1-TOPO® YL2 HindIII Unpublished 
pM1456-1 pCR®2.1-TOPO® YL31 HindIII Unpublished 
pM1457-1 pCR®2.1-TOPO® YL32 HindIII Unpublished 
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Plasmid Backbone Origin of the insert Restriction enzymes Reference 
pM1459-1 pCR®2.1-TOPO® YL44 HindIII Unpublished 
pM1460-1 pCR®2.1-TOPO® YL45 NcoI Unpublished 
pM1411-1 pSB-Bluescript ASF356 NotI Unpublished 
pM1412-4 pSB-Bluescript ASF360 NotI Unpublished 
pM1413-1 pSB-Bluescript ASF361 NotI Unpublished 
pM1414-1 pSB-Bluescript ASF457 NotI Unpublished 
pM1417-1 pSB-Bluescript ASF519 NotI Unpublished 
 
Table 11. S. Tm and E. coli strains 
Strains Lab-internal strain designation Genotype Reference 
S. Tm strains 
S. Tmwt SB300 S. Tm strain SL1344  (Hoiseth and Stocker 1981) 
S. Tmwt,gfp SB300_pM973 S. Tm carrying plasmid pM973 Unpublished 
S. Tmwt,amp SB300_pWKS30 S. Tm carrying plasmid pWKS30 (Wang and Kushner 1991) 
(Stecher, Denzler et al. 
2012)  
S. Tmavir M557 invG; sseD::aphT (Hapfelmeier, Ehrbar et al. 2004) 
S. TmcheY M957 cheY::cm (Stecher, Barthel et al. 2008) 
S. Tmavir2 M2702 invG; ssaV (Maier, Vyas et al. 2013) 
S. Tmavir2psicAgfp M2702_pM974 S. Tm carrying plasmid pM974 Unpublished 
S. Tmavir2,cheY SAB1-1 invG; ssaV; cheY::cm Unpublished 
E. coli strains 
E. coli DH5α   Invitrogen 
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 Media and buffers 3.1.4.
Liquid media and buffers were prepared as described in the following tables and sterilized by autoclaving 
at 121 °C, 1 bar, 20 min, unless otherwise stated. 
 
Table 12. Luria-Bertani (LB) medium 
Components Per liter medium 
NaCl 5 g 
Yeast Extract  5 g 
Tryptone  10 g 
All components were dissolved in dH2O. 
 
Table 13. LB agar and soft agar 
Components Per liter medium 
NaCl 5 g 
Yeast Extract  5 g 
Tryptone  10 g 
Agar* 15 g 
All components were dissolved in dH2O. * Soft agar: add 7 g/L instead. 
 
Table 14. LB 0.3 M NaCl 
Components Per liter medium 
NaCl 17.53 g 
Yeast Extract  5 g 
Tryptone  10 g 
All components were dissolved in dH2O. 
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Table 15. Brain-heart infusion (BHI) medium* 
Components Per liter medium 
Brain Heart Infusion 37 g 
Distilled water (dH2O) 1 L 
Autoclave and then add under anaerobic and sterile 
conditions: 
Cysteine-HCl.H2O# 0.25 g 
Na2S.9H2O# 0.25 g 
All components were dissolved in dH2O. # Sterile filtered. * for BHI agar, add 15 g/L agar. 
 
Table 16. Anaerobic Akkermansia medium (AAM) 
Components Per liter medium 
Brain Heart Infusion 18.5 g 
Trypticase soy broth 15 g 
Yeast extract 5 g 
K2HPO4 2.5 g 
Hemin 1 mg 
Glucose 0.5 g 
Distilled water (dH2O) 1 L 
Autoclave and then add under sterile conditions: 
Na2CO3 (5% stock solution)¤ 0.4 g 
Cysteine hydrochloride# 0.5 g 
Menadione# 0.5 g 
Fetal calf serum (complement-
inactivated)# 3 % 
Mucin from porcine stomach¤  0.25 % 
All components were dissolved in dH2O except for the hemin, which was resuspended in ethanol p.a. supplemented 
with NaOH until it is entirely dissolved and for the menadione, which was resuspended in ethanol p.a. ¤ Autoclaved. 
# Sterile filtered. 
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Table 17. Schaedler blood agar 
Components Per liter medium 
Pancreatic digest of casein 10 g 
Proteose Peptone No 3 5 g 
Glucose 5 g 
Yeast extract 5 g 
Tris 3 g 
Hemin 10 mg 
L-Cystine 0.4 g 
Agar 15 g 
Autoclave and then add under sterile conditions: 
Fetal calf serum (complement-
inactivated)# 3 % 
Defibrinated sheep or horse 
blood 50 ml 
All components were dissolved in dH2O except for the hemin, which was resuspended in ethanol p.a. supplemented 
with NaOH. # Sterile filtered. (Schaedler, Dubs et al. 1965). 
 
Table 18. WSB broth/agar 
Components Per liter medium 
Wilkinson-Chalgreen 
Anaerobe broth (Oxoid) 33 g 
Glucose 4 g 
Hemin 10 µg 
L-Cystine 0.4 g 
Agar* (Serva) 15 g 
Autoclave, cool to 50 °C and then add sterily: 
Defibrinated sheep blood 50 ml 
All components were dissolved in dH2O except for the hemin, which was resuspended in ethanol p.a. supplemented 
with NaOH. * Optional. 
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Table 19. AII medium 
Components Per liter medium 
Brain Heart Infusion (Oxoid) 18.5 g 
Yeast Extract (Oxoid)  5 g 
Trypticase soy broth (Oxoid) 15 g 
K2HPO4 2.5 g 
Hemin  10 µg 
Glucose 0.5 g 
Palladium chloride* 0.33 g 
Agar* (Serva) 15 g 
Autoclave and then add under anaerobic conditions: 
Na2CO3¤ 42 mg 
Cysteine hydrochloride# 50 mg 
Menadione# 5 µg 
Fetal calf serum (complement-
inactivated)# 3 % 
All components were dissolved in dH2O except for the hemin, which was resuspended in ethanol p.a. supplemented 
with NaOH and for the menadione, which was resuspended in ethanol p.a. * Optional. Adapted from (Aranki and 
Freter 1972). ¤ Autoclaved. # Sterile filtered. 
 
Table 20. Peptone-glycerol broth 
Components Per liter broth 
Peptone  20 g 
Glycerol 50 ml 
All components were dissolved in dH2O. 
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Table 21. Phosphate Buffered Saline (PBS) 10X 
Components Per liter buffer 
NaCl 80 g 
KCl 2 g 
Na2HPO4 unhydrated  6,1 g 
KH2PO4 2,4 g 
All components were dissolved in dH2O. 
 
Table 22. TE Buffer 
Components Final concentration 
Tris-HCl 10 mM 
EDTA 1 mM 
All components were dissolved in ddH20. pH was adjusted to 8.0 with NaOH. 
 
Table 23. CTAB/NaCl Buffer 
Components Final concentration 
CTAB 10 % 
NaCl 0.7 M 
All components were dissolved in ddH20. 
 
Table 24. Paraformaldehyde (PFA) 4 % 
Components Per liter buffer 
ddH2O 300 ml 
PFA 40 g 
NaOH (1 M) 100 µl 
PBS (10X) in ddH2O, pH 7.4 100 ml 
Components were heated up to 60 °C and stirred vigorously until PFA is dissolved. DdH2O was filled up to 1 L and 
pH was adjusted. Buffer was sterile filtered and stored at -20 °C. 
Materials and Methods 
 
39 
 
Table 25. Sucrose 20 % 
Components Per liter buffer 
Sucrose (D-Saccharose) 200 g 
PBS (1X) in ddH2O 1 L 
Buffer was sterile filtered and stored at 4 °C. 
 
Table 26. Composition of hybridization buffers (HB) for FISH 
Formamide (%): 0 5  10  15  20  25  30  35  40  45  50 55 70 
5 M NaCl 180 180 180 180 180 180 180 180 180 180 180 180 180 
1 M Tris / HCl 20 20 20 20 20 20 20 20 20 20 20 20 20 
ddH2O 799 749 699 649 599 549 499 449 399 349 299 249 99 
Formamide 0 50 100 150 200 250 300 350 400 450 500 550 700 
10 % SDS 1 1 1 1 1 1 1 1 1 1 1 1 1 
Volumes are in µl. 
 
Table 27. Composition of washing buffers (WB) for FISH 
Formamide (%): 0 5  10  15  20  25  30  35  40  45  50 55 70 
5 M NaCl 9.0 6.3 4.5 3.2 2.2 1.5 1.0 0.7 0.5 0.3 0.2 0.1 0 
1 M Tris / HCl 1 1 1 1 1 1 1 1 1 1 1 1 1 
0.5 M EDTA 0 0 0 0 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
ddH2O to 50 ml 
Volumes are in ml. 
 
Table 28. Blocking buffer for ELISA 
Components Per liter buffer 
Bovine serum albumin (BSA) 20 g 
PBS (1X) in ddH2O 1 L 
Buffer was freshly prepared each time (not autoclaved, not sterile filtered). 
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Table 29. Washing buffer for ELISA 
Components Per liter buffer 
Tween-20 0.5 ml 
PBS (1X) in ddH2O 1 L 
Buffer was freshly prepared each time (not autoclaved, not sterile filtered). 
 
Table 30. Substrate buffer for ELISA 
Components Per liter buffer 
NaH2PO4  13.8 g 
dH2O 1 L 
Buffer was autoclaved, stored at RT and pH was adjusted to 4.0. 
 
Table 31. Percoll gradient 
20 % Percoll: 
Components Per liter DMEM 
Percoll 200 ml 
 
40 % Percoll: 
Components Per liter 1X PBS 
Percoll 400 ml 
One volume 40 % Percoll was gently pipetted under 1 volume 20 % Percoll, using a Pasteur pipette. Percoll gradient 
solution was stored at 4 °C. 
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 Methods 3.2.
 Bacterial culture methods 3.2.1.
 Cryoconservation of bacteria 3.2.1.1.
S. Tm and E. coli strains. Bacteria streaked out from cryostocks were grown overnight (o.n.) on agar 
plates supplemented with the appropriate antibiotics at 37 °C. A single bacterial colony was inoculated in 
3 ml LB medium (with the appropriate antibiotics) and grown o.n. at 37 °C on a wheel rotor. Further, the 
o.n. culture was spun down at 4 °C for 20 min at 5,000 rpm. The supernatant was removed and the 
bacterial pellet was resuspended in 1 ml peptone-glycerol broth and stored in cryotubes at -80 °C. 
Anaerobic bacterial strains. 0.5 ml of pre-reduced 20 % glycerol supplemented with palladium crystals 
was aliquoted in 1.5 ml anoxic glass vials and sealed in the anaerobic chamber and autoclaved. 
Afterwards, 0.5 ml of actively growing anaerobic cultures, grown in respective culture media, was added 
into the autoclaved vials and immediately frozen at -80 °C. 
Strain deposition at the German type culture collection (DSMZ). Except of the strains ASF492, which 
could not be cultivated, all ASF and Oligo-MM12 strains were deposited at the German type culture 
collection (DSMZ; Deutsche Sammlung von Mikroorganismen und Zellkulturen). Individual strains were 
sent as a frozen stock to the DSMZ. There, the frozen stocks were revived and the resulting cultures were 
lyophilized and sent back in order to confirm the strain purity and identity using Gram staining, 16S rRNA 
gene amplification and sequencing, as described below. The corresponding accession numbers are listed in 
Table 32. 
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Table 32. Accession numbers of the strains deposited at DSMZ 
Strain ID Accession number 
ASF356 DSM26116 
ASF360 DSM28184 
ASF361 DSM 28185 
ASF457 DSM 26150 
ASF500 DSM 29473 
ASF502 DSM 26118 
ASF519 DSM 26086 
YL2 DSM 26074 
YL27 DSM 28989 
YL31 DSM 26117 
YL32 DSM 26114 
YL44 DSM 26127 
YL45 DSM 26109 
YL58 DSM 26115 
I46 DSM 26113 
I48 DSM 26085 
I49 DSM 32035 
KB1 DSM 32036 
KB18 DSM 26090 
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 Bacterial culture conditions 3.2.1.2.
Aerobic culture conditions. Bacteria from -80 °C cryostocks were grown o.n. on LB agar supplemented 
with the appropriate antibiotics at 37 °C. For mouse experiments, a single colony was inoculated in 3 ml 
LB medium containing 0.3 M NaCl (LB0.3), supplemented with the appropriate antibiotics and grown at 
37 °C on a wheel rotor for 12 h. Further, the o.n. culture was diluted 1:20 in fresh LB0.3 medium and 
grown at 37 °C on a wheel rotor for 4 h. The subculture was washed in ice-cold 1X PBS and the bacterial 
pellet was resuspended in cold 1X PBS at a concentration of ~1.108 cfu/ml. 
Anaerobic culture conditions. Anaerobic media, solutions and glass bottles were pre-reduced at least 2 
days before use under anoxic conditions (Formiergas: 3 % H2, Rest N2) in an anaerobic chamber. 
Cryostocks were defrozen at 37 °C into a water-bath. A single vial was inoculated into a sealed wheaton 
bottle containing 10 ml of pre-reduced medium. Liquid cultures were gassed (7 % H2, 10 % CO2, rest N2) 
and incubated until growth was observed. Anaerobic bacterial strains were grown either in anaerobic 
brain-heart infusion (BHI) broth or in anaerobic Akkermansia medium (AAM). To improve growth of 
YL44, AAM was supplemented with gastric mucin. 
Bacterial cultures for genomic DNA extraction and genome sequencing. Bacterial cultures were set up 
as described above except for that media were filtered using a bottle-top-filter system (0.2 µm) before 
autoclaving. 
 
 Streptomycin halo assay 3.2.1.3.
This assay was performed by Diana Ring (AG Stecher, MvP, Munich).  
E. coli strain DH5α (Invitrogen) was streaked out on LB agar plates from -80 °C cryostocks and incubated 
o.n. at 37 °C. Next, a single colony was grown in 3 ml LB medium for 12 h, on a wheel rotor, at 37 °C. 
LB agar plates were overlaid with either 6 ml LB soft agar mixed with 100 µl of an o.n. culture of E. coli 
DH5α or 15 ml LB soft agar mixed with 250 µl bacterial culture, depending on agar plate size. Blank 
antimicrobial susceptibility disks (Oxoid) were laid on each plate and 5 µl sample was spotted on each 
disk. A standard curve was performed using serial dilutions of streptomycin from 500 mg/ml to 5x10-13 
mg/ml with 10-fold diluting steps. Plates were incubated o.n. at 37 °C and inhibition zone (halo) size was 
measured using a ruler. Size of the blank disk was substrated to all values. 
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 Bacterial strains 3.2.2.
 Salmonella strains 3.2.2.1.
Salmonella spp. strains used in this study are listed in Table 11. The M2702 derivative SAB1-1 (invG; 
ssaV; cheY::cm) was constructed by P22 transduction of cheY::cat (CmR) allele from the S. Tm strain 
M957 into the recipient strain M2702 (invG; ssaV). 
 
 The Altered Schaedler Flora strains 3.2.2.2.
The Altered Schaedler Flora (ASF) strains ASF356, ASF360, ASF361, ASF457, ASF500 and ASF519 
were obtained from Charles River Laboratories. 
In order to isolate ASF502, an ASF-colonized C57Bl/6 mouse (ETH, Zurich) was killed and imported into 
an anaerobic chamber. The cecum content was resuspended in pre-reduced 1X PBS and plated on 
Schaedler blood agar (Table 17). Plates were exported into an anaerobic jar and incubated at 37 °C under 
anaerobic conditions. Single colonies were restreaked on fresh agar until pure growth is observed, and 
then transferred into 10 ml AAM and incubated at 37 °C. Strain identity was confirmed by 16S rRNA 
gene sequencing and sequences were blasted against NCBI blast (Altschul, Gish et al. 1990) and the 
Ribosomal Database Project (RDP) (Wang, Garrity et al. 2007). 
Taxonomic classification of the ASF strains is detailed further in Table 35.  
 
 Isolation of the Oligo-MM strains 3.2.2.3.
Isolation of I46, I48 and I49 strains by Ricco Robbiani (ETH, Zurich). Fecal pellets were collected 
from C57Bl/6J mice (Janvier, ETH, Zurich), directly resuspended in PBS and plated on Wilkins-Chalgren 
agar supplemented with 5 % defibrinated sheep blood (WSB agar). Plates were incubated in an anaerobic 
atmosphere (7 % H2, 10 % CO2, rest N2) at 37 °C for 3-5 days. Strains were identified by 16S rRNA gene 
sequencing and sequences were blasted against RDP. 
Isolation of YL2, YL27, YL31, YL32, YL44, YL45 and YL58 strains by Yvonne Loetscher (ETH, 
Zurich). C57Bl/6J mice (Janvier, ETH, Zurich) harboring a conventional gut microbiota were killed and 
then imported into an anaerobic chamber. Cecum contents were resuspended into a diluting fluid as 
described in (Aranki, Syed et al. 1969) and either directly plated on AII agar or plating on WSB agar after 
a heat treatment at 80 °C for 10 min or a chloroform-treatment as previously described (Itoh and Freter 
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1989). Plates were transferred into anaerobic jars, gassed (7 % H2, 10 % CO2, rest N2) and incubated at 37 
°C for one week. Single colonies were restreaked on fresh agar until pure growth is observed, and then 
transferred into pre-reduced AII liquid medium and incubated at 37 °C, in anaerobic conditions. Strains 
were identified by 16S rRNA gene sequencing and sequences were blasted against RDP. 
Isolation of KB1 and KB18 strains. Feces from a TCRMOG92-106/I-As transgenic (RR) SJL/J mouse 
(Berer, Mues et al. 2011) was heat-inactivated at 70°C for 15 min and frozen at -20°C (Kerstin Berer, 
MPI, Munich). Fecal pellets were imported in the anaerobic chamber and resuspended into pre-reduced 
1X PBS. Serial dilutions were either plated on BHI agar or transferred into BHI medium. Freshly 
inoculated bottles were heated for 1h at 70 °C and cooled down on ice. Agar plates and liquid bottles were 
incubated at 37 °C under anaerobic conditions (7% H2, 10% CO2, rest N2) until growth was observed. 
KB1 was isolated as a single colony from a BHI agar plate after an o.n. incubation. KB18 was isolated 
using a serial dilution approach and 8 days incubation. Strains were identified by 16S rRNA gene 
sequencing and sequences were blasted against NCBI and RDP. 
 
Table 33. Isolation and cultivation of the Oligo-MM strains 
Strain 
ID Mouse line of origin 
Isolation 
media 
Culture 
media Reference 
YL2 C57Bl/6J AII agar AAM or BHI Unpublished 
YL27 C57Bl/6J AII agar AAM or BHI Unpublished 
YL31 C57Bl/6J WSB agar AAM or BHI Unpublished 
YL32 C57Bl/6J WSB agar AAM or BHI Unpublished 
YL44 C57Bl/6J WSB agar AAMMucin Unpublished 
YL45 C57Bl/6J WSB agar AAM or BHI Unpublished 
YL58 C57Bl/6J WSB agar AAM or BHI Unpublished 
I46 C57Bl/6J WSB agar AAM or BHI Unpublished 
I48 C57Bl/6J WSB agar AAM or BHI Unpublished 
I49 C57Bl/6J WSB agar AAM or BHI Unpublished 
KB1 TCR
MOG92-106/I-As 
transgenic (RR) SJL/J BHI agar AAM or BHI Unpublished 
KB18 TCR
MOG92-106/I-As 
transgenic (RR) SJL/J BHI medium BHI Unpublished 
Taxonomic classification is detailed further in Table 35. 
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 Preparation of bacterial inocula as frozen stocks 3.2.2.4.
Oligo-MM10. The ten Oligo-MM strains (YL2, YL31, YL32, YL44, YL45, YL58, I46, I48, I49 and KB1) 
were anaerobically and individually grown. Then, OD600 of the cultures was determined. Purity of 
bacterial culture was confirmed by Gram staining. Further on, actively growing cultures were imported 
into the anaerobic chamber and mixed in a 1:1 ratio according to their OD600 measurements (except for the 
YL45 bacterial culture, which is translucent). In order to cryopreserve the frozen stock at -80 °C, 1 vol. 
bacterial mixture was mixed to 1 vol. 20 % glycerol solution supplemented with palladium black crystals, 
as previously described. Mixtures were aliquoted in 1.5 ml glass vials, sealed with butyl-rubber stoppers 
and frozen at -80 °C. 
ASF6. Similarly to the procedure described above, six ASF strains (ASF356, ASF360, ASF361, ASF457, 
ASF502 and ASF519) were anaerobically grown and actively growing cultures were imported into the 
anaerobic chamber. For each ASF strain, 3 ml culture was centrifuged 5 min, 8,000 rpm at 4 °C and cell 
pellets were directly frozen at -20 °C for further analyses. Cultures were mixed all together in a 1:1 ratio 
according to their OD600 measurements and aliquoted such as 1 vol. bacterial suspension was mixed with 1 
vol. glycerol solution supplemented with palladium black crystals. Mixtures were aliquoted in 1.5 ml glass 
vials, sealed with butyl-rubber stoppers and frozen at -80 °C. To inoculate ASF7 mixture, ASF6 inoculum 
was supplemented by ASF500 which was inoculated to mice as actively growing culture. 
For each bacterial inoculum, 3-6 ml of the mixture was centrifuged 5 min, 8,000 rpm at 4 °C and pellets 
were directly frozen at -20 °C for DNA extraction to confirm strain identity and presence using amplicon 
sequencing or/and qPCR. 
 
 Molecular biology methods 3.2.3.
 Genomic DNA extraction 3.2.3.1.
Genomic DNA extraction from bacterial cultures. Genomic DNA extraction was performed using a 
standard phenol/chloroform/isoamylalcohol protocol. Concentrations indicated in the next paragraph are 
given as final concentration. Briefly, bacterial pellets of Gram-positive strains were resuspended in TE 
buffer (Table 22) supplemented with 0.5 % SDS and 20 mg/ml lysozyme. Then, bacterial suspensions 
were incubated at 37 °C for 1 h 30 min. Further on, suspensions were supplemented with 0.1 µg/ml 
proteinase K and incubated at 55 °C for 1 h. The bacterial pellets of Gram-negative strains were directly 
resuspended in TE buffer supplemented with 0.5 % SDS and 0.1 µg/ml proteinase K, then incubated at 55 
°C for 1 h. Next, 0.64 M NaCl and 0.1 volume (vol.) CTAB/NaCl buffer (Table 23) were added and 
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incubated at 65 °C for 10 min. Then, 1 vol. of phenol/chloroform/isoamylalcohol and the suspensions 
were mixed, and then centrifuged. Supernatants were transferred into a new tube and gDNA was 
precipitated with 0.7 vol. isopropanol and 0.1 vol. 3 M sodium acetate. Tubes were mixed and centrifuged 
at full speed at 4 °C for 30 min. Genomic DNA was washed with 1 vol. ice-cold 70 % ethanol p.a. and 
centrifuged at 4 °C for 15 min. Finally, gDNA was dissolved using 20-50 µl TE buffer and stored at 4 °C 
for further whole genome sequencing or at -20 °C for other applications. Genomic DNA concentration 
was determined using Nanodrop (Peqlab Biotechnology) and DNA integrity was confirmed by agarose gel 
electrophoresis. 
Genomic DNA extraction from mouse intestinal contents and Oligo-MM10 inoculum. Small intestinal, 
cecal and fecal gDNA were extracted using the QIAamp DNA Stool Mini Kit (Qiagen) following the 
manufacturer’s instructions with two modifications: protocol was initialized by a bead-beating step (3 
min, 50 Hz) in buffer ASL using 2 glass bead sizes (0.5-0.75 mm and <106 µm) and lysozyme was added 
to the lysis buffer at a 20 mg/ml final concentration. 
Genomic DNA extraction from mouse biopsies. In order to genotype genetically modified mouse lines 
(i.e. AGR2 and MUC2 mice), murine gDNA was extracted using biopsies from tails or ears. Briefly, tail 
biopsies were suspended in 200 µl DirectPCR-Tail reagent (Peqlab Biotechnology) supplemented with 0.4 
mg/ml final concentration of proteinase K. After an o.n. incubation at 55 °C, 500 rpm, proteinase K was 
heat-inactivated at 85 °C for 45 min. Further on, suspensions were centrifuged 2 min at 11,000 rpm and 
directly used as a template for PCR or frozen at -20 °C. In order to extract gDNA from ear biopsies, the 
same protocol with adapted volumes of DirectPCR-Tail reagent (100 µl instead of 200 µl). 
 
 RNA extraction and microarray analysis 3.2.3.2.
Intestinal epithelial cell (IEC) isolation. Cecal IEC isolaton was performed together with Eva Rath 
(TUM-ZIEL, Freising-Weihenstephan, Germany) using a standard Percoll gradient protocol. 
Concentrations indicated in the next paragraph are given as final concentration. Briefly, after mouse 
sacrifice, cecum was sampled and cecal epithelial cells were exposed by inversion. In tube 1, tissues were 
resuspended in 1 volume (vol.) DMEM, supplemented with 1 mM DTT and vortexed for 1 min. Then, 
tissue suspensions were incubated at 37 °C for 15 min, at 200 rpm and vortexted for 1 min. Cecal tissues 
were transfered into a new tube (tube 2) with 1 vol. 1X PBS supplemented with 1.5 mM EDTA, then 
vortexed for 1 min. Cecal tissue suspensions were incubated at 37 °C for 10 min, at 200 rpm and vortexed 
for 1 min. Meanwhile, IEC suspensions in tube 1 were centrifuged at 4 °C for 7 min, at 300xg and IEC 
pellets were resuspended in 5 ml DMEM, and then stored on ice. In tube 2, Cecal tissues were discarded 
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and IEC suspensions were centrifuged at 4 °C for 7 min, at 300xg. Then, IEC pellets were resuspended 
with the 5 ml DMEM from tube 1. IEC suspensions were carefully pipetted onto the Percoll gradient 
(Table 31) and centrifuged at 4 °C for 30 min, at 600xg. IEC were isolated from the Percoll gradient using 
a Pasteur pipette into a new tube, supplemented with 0.025 vol. DMEM, and centrifuged at 4 °C for 5 min, 
at 300xg. IEC were washed once in 1X PBS, and then resuspended in adequate buffer. 
IEC RNA extraction. The RNA was extracted by Eva Rath (TUM-ZIEL, Freising-Weihenstephan, 
Germany). Total RNA was isolated from cecal IEC using the column-based RNeasy Mini kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s instructions. RNA quality and concentration was 
determined by spectrophotometric analysis (ND-1000 spectrophotometer, NanoDrop and Agilent 
bioanalyzer) and the RNA integrity number was >6 for all samples. Total RNA was sent to Mark 
Boekschoten (WU Agrotechnology & Food Sciences, Wageningen, Netherlands). 
Microarray analysis. The analysis was performed by Mark Boekschoten (WU Agrotechnology & Food 
Sciences, Wageningen, Netherlands). Genome-wide mRNA expression profiles were analyzed using the 
Gene set enrichment analysis (GSEA) approach, as described in (Subramanian, Tamayo et al. 2005). Gene 
sets were considered as significantly down- or upregulated when False Discovery Rate value (FDR q-val) 
was below 0.25. 
 
 16S rRNA gene amplification and sequencing 3.2.3.3.
Polymerase chain reaction (PCR) on bacterial genomic DNA targeting the 16S rRNA gene was carried out 
in order to clone and sequence the amplicon. PCR was performed as previously described (Weisburg, 
Barns et al. 1991). Briefly, one PCR reaction contained 0.125 µM each forward primers (fD1 and fD2, 
Table 4), 0.25 µM reverse primer (rP1, Table 4), 2 X DreamTaq PCR Master Mix and 200-300 ηg 
bacterial genomic DNA. PCR was performed using a peqSTAR 2X Gradient Thermocycler (Peqlab 
Biotechnology). PCR conditions were: 95 °C for 5 min, followed by 35 cycles of 95 °C for 30 s, 50 °C for 
30 s and 72 °C for 1 min. After 72 °C for 10 min, as final elongation step, PCR tubes were held at 8 °C for 
short term storage. A portion of all PCR products was subjected to agarose gel electrophoresis on a 1 % 
agarose gel. When a single PCR product band was detected at 1.5 kb, PCR products were purified directly 
from the PCR mix using NucleoSpin Gel and PCR Clean-up kit. When multiple amplicons were present, 
the 1.5 kb band was extracted from the gel using the same kit. Concentration of PCR products was 
determined using Nanodrop (Peqlab Biotechnology). Next, PCR products were directly cloned in plasmid 
vectors, as described below. 
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 AGR2 gene amplification 3.2.3.4.
In order to genotype AGR2 mice, PCR was performed using gDNA extracted from mouse biopsies. PCR 
protocol was adapted from (Park, Zhen et al. 2009). Briefly, one PCR reaction contained 0.25 µM each 
primers (AGR2-KO-fwd, AGR2-wt-fwd and AGR2-rev) (Table 4), 2 X DreamTaq PCR Master Mix and 
2 µl template genomic DNA taken from supernatant. PCR was performed using a peqSTAR 2X Gradient 
Thermocycler (Peqlab Biotechnology). PCR conditions were: 94 °C for 5 min, followed by 30 cycles of 
95 °C for 45 s, 59 °C for 45 s and 72 °C for 2 min. After 72 °C for 7 min, as final elongation step, PCR 
tubes were held at 8 °C for short term storage. PCR products were subjected to agarose gel electrophoresis 
on a 2 % agarose gel. A single PCR product band was detected at 267 bp for AGR2wt genotype and at 374 
bp for AGR2ko genotype. 
 
 Generation of plasmids containing full length 16S rRNA gene 3.2.3.5.
PSAB-labelled plasmids. Plasmids labelled with pSAB (Table 10) were generated using the CloneJETTM 
PCR Cloning kit (Thermo Fisher Scientific biosciences) and following manufacturer’s instructions. 
Briefly, 75 ηg purified PCR products amplified using primers fD1, fD2 and rP1 were blunted for 5 min at 
70 °C. Next, blunted products were inserted into 50 ηg pJET1.2 cloning vector and incubated at RT for 30 
min. Ligation mixture was transformed into electro-competent E. coli DH5α, as detailed in section 
3.2.3.9. Inserts were sequenced by GATC Biotechnology (Sanger sequencing approach) using universal 
primers pJet1-FP and pJet1-RP (Table 4). 
PM-labelled plasmids. To generate plasmids pM1456-1, pM1457-1, pM1459-1 and pM1460-1 (Table 
10), the 16S rRNA gene was amplified using the primers fD1-EcoRV-XbaI, fD2-EcoRV-XbaI and rP1-
EcoRV-BamHI (Table 4). Next, purified PCR products were inserted in the linear pCR®2.1-TOPO® vector 
in a 5 min cloning step, using the TOPO® Cloning kit and following manufacturer’s instructions 
(Invitrogen). Inserts were sequenced from both sides (Microsynth, Balgach, Switzerland) using the 
primers M13_F (GTAAAACGACGGCCAG, Invitrogen) and M13_R (CAGGAAACAGCTATGAC, 
Invitrogen). This work was performed by Yvonne Loetscher (ETH, Zurich). To generate plasmids 
pM1411-1, pM1412-4, pM1413-1, pM1414-1 and pM1417-1 (Table 10), 16S rRNA gene was amplified 
using fD1-EcoRV-XbaI, fD2-EcoRV-XbaI and rP1-EcoRV-BamHI primers. Next, purified PCR products 
were inserted in linearized pSB-Bluescript SK II vector (Stratagene). To generate pM1411-1, pM1412-4 
and pM1413-1, pSB-Bluescript SK II vector was linearized using EcoRV; for pM1414-1 using 
NotI/HindIII and for pM1417-1 using NotI/BamHI. To generate pM1414-1, 16S rRNA gene sequence was 
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previously cloned in pCR®2.1-TOPO® vector and from there cloned in pSB-Bluescript SK II vector. These 
plasmids were generated by Prof. Bärbel Stecher. 
Next, plasmid vectors were transformed in electro-competent E. coli DH5α, as detailed in section 3.2.3.9. 
Plasmids are listed in Table 10. 
 
 16S rRNA gene-based taxonomic assignment of the bacterial strains 3.2.3.6.
Identification of bacterial strains was achieved by sequencing the 16S rRNA gene previously cloned in 
plasmid vectors from both sides by GATC Biotechnology (Sanger sequencing approach) using appropriate 
primer pairs. Resulting sequences were trimmed and assembled using the software CLC DNA Workbench 
(version 6.0.2) and 16S rRNA gene sequences were blasted against the Ribosomal Database Project 
(RDP) (Wang, Garrity et al. 2007), NCBI blast (Altschul, Gish et al. 1990), Greengenes (DeSantis, 
Dubosarskiy et al. 2003) and Silva (Quast, Pruesse et al. 2013) databases in order to taxonomically assign 
the bacterial strains newly isolated. After comparison of all databases, SINA (Silva Incremental Aligner), 
the Silva Web Aligner, was preferred for taxonomic assignments. 
 
 Plasmid extraction 3.2.3.7.
Plasmids previously transformed in electro-competent bacterial strains E. coli DH5α or S. Tmwt as 
described in section 3.2.3.9. were extracted using NucleoSpin Plasmid kit according to the manufacturer’s 
instructions. Briefly, transformed E. coli or S. Tm strains were streaked out from cryostocks on LB or 
MacConkey agar, respectively, supplemented with appropriate antibiotics and incubated o.n. at 37 °C. 
Next, single colony was picked to inoculate 3-5 ml LB culture supplemented with appropriate antibiotics 
and incubate o.n. at 37 °C under agitation. Overnight cultures were spun down at 4 °C for 15 min at 5,000 
rpm and plasmids were extracted from bacterial pellets according to the manufacturer’s instructions. 
Extracted plasmids were transformed in appropriate S. Tm strains, used to sequence 16S rRNA gene or 
linearized to generate standard curves for qPCR. 
 
 Preparation of electro-competent bacteria 3.2.3.8.
A single bacterial colony was inoculated in 3-10 ml LB medium and grown o.n. at 37 °C on a wheel rotor. 
Further, o.n. culture was used to inoculate (1:20) 10-100 ml LB medium, incubated at 37 °C and 180 rpm. 
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At an OD600 of 0.5-0.8, the culture was chilled on ice for 30 min and subsequently spun down at 4 °C, 15 
min and 4,500 rpm. The supernatant was removed and pelleted cells were washed three times in 1 vol. 
sterile ice-cold dH2O, one time in 0.5 vol. sterile dH2O and one time in 0.1 vol. sterile ice-cold 10 % 
glycerol, respectively. After each step bacteria were spun down at 4 °C, 15 min and 4,500 rpm. Finally, 
bacteria were suspended in 0.02 vol. ice-cold 10 % glycerol, distributed into 80 µl aliquots, which were 
shock-frozen in liquid nitrogen and stored at -80 °C. 
 
 Electro-transformation of plasmid DNA 3.2.3.9.
A frozen stock of electro-competent cells was thawed on ice and 1-10 µl of the plasmid DNA was added. 
Bacteria were incubated for 10 min on ice, subsequently transferred into an ice-cold 1 mm electroporation 
cuvette and pulsed at 1,800 V/cm, 5 ms using Gene Pulser Xcell (Bio-Rad). Following this, 900 µl LB 
medium was added and bacteria were incubated for 1 h in a thermomixer at 37 °C and 850 rpm. 
Afterwards, bacteria were spun down at room temperature (RT) for 2 min, 10,000 rpm and 900 µl from 
the supernatant were removed. Pelleted cells were suspended in the remaining liquid and plated on LB 
agar plates supplemented with the appropriate antibiotic(s). 
 
 P22-transduction 3.2.3.10.
Preparation of P22–lysates. A single colony of the S. Tm donor strain was inoculated in 3 ml LB 
medium supplemented with 5 mM CaCl2 and grown o.n. at 37 °C on a wheel rotor. Further, 500 µl of the 
o.n. culture were added to 10 µl P22-lysate (kindly provided by Prof. Dr. M. Hensel) and incubated for 15 
min at 37 °C. Next, the mixture was used to inoculate 5 ml LB culture, which was incubated o.n. at 37 °C 
on a wheel rotor. On the next day 50 µl chloroform were added to the o.n. culture followed by an 
incubation for 30 min at 37 °C. Next, the culture was spun down at 4 °C, for 10 min at 4,500 rpm and the 
supernatant was filtered through (0.45 µm) and 20 µl chloroform were added to the 1.5 ml filtrate. Filtered 
lysate was stored at 4 °C for further use. Sterility of the lysate was verified by plating 50 µl on LB agar 
followed by an o.n. incubation at 37 °C. 
P22-transduction. A single colony of the S. Tm recipient strain was inoculated in 3 ml LB medium 
supplemented with 5 mM CaCl2 and grown o.n. at 37 °C on a wheel rotor. Next, 100 µl of the o.n. culture 
were added to 10 µl P22-lysate and incubated for 15 min at 37 °C. Subsequently, the bacteria-phage 
mixture was added to 900 µl LB medium supplemented with 10 mM EGTA and incubated in a 
thermomixer at 37 °C and 850 rpm. After 1 h incubation, the bacterial culture was spun down at RT for 2 
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min at 10,000 rpm and 900 µl of the supernatant were removed. Pelleted bacteria were resuspended in the 
remaining liquid and plated on 10 mM EGTA LB agar plates supplemented with the appropriate 
antibiotic(s). 
 
 Genome sequencing 3.2.3.11.
Complete genome sequence of strain KB18 was obtained by PacBio sequencing (DSMZ, Braunschweig, 
Germany). For the remaining eleven Oligo-MM strains, whole-genome shotgun sequencing was 
performed using the Illumina technology (Eurofins Genomics GmbH, Ebersberg, Germany). Libraries of 
500 bp insert size were prepared from the isolated genomic DNA and sequenced as 300 bp paired-end 
runs on an Illumina MiSeq v3 instrument. Raw Illumina reads were de novo assembled using the careful 
mode of SPAdes version 3.5.0 (Bankevich, Nurk et al. 2012) with a minimum read coverage cutoff of 20 
and minimum contig length of 500 bp. The quality of the Illumina draft genome assemblies was assessed 
with QUAST (Gurevich, Saveliev et al. 2013). Automatic annotation of the twelve Oligo-MM genomes 
was performed with RAST (Aziz, Bartels et al. 2008) to obtain a general overview of the genetic and 
functional content. Filtered raw reads from Illumina MiSeq sequencing of the eleven Oligo-MM genomes 
have been deposited in the Sequence Read Archive (SRA) under SRA Study Accession Number 
SRP060697 and following SRA Esperiment Accession Numbers: I46-SRX1092348, I48-SRX1092357, 
I49-SRX1092347, KB1-SRX1092355, KB18-SRX1092360, YL2-SRX1092353, YL27-SRX1092362, 
YL31-SRX1092358, YL32-SRX1092359, YL44-SRX1092354, YL45-SRX1092361 and YL58-
SRX1092352. 
 
 Metagenomics analysis 3.2.3.12.
Metagenomics analysis was performed by Carina Pfann and Ass.-Prof. David Berry (DOME, University 
of Vienna, Austria). The functional and metabolic capacity of the Oligo-MM community was predicted 
from annotated shotgun genomes and compared to those of the ASF community and of a conventional 
mouse gut microbiota by mapping against the KEGG (Kyoto Encyclopedia of Genes and Genomes) 
database. Input files for assembled Oligo-MM (see above) and ASF genomes (Wannemuehler, Overstreet 
et al. 2014) were either single genomes or artificial metagenomes, created by merging contigs of each 
community into a multi-fasta file. Metagenomic reads, derived from eight different samples to cover the 
heterogeneity of a conventional mouse gut microbiota (Sequence Read Archive accession numbers 
SRX313003 (JCVI 2013), DRX013306 (Milk 2014) and ERX166941 (Nanjing University 2013), and 
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MG-RAST accession numbers M4W0E1C1225, M4W0E2C1220, M4W1E1C1240, M4W1E2C1241 and 
M4W12E2C1226 (Wang, Linnenbrink et al. 2014)), were merged and assembled with Ray-Meta version 
2.3.1 with default parameters (Boisvert, Raymond et al. 2012). KEGG mapping was performed using a 
custom pipeline. Gene prediction was done with Prodigal version 2.60 (Hyatt, Chen et al. 2010, Hyatt, 
LoCascio et al. 2012) and the predicted protein files of the three groups (Oligo-MM, ASF and 
conventional) were aligned separately against a reduced KEGG database 
(http://huttenhower.sph.harvard.edu/kegg/) using RAPSearch version 2.23 (Ye, Choi et al. 2011, Zhao, 
Tang et al. 2012). Custom Python scripts were used for assignment against the KEGG database and to 
obtain information about the presence and completeness of each KEGG module, expressed as value 
between 0 (module complete, dark green) and 4 (module absent, white). 
 
 16S rRNA gene amplicon sequencing 3.2.3.13.
Generation and barcoding of 16S rRNA gene sequences. The variable regions V3-V6 of the 16S rRNA 
gene were amplified by PCR using gDNA extracted from intestinal contents or the Oligo-MM10 inoculum 
as detailed in section 3.2.3.1. PCR comprised two consecutive steps. In the first step, primers targeting the 
16S rRNA gene (italic) and specific primers carrying the 5’M13/rM13 adapters (bold) 338F-M13 
(GTAAACGACGGCCAGTGCTCCTACGGGWGGCAGCAGT) and 1044R-rM13 
(GGAAACAGCTATGACCATGACTACGCGCTGACGACARCCATG) are used to amplify the V3-V6 
region of the bacterial 16S rRNA gene. One PCR reaction contained 500 ηM of each primer (338F-M13 
and 1044R-rM13, see Table 4), 2 X DreamTaq PCR Master Mix and 50 ηg template gDNA. PCR reaction 
was performed in duplicates using a peqSTAR 2X Gradient Thermocycler (Peqlab Biotechnology). PCR 
conditions were: 95 °C for 10 min, followed by 20 cycles of 95 °C for 30 s, 55 °C for 30 s and 72 °C for 
45 s and a final elongation step at 72 °C for 10 min. Duplicate reactions were pooled and loaded on a 1 % 
agarose gel in order to confirm successful PCR amplification. After purification of PCR products using 
the NucleoSpin Gel and PCR Clean-up kit and manufacturer’s instructions, concentration and quality of 
the purified PCR products were assessed using Nanodrop (Peqlab Biotechnology). In order to barcode 
each PCR product with a specific MID sequence and to add the 454-specific Lib-L tag, a second PCR was 
performed using M13/rM13-specific primers containing the 454-specific Lib-L primers (underline) A-
M13 (CCATCTCATCCCTGCGTGTCTCCGACTCAG/MID sequence/GTAAACGACGGCCAGTG) 
and B-rM13 (CCTATCCCCTGTGTGCCTTGGCAGTCTCAGGGAAACAGCTATGACCATGA). The 
40 different MID 10 bp error-correcting barcodes for multiplexing are listed in Table 5. PCR was 
performed using 400 ηM of each primer (A-M13 and B-rM13). These primers extended the first PCR 
products and this extension was visualized on a 2 % agarose gel. 
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Purification of barcoded 16S rRNA gene sequences. In order to purify barcoded 16S rRNA gene 
sequences, amplicons of the second PCR were pooled and purified by ethanol precipitation. Briefly, the 
total volume was adjusted to 400 µl using ddH2O. Then, 0.1 vol. 3M sodium acetate and 2.5 vol. ethanol 
p.a. were added, mixed and centrifuged for 30 min, at 13,000 rpm, 4 °C. DNA pellets were suspended in 
1.25 vol. 70 % ethanol and centrifuged for 15 min, at 13,000 rpm, 4 °C. Finally, DNA was air-dried and 
suspended in 50 µl ddH2O. In a second time, purified PCR products were run on a 0.8 % agarose gel, 
bands corresponding to the barcoded 16S rRNA gene sequences were excised and amplicons were 
extracted using the NucleoSpin Gel and PCR Clean-up kit. Amplicons were eluted in ddH2O, further 
purified using Agencourt AMPure XP kit and finally resuspended in ddH2O. Concentration and quality of 
the purified barcoded amplicon sequences were assessed using a Nanodrop (Peqlab Biotechnology). 
Samples were stored at -20 °C. 
Amplicon sequencing platform. Amplicon sequencing was performed at Eurofins, on a 454 GS FLX 
Titanium platform from one side (Lib-L-A) according to the recommended procedures (454 Roche). 
Bioinformatic analysis. Sequence analysis was performed by Dr. Debora Garzetti (AG Stecher, MvP, 
Munich). The QIIME (Quantitative Insights Into Microbial Ecology) (Caporaso, Kuczynski et al. 2010) 
software package version 1.8 was used for read denoising and pre-processing, OTU clustering, taxonomic 
assignment, alpha diversity analysis and Principal Coordinate Analysis (PCoA) (Krzanowski 2000). 
Briefly, OTU clustering was performed at the 97 % similarity level using an open-reference method, based 
on a custom sequence collection of the full length 16S rRNA gene sequences of the 12 Oligo-MM and 5 
ASF strains (ASF360, ASF361, ASF457, ASF502 and ASF519). Taxonomy was assigned by the RDP 
classifier against either the Silva database (Quast, Pruesse et al. 2013) or the custom sequence collection. 
Alpha diversity was determined using the metric of observed species as measure of within-sample 
diversity. In order to compare all samples at equal sequencing depth for diversity analyses, the minimum 
number of reads present in all the analyzed samples was chosen as rarefaction level. Statistically 
differentially abundant operational taxonomic units (OTUs) were identified using LEfSe with α=0.01 and 
LDA score=2.0 (Segata, Izard et al. 2011). Microbiota composition shown in section 5. was analyzed the 
same way than detailed above except of the denoising step that was not performed. 
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 Quantitative PCR of bacterial 16S rRNA genes 3.2.3.14.
Quantitative polymerase chain reaction (qPCR) was established by Markus Beutler (AG Stecher, MvP, 
Munich). 
Generation of template plasmid DNA for standard curves. Plasmids containing full length 16S rRNA 
gene sequences from the 12 Oligo-MM strains, 7 ASF strains (ASF356, ASF360, ASF361, ASF457, 
ASF500, ASF502 and ASF519) and Salmonella Typhimurium M557 (Table 11) were transformed in E. 
coli DH5α. From 100 ml o.n. cultures, plasmids were purified using the Plasmid Plus Midi Kit following 
manufacturer’s instructions. Next, plasmid DNA was linearized using appropriate restriction enzymes, 
which have no restriction site within the 16S rRNA gene sequence. After digestion, linearized plasmids 
were cleaned up using NucleoSpin Gel and PCR Clean-up kit and following manufacturer’s instructions. 
Design of 16S rRNA specific primers and hydrolysis probes. In order to design 16S rRNA specific 
primers and hydrolysis probes, Primer Express 3 (Applied Biosystems, Life Technologies) software was 
applied to an alignment of full length 16S rRNA gene sequences. To enable duplex qPCR assays, 
hydrolysis probes were 5’-labelled with either 6-carboxyfluorescein (FAM) or 6-carboxyhexafluorescein 
(HEX). Additionally, each probe was conjugated with the black hole quencher 1 (BHQ1) at the 3’ end. 
Primers and probes were synthesized by Metabion (Table 6). 
Standard curves and qPCR conditions. Standard curves were determined using linearized plasmid as 
DNA template. Stocks of 10 ηg/µl each linearized plasmid were prepared and 16S rRNA gene copy 
numbers were calculated in order to prepare 10-fold dilutions (from 108 to 10-2 gene copies per µl). 
Plasmid DNA was diluted in 100 ηg/µl yeast t-RNA solution (Roche). Standard curves were run in 
triplicates only once to evaluate single qPCR assays. In further experiments, software LightCylcer96 
version 1.1 reproduced standard curves based on single DNA template with known DNA quantity as well 
as the efficiency derived from the standard curve of each qPCR assay which was initially run. Efficiency 
of each qPCR was calculated based on the slope of standard curves (qPCR efficiency: (10(-1/slope of standard 
curve)-1) x 100) using 1:10 dilution of linearized plasmid, as DNA template. Efficiencies of qPCR reactions 
were within the range of 90-110 %. QPCR reactions were performed in 96 well plates using the thermo 
cycler LightCycler96 (Roche). One PCR reaction (total volume: 20 µl) contained 300 ηM of each primer, 
250 ηM of the corresponding hydrolysis probe (see Table 6), FastStart Essential DNA Probes Master and 
5 ηg template gDNA. PCR reactions with DNA templates extracted from feces or cecal content were run 
in duplicates. PCR conditions were: 95 °C for 10 min, followed by 45 cycles of 95 °C for 15 s and 60 °C 
for 1 min. Fluorescence for each cycle was recorded after the step at 60 °C. Quantification cycle (Cq) as 
well as the baseline were automatically determined by the software LightCycler96 version 1.1 (Roche). 
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 Fluorescence in situ hybridization (FISH) 3.2.3.15.
Design of specific probes. In order to design strain-specific oligonucleotides, full length 16S rRNA gene 
sequences were aligned using CLC DNA Workbench 6.0.2 software (Table 4). To increase the fluorescent 
signal intensity, the oligonucleotides were double-labelled with either fluorescein isothiocyanate (FITC), 
cyanine 3 (Cy3) or Cy5 at the 3’ and 5’ ends (Table 34). All FISH probes were synthesized by Metabion 
(Munich). 
 
Optimization of probe specificity. To optimize the hybridization conditions of each probe, formamide 
(FA) concentration series were performed using a standard FISH protocol as previously described (Daims, 
Stoecker et al. 2005). The concentration of FA was increased in the hybridization buffer, while the 
concentration of NaCl was decreased in the washing buffer, concomitantly (Tables 26 and 27). Further 
on, all individual probes were tested with the optimal concentrations of FA on target and non-target strains 
in order to confirm their specificity (Table 34). 
 
Table 34. Fluorophores and optimal formamide (FA) concentrations established for the FISH probes 
targeting the Oligo-MM strains. 
Designation Fluorophores Fluorescence signal* Work in vivo Optimal formamide concentration 
YL2_180 2xCy3 Yes No 20 % 
YL27_180 2xCy3 or 2xFITC Yes Yes 30 % 
YL31_180 2xCy3 Yes  Yes 35 % 
YL32_180 2xCy3 or 2xFITC Yes Yes$ n.d. 
Muc1437 2xCy3 or 2xFITC Yes Yes 30 % 
BET940 2xCy3 Yes Yes 30 % 
YL58_180 2xFITC Yes Yes 30 % 
YL58_180_negctrl 2xFITC No  Yes n.d. 
I46_180 2xCy3 Yes  Yes$ n.d. 
I48_180 2xCy3 or 2xFITC Yes No n.d. 
I49_180 2xCy3 or 2xFITC Yes No n.d. 
KB1_180 2xCy3 Yes  Yes$ n.d. 
KB18_180 2xCy3 No  No n.d. 
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* The intensity of the fluorescence signal was evaluated at 35 % FA concentration on the corresponding pure 
bacterial culture, which was PFA-fixed. n.d.: not determined. $ Work but need to be optimized. 
 
Fixation of bacterial samples. One volume (vol.) of actively growing culture was directly fixed in 3 vol. 
of ice-cold 4 % paraformaldehyde (PFA) and incubated for 3 to 12 h at 4 °C. Later on, the suspension was 
washed 3 times in ice-cold 1X PBS in order to remove residual PFA. Finally, the pellet was suspended in 
1 vol. ice-cold 1X PBS and 1 vol. ice-cold 96 % ethanol p.a. Then, PFA-fixed samples were kept at -20 
°C. For FISH analysis, 3 to 5 µl were spotted on a 10-well epoxy-coated slide, dried for 5 min at 46 °C 
and directly used for FISH. 
Fixation of mouse samples. Cecum were fixed in 4 % paraformaldehyde (PFA) for 12 h at 4 °C, washed 
in 20 % sucrose o.n. at 4 °C, cryo-embedded in O.C.T., flash frozen in liquid nitrogen and then stored at -
80 °C. Cecal cryosections (5-7 µm thick) were mounted on superfrost plus glass slides using a cryotome 
CM1950 (Leica, Wetzlar) and air-dried at RT, at least o.n. 
 
FISH. Fluorescence in situ hybridization (FISH) was performed using double-labelled 16S rRNA-targeted 
oligonucleotide probes according to a standard protocol (Daims, Stoecker et al. 2005). Briefly, fixed-
bacterial or -mouse samples were dehydrated using increasing concentrations of ethanol 50 %, 80 % and 
96 % for 3 min each and were air-dried. Hybridization buffers (HB) were prepared as described in Table 
26 and vigorously mixed by vortexing. The FISH probes were added to HB at 5 ηg/µl final concentration 
and pipetted on the air-dried samples. Hybridization was performed for 4 h in a humid chamber saturated 
with HB at 46 °C in an oven, where the samples were protected from light. Later on, the slides were 
washed for 10 min at 48 °C in a water-bath using washing buffer (WB) (Table 27), rinsed 5 sec into ice-
cold ddH2O and air-dried. DAPI staining was performed using a solution of 1 µg/ml final concentration in 
ddH2O for 30 min at 4 °C in the dark. Sections were mounted with Vectashield and sealed with nail 
polish. Slides were observed under a Leica TCS SP5 confocal microscope (Leica, Wetzlar) within 24 h. 
TIFF images (1024 x 1024) were obtained using the software LAS AF (Leica, Wetzlar) and analyzed 
using the software DAIME (Digital Image Analysis in Microbial Ecology, version 2.0) (Daims, Lucker et 
al. 2006). In order to remove fluorescent background, FITC and Cy3 channels were subtracted to Cy3 and 
FITC channels, respectively (twice for YL44 analysis and thrice for YL58 analysis). Biovolume 
quantification was performed on object layers extracted from TIFF images using automatic 2D 
segmentation RATS (Robust Automated Threshold Selection) algorithm (Kittler, Illingworth et al. 1985) 
and ignoring objects up to 5 pixels. 
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 Immunofluorescence microscopy 3.2.3.16.
Fixation and preparation of cecal cryosections. Cecum were fixed in 4 % paraformaldehyde (PFA) for 
12 h at 4 °C, washed in 20 % sucrose o.n. at 4 °C, cryo-embedded in O.C.T., flash frozen in liquid 
nitrogen and then stored at -80 °C. Cecal cryosections (5-7 µm thick) were mounted on superfrost plus 
glass slides using a cryotome CM1950 (Leica, Wetzlar) and air-dried at RT, at least o.n. 
Fixation and preparation of paraffin-embedded cecal sections. In order to preserve the mucus layer on 
epithelial surfaces, cecum were fixed in water-free Carnoy’s solution (60 % absolute ethanol, 30 % 
chloroform, 10 % glacial acetic acid) and stored one to two weeks at 4 °C. Fixed-cecum were dehydrated 
twice in absolute ethanol for 30 min each and then, twice in absolute xylol for 1 h each. Further on, cecum 
were incubated in a 1:1 xylol/paraffin solution for 1 h at 60 °C. In order to remove xylol, xylol/paraffin 
solution was replaced by paraffin and incubated at 60 °C for 45 min. This step was repeated until xylol 
was evaporated. Then, cecal tissues were embedded in paraffin into histo-cassettes and cooled down at 
RT. Using a microtome type Reichert-Jung Hn-40, paraffin sections (5 µm thick) were stretched at 45 °C 
in 80 % ethanol bath in order to preserve the mucus layer, dried o.n. under the hood and incubated 2-3 h at 
37 °C. Before dewaxing, sections were fixed on the slide for 10 min at 60 °C. This protocol was adapted 
from (Johansson and Hansson 2012). 
Immunofluorescent staining of cecal cryosections. Prior immunofluorescent staining, cecal cryosections 
were fixed in 4 % PFA for 5 min at 4 °C. Paraffin-embedded cecal sections were dewaxed using xylol for 
10 min at 60 °C then xylol for 10 min at RT and rehydrated using decreasing concentrations of ethanol 
100 %, 95 % and 80 % for 5 min each at RT. This step was adapted from (Johansson and Hansson 2012). 
Immunofluorescent staining was performed as described in (Stecher, Robbiani et al. 2007). Cecal sections 
were washed in 1X PBS and blocked with 10 % (w/v) normal goat serum in PBS for 1 h. S. Tm was 
stained using a polyclonal rabbit anti-Salmonella O antigen group B serum (α-Salmonella B, 1:400, 10 % 
normal goat serum) and a dylight 549-conjugated goat anti-rabbit antibody (α-rabbit-dylight 549, 1:400, 
10 % normal goat serum). The specificity of α-Salmonella B antiserum was checked extensively by 
analyzing cecum cryosections from uninfected mice, as negative controls. MUC2 was stained using a α-
MUC2 H-300 (1:200, 10 % normal goat serum) and a dylight 549-conjugated goat anti-rabbit antibody (α-
rabbit-dylight 549, 1:400, 10 % normal goat serum). DNA was stained with sytox green (0.1 µg/ml final 
concentration) and/or DAPI (1 µg/ml final concentration). F-actin was stained with phalloidin 
FluoProbes® 647 (1:300, 10 % normal goat serum). Sections were mounted with Vectashield and sealed 
with nail polish. Slides were observed under a Leica TCS SP5 confocal microscope (Leica, Wetzlar) 
within 24 h. TIFF images were obtained using the software LAS AF (Leica, Wetzlar). 
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Intracelullar immunofluorescent staining in epithelial tissue cryosections. This staining and the 
corresponding analysis shown in Figure 27 were performed by Dr. Mikael Sellin (ETH, Zurich), as 
described in (Sellin, Muller et al. 2014). Briefly, cecal tissue was fixed in 4 % PFA/4 % sucrose, saturated 
in PBS/20 % sucrose, embedded in O.C.T., flash frozen in liquid nitrogen and stored at -80 °C. 
Cryosections (20 µm thick) were air-dried, rehydrated with PBS, permeabilized using 0.5 % Triton X-100 
and blocked with 10 % normal goat serum. For quantification of S. Tm in whole tissue, epithelium and 
lamina propria, cryosections were stained for ICAM-1/CD54 (clone 3E2, Becton Dickinson), AlexaFluor-
647 conjugated phalloidin (Molecular Probes) and DAPI (Sigma-Aldrich). Samples were mounted with 
Mowiol (Calbiochem). A Zeiss Axiovert 200 m microscope with 10x-100x objectives, a spinning disc 
confocal laser unit (Visitron) and two Evolve 512 EMCCD cameras (Photometrics) were used for 
imaging. For quantification of S. Tm, imaging was performed at 400x and 1,000x. Postcapture processing 
and analysis used the Visiview (Visitron) and Image J x64. Intracellular S. Tm was manually enumerated 
blindly in six to nine nonconsecutive sections per mouse. All data represent averages/section. 
 
 Lipocalin-2 quantification 3.2.3.17.
Lipocalin-2 (Lcn2) levels were determined by enzyme-linked immunosorbent assay (ELISA) in cecal 
content. This assay was performed by Diana Ring (AG Stecher, MvP, Munich) using kit and protocol 
from R&D Systems (Minneapolis, US). Briefly, 96-well plates were coated with Lcn2 capture antibody 
(1:200, 1X PBS) and incubated o.n. at 4 °C. On the next day, plates were washed 3 times using washing 
buffer (washing step) and incubated with blocking buffer for 1 h, at RT. After another washing step, plates 
were loaded with standard and mouse samples (Standard: starting concentration at 60 ηg/ml, then 1:3 
dilutions until 0.027 ηg/ml in blocking buffer. Mouse samples: undiluted, 1:20 and 1:200 in 1X PBS) then 
incubated 1 h, at RT. After two washing steps, plates were loaded with Lcn2 detection antibody (1:200, 
blocking buffer) and incubated 1 h, at RT. After two washing steps, plates were loaded with HRP-
streptavidin (1:1000, 1X PBS) and incubated 1 h, at RT. Plates were finally washed six times in washing 
buffer and developed with liquid substrate using 0.1 mg/ml ABTS diluted in substrate buffer and 
supplemented with 0.05 % H2O2 just before use. Afer 30 to 45 min at RT, absorbance was measured at 
λ405 using a plate reader. Lipocalin-2 was detected in the concentration range of 0.25-60 ηg/ml. Detection 
limit (DTL) was calculated for each experiment using the lowest concentration of Lcn2 detected in the 
assay (Lcn2, ηg/ml) respective to the highest amount of cecal content (AC, g) such as:  
DTL = lowest Lcn2
20
X 100
highest Ac
.  
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DTL was comprised between 0.18 and 0.57 ηg/mg cecal content, as shown in figures (red dotted line). 
 
 Mouse experiments 3.2.4.
 Mice used in this study 3.2.4.1.
Germfree C57Bl/6 mice were purchased from the Clean Mouse Facility (CMF, University of Bern, 
Switzerland) and housed under germfree conditions. They were directly inoculated with a mixture of 
either five ASF strains (ASF360, ASF361, ASF457, ASF502, ASF519) or four ASF strains (ASF356, 
ASF361, ASF502, ASF519). These mice were termed ASF5 and ASF4, respectively. C57Bl/6 mice 
colonized with the defined Oligo-MM12 consortium and termed as Oligo-MM12, were generated and 
provided by Prof. McCoy and Prof. Macpherson (University of Bern, Switzerland). Specific pathogen-free 
(SPF) C57Bl/6J mice harboring a conventional microbiota were purchased from Janvier (Le Genest-Saint-
Isle). AGR2tm1.2Erle mice, termed in this study as AGR2, were obtained from David Erle (Park, Zhen et al. 
2009), bred and kept under SPF conditions at the MvP mouse facility in individually ventilated cages 
(IVCs). AGR2 germfree mice, termed in this study as AGR2GF, were rederived from AGR2 heterozygous 
(AGR2het) and homozygous (AGR2ko) conventional mice by Prof. Bleich and Dr. Basic (Hannover 
medical school, Hannover). Gnotobiotic mice ASF5, ASF4, Oligo-MM12 and AGR2GF were bred under 
germfree conditions in flexible film isolators (Harlan Laboratories). 
 
 Animal inoculation experiments 3.2.4.2.
All gnotobiotic experiments were performed in gnotocages (Han, Bioscape, Emmendingen), at the Max-
von-Pettenkofer Institute (LMU, Munich). Gnotobiotic mice, 6 to 8 week old, were orally and rectally 
inoculated with about 100 µl bacterial mixture of frozen stocks (SPF cecum content, Oligo-MM10 
consortium, ASF6 consortium, other single strains) or actively growing culture (e.g. ASF500). 
 
 Animal infection experiments 3.2.4.3.
Germfree and gnotobiotic animal infection. Animals were infected by oral gavage with S. Tmavir or S. 
Tmwt in 50 µl 1X PBS at 12 to 24 week old depending on previous treatments. Strain identity and 
corresponding infective doses are indicated elsewhere, in result and legend parts. 
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SPF animal infection. SPF C57Bl/6 and AGR2 mice were housed in IVCs, pretreated by oral gavage 
either with streptomycin (25 mg/mouse) or ampicillin (25 mg/mouse) one day prior infection and infected 
by oral gavage with S. Tm. Strain identity and corresponding infective doses are indicated elsewhere, in 
result and legend parts. 
All mice were sacrificed in S2 conditions by cervical dislocation. Live bacterial loads in feces, cecal 
content, liver, spleen and mLN were determined by plating on MacConkey agar with respective antibiotics 
(streptomycin 50 μg/ml and ampicillin 100 μg/ml). 
 
 Ethics statement 3.2.4.4.
All animal experiments were reviewed and approved by the local ethics committee (55.2-1-54-2532-49-
11, 55.2-1-54-2532-13-15 and 55.2-1-54-2532-145-14) and performed according to the legal 
requirements. 
 
 Histopathological analysis 3.2.4.5.
Histology of the cecum was done at necropsy. Cecal tissue was embedded in Tissue-Tek Optimal Cutting 
Temperature (O.C.T.) compound, flash frozen in liquid nitrogen and stored at -80 °C. Cryosections (5 µm 
thick) of the cecal tissue were stained using hematoxylin and eosin (H&E), and then scored as described in 
(Stecher, Robbiani et al. 2007). Briefly, evaluation scored submucosal edema (score 0-3), 
polymorphonuclear neutrophils infiltration into the lamina propria (score 0-4), loss of goblet cells (score 
0-3) and epithelial damage (score 0-3). The total histopathological score for each tissue section was 
determined as the sum of all of these individual scores. Combined score 0-3: no to minimal signs of 
inflammation that are not sign of a disease. Combined score 4-7: moderate inflammation. Combined score 
above 8: severe inflammation. 
 
 Statistical analysis 3.2.4.6.
Determination of significance of differences among mouse groups was assessed using the exact Mann-
Whitney U test (MW) for comparison of two groups and the one-way ANOVA nonparametric Kruskal-
Wallis test for comparison of more than two groups. Statistical tests were performed using the software 
GraphPad Prism version 5.01 for Windows (GraphPad Software, La Jolla California USA, 
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www.graphpad.com). P values of less than 0.05 (two-tailed for MW) were considered as statistically 
significant. * P<0.05, ** P<0.01, *** P<0.001. 
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 Results – Establishment of a novel gnotobiotic mouse model to 4.
study host-microbiota-pathogen interactions 
 Gnotobiotic mice harboring a defined gut microbiota are widely used to study the complex 
mechanisms involving host-microbiota-pathogen interactions. Moreover, it is well established that the gut 
microbiota coevolves with its host (Seedorf, Griffin et al. 2014). Most of the gnotobiotic mouse models 
currently used is based on bacterial strains isolated from humans (Faith, Ahern et al. 2014, Slezak, 
Krupova et al. 2014). Up-to-date, the bacterial community of the Altered Schaedler Flora (ASF) model is 
the only one involving only mouse-derived bacteria (Dewhirst, Chien et al. 1999). However, ASF strains 
are not available in public strain collections, yet. 
 In this first chapter, I will present the establishment of a novel gnotobiotic mouse model based on 
a collection of mouse-derived strains. In order to generate a mouse-derived consortium, we isolated and 
characterized twelve intestinal commensal strains from specific pathogen-free (SPF) mice, the Oligo-
Mouse Microbiota (Oligo-MM). To colonize germfree mice in a reproducible manner, we established a 
method to inoculate the Oligo-MM as a single dose. To specifically detect the Oligo-MM strains and 
analyze microbial community composition, we developed three Oligo-MM specific analysis tools: a 16S 
rRNA gene-based amplicon sequencing approach, a quantitative fluorescence in situ hybridization (FISH) 
approach and a quantitative PCR assay. Moreover, we show that the Oligo-MM mediates colonization 
resistance (CR) against the human enteric pathogen Salmonella enterica serovar Typhimurium (S. Tm). 
Therefore, the Oligo-MM is a highly useful reductionist model system to study host-microbiota-pathogen 
interactions. 
 The Oligo-Mouse Microbiota, a consortium of mouse-derived 4.1.
commensal strains 
 Isolation of the Oligo-MM strains 4.1.1.
 To isolate mouse-derived commensal strains, we used cecal and fecal specimen from conventional 
mice raised in SPF conditions (Table 33). In order to sample cecal contents, mice were sacrificed, 
imported into an anaerobic chamber and dissected under anoxic conditions. To increase the proportion of 
spore-forming bacteria, a part of the fecal samples was sampled, heat-treated and directly frozen at -20 °C. 
Cecal and fecal contents were resuspended in anaerobic media and either plated on rich media or directly 
Results 
 
 
64 
 
used to inoculate liquid cultures. Furthermore, plates and cultures were incubated under anaerobic 
conditions. Once obtained in pure culture, the strains were grown using different anaerobic media, as 
detailed in Materials & Methods (3.2.1.2). We also established a method to cryopreserve anaerobic 
strains in glass vials at -80 °C using reducing agents, such as palladium black. 
 
 Morphology and taxonomic assignment of the Oligo-MM strains 4.1.2.
 In order to confirm the purity of each culture, we performed Gram staining and assessed bacterial 
morphology by light microscopy. We observed rather heterogeneous morphologies between individual 
pure cultures (Figure 6). 
 
Figure 6. Morphology of the Oligo-MM strains.  
Pure cultures (late logarithmic or stationary growth 
phase) were Gram-stained and bacteria were 
imaged using a light microscope (100-fold 
magnification). Color code refers to the phylum: 
bright blue: Actinobacteria; light orange: 
Bacteroidetes; red: Proteobacteria; purple: 
Verrucomicrobia and green: Firmicutes. Scale bar: 
10 µm. For taxonomic assignment, refer to Table 
35. 
 
 
  
 To taxonomically assign each strain, we used 16S rRNA gene sequencing. The full length 16S 
rRNA genes were amplified, cloned into a plasmid vector and sequenced. The 16S rRNA genes were 
aligned against different 16S rRNA databases (RDP, SILVA, NCBI blast, Greengenes) for taxonomic 
assignment (Table 35). 
 Finally, we isolated more than sixty strains from the mice. Out of this initial collection, we 
selected strains to meet the following criteria. The strains are cultivable in a reproducible fashion, 
cryopreservable and represent a diverse range of bacterial phyla abundant in the murine gut. In this way, 
twelve strains (the Oligo-MM12, Table 35) were selected: six strains were assigned to the phylum 
Firmicutes (YL31, YL32, YL58, I46, I49 and KB1), one strain to the Bacteroidetes (I48), one strain to the 
Actinobacteria (YL2), one strain to the Proteobacteria (YL45) and one strain to the Verrucomicrobia 
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(YL44). Two strains were included at a later time point: one strain assigned to the phylum Firmicutes 
(KB18) and one to the Bacteroidetes (YL27). The initial characterization was performed using only the 
first ten strains (the Oligo-MM10). Finally, among the Oligo-MM12 strains, four were taxonomically 
assigned as species Incertae Sedis, suggesting that they represent a novel species or even genus. 
 
Table 35. Taxonomic assignment of the Oligo-MM strains 
Taxonomic  
classification 
Strain 
ID 
Taxonomic  
Identity (Genus) 
SINA alignment 
score 
phylum Actinobacteria 
  class Actinobacteria 
    order Bifidobacteriales 
      family Bifidobacteriaceae 
 
 
 
YL2 
 
 
 
Bifidobacterium 
 
 
 
0.998 
phylum Bacteroidetes 
  class Bacteroidia 
    order Bacteroidales 
      family Bacteroidaceae 
 
 
YL27 
I48 
 
 
Bacteroidales; Incertae Sedis 
Bacteroides 
 
 
0.989 
0.999 
phylum Proteobacteria 
  class Betaproteobacteria 
    order Burkholderiales 
      family Sutterellaceae 
 
 
 
YL45 
 
 
 
Parasutterella 
 
 
 
0.978 
phylum Verrucomicrobia 
  class Verrucomicrobiae 
    order Verrucomicrobiales 
      family Verrucomicrobiaceae 
 
 
 
YL44 
 
 
 
Akkermansia 
 
 
 
0.998 
phylum Firmicutes 
  class Bacilli 
    order Lactobacillales 
      family Enterococcaceae 
      family Lactobacillaceae 
  class Clostridia 
    order Clostridiales 
      family Lachnospiraceae 
       
      family Ruminococcaceae 
   
class Erysipelotrichia 
    order Erysipelotrichales 
      family Erysipelotrichaceae 
 
 
 
KB1 
I49 
 
 
YL32 
YL58 
YL31 
KB18 
 
 
I46 
 
 
 
Enterococcus 
Lactobacillus 
 
 
Lachnospiraceae; Incertae Sedis 
Blautia 
Flavonifractor 
Ruminococcaceae; Incertae Sedis 
 
 
Erysipelotrichaceae; Incertae Sedis 
 
 
 
0.998 
0.999 
 
 
0.997 
0.997 
0.989 
0.986 
 
 
0.996 
Full length 16S rRNA gene sequences were aligned against the SILVA database using SINA alignment. 
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 Representation of the ASF and Oligo-MM strains in a conventional murine 4.1.3.
gut microbiota 
In order to determine if the isolated strains are abundant members of a conventional mouse 
microbiota, we generated a phylogenetic tree including full-length 16S rRNA gene sequences of a normal 
microbiota, the Oligo-MM12 and 8 ASF (ASF356, ASF360, ASF361, ASF457, ASF492, ASF500, ASF502 
and ASF519; ASF8) strains. We used full-length 16S rRNA gene sequences from the cecum of 
unmanipulated SPF mice harboring a conventional microbiota (Stecher, Robbiani et al. 2007). In this 
study, cecal contents from conventional mice were recovered and cecal DNA was extracted. The full 
length bacterial 16S rRNA genes were amplified by PCR, cloned into plasmid vectors and the inserts were 
sequenced. To this data set were included the full-length 16S rRNA gene sequences from the ASF8 and 
Oligo-MM12 strains. 
 
 Phylum distribution and abundance 4.1.3.1.
The ASF and Oligo-MM12 consortia harbor members taxonomically assigned to three and five of the 
most abundant bacterial phyla, respectively, from the seventeen phyla identified in the murine gut so far 
(Linnenbrink, Wang et al. 2013). In our dataset, we identified 7 different bacterial phyla. Two phyla, the 
Cyanobacteria and the Tenericutes, were only found in the samples from conventional mice (Figure 7). 
These two phyla were of low abundance, as only four and two reads were assigned to the Tenericutes and 
the Cyanobacteria, respectively (Table 36). One phylum was unique to the Oligo-MM12: the 
Actinobacteria (YL2). The phylum Deferribacteres, representing 4.2 % of the total reads in the 
conventional mouse gut (Table 36) is represented in the ASF (ASF457) but not in the Oligo-MM12. 
Compared to other studies, we found that another phylum, the TM7, was neither detected in the 
conventional mouse gut nor represented by ASF8 or Oligo-MM12 (Krych, Hansen et al. 2013). To 
conclude, ASF8 and Oligo-MM12 consortia represent three and four phyla, respectively found in the 
conventional mouse gut and one phylum, the Actinobacteria, was unique to the Oligo-MM12. 
 
Results 
 
 
67 
 
 
Figure 7.  Representation of Oligo-MM and ASF strains in a conventional mouse microbiota 
based on 16S rRNA gene sequences. 
Full length 16S rRNA gene sequences of the 12 Oligo-MM strains (red) as well as the 8 ASF 
strains (blue) (Dewhirst,  Chien et al.  1999) were compared against a set of 865 full-length high 
qualit y 16S rRNA gene sequences from 2 types of convent ional unmanipulated SPF mice (Stecher,  
Robbiani et al.  2007). All sequences were aligned against  the SILVA database version 111 NR 
(Quast,  Pruesse et al.  2013) using MEGABLAST version 2.2.28+ on a 97 % ident it y level,  yielding 
47 different  taxonomic ident it ies.  The best hit  of each of the 47 taxonomies from the database was 
used for the generat ion of a mult iple sequence alignment  using Infernal,  respect ively.  A 
phylogenet ic tree was generated using fast tree (Price,  Dehal et al.  2009). The number of sequences 
per taxonomic ident ity in the convent ional mice is indicated (e.g.  mice=20). The Oligo-MM 
strains,  which have at least one representat ive in the mouse dataset, are highlighted in bold.  Color 
code refers to  the phylum: br ight  blue: Actinobacteria; light  orange: Bacteroidetes; red: 
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Proteobacteria; purple: Verrucomicrobia; green: Firmicutes; light  blue: Deferribacteres and 
white: others.  Data analysis was performed by Hans-Joachim Ruscheweyh, Universit y of 
Tubingen. 
 
 OTU distribution and abundance 4.1.3.2.
For seven Oligo-MM12 strains, representatives at the OTU (Operational Taxonomic Unit) level were 
detected in the conventional mouse microbiota. Five were apparently not present in this community. 
However, we used other mice for isolation of the Oligo-MM strains (Table 36). Interestingly, YL27 was 
assigned to the most abundant taxon (i.e. S24-7) of the mouse microbiota. In contrast, three ASF strains 
were represented at the OTU level while five were not detected. We conclude that the Oligo-MM12 
consortium is quantitatively and qualitatively more complex than the ASF consortium and represents a 
diverse spectrum of the mouse microbiota. However, this data shows that a significant number of taxa 
represented in a conventional microbiota are not included in either consortium of strains. 
 
Table 36. Quantitative representation of Oligo-MM and ASF strains in a conventional mouse microbiota 
Phylum Class Family Genus Species Reads* Strain ID 
Bacteroidetes Bacteroidia S24-7     295 YL27 
Firmicutes Clostridia Lachnospiraceae     137   
Firmicutes Clostridia Ruminococcaceae     44   
Firmicutes Clostridia Ruminococcaceae Incertae Sedis   39 KB18 
Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides goldsteinii 39 ASF519 
Verrucomicrobia Verrucomicrobiae Verrucomicrobiaceae Akkermansia muciniphila 34 YL44 
Deferribacteres Deferribacteres Deferribacteraceae Mucispirillum   34 ASF457 
Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides   23 I48 
Bacteroidetes Bacteroidia Rikenellaceae Alistipes   21   
Firmicutes Clostridia Ruminococcaceae Oscillibacter   20   
Firmicutes Bacilli Lactobacillaceae Lactobacillus   18   
Firmicutes Clostridia Ruminococcaceae Anaerotruncus   14   
Bacteroidetes Bacteroidia Porphyromonadaceae Odoribacter   11   
Firmicutes Clostridia       11   
Bacteroidetes Bacteroidia S24-7     9   
Bacteroidetes Bacteroidia Bacteroidaceae Bacteroides acidifaciens 9   
Firmicutes Clostridia Lachnospiraceae Incertae Sedis   8   
Proteobacteria Deltaproteobacteria Desulfovibrionaceae Bilophila   7   
Firmicutes Clostridia Lachnospiraceae Coprococcus   6   
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Phylum Class Family Genus Species Reads* Strain ID 
Firmicutes Clostridia Ruminococcaceae Flavonifractor plautii 4 YL31 
Firmicutes Clostridia Ruminococcaceae Ruminococcus   4   
Tenericutes Mollicutes Anaeroplasmataceae Anaeroplasma   4   
Bacteroidetes Bacteroidia Prevotellaceae uncultured   4   
Firmicutes Bacilli Lactobacillaceae Lactobacillus reuteri 3 I49 
Firmicutes Clostridia Lachnospiraceae Roseburia   3   
Firmicutes Clostridia Peptococcaceae     3   
Proteobacteria Betaproteobacteria Alcaligenaceae Parasutterella   2 YL45 
Firmicutes Erysipelotrichi Erysipelotrichaceae Allobaculum   2   
Cyanobacteria 4C0d-2       2   
Bacteroidetes Bacteroidia Rikenellaceae     1   
Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides distasonis 1   
Bacteroidetes Bacteroidia Porphyromonadaceae Parabacteroides   1   
Firmicutes Clostridia Ruminococcaceae Incertae Sedis   1 ASF500 
Firmicutes Clostridia Ruminococcaceae Anaerotruncus colihominis 1   
Firmicutes Clostridia Ruminococcaceae     1   
Firmicutes Clostridia Lachnospiraceae     1   
Proteobacteria Deltaproteobacteria Desulfonatronaceae Desulfonatronum   1   
Firmicutes Bacilli Enterococcaceae Enterococcus   -  KB1 
Firmicutes Erysipelotrichi Erysipelotrichaceae Incertae Sedis   - I46 
Firmicutes Clostridia Lachnospiraceae Clostridium clostridioforme - YL32 
Firmicutes Clostridia Lachnospiraceae Blautia   - YL58 
Actinobacteria Actinobacteria Bifidobacteriaceae Bifidobacterium   - YL2 
Firmicutes Clostridia Lachnospiraceae Eubacterium plexicaudatum - ASF492 
Firmicutes Clostridia Lachnospiraceae Clostridium   - ASF356 
Firmicutes Clostridia Lachnospiraceae Clostridium   - ASF502 
Firmicutes Bacilli Lactobacillaceae Lactobacillus   - ASF360 
Firmicutes Bacilli Lactobacillaceae Lactobacillus animalis - ASF361 
The number of sequences per taxonomic identity in the conventional mice (reads) is listed in descending order. 
Oligo-MM strains as well as their respective abundance in conventional microbiota are highlighted in bold (right 
column). Color code refers to the phylum: bright blue: Actinobacteria; light orange: Bacteroidetes; red: 
Proteobacteria; purple: Verrucomicrobia; green: Firmicutes; light blue: Deferribacteres and white: others. * Number 
of 16S rRNA gene sequences per taxonomic identity in conventional mice is taken from Stecher et al., 2007 (Stecher, 
Robbiani et al. 2007). Total number of reads analysed: 818 reads. 
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 Deposition of the Oligo-MM strains at the German type culture collection 4.1.4.
(DSMZ) 
Despite their broad application in preclinical research, ASF strains are not publicly available, which 
hampers in vitro and in vivo studies and limits utility of gnotobiotic ASF mouse model to analyze host-
microbiota-pathogen interactions. Therefore, in order to ensure long-term preservation and public 
accessibility, each strain was deposited in the German type culture collection (DSMZ; Deutsche 
Sammlung von Mikroorganismen und Zellkulturen). Briefly, each strain was sent to the DSMZ as a frozen 
vial, where lyophilized bacterial glass ampoules were generated. The ampoules were recovered from the 
DSMZ and strain purity and identity was confirmed by 16S rRNA gene sequencing. The accession 
numbers of the strains are listed in Table 32. 
 
 The Oligo-MM10 can be reproducibly transplanted to gnotobiotic 4.2.
mice from a frozen mixture 
To test whether the Oligo-MM strains can stably colonize the murine intestine, we aimed to inoculate 
ten of the strains (Oligo-MM10) into gnotobiotic ASF-colonized mice and follow bacterial colonization 
over time. To achieve this, we first established a protocol which allows reproducible colonization of 
gnotobiotic mice using a standard inoculum. 
In order to standardize inoculation of the Oligo-MM10 into gnotobiotic mice and to avoid repeated 
anaerobic culturing which might lead to significant experimental variation, we tested a method to 
inoculate the Oligo-MM10 mixture from frozen stocks. We reasoned that a frozen mixture containing all 
strains could be used as direct inoculum and thereby limit variations as e.g. introduced by bacterial growth 
state. In order to prepare the frozen stock, each Oligo-MM10 strain was grown individually. Actively 
growing cultures were mixed under anaerobic conditions and frozen at -80 °C as glycerol stocks. Frozen 
vials were thawed and used directly to orally and rectally inoculate mice under germfree conditions. 
Next, we tested if gnotobiotic mice could be reproducibly colonized with the Oligo-MM10. The mice 
used in these explorative experiments were colonized with a low-complexity microbiota harboring five 
ASF strains (the ASF5 mice) and bred in a germfree isolator. For the experiments, ASF5 mice were 
exported from the isolator and transferred into gnotocages. In order to monitor the Oligo-MM10 
composition over the course of 43 days, we performed two independent experiments where ASF5 mice 
were inoculated with the frozen Oligo-MM10 or left untreated as controls. In the first experiment, mice 
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were sacrificed either at day 0 before Oligo-MM10 inoculation (d0, ASF5) or at days 10 and 20 (d10, d20, 
ASF5 + Oligo-MM10). In the second experiment, mice were sacrificed at days 22 and 43 (d22, d43, ASF5 + 
Oligo-MM10) or left untreated for 43 days (d43, ASF5). All mice were housed in gnotocages throughout 
the experiments to avoid any possible contaminations (Figure 8A). 
 
 
Figure 8. Oligo-MM10 inoculation in ASF5 mice using frozen stocks harboring 10 Oligo-MM strains is efficient 
and reproducible. 
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Gnotobiotic mice stably colonized with 5 ASF strains (ASF360, ASF361, ASF457, ASF502 and ASF519; ASF5) 
were inoculated under germfree conditions with a frozen vial containing either 10 Oligo-MM strains (I46, I48, I49, 
KB1, YL2, YL31, YL32, YL44, YL45, YL58; Oligo-MM10) or the sterile media, as a negative control (no 
transplant). Briefly, Oligo-MM10 strains were separately grown to exponential phase and mixed before freezing. 
Frozen vials were defrozen at room temperature and directly used for oral and rectal inoculation. Microbial 
transplantation was performed at two independent occasions as indicated with star (*) and hash (#) symbols. In the 
first experiment, feces were sampled at days 0 (d0) and mice were sacrificed at d10 and d20 post-inoculation. In the 
second experiment, mice were sacrificed at d22 and d43 post-inoculation. Three mice were left untreated, as a 
negative control (ASF5, d43). (A) Experimental design. (B) Microbial composition of the Oligo-MM10 inoculum was 
determined using a hydrolysis probe based quantitative PCR assay with strain-specific primers and hydrolysis probe 
combinations. Data are expressed as relative abundance. (C-D) Microbiota composition of (C) feces at days 0, 10, 
20, 22 and 43 and (D) small intestine at days 10 and 20 was determined using amplicon sequencing. Sequencing data 
were processed using the QIIME pipeline and taxonomy was assigned using the Silva database. Data are presented as 
relative abundance at the taxonomic family level (1 mouse per column). Color code is indicated in taxonomic legend 
box. Taxonomic affiliation of the Oligo-MM and ASF strains is indicated (brackets). 
 
To confirm the presence of the individual Oligo-MM strains in the frozen Oligo-MM10 stock, bacterial 
gDNA was extracted and microbiota composition was analyzed by 16S rRNA amplicon sequencing and 
quantitative PCR (qPCR). In order to analyze the Oligo-MM10 composition over time, gDNA was 
extracted from fecal samples. In addition, DNA was extracted from small intestinal contents. Microbiota 
composition was analyzed by 16S rRNA amplicon sequencing and qPCR at different time points. Data 
were analyzed using the QIIME pipeline (Quantitative Insights Into Microbial Ecology) (Caporaso, 
Kuczynski et al. 2010) using either an open-reference database or a custom database containing all the 
twelve Oligo-MM and five ASF strains. To get an overview on microbial complexity, the alpha diversity 
was calculated using the amplicon sequencing data. We also determined the relative cecal weight which is 
known to be indicative for microbiota complexity (Bleich and Hansen 2012). 
All ten Oligo-MM strains were detected in the frozen Oligo-MM10 inoculum (Figures 8B and 9C). 
Interestingly, I46 was not detected with the qPCR assay, while it was detected by the amplicon sequencing 
analysis. Processed data of qPCR and amplicon sequencing are shown in annexed Tables 37, 38 and 39. 
Furthermore, about 70 % and 80 % of the fecal microbiota population were assigned to Gram-negative 
strains using qPCR and amplicon sequencing, respectively (Figures 8C, 9A and 12). Analysis of the fecal 
microbiota revealed that the majority of the Oligo-MM10 strains are detectable in the mouse gut at day 10, 
20, 22 and 43 post-inoculation. Their colonization appeared to be stable over 43 days (Figures 8C and 
9A). Interestingly, about 80 % of the fecal microbiota was assigned to Gram-negative bacteria (i.e. to 
Verrucomicrobia and Bacteroidetes) despite the inoculation of a relatively high number of Gram-positive 
strains (7 out of 10 strains, belonging to the phyla Firmicutes and Actinobacteria). Most of the Gram-
positive strains are present only at very low abundance and four strains, YL2, KB1, I46 and I49, were not 
detected in fecal samples by amplicon sequencing (Figures 8C and 9A). 
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Figure 9. Data from Figure 8 analyzed using open-reference approach based on a custom 16S sequence 
database. 
Microbiota composition was analyzed using the QIIME pipeline and taxonomy was assigned against a custom 
sequence database of the full length 16S rRNA gene sequences of the Oligo-MM12 and the ASF5 strains. (A) Fecal 
microbiota composition at days 0, 10, 20, 22 and 43. (B) Microbiota composition of the small intestine at days 10 
and 20. (C) Microbial composition of the frozen inoculum. Data are presented as relative abundance at the 
taxonomic genus level (1 mouse per column). Color code is indicated in taxonomic legend box. Taxonomic 
affiliation of the Oligo-MM and ASF strains is indicated (brackets). 
 
Significant differences in microbiota composition analyzed by amplicon sequencing were observed 
between the feces and the small intestine (Figures 9A,B). Three strains, YL2, KB1 and I46, were 
undetected in the feces but detectable in the small intestine. As I49 was assigned to the same genus as 
ASF360 and ASF361 (i.e. Lactobacillaceae, genus Lactobacillus), even though the Lactobacillus genus 
was detected, its absence remained unclear. We noticed similarities when comparing amplicon sequencing 
data processed with an open-reference database and a custom sequence collection (Figures 8D and 9B). 
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Furthermore, we found that cecal and fecal microbiota had comparable microbiota composition (Figure 
10). 
 
 
Figure 10. Comparison of fecal and cecal microbiota composition of ASF5 mice colonized with the Oligo-MM10 
consortium analyzed using open-reference approach based on a custom 16S sequence database. 
Data from Figure 9. Briefly, fecal and cecal microbiota compositions at days 10 and 20 (d10 and d20, respectively) 
were determined using amplicon sequencing. Sequencing data were processed using the QIIME pipeline and 
taxonomy was assigned against a custom sequence collection of the full length 16S rRNA gene sequences of the 12 
Oligo-MM (YL2, YL27, YL31, YL32, YL44, YL45, YL58, KB1, KB18, I46, I48, I49) and 5 ASF strains (ASF360, 
ASF361, ASF457, ASF502, ASF519). Data are presented as relative abundance at the taxonomic genus level and is 
representative of 1 experiment (1 mouse per column). Color code is indicated in taxonomic legend box. Taxonomic 
affiliation of the Oligo-MM and ASF strains is indicated (brackets). 
 
In conclusion, we established a method to reproducibly inoculate the Oligo-MM10 consortium as a 
frozen stock to gnotobiotic mice. These data point out that the majority of the Oligo-MM10 strains stably 
colonize the mouse gut over a time-course of 43 days. Besides the taxonomic profile, we also analyzed 
microbiota complexity using alpha diversity based on amplicon sequencing data and relative cecal weight. 
To calculate alpha diversity of the fecal microbiota, we used amplicon sequencing data (Figure 11A). 
To determine relative cecal weight, we recorded mouse and cecal weights from the two previous 
independent experiments as well as six extra control mice colonized with ASF5 (Figure 11B). 
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Figure 11. Microbiota complexity of ASF5-colonized mice increases after Oligo-MM10 inoculation. 
(A) Alpha diversity was determined as the observed species metric using amplicon sequencing data from Figure 8. 
Data are presented as mean and standard deviation. (B) Mouse cecum and body weight were recorded at different 
days post-inoculation and at three independent occasions as indicated with dollar ($), star (*) and hash (#) symbols. 
Data were plotted as relative cecal weight (%). Bars represent the median. ASF5 mice at d0 and d43 are depicted as 
half-empty circle and empty circle, respectively. ASF5 mice inoculated with the Oligo-MM10 consortium for 10, 20, 
22 and 43 days are depicted as square, triangle, inverted triangle and diamond, respectively. Mann-Whitney U test: * 
P<0.05. One-way ANOVA Kruskal-Wallis test: (B) P=0.0178. 
 
It has been shown that germfree mice exhibit a relative cecal weight of about 10 % (Stecher, Chaffron 
et al. 2010). At day 0, the relative cecal weight of ASF5 mice ranged between 6 to 8 %. We observed a 
slight decrease of the relative cecal weight after ten days of Oligo-MM10 inoculation. Interestingly, we 
noticed a second significant decrease at day 43 post-inoculation (Figure 11B). Surprisingly, the relative 
cecal weight of ASF5 mice was increased (from 6-8 % at d0 to 8-9 % at d43 post-inoculation). The reason 
for this remains unclear. Moreover, ASF5 + Oligo-MM10 mice showed increased microbiota complexity 
from day 10 to day 43 post-inoculation, as compared to ASF5 mice (Figure 11A). This correlates 
decreased relative cecal weight with increased microbiota complexity, as it was also previously observed 
(Itoh and Mitsuoka 1985). 
 Taken together, we established a method to efficiently and reproducibly colonize gnotobiotic mice 
with a well-defined anaerobic microbial consortium, the Oligo-MM10. Colonization of all Oligo-MM10 
strains was confirmed along the murine intestinal tract (except of YL2, which could not be detected). 
Importantly, we established the most complex-defined mouse-derived microbiota described until now. In 
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the next step, we set out to generate a mouse colony stably colonized with the Oligo-MM strains over 
several generations, the Oligo-MM mice. 
 
 The Oligo-MM12 stably colonizes the murine gut and is vertically 4.3.
transmitted over at least 4 filial generations 
 Next, we aimed to inoculate Oligo-MM strains into germfree mice in order to generate a mouse 
colony stably colonized with the Oligo-MM over consecutive filial generations.  
 To create the Oligo-MM12 consortium, we included two additional strains, YL27 and KB18. YL27 
was assigned to the Bacteroidales and KB18 to the Ruminococcaceae (for further details, refer to 
Figure 7). These strains were included as these two phylotypes belong to the most abundant in 
conventional mice (Table 35). Colonization of germfree mice was performed by Prof. Kathy McCoy at 
the University of Bern (Switzerland) using our established protocol. Two germfree breeding pairs (termed 
F0) were inoculated with the Oligo-MM12 and bred under germfree conditions in an isolator. Two 
breeding pairs from the F2 generation were shipped to our germfree facility and further bred in a germfree 
isolator. For each generation (from F0 to F4), feces from individual adult mice was sampled. Fecal DNA 
was extracted and microbiota composition was determined by qPCR (Markus Beutler, AG Stecher). 
Briefly, specific 16S-targeted primers and hydrolysis probes were designed to detect each 16S rRNA gene 
by absolute quantification. Relative abundance of each strain is shown by the fraction of individual 
divided by the sum of all. Besides lower costs compared to amplicon sequencing, one of the advantage of 
the qPCR assay is that it allows a more accurate quantification of the Oligo-MM12. However, bacterial 
contaminants cannot be detected. 
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Figure 12. Oligo-MM12 consortium stably colonizes germfree mice and is vertically transmitted over at least 4 
filial generations. 
Germfree C57Bl/6 mice were inoculated with a frozen mixture containing 12 Oligo-MM strains (I46, I48, I49, KB1, 
KB18, YL2, YL27, YL31, YL32, YL44, YL45, YL58; Oligo-MM12) and bred for 4 generations in germfree isolators 
at the Clean Mouse Facility, University of Bern (F0-F1) and Max-von-Pettenkofer Institute (F2-F4). Fecal samples 
were collected at each generation (F0 to F4). After gDNA extraction, fecal microbiota composition was determined 
using a hydrolysis probe based quantitative PCR assay. Data are given as relative abundance. One column represents 
one fecal sample. 
 
 We found that composition of the Oligo-MM12 remained stable over 4 filial generations (Figure 
12 and annexed Table 44). More than 90 % of the microbial population was composed of three strains 
(YL44; Verrucomicrobia and I48, YL27; Bacteroidetes). About 4 % of the fecal microbiota was assigned 
to YL45 (Proteobacteria). The Firmicutes strains made up only 5 % of the microbiota detected in the 
feces of Oligo-MM12-colonized mice. In decreasing order of abundance, we detected YL31, YL32 and 
YL58. I49, KB1 and KB18 were just above detection limit while the isolates I46 and YL2 were never 
detected with this approach. However, I46 was re-isolated by plating cecal content of a F3 generation 
mouse. Thereby, we confirmed that I46 colonized the Oligo-MM12 mice, even though it was not detected 
by qPCR (data not shown). 
 Surprisingly, we noted that the majority (95 %) of the fecal microbiota in Oligo-MM12 mice were 
Gram-negative strains, mainly assigned to the Verrucomicrobia (YL44) and the Bacteroidetes (YL27, 
I48). The minority left (5 %) was Gram-positive strains assigned to the Firmicutes. We reasoned that this 
might be due to a general low DNA extraction efficiency from the Gram-positive strains. 
 To conclude, we confirmed that eleven of the twelve Oligo-MM12 strains can colonize murine 
intestinal tract over 4 filial generations. Regarding YL2, we assume that this strain does either not 
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colonize the intestine of adult mice or is below the detection limit in the feces or present at higher 
abundance in other regions of the intestinal tract or is not viable after freezing. In conclusion, the Oligo-
MM12 stably colonizes the murine gut and is vertically transmitted over at least four generations. Up-to-
date, this Oligo-MM12 mouse colony represents the second gnotobiotic mouse model, after the ASF mice, 
harboring a defined consortium of mouse-derived bacterial strains. 
 
 The Oligo-MM12 consortium partially restores colonization resistance 4.4.
against Salmonella 
 It has been shown in a previous study that ASF-colonized mice lack colonization resistance (CR) 
against the enteric pathogen Salmonella enterica serovar Typhimurium (S. Tm) (Stecher, 2010). 
Regarding the importance of studying the mechanisms of CR in the gut, we tested whether the Oligo-
MM12 microbiota was able to restore CR against S. Tm. 
 In order to determine whether the Oligo-MM12 consortium conferred CR against S. Tm, we used 
ASF-colonized mice harboring five ASF strains (ASF5), which lack colonization resistance. One group of 
ASF5 mice was inoculated with the Oligo-MM12 strains (ASF5 + Oligo-MM12), one group with cecum 
content from a conventional donor mouse (ASF5 + CON) and one mock-inoculated with sterile media as 
control. After microbiota transplantation, the microbiota was allowed to stabilize for 40 days (Figure 
13A). It has been shown that a complex conventional microbiota can restore CR in germfree mice against 
enteropathogens such as S. Tm (Stecher, Chaffron et al. 2010). For infection, we used an avirulent S. Tm 
strain (S. Tmavir) (Hapfelmeier, Ehrbar et al. 2004) as intestinal inflammation induced by S. Tmwt can alter 
microbiota composition and thereby alleviate colonization resistance (Stecher, Robbiani et al. 2007, 
Winter, Thiennimitr et al. 2010). Therefore, we can separate colonization resistance from S. Tm-mediated 
virulence mechanisms. 
 First, we determined gut microbiota composition and complexity at day 40 post-transplantation. 
We analyzed the fecal microbiota composition using 16S amplicon sequencing as well as qPCR and 
determined microbiota complexity of each experimental group by calculating the alpha diversity. To test 
whether the Oligo-MM12 restores CR against S. Tmavir, we orally infected mice with 106 colony forming 
unit (CFU) S. Tmavir and determined the bacterial load at day 1 post-infection (d1 p.i.) in feces and at d2 
p.i. in cecum content and mesenteric lymph nodes (mLN). In addition, we also determined the relative 
cecal weight at d2 p.i. 
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Figure 13. Fecal microbiota composition and diversity 40 days after transplantation with Oligo-MM12 or 
complex microbiota. 
(A) Experimental design. C57Bl/6 mice colonized with 5 ASF strains (ASF5 mice) were inoculated with either the 
Oligo-MM12 (ASF5 + Oligo-MM12; square, 4 mice) or frozen cecum content harvested from a conventional mouse 
(ASF5 + CON; triangle, 5 mice) or mock-inoculated with sterile media as a control (ASF5; circle, 5 mice). After 40 
days (d40), mice were orally infected with 106 CFU of an avirulent strain of S. Tm (S. Tmavir). Feces were sampled at 
day 1 post-infection (p.i.). At day 2 p.i., mice were sacrificed, organs sampled and the relative cecal weight was 
determined. (B) Alpha diversity was determined at d40 as the observed species metric. Data are presented as mean 
and standard deviation. ASF5; circle, ASF5 + Oligo-MM12; square, ASF5 + CON; triangle. (C) Fecal microbiota 
composition at d40 was determined using 16S rRNA gene amplicon sequencing. Sequencing data were processed 
using the QIIME pipeline and taxonomy was assigned against the Silva database. Data are presented as relative 
abundance at the taxonomic family level. One column represents one mouse. Color code is indicated in taxonomic 
legend box. Taxonomic affiliation of the Oligo-MM and ASF strains is indicated (brackets). 
 
 Using alpha diversity measurement, we confirmed that the three mouse groups harbored different 
microbiota complexities. In decreasing order, microbiota of ASF5 + CON mice was strikingly more 
complex than the microbiota of ASF5 + Oligo-MM12 mice, which was more complex than the microbiota 
of ASF5 mice (Figure 13B). Using 16S amplicon sequencing, we analyzed fecal microbiota composition. 
In ASF5 mice, four taxonomic family levels were detected suggesting that the five ASF strains would be 
present in the ASF5 mouse group (Figure 13C). However, both ASF360 and ASF361 strains are affiliated 
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to Lactobacillaceae. Therefore, we used a qPCR assay to detect more specifically bacterial strains. 
Contrary to ASF361 which was present in all ASF5 mice, ASF360 was never detected (Figure 14). Its 
presence remains unclear. In ASF5 + Oligo-MM12 mice, ten taxonomic family levels out of twelve were 
detected using 16S amplicon sequencing (Figure 13C). However, Erysipelotrichaceae and 
Deferribacteraceae were only detected in very low abundance. As for ASF5 mice, several strains were 
affiliated to the same taxonomic family. Using qPCR, we detected YL31 among the Ruminococcaceae as 
well as YL32 and YL58 among the Lachnospiraceae (Figure 14). Interestingly, ASF457 was better 
detected using qPCR. Finally, in ASF5 + Oligo-MM12 mice, the bacterial strains YL2, KB1, I49, KB18, 
ASF502, ASF360 and ASF361 were either not colonizing or under detection limit. In ASF5 + CON mice, 
microbiota composition analysis revealed fifteen different OTUs at the taxonomic family level (Figure 
13C). 
 
 
Figure 14. Fecal microbiota composition of ASF5 mice colonized with the Oligo-MM12 or mock-inoculated, 
analyzed using a hydrolysis probe based quantitative PCR assay. 
Fecal DNA from the experiment described in Figure 13 was analyzed to determine fecal microbiota composition 
using a hydrolysis probe based quantitative PCR assay. Data are given as relative abundance of the summed total 
reads of the individual strains. One column represents one fecal sample. 
  
 In summary, we confirmed the presence of four bacterial strains in ASF5 mice and ten strains in 
ASF5 + Oligo-MM12 mice. We showed that the majority of the Oligo-MM12 strains were present in ASF5 + 
Oligo-MM12 mice. Furthermore, we also set up three experimental groups with an increased microbiota 
complexity such as four different OTU at the taxonomic family level are present in ASF5 mice, ten in 
ASF5 + Oligo-MM12 mice and fifteen in ASF5 + CON mice.  
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 Next, we aimed to study CR in these three mouse groups. Therefore, we infected mice with 106 
CFU S. Tmavir and determined the bacterial load at d1 p.i. in feces and at d2 p.i. in cecum content and 
mLN. We also determined the relative cecal weight at d2 p.i. 
 At day 1 p.i., total pathogen loads were significantly reduced in feces from ASF5 + Oligo-MM12 
mice compared to the ASF5 mice (Figure 15A, p-value 0.0079) showing that Oligo-MM12 consortium 
increases CR of ASF5-colonized mice. Interestingly, there was no significant difference between the ASF5 
+ Oligo-MM12 and the ASF5 + CON mice. At day 2 post-infection, S. Tmavir loads were still significantly 
lower in ASF5 + Oligo-MM12 mice compared to ASF5 mice (Figure 15B). Similarly, in mLN, S. Tmavir 
loads were intermediate in ASF5 + Oligo-MM12 mice (Figure 15C). Relative cecal weight was 
significantly reduced in ASF5 + Oligo-MM12 mice. Mice transplanted with CON microbiota exhibited a 
low relative cecal weight which is in the normal range of conventional mice (Figure 15D) (Stecher, 
Chaffron et al. 2010). 
 These data indicate that the Oligo-MM12 consortium partially restored CR against S. Tmavir. 
Furthermore, the data suggest that a number of strains from a conventional microbiota are still missing in 
order to provide full colonization resistance. However, our data indicated that microbiota complexity 
positively correlates with CR. This could be due to the higher metabolic and functional diversity of a more 
complex microbiota. 
 In order to test this idea, we analyzed and compared the functionome of each microbial 
consortium using metagenomics analysis. 
Results 
 
 
82 
 
 
Figure 15. Oligo-MM12 consortium partially restores colonization resistance against S. Tmavir. 
S. Tmavir load at day 1 p.i. in (A) feces and at day 2 p.i. in (B) cecum and (C) mesenteric lymph nodes (mLN). (D) 
Relative cecal weight at day 2 p.i. Dotted lines: detection limit. Bars indicate medians. Mann-Whitney U test: ns=not 
significant (P≥0.05), ** P<0.01. One-way ANOVA Kruskal-Wallis test: (A) P=0.0045, (B) P=0.0025, (C) P=0.0024, 
(D) P=0.0019. 
  
 Functional analysis correlates functional capacity of intestinal 4.5.
microbiota and CR against Salmonella 
 To analyze and compare the functionome of each microbial consortium, we first performed whole-
genome shotgun sequencing of each Oligo-MM strains. Using either single shotgun genomes of Oligo-
MM and ASF strains (Wannemuehler, Overstreet et al. 2014) or metagenomes of conventional mice 
(JCVI 2013, Nanjing University 2013, Milk 2014, Wang, Linnenbrink et al. 2014), we generated artificial 
metagenomes which correspond to the three experimental communities: ASF5, ASF5 + Oligo-MM12 and 
ASF5 + CON. To determine the presence and completeness of functional modules in each community, 
predicted protein sequences were aligned against the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
database (Ogata, Goto et al. 1999) and gene families were organized into different functional units 
(Kanehisa, Goto et al. 2014). 
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 We found that, ASF5 + CON community encodes proteins belonging to more functional modules 
than ASF5 + Oligo-MM12 and ASF5, in decreasing order (Figure 16). This observation positively 
correlates with gut microbiota complexity and CR against S. Tmavir (Figures 13B and 15). Based on this, 
we hypothesized that the more functional modules are present within a gut community, the higher is the 
functional capacity of the community and, therefore, the more CR against S. Tmavir is observed. However, 
deciphering CR mechanisms appears challenging using functionome predictions based on complex gut 
communities. 
 Next, we aimed to study CR mechanisms by using decreased microbiota complexity based on 
ASF and Oligo-MM strains only. 
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Figure 16. Functionome analysis correlates functional diversity with colonization resistance. 
Heat maps illustrating KEGG module presence predicted for each artificial metagenome. Briefly, single shotgun 
genome sequences of 5 ASF and 12 Oligo-MM strains were used to create artificial metagenomes (ASF5 and Oligo-
MM12, respectively). KEGG analysis was performed to analyze functional diversity of microbiota ASF5, ASF5 + 
Oligo-MM12 and ASF5 + CON. A metagenome from 8 conventional mice was used (JCVI 2013, Nanjing University 
2013, Milk 2014, Wang, Linnenbrink et al. 2014). (A) KEGG modules absent from ASF5 microbial consortium and 
fully or partially present in ASF5 + CON and ASF5 + Oligo-MM12, respectively. (B) KEGG modules predicted as 
present in all three microbial communities, except of putative peptide transport system (M00583) which is only 
present in ASF5 + Oligo-MM12 community. Each line represents one KEGG module. Color code refers to 
completeness indicator of KEGG module: dark green: module complete; light green: 1 block missing; apple-green: 2 
blocks missing and white: module not present. 1: ASF5 + CON; 2: ASF5 + Oligo-MM12 and 3: ASF5. 
  
 Colonization resistance of Oligo-MM12 mice can be increased by 4.6.
transfer of ASF7 
 Our previous results showed that transplantation of the Oligo-MM12 can increase CR of ASF5 
mice against S. Tmavir and that functional capacity of the microbiota community correlated positively with 
CR. In order to better study the correlation between CR and functionome, we used two well-defined 
microbiota: the Oligo-MM12 and a consortium of eight ASF strains (ASF356, ASF360, ASF361, ASF457, 
ASF492, ASF500, ASF502, ASF519; ASF8). We first predicted and compared the functionome of CON 
community, the Oligo-MM12 and the ASF8, using metagenomics and KEGG module analysis, as described 
in Figure 16. 
 We found that CON community encodes proteins belonging to more functional modules than 
Oligo-MM12 and ASF8, in decreasing order (Figure 17). Interestingly, we also found that some functional 
modules are present in ASF8 community but absent from Oligo-MM12 (Figure 17A).  
 Previously, we hypothesized that the more functional modules are present within a gut community 
and the more CR against S. Tmavir is observed. Therefore, we aimed to generate a microbiota with 
increased number of functional modules by transplanting Oligo-MM12 mice with ASF8 microbiota. 
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Figure 17. Functionome analysis correlates microbiota complexity with functional diversity. 
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KEGG analysis was performed to analyze functional diversity of microbiota ASF8, Oligo-MM12 and CON. (A) Heat 
maps illustrating KEGG module presence predicted for each artificial metagenome. (B) KEGG modules predicted as 
present in all three microbial communities, except of putative peptide transport system (M00583) which is only 
present in Oligo-MM12 community. Each line represents one KEGG module. Color code refers to completeness 
indicator of KEGG module: dark green: module complete; light green: 1 block missing; apple-green: 2 blocks 
missing and white: module not present. 1: CON; 2: Oligo-MM12 and 3: ASF8. 
 
 To test whether transplantation of Oligo-MM12 mice with additional ASF strains would influence 
functionome predictions and CR, we used mice stably colonized with four ASF strains (ASF356, ASF361, 
ASF502, ASF519; ASF4) and mice stably colonized with the twelve Oligo-MM strains (Oligo-MM12). 
ASF4 and Oligo-MM12 mice were bred in different isolators and mice were transferred into gnotocages 
prior to the start of the experiment. In order to test whether transplantation of additional bacterial strains 
may influence CR, we inoculated a consortium of seven ASF strains (ASF356, ASF360, ASF361, 
ASF457, ASF500, ASF502, ASF519; ASF7) in either ASF4 or Oligo-MM12 mice. In addition, we 
transplanted ASF4 and Oligo-MM12 mice with sterile media, as controls (Figure 18A). Frozen inoculum 
of ASF7 was prepared as described in Materials & Methods (3.2.2.4.). After inoculation, the microbiota 
was allowed to stabilize for 40 days in gnotocages under germfree conditions. To analyze microbiota 
composition, feces were sampled at day 40 post-inoculation, fecal DNA was extracted and microbiota 
composition was analyzed by qPCR. At day 40 post-inoculation, all mice were orally infected with 5x106 
CFU S. Tmavir. Total pathogen loads were determined at day 1 post-infection (d1 p.i.) in feces and at d2 
p.i. in cecal content and in the mLN. We also calculated the relative cecal weight as a marker of 
microbiota complexity. 
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Figure 18. Establishment of gnotobiotic mice harboring an increased microbiota complexity. 
(A) Experimental design. C57Bl/6 mice harboring either 4 ASF strains (ASF356, ASF361, ASF502 and ASF519; 
ASF4) or 12 Oligo-MM strains (YL2, YL27, YL31, YL32, YL44, YL45, YL58, KB1, KB18, I46, I48, I49; Oligo-
MM12) were either inoculated with 7 ASF strains (ASF4 + ASF7, 5 mice; empty circle and Oligo-MM12 + ASF7, 6 
mice; empty square, respectively) or sterile media as control (ASF4, 3 mice; circle and Oligo-MM12, 6 mice; square, 
respectively). Seven ASF strains were orally and rectally inoculated with 6 ASF strains prepared as a frozen stock 
(ASF356, ASF360, ASF361, ASF457, ASF502, ASF519) and 1 ASF (ASF500) as actively growing culture. After 40 
days, mice were orally infected with 6x106 CFU S. Tmavir. Feces was sampled at day 1 post-infection (p.i.). At day 2 
p.i., mice were sacrificed and organs sampled. Relative cecal weight was determined at day 2 p.i. (B) Fecal 
microbiota composition was determined using a hydrolysis probe based quantitative PCR assay. Data are shown as 
relative abundance. One column represents one mouse. 
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 At day 40 post-inoculation, three bacterial strains were detected by qPCR in fecal samples of 
ASF4-colonized mice, four in ASF4 + ASF7, seven in Oligo-MM12 and twelve in Oligo-MM12 + ASF7 
(Figure 18B). Six bacterial strains (ASF360, ASF500, ASF502, YL2, I46, KB18) were never detected and 
two (I49 and KB1) were only found in feces at low levels. 
 At day 1 p.i., total pathogen loads were significantly reduced in feces from Oligo-MM12-colonized 
mice compared to ASF4 mice showing that stable colonization with the Oligo-MM12 consortium confers 
CR against S. Tmavir (Figure 19A, p-value 0.0275). Surprisingly, ASF4 mice harbouring three additional 
ASF strains (ASF4 + ASF7 mice) had higher pathogen loads compared to the Oligo-MM12 mice (p-value 
0.0043). This suggests that, in this case, the three additional ASF strains ASF360, ASF457 and ASF500 
(with only ASF457 being detected by qPCR) decreased CR against S. Tmavir. At day 2 p.i., S. Tmavir loads 
were still significantly lower in Oligo-MM12 mice as compared to ASF4 mice (Figure 19B, p-value 
0.0238). Similarly, S. Tmavir loads were significantly lower in Oligo-MM12 + ASF7-colonized mice as 
compared to ASF4 + ASF7-colonized mice (p-value 0.0043). Strikingly, pathogen loads were significantly 
lower in mice harbouring the Oligo-MM12 + ASF7 consortium as compared to their Oligo-MM12-colonized 
littermate controls (p-value 0.0043) suggesting that the increase of microbiota complexity correlates with 
the increase in CR, in this case. Thus, the addition of ASF strains can only increase CR in the context of 
the Oligo-MM12. This suggests that ASF strains might occupy different niches in ASF4-colonized mice as 
compared to Oligo-MM12 mice. Interestingly, very low or no pathogen colonization was observed in mLN 
of Oligo-MM12- and Oligo-MM12 + ASF7-colonized mice, respectively, whereas mLN of ASF4- and ASF4 
+ ASF7-colonized mice were significantly higher colonized by S. Tmavir, as compared to Oligo-MM12-
colonized mice (Figure 19C, p-values 0.0357 and 0.0079, respectively). Relative cecal weight was 
significantly reduced in Oligo-MM12- and Oligo-MM12 + ASF7-colonized mice as compared to ASF4- and 
ASF4 + ASF7-colonized mice (Figure 19D). 
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Figure 19. Microbiota complexity correlates with increased colonization resistance against S. Tmavir. 
S. Tmavir load at day 1 p.i. in (A) feces and at day 2 p.i. in (B) cecum and (C) mesenteric lymph nodes (mLN). (D) 
Relative cecal weight at day 2 p.i.. Dotted lines: detection limit. Bars represent medians. Mann-Whitney U test: ** 
P<0.01. One-way ANOVA Kruskal-Wallis test: (A) P=0.0013, (B) P=0.0009, (C) P=0.0013, (D) P=0.0028. 
 
 In conclusion, these results clearly show that Oligo-MM12-colonized groups are more resistant 
against S. Tmavir colonization than ASF4-colonized groups. 
 In order to investigate potential CR mechanisms, we analyzed and compared the functionome of 
each microbiota using metagenomics and KEGG module analysis as described in Figure 16. We 
hypothesized that analyzing these well-defined consortia combined with their respective CR phenotypes 
observed during S. Tmavir infection would help us deciphering potential functional modules responsible for 
CR against S. Tmavir. 
 We found that Oligo-MM12 + ASF7 community encodes proteins belonging to more functional 
modules than Oligo-MM12, ASF4 + ASF7 and ASF4, in decreasing order (Figure 20A). As previously 
noticed in Figure 16, this observation correlates with gut microbiota complexity and CR property against 
S. Tmavir (Figures 18B and 19B). When comparing Oligo-MM12- with ASF4-colonized mouse groups, the 
analysis revealed that functional modules pointed out in block “B” was present in Oligo-MM12- but not in 
ASF4-colonized mouse groups (Figure 20B). Combined with S. Tmavir infection experiment (Figure 19), 
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it suggests that either a part or all of these functional modules (e.g. nitrate respiration and osmotic stress 
response) may be implicated in CR mechanisms against S. Tmavir. When comparing Oligo-MM12 + ASF7 
and Oligo-MM12 communities, we found that encoded proteins belonging to functional modules showed in 
block “D” are present in Oligo-MM12 + ASF7-colonized mice but not in Oligo-MM12 community (Figure 
20D). Together combined with S. Tmavir infection experiment (Figure 19), it suggests that functional 
modules found in this “D” block (e.g. type VI secretion system and envelope stress response) may be 
important for CR. We have previously shown that S. Tmavir loads in feces, cecal content and mLN of 
ASF4- and ASF4 + ASF7-colonized mice were similar (Figure 19A-C). According to this functionome 
analysis, ASF4 + ASF7 community showed encoded proteins belonging to functional modules presented in 
block “C” and in a subpart of block “D” which are absent of ASF4 community (Figure 20C,D) which 
suggests that these functional modules may not play a direct role in CR against S. Tmavir. As an example, 
type VI secretion system might not be a good candidate involved in CR mechanisms against S. Tmavir or 
may be differentially activated in the context of Oligo-MM12 + ASF7 mice as compared to ASF4 + ASF7-
colonized mice.  
 We conclude that by using this approach, we are able to generate hypotheses about potential 
pathways and functions involved in CR. 
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Figure 20. Functionome analysis indicates potential metabolic pathways involved in CR against S. Tm 
KEGG module analysis was performed to analyze functional capacity of ASF4, ASF4 + ASF7, Oligo-MM12 and 
Oligo-MM12 + ASF7 microbiota. In silico assemblies (artificial metagenomes) of individual genome sequences were 
generated. (A) Overview. Heat map illustrating presence and absence of KEGG modules in each artificial 
metagenome. (B-D) Zoom in of rectangles. (B) Modules only present in Oligo-MM12-colonized groups. (C) Modules 
absent from ASF4 mice and present in other groups. (D) Modules entirely or partially present in ASF-colonized 
groups. Each line represents one KEGG module. Color code refers to completeness indicator of KEGG module: dark 
green: module complete; light green: 1 block missing; apple-green: 2 blocks missing and white: module not present. 
1: Oligo-MM12 + ASF7; 2: Oligo-MM12; 3: ASF4 + ASF7 and 4: ASF4. 
 
 Next, we aimed to decipher single bacterial strains involved in CR against S. Tm. To this end, we 
combined previous results from functional analysis of artificial metagenomes with functional analysis of 
single ASF and Oligo-MM strains. 
 Firstly, we found that some KEGG modules potentially involved in CR against S. Tmavir were 
specific to few strains only (Figure 21A). For example, KEGG module predicted to be involved in 
envelope stress response (M00450) is only found in ASF502; KEGG modules predicted to be involved in 
osmotic stress response (M00445 and M00461) are only present in YL45 and KB1, respectively. More 
generally, KEGG modules predicted to encode proteins involved in respiration, dissimilation, reduction or 
assimilation of nitrate are present in the bacterial strains YL45, I48, I49, ASF457 and ASF519 (Figure 
21A). Secondly, we found that some KEGG modules were more likely specific of either Gram-positive or 
Gram-negative strains (blocks “C” and “D”, respectively) (Figure 21B). Finally, other KEGG modules 
(block “E”) were mostly predicted as conserved functions in all bacterial strains (Figure 21B). 
Importantly, the incompleteness of KEGG modules (i.e. one or two block missing) could be due to 
sequencing errors or incomplete databases. Most likely, the genomes of these organisms contain a high 
fraction of genes with unknown functions, which remains to be described. All together, these observations 
suggest that CR might be explained by the presence or the absence of certain KEGG modules. 
 In conclusion, further experiments are required to determine the contribution of individual strains 
and their functions in CR against S. Tm. 
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Figure 21. KEGG module analysis of single ASF and Oligo-MM strains. 
Heat map illustrating the functionome analysis of 8 ASF strains (ASF356, ASF360, ASF361, ASF457, ASF492, 
ASF500, ASF502 and ASF519) and 12 Oligo-MM strains (YL2, YL27, YL31, YL32, YL44, YL45, YL58, KB1, 
KB18, I46, I48, I49) using KEGG analysis. (A) Modules mostly specific of few strains. (B) Modules present or 
absent in all strains and mainly present in Gram-positive strains (block C), Gram-negative strains (block D) or 
conserved (block E). Each line represents one KEGG module. Color code refers to completeness indicator of KEGG 
module: dark green: module complete; light green: 1 block missing; apple-green: 2 blocks missing and white: 
module not present. Each column represents one strain. 
 
 To conclude, using this well-defined experimental design combined with metagenomics and 
functionome analyses, we generated new hypotheses and isolated functional modules which could be 
involved in CR against S. Tmavir. As an example, we showed that nitrate respiration and stress responses 
may be potentially involved in CR mechanisms (Figures 19 and 20). We also pointed at other pathways 
specific to conventional microbiota, which remain to be described (Figures 15 and 16). Finally, we 
demonstrated that the Oligo-MM model is a powerful tool to study CR mechanisms using metagenomics, 
functionome analysis, qPCR, 16S rRNA gene-based amplicon sequencing and single strain cultivation. 
 
 Establishment of a fluorescence in situ hybridization assay to detect, 4.7.
localize and quantify individual Oligo-MM strains 
 The majority of research groups studies gut microbiota composition by gDNA extraction-based 
approaches such as qPCR and 16S rRNA gene amplicon sequencing. However, it becomes more and more 
apparent that such techniques misestimate the true ratio between Gram-positive and Gram-negative 
bacteria, as Gram-positive bacteria are partially refractory to cell lysis in DNA extraction protocols. This 
leads to underestimate the abundance of Gram-positive strains. Moreover, such techniques do not provide 
any information on bacterial localization in the gut, which impedes ecological and interactional studies. 
 In order to detect and localize single bacterial strains in tissue sections, we established a 
fluorescence in situ hybridization (FISH) assay. To quantify the abundance of specific bacterial 
populations and confirmed gDNA extraction-based data, we also developed a computational approach 
using the software digital image analysis in microbial ecology (DAIME) (Daims, Lucker et al. 2006). 
 FISH was performed as described in Materials & Methods (3.2.3.15.). Briefly, full-length 16S 
rRNA genes of ASF and Oligo-MM strains were computationally aligned and specific probes were 
designed using CLC DNA Workbench 6.0.2 software. To increase the fluorescence signal, each 
oligonucleotide probe was double-labelled with either fluorescein isothiocyanate (FITC) or cyanine 3 
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(Cy3). To target the entire eubacterial population, a 1:1 mixture of Eub338 I (Amann, Binder et al. 1990) 
and Eub338 III (Daims, Bruhl et al. 1999) (Eub338 I/III) was double-labelled with cyanine 5 (Cy5). After 
optimization of fluorescence signal using formamide concentration series (Table 34), probe specificity 
was tested on all other strains. FISH was performed on PFA-fixed cecal cryosections and images were 
taken using confocal microscopy. Images were analyzed using the DAIME software (Daims, Lucker et al. 
2006). It is known that intestinal cells and plant fibers emit auto-fluorescence which hampers 
computational image analysis. In order to deplete this unspecific auto-fluorescent background, FITC and 
Cy3 channels were subtracted from Cy3 and FITC channels, respectively, using the DAIME software. 
 Gut environment harbors different bacterial niches. For example, microbiota composition of 
mucus layer differs from the gut lumen (Li, Limenitakis et al. 2015). First, we wanted to test whether we 
could detect mucosal enrichment of a bacterial population using this approach. It is known that 
Akkermansia muciniphila is able to degrade mucin (Derrien, Vaughan et al. 2004). Therefore, we used the 
Oligo-MM strain YL44. We hypothesized that YL44 might be enriched at the cecal mucus layer. 
 To confirm that Muc1437 probe allowed detection of YL44 in vivo, we used gnotobiotic mice 
colonized with a low complexity microbiota (LCM) as negative control and LCM mice colonized with 
YL44 (LCM + YL44) for 21 days, as positive control. We performed FISH and DAIME analysis on these 
mice as well as on Oligo-MM12-colonized mice (Oligo-MM12) to analyze the distribution of bacterial 
population across cecal cross-sections. Sections were hybridized with Muc1437-Cy3 and Eub338 I/III-
Cy5, and then DNA was stained with DAPI. Confocal images were taken and merged images were 
virtually sliced from the epithelial border to the gut lumen (40 µm thick) and slicer templates were applied 
to grey level images (Figure 22D-F). Biovolume of targeted bacterial population (Muc1437-Cy3+) was 
calculated relative to biovolume of all Eub338 I/III-Cy5+ population. 
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Figure 22. Establishment of a FISH assay to localize and quantify single strains in the Oligo-MM12 mouse gut. 
Gnotobiotic mice stably colonized with a low complexity microbiota (LCM) (A, D, G) were inoculated with YL44 
for 21 days (LCM + YL44) (B, E, H). Mice were stably colonized with 12 Oligo-MM strains (I46, I48, I49, KB1, 
YL2, YL27, YL31, YL32, YL44, YL45, YL58, KB18; Oligo-MM12) (C, F, I). Upper right squares in A-C are the 
respective zoom in. (A-C) FISH on PFA-fixed cecal cryosections targeting all bacteria (Eub338-I/III, blue), YL44 
(Muc1437, red) or gDNA (DAPI, grey). Scale bars: 25 µm. White line: epithelial border. (D-F) Slicer template 
generated by DAIME. Same magnification as for (A-C). Colors represent the different virtual layers from the 
epithelial border (dark red) to the gut lumen (light blue). Thickness: 40 µm. (G-I) YL44 biovolume quantification 
relative to Eub338 probe signal using DAIME in (G) LCM-colonized mouse (3 mice, 12 pictures), in (H) LCM + 
YL44-colonized mouse (3 mice, 34 pictures) or in (I) Oligo-MM12-colonized mice (5 mice, 33 pictures). Detection 
limit is given by signal detected in (G): 0.65 %. Data are given as mean and standard deviation. Mann-Whitney U 
test: *** P<0.001. One-way ANOVA Kruskal-Wallis test: (G) P=0.6514, (H) P<0.0001, (I) P=0.0643. 
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 On cecal cross-sections of LCM-colonized mice, we observed low Muc1437 signal (Figure 
22A,G). As this signal was not co-localized with Eub338 I/III signal, we concluded that the signal derived 
from unspecific binding of the probe to the cecal content, which might be due to the fluorophore itself 
(Cy3, in this case). We confirmed this hypothesis using another fluorophore (FITC) which appeared to 
exhibit less unspecific binding (data not shown). On cecal sections of LCM + YL44-colonized mice, we 
observed that Muc1437 probe hybridized to small coccoid bacterial cells similar to YL44 which seemed to 
be enriched at the epithelial border (Figure 22B). When calculating YL44 relative biovolume, we 
confirmed that YL44 was significantly enriched between 0 and 40 µm from the epithelial border 
compared to deeper layers within the lumen (Figure 22H). However, on cecal sections of Oligo-MM12-
colonized mice, YL44 was homogenously distributed in cecal cross-section (Figure 22C). This was 
confirmed by the relative biovolume showing no enrichment between 0 and 240 µm from the epithelial 
border (Figure 22I). 
 To sum up, we established a new approach combining FISH and DAIME analysis in order to 
specifically detect and quantify a bacterial population through cecal cross-sections. We showed that YL44 
was enriched at the epithelial border in LCM + YL44-colonized mice but not in Oligo-MM12-colonized 
mice. This suggests that the distribution of YL44 bacterial population in mouse cecum is dependent on 
microbial context. 
 Due to different composition of their cell wall, Gram-negative and Gram-positive bacteria exhibit 
distinct cell wall permeability. This can also affect bacterial lysis during gDNA extraction, which is used 
for qPCR or 16S rRNA gene-based microbiome analysis (Salonen, Nikkila et al. 2010, Maukonen, Simoes 
et al. 2012). Therefore, we wanted to validate this approach for a Gram-positive strain assigned to the 
Lachnospiraceae family (YL58). By FISH, we aimed at comparing relative biovolumes of YL58 and 
YL44 which are Gram-positive and -negative strains, respectively, with relative 16S rRNA gene copy 
abundance determined using qPCR and 16S rRNA gene-based amplicon sequencing in stably colonized 
Oligo-MM12 mice. To specifically target YL58, we designed probe YL58_180 (Table 4). In order to test 
binding specificity, we used another negative control approach and designed the YL58_180_negctrl probe. 
YL58_180_negctrl probe is the reverse-complement sequence of YL58_180 and is not targeting any of the 
Oligo-MM strains. Finally, we compared the relative abundance of 16S rRNA gene copy numbers with 
the relative biovolume for both strains. All three analyses were performed on Oligo-MM12 mice (Figure 
23). 
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Figure 23. Detection and relative quantification of, YL58, a Gram-positive strain present in Oligo-MM12 
mouse cecum. 
FISH on PFA-fixed cecal cryosections of Oligo-MM12 mice targeting all bacteria (Eub338-I/III), gDNA (DAPI) and 
either none as negative control (YL58_180_negctrl, reverse complement probe of YL58_180) (A) or YL58 
(YL58_180) (B). (A) Background and unspecific signal relative to Eub338-I/III signal quantified using DAIME (3 
mice, 9 images). (B) YL58 biovolume quantification relative to Eub338-I/III signal using DAIME (5 mice, 39 
images). Colors represent the different virtual layers from the epithelial border (dark red) to the gut lumen (light 
blue). Thickness: 40 µm. Detection limit is given by signal detected in (A): 0.17 %. Data are presented as mean and 
standard deviation. One-way ANOVA Kruskal-Wallis test: (A) P=0.2248, (B) P=0.7612. 
 
 We found that YL58 was homogeneously distributed in Oligo-MM12-colonized mice between 0 
and 240 µm from the epithelial border (Figure 23). As the FISH and DAIME analysis were not performed 
on all Oligo-MM strains, biovolume data were determined as relative to Eub338 I/III signals. Therefore, 
we could not directly compare gDNA-extraction and rRNA-based approaches. Interestingly, we could 
show that 26.1±6.1 % and 24±7.7 % 16S rRNA gene copy abundance of YL44 were detected using qPCR 
and 16S rRNA gene-based amplicon sequencing, respectively, whereas about 8.3±5 % was detected using 
FISH (Figure 24). We also found that 0.34±0.09 % and 0.24±0.07 % 16S rRNA gene copy abundance of 
YL58 were detected using qPCR and 16S rRNA gene-based amplicon sequencing, respectively, whereas 
more than 20 % was detected using FISH. 
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Figure 24. Detection and relative quantification of YL58 and YL44 by FISH analysis reveals misestimation of 
this strain using gDNA-based quantitative approaches. 
Quantitative real-time PCR (qPCR), amplicon sequencing (454-seq) and FISH were performed on the same Oligo-
MM-colonized mice (n = 4, F2 generation, 8-9 weeks old females) in order to compare different analysis methods. 
Fecal gDNA were extracted using a modified QIAmp DNA Stool kit protocol including a bead-beating step and 
relative bacterial abundance was determined by qPCR and amplicon sequencing, as described in Figures 9 and 12. 
Relative abundance of 16S rRNA gene copies is given in percentage. FISH was performed as previously described 
(see Figures 22 and 23) on cecal cryosections. Relative biovolume abundance is given in percentage. Color code 
refers to the strain: purple: YL44 and green: YL58. 
 
 In conclusion, we validated FISH and DAIME analysis for a Gram-positive strain, YL58. We 
showed that in cecum of Oligo-MM12-colonized mice YL58 was equally distributed between 0 and 240 
µm from the epithelial border. Moreover, our results point out at under- and over-estimation of the 
abundance of Gram-positive and –negative strains, respectively, using qPCR and 16S rRNA gene-based 
amplicon sequencing, as compared to FISH approach. 
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 Results - The role of the mucus layer and the microbiota during 5.
Salmonella enterica serovar Typhimurium infection 
 The intestinal mucus layer is widely known to provide protection against enteric infections. 
Mucus-deficient mice were shown to be more susceptible to infection with enteric pathogens such as 
Citrobacter rodentium and Salmonella enterica serovar Typhimurium (S. Tm) as compared to 
heterozygous mice (Bergstrom, Kissoon-Singh et al. 2010, Zarepour, Bhullar et al. 2013). However, 
mucus-deficient mice also develop spontaneous colitis already at young age, which hampers analyzing the 
course of enteric pathogen infections and induction of inflammation (Van der Sluis, De Koning et al. 
2006, Wenzel, Magnusson et al. 2014). Anterior gradient homolog 2 (AGR2) is a member of the protein 
disulfide isomerase family (Persson, Rosenquist et al. 2005). Expressed in mucus-producing cells, AGR2 
is essential for correct folding and export of MUC2, the major component of the cecal and colonic mucus 
layer (Park, Zhen et al. 2009). Contrary to previous studies (Zhao, Edwards et al. 2010), we never 
observed spontaneous colitis of AGR2-deficient (AGR2ko) mice in our animal facility. 
 The second chapter of this thesis deals with the role of the intestinal mucus layer and the 
microbiota in enteric S. Tm infection of AGR2ko mice. We observed that streptomycin-treated AGR2-
deficient (AGR2ko) mice but not ampicillin-treated mice were protected against early S. Tm-induced 
colitis (day 1 p.i.) as compared to heterozygous littermate controls (AGRhet). Analyses of the composition 
of the intestinal microbiota revealed that this protective effect might be due to a differential microbiota 
composition in AGR2ko vs AGR2het mice rather than the genetic background of the mice. Microbiome 
analyses of streptomycin- versus ampicillin-treated animals enabled us to narrow down potential 
protective candidates against S. Tm-induced colitis. In addition, by using GFP-reporters of S. Tm 
virulence gene expression, we could show that expression of the type III secretion system 1 (T3SS-1) was 
downregulated in the protected group and significantly less S. Tm were found to invade the mucosa of 
streptomycin-treated (sm-treated) AGR2ko mice. 
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  AGR2ko mice exhibit a defect in MUC2 secretion in the cecal mucosa 5.1.
 In 2009, Park et al., showed that AGR2 wild-type (AGR2wt) mice secrete the intestinal mucin 
MUC2 but not AGR2ko mice (Park, Zhen et al. 2009). In order to investigate whether AGR2het mice also 
secrete MUC2 in cecum, we performed immunofluorescent staining of MUC2, a major component of the 
cecal mucus layer. As Bergström et al., we found that cecal goblet cells of AGR2het mice secreted MUC2 
which was absent in AGR2ko littermates (Figure 25) (Bergstrom, Berg et al. 2014). Thus, we decided to 
use AGR2het mice as controls to study the role of the mucus layer in the AGR2ko mouse model. In order to 
obtain a higher proportion of KO genotype in littermate experimental groups, we bred AGR2het X AGR2ko 
mice. 
 
Figure 25. AGR2ko mice show defective mucin 
secretion compared to AGR2het littermate controls. 
Immunofluorescent staining of MUC2 on paraffin 
embedded cecal sections of AGR2ko and AGR2het mice. 
Mice were sacrificed before (untreated) or 24 h after 
streptomycin treatment (sm-treated), cecal tissue was 
sampled, fixed in Carnoy’s solution and embedded in 
paraffin. Immunofluorescent staining was performed on 
sections (5 µm thick) using DAPI (light grey) and sytox 
green (green) to visualize nuclei and bacterial DNA, 
respectively, as well as anti-MUC2 H-300 antibody (red) 
to visualize MUC2 production in goblet cells as well as 
intestinal secretions (arrows). Pictures were taken using 
confocal microscopy and are representatives of 2 
independent experiments (5-6 mice per group, 3 pictures 
per mouse). Scale bar: 40 µm. 
 
 
 AGR2ko mice show significantly attenuated inflammation 1 day post 5.2.
S. Tm infection compared to littermate controls in sm-treated mice 
 Because the intestinal microbiota is known to provide colonization resistance (CR) against S. Tm 
in specific pathogen-free (SPF) mice, we used streptomycin (sm) treatment to decrease microbiota density 
and allow S. Tm to colonize mouse intestine and induce colitis (Barthel, Hapfelmeier et al. 2003). To test 
whether mucins were still secreted in AGR2het mice after sm-treatment, we also used immunofluorescent 
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staining targeted MUC2. We observed that sm-treated AGR2het cecal epithelial cells were still covered by 
mucus layer while AGR2ko were not showing MUC2 secretion (Figure 25). 
 It is already known that mice deficient in mucus secretion are more susceptible to infection with 
different enteric pathogens. However, it remains unclear whether this increased susceptibility to infections 
is correlated with spontaneous colitis. The lack of MUC2 allows the microbial community to come in 
direct contact with the epithelial border, penetrate deeply in the normally sterile crypt space or even 
invade into epithelial cells. This leads to spontaneous colitis in the majority of mucus-deficient mouse 
models such as Muc2ko, AGR2ko and Winnie mouse models (Van der Sluis, De Koning et al. 2006, Zhao, 
Edwards et al. 2010, Eri, Adams et al. 2011). 
 In order to determine whether AGR2ko mice, which exhibit reduction of MUC2 secretion in the 
large intestine, are more susceptible to S. Tm infection as compared to AGR2het littermates, we infected 
sm-pretreated mice with 105 to 106 CFU S. Tm wild-type (S. Tmwt) harbouring a plasmid that encodes 
GFP under control of the SPI-2 promoter pssaG (S. Tmwt,gfp). S. Tmwt,gfp infection was performed one day 
after sm-treatment (25 mg/mouse). Mice were sacrificed and total pathogen loads were determined at days 
1, 2 and 3 p.i. in cecal content and mesenteric lymph nodes (mLN). As markers of inflammation and 
pathology, we determined the inflammation marker lipocalin-2 (Lcn2) concentrations in cecal content and 
assessed cecal inflammation using a histopathological score, respectively. We also recorded the mouse 
weight over-time. 
 At days 0, 1 and 2 p.i., weight loss of sex and age matched AGR2ko mice was significantly more 
pronounced in AGR2ko mice, in particular 24 h after sm-treatment (Figure 26A, p-value <0.0001). The 
reason for this currently remains unclear. At d1 p.i., total pathogen loads were significantly increased in 
cecal content of AGR2ko mice as compared to AGR2het mice (Figure 26B, p-value 0.0195). This 
difference disappeared from d2 p.i. on. AGR2ko and AGR2het mice show similar increase of pathogen 
loads in mLN over-time showing an increased tissue invasion and/or S. Tmwt,gfp cell replication (Figure 
26C, p-value 0.0099). Surprisingly, despite increased S. Tmwt,gfp loads in cecal content of AGR2ko mice, 
AGR2ko mice showed less inflammation in the cecum at d1 p.i. as compared to AGR2het mice (Figure 
26D,F, p-value 0.0004). This has been confirmed by significantly reduced Lcn2 levels on the cecal 
content at d1 p.i. (Figure 26E). 
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Figure 26. AGR2ko mice show attenuated inflammation 1 day post-S. Tmwt oral infection compared to 
AGR2het mice. 
AGR2het and AGR2ko mice were orally gavaged with a single dose of streptomycin (sm; 25 mg/mouse). One day 
after sm-treatment (d0), mice were orally gavaged with 105 to 106 CFU S. Tmwt harbouring pM973 plasmid, which 
constitutively expresses GFP (S. Tmwt,gfp). Infected and uninfected mice were sacrificed either before infection (d0) 
or post-infection (p.i.) at days 1, 2 or 3 (d1, d2 or d3). (A) Mouse weight was recorded over-time and is relative to 
the initial weight recorded before sm-treatment. Data are given as percentage. (B-C) S. Tmwt,gfp load was determined 
at days 1, 2 and 3 p.i. in (B) cecum and (C) mesenteric lymph nodes (mLN) by plating. (D) Histopathological 
analysis of cecal tissue of the infected mice shown in (A-E). Cecal tissue sections were stained using hematoxylin 
and eosin. The degree of submucosal edema, neutrophil infiltration and epithelial damage was scored in a double-
blinded manner. Data are given without the goblet cells score. 0-3: no pathological changes; 4-7: moderate 
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inflammation; above 8: severe inflammation. (E) Lipocalin-2 amount in cecal content at day 1 p.i. was determined 
using ELISA on 4-5 mice per group, randomly chosen. Data are given as ηg lipocalin per mg cecal content. (F) 
Representative hematoxylin and eosin stained sections of infected mice at day 1 p.i. shown in (D). Magnification: 
100-fold. Enlarged sections (squares) are shown in the lower panels. Dotted red lines: detection limit. Bars represent 
the median. Mann-Whitney U test: ns=not significant (P≥0.05), * P<0.05, ** P<0.01, *** P<0.001. One-way 
ANOVA Kruskal-Wallis test: (A) P<0.0001, (B) P=0.0195, (C) P=0.0099, (D) P=0.0004. 
 
 Intriguingly, these data indicate that AGR2ko mice, which lack the intestinal mucus layer, are 
better protected against S. Tmwt,gfp-induced inflammation in cecum, as compared to AGR2het mice. This 
observation could be explained by (1) altered immune defense or mucosal metabolism and nutrient 
transport mechanisms in the cecal mucosa of mice (2) differential S. Tmwt,gfp loads in cecal tissues due to 
altered tissue invasion efficiency (3) or different pharmacokinetics of streptomycin and/or as a 
consequence (4) different microbiota composition in AGR2ko vs AGR2het mice. 
 
 Microarray analysis 5.3.
 Next, we wanted to analyze whether AGR2ko and AGR2het mice exhibit different gene expression 
profiles in the cecal epithelium. We hypothesized that this difference (e.g. increased immune defenses) 
may lead to the decreased susceptibility to S. Tm-induced inflammation observed at d1 p.i. 
 In order to analyze genome-wide mRNA expression in the cecal epithelium of AGR2ko and 
AGR2het mice, we isolated cecal epithelial cells and extracted total RNA. Then, we performed microarray 
analysis and interpreted genome-wide mRNA expression profiles using the Gene set enrichment analysis 
(GSEA) approach (Subramanian, Tamayo et al. 2005). Gene sets are groups of genes that share common 
biological function, chromosomal location or regulation. They are defined based on prior biological 
knowledge and experimental results. Gene sets were considered as significantly down- or upregulated 
when the False Discovery Rate value (FDR q-val) was below 0.25, which means that less than 25 % of the 
gene set of interest is estimated as false positive. This setting is considered as reasonable in the setting of 
an exploratory discovery (Subramanian, Tamayo et al. 2005). The analysis was performed by Mark 
Boekschoten (WU Agrotechnology & Food Sciences, Wageningen, Netherlands). 
 Three gene sets were found as significantly enriched in AGR2ko mice as compared to AGR2het 
littermates e.g. gene sets involved in cholesterol biosynthesis (Annexed Table 49). This could be due to 
dysregulation of endoplasmic reticulum (ER) responses, as cholesterol is mainly synthetized by ER (van 
Meer, Voelker et al. 2008). Most of gene sets found to be downregulated in AGR2ko mice as compared to 
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AGR2het littermates were predicted to be involved in cell cycle, metabolism, damage response and cancer 
pathways. These results are in line with previous work showing that AGR2ko mice exhibit elevated 
endoplasmic reticulum stress response and differential gene expression involved e.g. in breast cancer 
genesis (Zhao, Edwards et al. 2010, Li, Wu et al. 2015). Only few gene sets involved in immune responses 
(e.g. interleukin-2 signaling and immunoregulatory interactions between a lymphoid and a non-lymphoid 
cells) were found to be downregulated in AGR2ko mice (Annexed Table 50). 
 It is tempting to speculate that the few gene sets involved in immune response mechanisms could 
play a role in lowering the inflammatory response to S. Tm infection in AGR2ko mice. However, even if 
this type of analysis provides large amounts of predictions, verification of all results is required to confirm 
these predictions and can be tested using appropriated KO mouse models. In parallel, we followed another 
approach to decipher protective mechanisms against S. Tm present in AGR2ko mice. 
 
 Presence of S. Tm in cecal tissue is reduced in AGR2ko mice as 5.4.
compared to littermate controls 
 It has been well characterized that in order to infect mucosal tissues and cause disease, S. Tm 
employs several virulence factors. The most important are two type III secretion systems (T3SS) T3SS-1 
and T3SS-2, located on Salmonella pathogenicity island 1 (SPI-1) and SPI-2, respectively (Kaiser, Diard 
et al. 2012). Whereas T3SS-1 mediates epithelial cell invasion, T3SS-2 allows S. Tm to survive and 
replicate intracellularly in epithelial cells as well as in different cell types in the lamina propria (Patel and 
McCormick 2014). Together, T3SS-1 and T3SS-2 cooperate to promote bacterial tissue invasion and lead 
to the induction of a strong mucosal inflammatory response, causing severe enterocolitis in mice. As 
previously shown, AGR2ko mice are better protected against S. Tmwt,gfp-induced cecal inflammation than 
their AGR2het littermates. Therefore, we hypothesized that this might be reflected by lower S. Tm tissue 
loads in AGR2ko mice compared to AGR2het mice. 
 In order to test this hypothesis, we used part of cecum sampled at day 1 p.i. from the animal 
experiment presented in Figure 26. The lamina propria was stained using an ICAM-1/CD54 antiserum. 
The epithelium was visualized by actin-staining with conjugated phalloidin. S. Tmwt,gfp expresses GFP 
only when it resides in a S. Tm-containing vacuole, intracellularly. Immunostaining and image analysis 
were performed by Mikael Sellin (ETH, Zurich), as described in (Sellin, Muller et al. 2014). 
 At day 1 p.i., loads of the T3SS-2 reporter strain S. Tmwt,gfp in epithelial cells and in lamina 
propria were significantly reduced in AGR2ko mice as compared to their AGR2het littermates (Figure 27A, 
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p-value 0.0159 and 0.0159, respectively). This suggests that S. Tmwt,gfp is less invasive and/or that there is 
less replication of intracellular bacteria in the mucosa of AGR2ko as compared to AGR2het mice. Overall, 
S. Tmwt,gfp loads were higher in epithelial cells as compared to lamina propria, as also shown previously 
(Figure 27A, p-value 0.0317 and 0.0286, respectively) (Hapfelmeier, Stecher et al. 2005). The cecal 
mucosa of AGR2ko mice was thinner as compared to AGR2het mice due to the absence of inflammation 
(Figure 27B). 
 
 
Figure 27. Presence of S. Tm in cecal tissue is reduced in AGR2ko mice as compared to littermate controls. 
AGR2het and AGR2ko littermate mice were orally gavaged with a single dose of streptomycin (sm; 25 mg/mouse). 
After 24 h, mice were orally infected with 5x106 CFU S. Tmwt,gfp, which constitutively expresses GFP. At day 1 p.i., 
mice were sacrificed, cecal tissue was fixed in 4 % PFA and frozen in O.C.T. at -80 °C. Intracellular immunostaining 
of cryosections (20 µm thick) and image analysis were performed by Mikael Sellin, as described in (Sellin, Muller et 
al. 2014). For quantification of S. Tmwt,gfp, imaging was performed at 400x and 1,000x and intracellular S. Tmwt,gfp 
was manually enumerated blindly in six to nine nonconsecutive sections per mouse. 4-5 mice per group. (A) S. 
Tmwt,gfp load in tissue per 20 µm section in epithelial cells (circles) and in lamina propria (triangles). All data 
represent mean/section of S. Tmwt,gfp numbers. Filled symbols; AGR2het mice, empty symbols; AGR2ko mice. (B) 
Representative confocal images of cecal sections from AGR2het and AGR2ko mice. Scale bar: 100 µm. Mann-
Whitney U test: * P<0.05. One-way ANOVA Kruskal-Wallis test: (A) P=0.0033. 
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 All together, these observations indicate that the protective effect found at day 1 p.i. in AGR2ko 
mice may be due to different invasion properties of S. Tmwt,gfp and that the mucus layer might be directly 
or indirectly involved. However, the mechanisms modulating S. Tmwt,gfp invasion still remain unknown. 
 The intestinal microbiota is known to provide CR against S. Tm (Stecher, Chaffron et al. 2010, 
Deriu, Liu et al. 2013). Moreover, both the mucus layer and antibiotic-treatment have been shown to 
affect and modulate the intestinal microbiota. Thus, we next aimed at studying the effect of sm-treatment 
and the mucus layer on microbiota density and composition. 
 
 Microbiota of AGR2ko mice is less susceptible to streptomycin-5.5.
treatment than the microbiota of AGR2het littermates despite similar 
sm concentration along the intestinal tract of both AGR2ko and 
AGR2het mice 
 In order to investigate how oral sm-treatment influences microbiota density in the cecum, we 
stained commensal bacteria on cecal cryosections of untreated and sm-treated AGR2ko and AGR2het mice, 
sacrificed 24 hours after treatment with 25 mg of streptomycin. We used sytox green to visualize 
commensal bacteria and quantified bacteria per area unit within the cecal lumen. 
 Twenty-four hours after sm-treatment, cecal microbiota density of AGR2het mice decreased by 
about 98 % (median) as compared to AGR2het untreated mice. No difference was noted in cecal microbiota 
density of untreated littermates. Microbiota density of sm-treated AGR2ko mice was significantly higher 
compared to their sm-treated AGR2het littermates (Figure 28A,B, p-value <0.0001) showing that sm-
treatment is less efficient on the microbiota of AGR2ko than AGR2het mice. This could be due to (1) 
different pharmacokinetics of streptomycin or (2) different microbiota composition in AGR2ko vs AGR2het 
mice. 
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Figure 28.   Microbiota of AGR2ko mice is less susceptible to streptomycin treatment than the microbiota of 
AGR2het littermates. 
AGR2het and AGR2ko littermate mice were either orally gavaged with a single dose of streptomycin (sm; 25 
mg/mouse) or left untreated. After 24 h, mice were sacrificed, cecum were fixed in 4 % PFA and frozen in O.C.T. at 
-80 °C. Cryosections (7 µm thick) were stained using phalloidin (purple, actin), sytox green (green, bacterial DNA) 
and DAPI (blue, nuclei DNA). Confocal images were taken at the epithelial border and luminal bacteria were 
manually counted in a blind manner such as 4 areas (20 µm2 each) per picture were randomly counted, 3 pictures per 
mouse and 3-4 mice per condition. (A) Representative confocal images of cecal sections from AGR2het and AGR2ko 
mice untreated or pre-treated with streptomycin (after sm-treatment). Scale bars: 50 µm. (B) Luminal bacterial 
counts. Bars represent the median. Dotted red line represents the detection limit. Mann-Whitney U test: * P<0.05, 
*** P<0.001. One-way ANOVA Kruskal-Wallis test: (B) P<0.0001. 
 
 The mucus layer has been shown to play a role in antibiotic absorption (Goddard 1998, 
Hagesaether, Christiansen et al. 2013). To test whether sm was differently absorbed in AGR2ko vs AGR2het 
mice, we measured sm concentration in different parts of the intestinal tract at different time points after 
sm-treatment using a bioassay. We determined the sm concentration in the small intestine, the cecal 
content and the feces, as well as in the serum. To study the dynamics of sm distribution, we sacrificed 
mice at different time points after oral sm-treatment at 1, 3, 8 and 24 h after sm-treatment (25 mg/mouse). 
 Interestingly, no difference was observed between AGR2ko and AGR2het mice along the intestinal 
tract and in the serum (Figure 29). This indicates that the increased microbiota density observed in Figure 
28 might be due to differential microbiota composition in AGR2ko mice as compared to AGR2het mice 
rather than different rates of sm absorption due to differences in the intestinal mucus layer. 
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Figure 29. Microbiota of AGR2ko and AGR2het mice encounter same amount of effective streptomycin over-
time along the intestinal tract. 
AGR2het and AGR2ko mice were orally gavaged with a single dose of streptomycin (sm; 25 mg/mouse). After 1 h, 3 
h, 8 h or 24 h post-sm treatment (hours p.sm), mice were sacrificed. Serum and intestinal contents were sampled and 
concentration of sm was determined using a halo assay. Briefly, blank antimicrobial susceptibility disks were laid on 
top of sm-sensitive E. coli DH5α strain and 5 µl mouse sample was spotted on each disk. Plates were incubated o.n. 
at 37 °C and inhibition zone (halo) size was measured using a ruler. Size of the blank disk was substrated to all 
values. Later on, halo size values were correlated with a standard curve and sample weight or volume in order to 
determine the exact sm concentration. Untreated littermate mice were taken as negative controls (untreated) to 
exclude other inhibitory effects in the intestinal content. (A) Sm concentration in serum is given as µg/ml. (B) Sm 
concentration in the whole small intestine content is expressed in µg. (C) Sm concentration in cecal content is given 
as µg/mg content. (D) Sm concentration in feces is given as µg/mg feces. Filled symbols; AGR2het mice, empty 
symbols; AGR2ko mice. Dotted red lines: detection limit. Bars represent the median. Mann-Whitney U test: * 
P<0.05, ns=not significant. One-way ANOVA Kruskal-Wallis test: (B) P=0.0039, (C) P=0.0009, (D) P=0.0014.  
 
 In order to analyze microbiota composition of AGR2ko and AGR2het mice, bacterial gDNA was 
extracted from feces and microbiota composition was analyzed by 16S rRNA amplicon sequencing. Data 
were analyzed using the QIIME pipeline (Quantitative Insights Into Microbial Ecology) (Caporaso, 
Kuczynski et al. 2010) using an open-reference database. To identify different taxon distribution in 
AGR2ko vs AGR2het mice, we performed a LDA Effect Size (LEfSe) analysis (Segata, Izard et al. 2011). 
LEfSe algorithm allows the identification of features (e.g. enriched bacterial taxa) that characterize the 
differences between two or more biological conditions (e.g. genotype and antibiotic treatment). 
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 Overall, we observed similar microbiota composition at the taxonomic family and genus levels in 
AGR2ko and AGR2het mice (Figure 30A,B). However, Principal Coordinate Analysis (PCoA) showed 
distinct clustering between AGR2ko and AGR2het microbiota (Figure 30C). Strikingly, LEfSe analysis 
revealed that 10 taxa assigned to Prevotellaceae, Bacteroidales, Anaeroplasmatales and Clostridiales were 
enriched in AGR2ko mice as compared to AGR2het mice. On the other hand, 4 taxa assigned to 
Erysipelotrichaceae and Marvinbryantia were enriched in AGR2het mice as compared to AGR2ko mice 
(Figure 30D). Thus, higher microbiota density observed in AGR2ko mice after sm-treatment could be due 
to different microbiota composition. 
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Figure 30. Comparison of microbiota composition of AGR2ko and AGR2het untreated mice analyzed using 16S 
rRNA gene amplicon sequencing. 
Fecal microbiota composition of AGR2ko and AGR2het untreated mice was determined using 16S rRNA gene 
amplicon sequencing. Sequencing data were processed using the QIIME pipeline and taxonomy was assigned against 
the Silva database. Data are given as relative abundance at the taxonomic (A) family and (B) genus levels. One 
mouse per column. Color code is indicated in taxonomic legend boxes. (C) Corresponding Principal Coordinate 
Analysis (PCoA) plots of Weighted UniFrac distances of 16S rRNA genes. Color code refers to AGR2 genotype: 
green: AGR2ko and purple: AGR2het. One mouse per dot. (D) Bacterial taxa enriched in fecal microbiota of AGR2ko 
and AGR2het untreated mice analyzed using LEfSe analysis. Color code refers to AGR2 genotype: green: AGR2ko 
and red: AGR2het. 
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 Streptomycin-treatment leads to pronounced alteration of gut 5.6.
microbiota composition in both AGR2het and AGR2ko mice 
 We have shown that sm-treated AGR2ko mice are better protected against S. Tm-induced 
inflammation at d1 p.i. and harbored higher microbiota density in cecum where S. Tm invasion was also 
significantly reduced as compared to their AGR2het littermate controls. These data point at a protective 
effect of the AGR2ko microbiota during S. Tm infection and after sm-treatment. 
 In order to analyze microbiota composition of AGR2ko and AGR2het mice after sm-treatment, 
bacterial gDNA was extracted from feces then microbiota composition was analyzed by 16S rRNA 
amplicon sequencing. 
 Microbiota composition analysis of AGR2het and AGR2ko mice revealed deep changes after sm-
treatment, at taxonomic family and genus levels (Figure 31). There was a high variability in microbiota 
composition in the sm-treated mice. Based on these data, identification of candidates that could be 
protective in sm-treated AGR2ko mice appeared very challenging. 
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Figure 31. Fecal microbiota composition of AGR2ko and AGR2het mice shows pronounced alterations after 
streptomycin treatment. 
Fecal microbiota composition of AGR2ko and AGR2het mice before (untreated) and 1 day after sm-treatment (after 
sm) was determined using 16S rRNA gene amplicon sequencing. Sequencing data were processed using the QIIME 
pipeline and taxonomy was assigned against the Silva database. Data are given as relative abundance at the 
taxonomic (A) family and (B) genus levels. One mouse per column. Color code is indicated in taxonomic legend 
boxes. 
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  Ampicillin treatment renders AGR2ko mice susceptible to S. Tm-5.7.
induced colitis 
 Streptomycin is an aminoglycoside widely used against Gram-negative bacteria and well known 
to enable S. Tm expansion in gastrointestinal tract (Ng, Ferreyra et al. 2013). Other antibiotics such as 
ampicillin or metronidazole have been shown to increase colonization of enteric pathogens, such as S. Tm 
and Citrobacter rodentium (Endt, Stecher et al. 2010, Wlodarska, Willing et al. 2011). We hypothesized 
that some members of the intestinal microbiota, which would be sm-resistant might play a role in 
protecting sm-treated AGR2ko mice from S. Tmwt-induced inflammation. We reasoned that treatment with 
another class of antibiotics would target a different spectrum of the microbiota and thereby overcome 
differences in microbiota composition caused by sm. We used the broad spectrum antibiotic ampicillin 
(amp) which targets both Gram-positive and Gram-negative bacteria. To analyze the effect of amp on 
microbiota density of AGR2ko and AGR2het mice, we first stained commensal bacteria on cecal 
cryosections of amp-treated mice using sytox green and quantified single bacteria per area unit, as 
previously described in Figure 28. 
 After amp-treatment, microbiota density of AGR2het mice was reduced to the detection limit (1 
bacteria per area unit). Moreover, cecal microbiota density of AGR2ko mice was significantly reduced 
after amp-treatment as compared to sm-treated AGR2ko mice showing that microbiota of AGR2ko mice is 
more susceptible to ampicillin than to streptomycin (Figure 32). This observation already suggested that 
microbiota composition of AGR2ko mice differs after sm- and amp-treatment. 
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Figure 32. Microbiota of AGR2ko and AGR2het mice are highly susceptible to ampicillin treatment. 
AGR2het and AGR2ko littermate mice were orally gavaged with a single dose of either ampicillin (amp; 25 
mg/mouse) or streptomycin (sm; 25 mg/mouse). After 24 h, mice were sacrificed, cecal tissue was fixed in 4 % PFA 
and frozen in O.C.T. at -80 °C. Cryosections (7 µm thick) were stained using phalloidin (purple, actin), sytox green 
(green, bacterial DNA) and DAPI (blue, nuclei DNA). Confocal images were taken at the epithelial border and 
luminal bacteria were manually counted in a blind manner such as 4 areas (20 µm2 each) per picture were randomly 
counted, 3 pictures per mouse and 3-4 mice per condition. (A) Representative confocal images of cecal sections from 
AGR2het and AGR2ko mice after ampicillin or streptomycin treatment (after amp and after sm, respectively). Scale 
bars: 50 µm. (B) Luminal bacterial counts. Bars represent the median. Dotted red line represents the detection limit. 
Mann-Whitney U test: *** P<0.001. One-way ANOVA Kruskal-Wallis test: (B) P<0.0001. 
 
 In order to analyze microbiota composition of AGR2ko and AGR2het mice after amp-treatment, 
bacterial gDNA was extracted from feces then microbiota composition was analyzed by 16S rRNA 
amplicon sequencing. To get an overview on microbial complexity before and after sm- and amp-
treatments, we calculated the alpha diversity using the amplicon sequencing data. 
 As after sm-treatment, microbiota composition analysis of AGR2het and AGR2ko mice revealed 
pronounced changes after amp-treatment, at all taxonomic levels (Figure 33A,B). We observed higher 
microbiota variability in amp-treated AGR2het mice as compared to amp-treated AGR2ko mice (Figure 
33C). Using this analysis, we also showed that after antibiotic treatments, AGR2ko microbiota tended to be 
less complex than AGR2het microbiota, independently of the antibiotic used, although not statistically 
significant. Untreated AGR2ko and AGR2het mice harbored the most complex intestinal microbiota. 
Interestingly, sm-treated AGR2ko mice, which were better protected against S. Tmwt,gfp at d1 p.i. than their 
heterozygous littermates, harbor similarly complex microbiota as compared to amp-treated AGR2het mice. 
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This suggests that microbiota composition and not diversity may account for the protective function of the 
sm-treated AGR2ko microbiota. 
 
Figure 33. Analysis of microbiota composition of AGR2ko and AGR2het mice pretreated with ampicillin reveals 
gut microbiota composition different from sm-treated mice. 
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Fecal microbiota composition of AGR2ko and AGR2het mice before (untreated) and 1 day after amp-treatment (after 
amp) was determined using 16S rRNA gene amplicon sequencing. Sequencing data were processed using the QIIME 
pipeline and taxonomy was assigned against the Silva database. Data are given as relative abundance at the 
taxonomic (A) family and (B) genus levels. One mouse per column. Color code is indicated in taxonomic legend 
boxes. (C) Alpha diversity was determined as the observed species metric using the QIIME software package version 
1.8 from the amplicon sequencing data shown in Figures 31 and 33. Data are given as mean and standard deviation. 
Untreated mice are represented in orange, sm-treated mice in blue and amp-treated mice in red. AGR2het as full 
symbols and AGR2ko as empty symbols. 
 
 Next, we sought to determine whether amp-treated AGR2ko and AGR2het mice were susceptible to 
S. Tmwt-induced colitis. To test this, we treated AGR2ko and AGR2het mice with a single dose of ampicillin 
(25 mg/mouse) and orally infected them with 106 CFU S. Tmwt harbouring a plasmid which contains an 
ampicillin resistance cassette (S. Tmwt,amp). At 24 hours after amp-treatment, mice were sacrificed and total 
pathogen loads were determined in cecal content. As markers of inflammation and pathology, we 
determined the Lcn2 concentration in cecal content and quantified the histopathological changes in cecal 
tissues, respectively. 
 Similarly to sm-treated mice, at 24 hours after amp-treatment (d0), AGR2ko mice showed 
significant weight loss in contrast to AGR2het mice (Figure 34A, p-value <0.0001). The reason for this 
remains unclear. We reasoned that this weight loss might be attributable to antibiotic treatment and/or S. 
Tm infection. At d1 p.i., total pathogen loads were significantly increased in cecal content of AGR2ko 
mice as compared to AGR2het mice (Figure 34B). Interestingly, both AGR2ko and AGR2het mice showed 
similar signs of cecal inflammation, characteristic for this early time point after oral S. Tm infection 
(Figure 34C,E) (Stecher, Robbiani et al. 2007). Similar degree of inflammation was also confirmed by 
Lcn2 measurement in cecal content of AGR2ko and AGR2het mice (Figure 34D). This suggests that the 
differences in microbiota composition and not the host genotype account for the protection of sm-treated 
AGR2ko mice at early time point. 
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Figure 34. Ampicillin reduces colonization resistance against S. Tmwt in AGR2ko mice. 
AGR2het and AGR2ko mice were orally gavaged with a single dose of ampicillin (amp; 25 mg/mouse). After 24 h, 
mice were orally infected with 106 CFU S. Tmwt,amp (Stecher, Denzler et al. 2012) harbouring pWKS30 (Wang and 
Kushner 1991), which contains an ampicillin resistance cassette. Mice were sacrificed at day 1 p.i. (A) Mouse weight 
was recorded over-time and is relative to the initial weight recorded before amp-treatment. Data are given as 
percentage. (B) S. Tmwt,amp load was determined at day 1 p.i. in cecal content by plating. (C) Histopathological 
analysis of cecal tissue of infected mice. Cecal tissue sections were stained using hematoxylin and eosin. The degree 
of submucosal edema, neutrophil infiltration, epithelial damage was scored in a double-blinded manner. Data are 
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given without the goblet cells score. 0-3: no pathological changes; 4-7: moderate inflammation; above 8: severe 
inflammation. (D) Lipocalin amount in cecal content at day 1 p.i. was determined using ELISA on 5 mice per group, 
randomly chosen. Data are given as ηg lipocalin per mg cecal content. (E) Representative hematoxylin and eosin 
stained sections of infected mice at day 1 p.i. Magnification: 100-fold. Enlarged sections (squares) are shown in the 
lower panels. Dotted red lines: detection limit. Bars represent the median. Mann-Whitney U test: ns=not significant 
(P≥0.05), ** P<0.01, *** P<0.001. One-way ANOVA Kruskal-Wallis test: (A) P<0.0001. 
 
 These data indicate that both AGR2ko and AGR2het mice are equally susceptible to S. Tmwt,amp-
induced colitis at d1 p.i., after amp-treatment. Using microbiota composition analyses, we showed that 
pronounced changes of microbiota composition are not sufficient to allow S. Tmwt to induce inflammation 
in sm-treated AGR2ko mice. Sm-treated AGR2ko mice are protected against S. Tm-induced colitis but the 
reasons remain unclear. We speculated that some taxa or bacteria of the microbiota of sm-treated AGR2ko 
mice mediate protection. 
 
  Enrichment of Deferribacteres phylum correlates with protection 5.8.
against S. Tm-induced colitis 
 So far, our data show that sm-treated AGR2ko mice are protected against S. Tm-induced colitis. In 
contrast, all other groups (AGR2ko and AGR2het amp-treated and sm-treated AGR2het mice) were 
susceptible. We reasoned that sm-treated AGR2ko microbiota harboured members which could mediate the 
protective effect. In order to identify these members, we thoroughly compared the microbiota composition 
of all 4 groups using principal coordinate analysis (PCoA) and the microbiota composition of sm- and 
amp-treated AGR2ko mice using an algorithm for high-dimensional biomarker discovery: LEfSe (Segata, 
Izard et al. 2011). Using LEfSe algorithm, we aimed at identifying taxa which are uniquely enriched in the 
protective group (sm-treated AGR2ko mice). 
 Weighted UniFrac PCoA analysis revealed that antibiotic treated mice harbored different 
microbiota composition as compared to untreated mice (Figure 35A). Microbiota composition analyzed 
using LEfSe approach showed forty-eight OTUs enriched in sm-treated AGR2ko mice as compared to 
amp-treated AGR2ko mice. Enriched OTUs were assigned to six phyla: Firmicutes, Bacteroidetes, 
Actinobacteria, Proteobacteria, Deferribacteres and TM7. Three OTUs enriched in amp-treated mice 
were assigned to the phylum Firmicutes (Figure 35B). The taxa found to be enriched in AGR2ko protected 
mice may account for protection against S. Tm-induced colitis. 
 
Results 
 
 
124 
 
 
Figure 35. Comparison of microbiota composition of AGR2ko mice before and after sm- or amp-treatment. 
(A) Corresponding Principal Coordinate Analysis (PCoA) plots of Weighted UniFrac distances of 16S rRNA genes. 
Color code refers to pretreatment: orange: untreated; blue: after sm and red: after amp. One mouse per dot. (B) 
Bacterial taxa enriched in fecal microbiota of AGR2ko either after sm or after amp analyzed using LEfSe analysis. 
Color code refers to antibiotic treatment: green: after sm and red: after amp. 
 
 In order to further narrow down the potential candidates for protective bacteria, we compared the 
three susceptible mouse groups showing inflammation at d1 p.i. (amp-treated AGR2ko and AGR2het mice 
and sm-treated AGR2het mice) against the protected group (sm-treated AGR2ko mice).  
 We found that eight OTUs were enriched in sm-treated AGR2ko mice. Six enriched OTUs were 
assigned to the phylum Deferribacteres and two were assigned to the phylum Firmicutes (Figure 36). 
Regarding the high number of enriched OTUs assigned to the phylum Deferribacteres, we hypothesized 
that members assigned to this phylum (e.g. Mucispirillum spp.) might be involved in protection against S. 
Tm-induced colitis in sm-treated AGR2ko mice. 
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Figure 36. Comparison of AGR2ko and AGR2het mice after antibiotic treatment depending on their 
pathological score at day 1 p.i. 
LEfSe analysis was performed using streptomycin- and ampicillin-treated mice presented in Figures 26 and 34, 
respectively. Mice were ranged according to their pathological score at d1 p.i. 0-3: no pathological changes; 4-7: 
moderate inflammation; above 8: severe inflammation. AGR2ko sm-treated mice were considered as protected 
against inflammation (protected). AGR2ko & AGR2het amp-treated mice and AGR2het sm-treated mice were 
considered as susceptible to inflammation (susceptible). Color code refers to susceptibility to inflammation: green: 
susceptible and red: protected. 
 
  Generation of AGR2 germfree mice to study S. Tm-microbiota 5.9.
interactions under highly defined conditions 
 Our data so far point at highly complex interactions between the microbiota and the mucus layer. 
The interplay of these partners leads to protection against S. Tm-induced colitis. Using antibiotic treated 
mice, we could identify bacteria which might interact with S. Tm and the mucus layer and influence the 
outcome of the infection. However, future mechanistic analysis is not possible in mice harbouring a 
complex and undefined microbiota. Therefore, we sought to investigate the interplay of the microbiota, S. 
Tm and the mucus layer in a gnotobiotic mouse model. AGR2 mice were rederived germfree (AGR2GF) 
and bred in an isolator under germfree conditions, at the Hannover Medical School. 
 To test whether AGR2GF mice were susceptible to S. Tm infection, we orally infected them with 
107-108 CFU S. Tm. Already at 20h p.i., we observed high mortality of AGR2ko,GF mice and therefore did 
not follow up longer time points for ethnical reasons. At 20h p.i., mice were sacrificed. Total pathogen 
loads were determined in cecal content, mLN, spleen and liver. As a marker of inflammation and 
pathology, we determined the Lcn2 concentration in cecal content and quantified cecal histopathology, 
respectively. 
 At 20h p.i., we found similar pathogen loads in cecal content of AGR2GF mice (Figure 37A). 
Equivalent pathogen loads were also found in mLN, whereas spleen and liver showed higher S. Tm loads 
in AGR2ko,GF mice than in AGR2het,GF mice (Figure 37B). For both genotypes, we observed high 
histopathological score as well as high Lcn2 levels pointing at severe inflammation (Figures 37C,D). 
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Figure 37. AGR2 germfree mice are highly susceptible to S. Tm infection. 
AGR2het and AGR2ko littermates were orally gavaged with 107-108 CFU S. Tmwt. After 20 h, mice were sacrificed 
and S. Tmwt load was determined in (A) cecal content and in (B) mesenteric lymph nodes (mLN), spleen and liver by 
plating. (C) Histopathological score of cecal tissue of infected mice. Cecal tissue sections were stained using 
hematoxylin and eosin. The degree of submucosal edema, neutrophil infiltration and epithelial damage was scored in 
a double-blinded manner. Data are given without the goblet cells score. 0-3: no pathological changes; 4-7: moderate 
inflammation; above 8: severe inflammation. (D) Lipocalin-2 concentration in cecal content at 20 h p.i. was 
determined by ELISA on 2-3 mice per group, randomly chosen. Data are given as ηg Lcn2 per mg cecal content. 
 
 In conclusion, we demonstrated that the mucus layer was also involved in protection against S. 
Tm-induced colitis in AGR2GF mice but in the opposite way as compared to sm-treated AGR2 mice. 
Combined with previous data (cf Figure 26), we concluded that despite similar pathogen loads in cecal 
content of both conventional AGR2 and AGR2GF mice, conventional mice are better protected against S. 
Tm-induced inflammation than germfree mice. These data highlight the crucial role of intestinal 
microbiota to protect its host, even in absence of mucus layer. As the most striking protective effect was 
observed for sm-treated AGR2ko mice, it appeared plausible that microbiota members enriched in sm-
treated AGR2ko mice could be responsible for this protective effect, in a direct or indirect manner. Further 
gnotobiotic experiments need to be done to confirm this hypothesis. 
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 S. Tm T3SS-1 expression is downregulated in sm-treated AGR2ko 5.10.
mice 
 In order to invade intestinal epithelial cells and to trigger inflammation, S. Tm employs virulence 
factors including flagella-mediated motility and type III secretion systems (T3SS) (Kaiser, Diard et al. 
2012, Thiennimitr, Winter et al. 2012). Whereas motility allows S. Tm to penetrate the mucus layer and to 
access the epithelial border, the SPI-1 type III secretion system (T3SS-1) is required for epithelial cell 
invasion and induction of inflammation. Moreover, in murine gut tissue, most of S. Tm expresses T3SS-1 
(T3SS-1+) but in gut lumen and in vitro only 15 % of S. Tm population are T3SS-1+ (Ackermann, Stecher 
et al. 2008). So far, our data show that sm-treated AGR2ko mice exhibit delayed inflammation at day 1 p.i. 
as compared to sm-treated AGR2het littermates and amp-treated AGR2ko and AGR2het mice. Moreover, our 
microbiome analysis suggests that microbiota composition of sm-treated AGR2ko mice might be 
responsible for the protective effect. We hypothesized that deficiency of the mucus layer and/or the 
microbiota composition in sm-treated AGR2ko mice may affect T3SS-1 expression. 
 In order to test whether the T3SS-1 expression is altered in sm-treated AGR2ko mice, we infected 
sm- or amp-treated AGR2het and AGR2ko mice with 104-106 CFU S. Tm psicAgfp. S. Tm psicAgfp is a reporter 
strain for T3SS-1 expression which harbors gfp fused to the promoter of sicA, a component of the T3SS-1. 
Because S. Tm-induced inflammation leads to microbiota dysbiosis (Stecher, Robbiani et al. 2007), we 
used an avirulent S. Tm strain, S. Tmavir2psicAgfp. At day 1 p.i., mice were sacrificed and cecum was 
sampled, fixed and cryopreserved. Cecal cryosections were stained using polyclonal antibodies against S. 
Tm lipopolysaccharide (LPS, α-Salmonella B test serum anti-O) and DAPI (DNA). Confocal images were 
taken randomly at the epithelial border and in cecal lumen. LPS+ and GFP+ S. Tmavir2psicAgfp cells were 
counted in order to calculate the relative rate of T3SS-1 expression. 
 At day 1 p.i., all experimental groups showed similar S. Tmavir2psicAgfp loads (Figure 38E). S. 
Tmavir2psicAgfp in sm-treated AGR2ko mice exhibited significantly less T3SS-1 expression at the epithelial 
border and in the cecal lumen than in sm-treated AGR2het littermates (Figure 38A,B, p-value 0.0021 and 
0.0011, respectively and Figure 38C,D), suggesting that the mucus layer or the microbiota has an effect 
on T3SS-1 expression. Conversely to what was observed after sm-treatment, we found that after amp-
treatment, AGR2ko mice showed significantly increased T3SS-1 expression as compared to AGR2het 
littermates at epithelial border (Figure 38A, p-value 0.0170). This result indicates that the mucus layer 
might not be the only factor influencing T3SS-1 expression. Moreover, relative T3SS-1 expression was 
significantly reduced in sm-treated AGR2ko mice as compared to amp-treated AGR2ko mice, both at 
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epithelial border and in lumen (Figure 38A,B, p-value <0.0001), pointing at a role of intestinal microbiota 
in T3SS-1 activation. 
 
Figure 38. T3SS-1 expression is reduced in AGR2ko mice after streptomycin treatment as compared to 
ampicillin treatment.  
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AGR2het and AGR2ko littermate mice were orally gavaged with a single dose of either streptomycin (sm; 25 
mg/mouse) or ampicillin (amp; 25 mg/mouse). After 24 h, mice were orally infected with 104 CFU after sm or 106 
CFU after amp with S. Tmavir2psicAgfp, an avirulent T3SS-1 reporter strain. At day 1 p.i., mice were sacrificed, cecal 
tissue was fixed in 4 % PFA and frozen in O.C.T. at -80 °C. Cryosections (7 µm thick) were stained using anti-
Salmonella B test serum anti-O (red, LPS+ S. Tmavir2psicAgfp) and DAPI (blue, nuclei DNA). T3SS-1 expression was 
represented by GFP signal (green, GFP+). Confocal images were taken at the epithelial border and in the lumen. 
Bacteria were manually counted in a blind manner such as all LPS+ S. Tmavir2psicAgfp bacteria were counted first, and 
then the GFP+ cells which colocalized with LPS+ S. Tmavir2psicAgfp. 4-8 images at the epithelial border per mouse, 5-7 
images in the lumen per mouse and 3 mice per condition. (A-B) Bacterial counts (A) at epithelial border and (B) in 
cecal lumen. (C-D) Representative confocal images of cecal sections from AGR2het and AGR2ko mice after either sm 
or amp (C) at epithelial border or (D) in cecal lumen. Scale bars: 50 µm. e; epithelial border. (E) S. TmavirpsicAgfp load 
was determined at day 1 p.i. in cecum by plating with appropriate antibiotics. Bars represent the median. Dotted red 
line represents the detection limit. Circle; sm-treated mice, inverted triangle; amp-treated mice, full symbols; 
AGR2het, empty symbols; AGR2ko. Mann-Whitney U test: ns=not significant (P≥0.05), * P<0.05, ** P<0.01, *** 
P<0.001. One-way ANOVA Kruskal-Wallis test: (A) P<0.0001, (B) P<0.0001, (E) P=0.0752. 
 
 All together, these results indicate that the mucus layer might play an indirect role in T3SS-1 
activation by modulating the intestinal microbiota. Indeed, as previously shown, the intestinal microbiota 
differs in sm-treated AGR2ko mice, which are better protected against S. Tm-induced inflammation as 
compared to sm-treated AGR2het littermates as well as amp-treated AGR2ko and AGR2het mice. Therefore, 
it is tempting to speculate that the potentially protective microbiota of sm-treated AGR2ko might inhibit 
T3SS-1 activation and, consequently, delay intestinal inflammation. 
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 Discussion 6.
 The Oligo-MM: a defined microbial consortium to study microbiota-6.1.
host pathogen interaction in gnotobiotic mice 
 The Oligo-MM can be used as platform to identify bacteria and 6.1.1.
mechanisms underlying colonization resistance 
 Numerous approaches have been used to investigate CR mechanisms in vivo. Early studies 
already showed that antibiotic treatment alleviates the protective role of conventional microbiota against 
enteropathogen infection (Miller, Bohnhoff et al. 1956, van der Waaij, Berghuis-de Vries et al. 1971, 
Pongpech, Hentges et al. 1989). Attempts were made to identify CR mechanisms by characterizing 
physiology of the antibiotic-treated mice. For example, antibiotic treatment has been reported to inhibit 
innate and adaptive immune responses (e.g. intestinal expression of RegIIIγ and colonic Tregs) (Brandl, 
Plitas et al. 2008, Smith, Howitt et al. 2013), favor the expansion of oxygen-tolerant bacteria such as 
Enterobacteriaceae (Thijm and van der Waaij 1979) and decrease SCFA levels which are involved in CR 
(Lawhon, Maurer et al. 2002, Fukuda, Toh et al. 2011, Wichmann, Allahyar et al. 2013). Moreover, 
antibiotic treatment has been used in combination with transplantation of conventional or low complexity 
microbiota to identify bacteria that restore CR against enteropathogens (Koopman, Kennis et al. 1984, 
Stecher, Chaffron et al. 2010, Lawley, Clare et al. 2012). Nowadays, fecal transplantation from healthy 
human donors is successfully used in humans to treat intestinal infections (e.g. against C. difficile and 
Staphylococcus aureus) (Konturek, Haziri et al. 2015, Wei, Gong et al. 2015). However, the biggest 
limitation to study mechanisms underlying CR and identify protective bacteria remains the enormous 
microbiota complexity. Therefore, comparative microbiome analyses of protective vs susceptible cohorts 
were developed to identify candidate bacterial taxa that correlate with protection against infection 
(Schubert, Sinani et al. 2015). Elegantly, some studies went one step further and used gnotobiotic mouse 
models to prove that some candidate strains were indeed responsible for CR (Hsiao, Ahmed et al. 2014, 
Buffie, Bucci et al. 2015). Gnotobiotic mouse models which are colonized with individual bacteria or 
mixtures have been proven as a powerful tool to investigate mechanisms underlying CR (Reeves, 
Koenigsknecht et al. 2012, Ganesh, Klopfleisch et al. 2013). 
 In this study, we assembled a broad spectrum of phylogenetically different gut bacteria in order to 
establish a minimal bacterial consortium. In this way, we generated the first defined bacterial consortium 
of mouse-derived strains which was able to provide significant CR against S. Tmavir in mice (Figure 15).
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Next, we developed a completely new approach to identify possible CR mechanisms by comparing 
artificial metagenomes of the Oligo-MM12 strains to the “real” metagenome of conventional mice. In this 
way, we identified functions which might still be missing in Oligo-MM12 consortium. We hypothesized 
that these functions could play a role in CR. And indeed, we validated this hypothesis by using ASF 
strains, which harbor some of the metabolic pathways present in conventional microbiota but absent from 
Oligo-MM12. To my knowledge, this is the first time that a combinatory approach of cultivation and 
metagenomics is described in order to identify bacteria which confer functionality of a normal gut 
microbiota.  
 
 Which mechanisms underlie colonization resistance mediated by the Oligo-6.1.2.
MM? 
 An approach to analyze the functional capacity (functionome) of a microbial community is based 
on metagenomics and uses the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (Ogata, 
Goto et al. 1999) to classify genes into different functional units (Kanehisa, Goto et al. 2014). This 
approach has already been used successfully on single bacteria, for example, to predict metabolic 
pathways of S. Tm which might play a role during infection (Raghunathan, Reed et al. 2009). It has also 
been developed to predict the functional capacity of the gut microbiota under different conditions. For 
example, it was shown that zinc deficiency which leads to impairment of health status alters the metabolic 
capacity of gut microbiome by depleting pathways involved in lipid metabolism, carbohydrate digestion 
and mineral absorption. Combined with microbiota composition and host phenotype analyses, the authors 
correlated several bacterial OTUs (e.g. decrease of the taxonomic family Peptostreptococcaceae which 
belongs to the Firmicutes) with zinc depletion (Reed, Neuman et al. 2015). However, to confirm that these 
OTUs are indeed responsible for pathological states under zinc deficiency conditions, availability of 
bacterial strains as pure culture would be a valuable tool to perform proof of concept studies in gnotobiotic 
mice. 
 In our study, we performed functional analysis based on metagenomics to determine the presence 
and completeness of functional KEGG modules in individual strains and in different defined bacterial 
communities. We also identified KEGG modules that are present in conventional microbiota but absent of 
Oligo-MM12 (Figure 17). Based on this finding, we hypothesized that increasing the metabolic capacity of 
Oligo-MM12 could also increase CR against S. Tmavir. Therefore, Oligo-MM12 could be supplemented with 
bacterial taxa (e.g. ASF strains) which are predicted to possess these missing KEGG modules. We tested 
this hypothesis by transplanting the ASF7 consortium in Oligo-MM12 mice. We found that Oligo-MM12 + 
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ASF7-colonized mice showed increased CR against S. Tmavir as compared to Oligo-MM12-colonized mice 
(Figure 19). We concluded that ASF7-specific KEGG modules might play a role in CR (Figure 20, block 
“D”). These include T6SS, transport systems for nickel, sodium, heme, phosphanate, trehalose/maltose 
and rhamnose, as well as degradation systems for xylene, toluene and acylglycerol. It is known that T6SS 
of Vibrio cholerae displays antimicrobial activity against S. Tm (MacIntyre, Miyata et al. 2010). Using 
our metagenomics approach, we found that ASF457 possesses a T6SS. It would be interesting to test 
whether ASF457 plays a role in CR against S. Tm or whether some effector proteins are missing. 
 Yet, transplantation of conventional microbiota into ASF5 mice increased even further CR 
(Figure 15). This suggests that Oligo-MM12 + ASF7 consortium is not as functional as a conventional 
microbiota to restore CR and that some bacterial taxa are still missing in Oligo-MM12 to reproduce a 
conventional-like CR phenotype. Using comparative metagenomics analysis, we identified other KEGG 
modules that are specific for the conventional microbiota and might also play a role in CR. These include 
transport systems for carbohydrates and amino acids such as trehalose, glycerol, erythritol, histidine, 
taurine and lysine/arginine/ornithine. We also identified transport systems for hemin, tungstate, 
manganese/zinc/iron, sulfate, nitrate/nitrite as well as urea and vitamin B12. Of note, some of these 
components are already known to influence enteric infections. For example, consumption of vitamin B12 
by Bacteroides thetaiotaomicron decreases the level of Shiga toxin 2 which is the main virulence factor of 
EHEC (Cordonnier, Le Bihan et al. 2016). Additionally, we identified an enrichment of various 
cytochrome modules in the conventional microbiota. As our different defined consortia are mainly 
composed of strict anaerobic bacteria, it is reasonable to hypothesize that facultative anaerobic bacteria 
would also play a role in CR, as they would be competing for oxygen with S. Tm. It was already known 
that E. coli induces CR against S. Tm in GF mice (Hudault, Guignot et al. 2001). Remarkably, the 
hypothesis that facultative anaerobic (e.g. E. coli) could also induce CR when added to the Oligo-MM12 
has been successfully verified in our laboratory (unpublished data). These observations as well as the 
correlation between microbiota complexity and CR (Figure 19) are consistent with the Freter’s nutrient-
niche hypothesis (Freter, Brickner et al. 1983). It postulated that a bacterium cannot invade a resident 
microbiota if its metabolic niche is already occupied by other strains. This suggests that in order to invade 
a host, a bacterium (e.g. enteropathogen) would have to use a specific limiting nutrient more efficiently 
than the rest of the microbiota. 
 As previously mentioned, there are other mechanisms involved in CR. For example, the 
microbiota can also mediate gut epithelial cell maturation (e.g. via production of SCFA) (Ploger, Stumpff 
et al. 2012) and influence gut immune responses (e.g. via educating the host immune system) (Backhed 
2012, Smith, Howitt et al. 2013). An approach to elucidate the indirect effects of gut microbiota on its host 
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would be to colonize mice with different defined bacterial consortia and perform metatranscriptomics 
analysis on host cells to identify differential regulation of genes involved in immune defenses. This would 
generate hypotheses that could be tested using appropriate mouse KO strains, for example. Ultimate 
evidence could also be obtained using genetically modifying anaerobic commensals, which is hardly 
possible for now. 
 In conclusion, the approach we have taken is a powerful tool to study functional capacity of 
microbial communities as well as to identify bacterial taxa and metabolic pathways of interest. Moreover, 
the recent development of mouse-derived strain collections (e.g. the Mouse Intestinal Bacterial Collection 
(Lagkouvardos et al., submitted)) offers new perspectives to functionally mimic a conventional gut 
microbiota with a fully defined bacterial consortium. 
 However, comparative metagenomics analysis also presents some limitations. First, it can predict 
the presence of open reading frames (ORFs) but not their expression. It is also based on databases that 
only refer to known functions and pathways. Therefore, the completeness of databases as well as the 
sequence annotation and discovery are additional limitations. It is also plausible that some of our strains 
(e.g. representatives of novel species, genera or families) harbor pathways that remain to be discovered 
and described. Finally, in metagenomics datasets, a metabolic pathway is considered as complete whether 
or not its individual components (e.g. enzymes) are present in the same bacterium or in several different 
organisms. Nevertheless, this approach remains as a powerful tool to generate numerous hypotheses. 
Testing all these hypotheses is challenging particularly due to the fact that the methodology for genetic 
manipulation of anaerobic bacteria is still very limited. Thus, attempts have to be made in order to develop 
genetic systems for a wide number of commensal bacteria. 
 
 Minimal gut microbiota as a tool for gnotobiotic studies 6.1.3.
 An experimental strategy to decipher interactions between host and microbiota is first to study the 
host environment devoid of bacteria (i.e. under germfree conditions), and compare it to the situation after 
adding individual strains or defined bacterial consortia. Germfree (GF) mice are well known to harbor 
impaired intestinal environment, morphology, motility and physiology (Berg 1996). For example, GF 
mice show decreased numbers of goblet cells (Stefka, Feehley et al. 2014), lower rate of epithelial cell 
turnover (Falk, Hooper et al. 1998) and decreased mucus production (Jakobsson, Rodriguez-Pineiro et al. 
2015) as well as impaired immune system (Round and Mazmanian 2009). Due to these abnormalities, GF 
animals are more susceptible to infections with enteropathogens such as S. Tm and Listeria 
monocytogenes (Inagaki, Suzuki et al. 1996, Hudault, Guignot et al. 2001). In an attempt to study host-
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microbiota-pathogen interactions using a simplified gut ecosystem as well as to decipher the mechanisms 
that lead to gut normalization (i.e. restoration of a fully functional microbiota by fecal transplantation of a 
complex microbiota into GF mice), minimal gut microbiota were generated and inoculated to GF mice. 
 One of the first defined bacterial consortia was named as Schaedler flora and consists of six 
strains isolated from mice (Schaedler, Dubs et al. 1965). Later, this consortium was modified and became 
one of the most popular models of minimal mouse-derived microbiota: the “altered Schaedler flora” 
(ASF) (Orcutt, Giannim et al. 1987). The ASF encompasses eight different strains: Parabacteroides spp., 
Mucispirillum spp., Eubacterium spp., three Clostridium spp. and two Lactobacillus spp. (Dewhirst, Chien 
et al. 1999). Each strain has been fully sequenced and genome information is now publicly available, in 
contrast to the strains which are still protected by a patent (Wannemuehler, Overstreet et al. 2014, 
Wymore Brand, Wannemuehler et al. 2015). GF mice colonized with the ASF are partially normalized as 
compared to conventional mice (Wymore Brand, Wannemuehler et al. 2015). For example, ASF-
colonized mice show partial normalization of the cecum morphology (Schaedler, Dubs et al. 1965), the 
mucosal immune system and the innate defense (Stecher, Chaffron et al. 2010). However, their high 
susceptibility to S. Tm infection compared to GF and conventional mice suggest that ASF mice are not 
entirely normalized (Stecher, Macpherson et al. 2005, Stecher, Chaffron et al. 2010). This was also 
confirmed by other studies (Berry, Stecher et al. 2013, Maier, Vyas et al. 2013). Since then, other defined 
minimal gut microbiota, which are all based on human-derived strains have been developed. The 
laboratory of J. Gordon uses routinely GF mice colonized with human-derived microbiota to study host-
microbiota interactions (e.g. in response to diet changes). Thus, Faith et al colonized mice with ten 
sequenced bacterial species to study the response of this defined community to different diets (Faith, 
McNulty et al. 2011). Using a linear approach, they established a method to predict the variation in 
abundance of each strain according to the concentration of dietary ingredients fed to the mice. They also 
found that in response to diet changes, each bacterial strain rather changes its absolute abundance than its 
gene expression. However, this elegant and prediction model requires to know the exact bacterial species 
composition of the microbiota and therefore, cannot be applied to conventional microbiota. In another 
study, different human-derived bacterial consortia were used to identify microbial genes involved in the 
establishment of Bacteroides thetaiotaomicron in the gut (Goodman, McNulty et al. 2009). Using a 
transposon mutant library, it was shown that genes involved in competition for nutrients (e.g. synthesis 
and utilization of vitamin B12-dependent cofactors) as well as microbiota composition were critical for B. 
thetaiotaomicron fitness in the gut of gnotobiotic mice. Furthermore, a simplified human intestinal 
microbiota (SIHUMI) consisting of eight bacterial species was established in gnotobiotic rats (Becker, 
Kunath et al. 2011). Germfree rats colonized with SIHUMI showed metabolic functions such as 
production of SCFA and degradation of mucins, which were to some extent comparable to conventional 
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rats. Further on, SIHUMI was also inoculated in GF mice where it was shown to stably colonize the 
mouse gut overtime and to be vertically transmitted to the offspring (Ganesh, Klopfleisch et al. 2013, 
Woting, Pfeiffer et al. 2014). By modulating the bacterial composition of SIHUMI, Woting et al. 
investigated the role of two members of SIHUMI (i.e. Clostridium ramosum and Bifidobacterium longum) 
towards obesity and metabolic disorders in mice. They demonstrated that, in their animal model, C. 
ramosum was promoting diet-induced obesity independently of B. longum, which has been inversely 
correlated to obesity phenotypes in human (Woting, Pfeiffer et al. 2014, Woting, Pfeiffer et al. 2015). By 
supplementing SIHUMI consortium with two other strains, Akkermansia muciniphila and S. Tm, they 
showed that the mucin degrader A. muciniphila was able to exacerbate S. Tm-induced inflammation by 
interfering with the gut mucus homeostasis (Ganesh, Klopfleisch et al. 2013). 
 To date, GF mice colonized with human-derived strains termed as humanized gnotobiotic mice 
have been widely used and have provided valuable insights into host-microbiota interactions. The 
increased accessibility to human microbiota strain collections and genome sequences reflects a great 
potential to perform mechanistic studies and investigate molecular interactions between host, microbiota 
and pathogen. However, interactions between microbiota and its host cannot be completely mirrored by 
humanized gnotobiotic mice. In an elegant study, Seedorf et al. investigated the host-specificity of 
selection and colonization of mouse-adapted vs human-adapted microbiota (Seedorf, Griffin et al. 2014). 
Knowing that mice can efficiently exchange their gut microbiota due to coprophagic habits, GF mice were 
co-housed together with mice harboring either mouse- or human-adapted microbiota. After 14 days, gut 
microbiota of the previous GF mice exhibited 99.8 % of mouse-adapted taxa, showing that mouse-adapted 
microbiota invade and colonize mouse gut better than human-adapted microbiota. Similarly, some 
bacterial strains have been reported to be unable to colonize the mouse gut. For example, the human strain 
Lactobacillus reuteri F275 is unable to colonize Lactobacillus-free mice, contrary to rodent-adapted 
strains (Frese, Benson et al. 2011). This could be due to the presence of specific genes such as urease or 
xylose clusters, which are absent from human-adapted strains. Additionally, a mouse-derived microbiota 
was shown to better restore CR against enteropathogens (e.g. S. Tm) compared to human-derived 
microbiota (Chung, Pamp et al. 2012). Interestingly, the degree of CR was also reported to differ between 
gut microbiota of different mouse strains. Using microbiota transplantation experiments between mouse 
strains, Willing et al. showed that microbiota of NIH Swiss mice enhanced CR against Citrobacter 
rodentium compared to C3H/HeJ-associated mouse microbiota (Willing, Vacharaksa et al. 2011). They 
also found that this enhanced CR occurred in an IL-22 dependent manner, suggesting the importance of 
the cross-talk between mouse strain-specific microbiota and genetic determinants of its host. This was also 
confirmed by Chung et al. who reported that mice colonized with a human microbiota exhibit an impaired 
immune system as compared to mice colonized with a murine microbiota (Chung, Pamp et al. 2012). In 
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conclusion, these observations highlight the tremendous importance of using microbiota, which are 
specifically adapted to their host at a species level, or even genetic background. 
 For all these reasons, we used mouse-adapted bacteria to study the interactions between the mouse 
gut and its microbiota. Except for KB1 and KB18, all bacterial strains were isolated from C57Bl/6J mice 
and inoculated into C57Bl/6J gnotobiotic mice. To my knowledge, the Oligo-MM consortium is the first 
defined mouse-adapted microbiota described where all strains as well as their respective genome 
sequences are publicly available. I am convinced that this model will be a valuable tool to address 
questions related to host adaptation and specificity of the microbiota. For example, comparative genomic 
analysis of human- and mouse-adapted strains would highlight to which extends the knowledge acquired 
on host-microbiota interactions can be transposed from mouse to human gut. To my knowledge, this 
question has never been addressed using defined microbiota despite some reports questioning the 
relevance of mouse models for human health (Bibiloni 2012, Nguyen, Vieira-Silva et al. 2015). 
 
 What are the potential limitations of the Oligo-MM model? 6.1.4.
 Do all Oligo-MM strains colonize the mouse gut? 6.1.4.1.
 In this study, I established a gnotobiotic mouse model which harbors a defined consortium of 
mouse-adapted gut bacteria. While most of Gram-negative strains were detected at high abundance level 
using gDNA-based methods (i.e. 16S rRNA gene amplicon sequencing and qPCR), Gram-positive strains 
were barely detected, if at all. This difference of detection between Gram-negative and -positive strains 
was also reported elsewhere and can have many reasons (Goodman, McNulty et al. 2009, Faith, McNulty 
et al. 2011, Li, Limenitakis et al. 2015). For example, these strains may colonize below the detection limit 
or at different intestinal sites than in cecum and feces. Alternatively, their cell wall remains resistant to the 
DNA extraction method. Lastly, they may not colonize at all. In our study, KB18 and YL2, which are 
taxonomically assigned to the Ruminococcaceae; Incertae Sedis and Bifidobacterium spp., respectively, 
were detected at very low abundance in few mice using gDNA-based methods (Figures 12 and 18B; 
annexed Tables 45 and 48). YL2 was detected at low abundance in the small intestinal content using 
amplicon sequencing (Figure 9B; annexed Table 42). This suggests that YL2 either colonizes 
preferentially the small intestine or its abundance is too low compared to the other strains to be detected in 
cecal and fecal contents. KB18 might have a cell wall resistant to gDNA extraction, as its gDNA is 
already very hard to extract from pure culture (not shown) and its cell wall was shown to be impermeable 
to FISH probes (not shown) (Table 34). Therefore, presence of YL2 and KB18 in cecal and fecal contents 
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remains unclear. Similarly, I49 (Lactobacillus spp.) and KB1 (Enterococcus spp) were detected at very 
low abundance in cecal and fecal contents using qPCR and amplicon sequencing (Figures 12, 14 and 
18B; annexed Tables 45,47 and 48). They were both detected in small intestinal content (Figure 9B; 
annexed Table 42) and re-isolated on agar from the cecum of a F3 generation offspring stably colonized 
with the Oligo-MM12 consortium (not shown). This suggests that KB1 and I49 colonize and are vertically 
transmissible, despite their detection at low abundance. The fact that some Gram-positive strains are 
detected at higher loads in small intestine than in cecum can be due either to their preferences for small 
intestine niches or to an increased relative abundance, for example caused by a decreased relative 
abundance of bacterial OTUs such as the Bacteroidetes, which are highly represented in cecum but not in 
small intestine (Sarma-Rupavtarm, Ge et al. 2004). Finally, I46 (Erysipelotrichaceae; Incertae Sedis) was 
detectable using amplicon sequencing (Figure 8C and D; annexed Tables 39 and 40) and FISH (not 
shown) but not using qPCR. Moreover, we confirmed its colonization by re-isolating it on agar from the 
cecum of a F3 generation offspring (not shown). Therefore, we concluded that I46 colonized and was 
vertically transmitted. By comparing the 16S rRNA gene sequence of the assembled genome and of the 
16S rRNA gene-containing plasmid used to establish the qPCR, we found a mismatch in the 
primers/probe used to perform the qPCR. As we generated new I46-specific primers and probe, we 
detected I46 by qPCR in cecum, feces and inoculum at similar abundance level than I49 (data 
unpublished). 
 
 Are Gram-positive strains systematically underestimated? 6.1.4.2.
 Interestingly, in our model, the majority of strains abundantly detected with gDNA-based methods 
were Gram-negative strains (Figures 8 and 12). This can be due to several reasons. It is known that 
microbiota composition analysis using amplicon sequencing reveals higher abundance of Gram-negative 
than Gram-positive strains (Goodman, McNulty et al. 2009, Xiong, Frank et al. 2012, Li, Limenitakis et 
al. 2015, Rojo, Gosalbes et al. 2015). This observation could be due to the gDNA extraction method used. 
It was shown that members of the Bacteroidetes phylum (Gram-negative strains) are easier to lyze than 
Actinobacteria (Gram-positive strains) and that lysis efficiency depends also on the extraction method 
used (Salonen, Nikkila et al. 2010, Ferrand, Patron et al. 2014). When using 16S rRNA-based amplicon 
sequencing, number of sequencing reads which determines the detection limit can play a role as some 
bacterial strains such as Enterobacter hormachei and Proteus vulgaris have been shown as undetectable 
below 2,000-3,000 sequencing reads per sample (Belzer, Gerber et al. 2014). Importantly, primer sets used 
to amplify variable regions of 16S rRNA gene generally lead to underestimation of some key members of 
the gut microbiota such as Bifidobacterium longum, and consequently to overestimation of other members 
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like Bacteroides thetaiotaomicron (Milani, Hevia et al. 2013). In an attempt to investigate the degree of 
bias of microbiota composition analysis, some studies performed comparative analyses between culture, 
gDNA-based methods and FISH. Harmsen et al. analyzed human fecal microbiota using cultivation and 
FISH techniques (Harmsen, Gibson et al. 2000). They found that total count of anaerobic bacteria was 
generally higher using quantification by FISH as compared to plating (except for Clostridia strains). This 
observation was also confirmed elsewhere (Vieira-Pinto, Bernardo et al. 2007). However, they used only 
one type of agar medium per targeted phylum, despite the tremendous heterogeneity of gut microbiota. 
Another study analyzed human microbiota composition using FISH, 16S rRNA gene-based microarray 
hybridization and amplicon sequencing (Shankar, Hamilton et al. 2014). This study showed that amplicon 
sequencing data reveals higher variability of microbiota composition compared to microarray analysis. 
This could either be due to the fact that microarray allows detection of only 775 bacterial phylotypes or 
that amplicon sequencing targets the V6 hypervariable region of 16S rRNA gene while microarray 
hybridized the whole amplified gene. It could also be due to chimera formation that occurs during the 
amplicon sequencing process and which artificially blows up diversity or to PCR amplification biases 
(Chakravorty, Helb et al. 2007, Paliy, Kenche et al. 2009, Schwab, Berry et al. 2014). Interestingly, they 
reported that quantification of bacterial abundance was similar using FISH and microarray hybridization 
for the major microbial bacterial classes (i.e. Clostridia, Bacteroidia and combined Proteobacteria). 
However, they did not investigate underestimated microbial OTUs such as Actinobacteria and used 
conventional microbiota to compare gDNA- and rRNA-based techniques, as most of comparative studies. 
 In this thesis, we used gnotobiotic mice colonized with Oligo-MM12 strains to compare gDNA- 
and rRNA-based techniques. We showed that YL44, a Gram-negative strain, was detected at higher 
relative abundance using gDNA-based methods (i.e. 16S rRNA gene-based amplicon sequencing and 
qPCR) as compared to rRNA-based approach (i.e. FISH). Conversely, YL58 was less detected using 
gDNA-based methods than rRNA-based approach (Figure 24). We also highlighted the overestimation of 
the relative abundance of a Gram-negative strain and the underestimation of a Gram-positive strain, in our 
model. Therefore, we draw attention on the risk of global misestimation of bacterial strains depending on 
their cell wall composition which can lead to impaired analysis of microbiota composition. To my 
knowledge, this thesis reports the first study using gDNA- and rRNA-based techniques applied to a 
defined “mid-complex” microbiota in order to demonstrate systemic under- and overestimation of Gram-
positive and -negative strains, respectively. Our results also underline the importance of using 
complementary approaches to analyze microbiota composition. 
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 Localization and quantification of individual bacterial strains using FISH 6.1.4.3.
 FISH exhibits several limitations that hamper its use to study bacterial niches and gut ecology in 
conventional microbiota. First, it is challenging to test probe specificity in complex and undefined 
microbial communities. Moreover, mono- or poly-labelled FISH probes can show different sensitivity to 
detect low abundant bacteria or bacteria with cell walls that exhibit low-permeability properties to probes 
(e.g. some Gram-positive strains) (Pernthaler, Preston et al. 2002). Finally, there is a real limitation to 
enumerate fluorescently labelled bacteria principally because gut ecosystem harbors many autofluorescent 
particles (e.g. plant fibers). Some studies report manual counting whether others developed automated 
enumeration approaches (Thiel and Blaut 2005, Earle, Billings et al. 2015). Up-to-date, one study 
established a software platform to allow quantification of bacteria as well as their localization in the gut 
(Earle, Billings et al. 2015). To this end, they used GF mice colonized either with a low-complexity 
microbiota or with a human conventional microbiota. In this thesis, we used a defined “mid-complex” 
microbiota and developed another approach using the DAIME software to quantify and localize bacterial 
strains. One of the advantages of DAIME is that it also allows spatial arrangement analysis of bacterial 
populations to study microbial population interactions, for example (Schillinger, Petrich et al. 2012). We 
showed that in Oligo-MM12-colonized mice, YL44 was enriched at the epithelial border in contrast to 
YL58 (Figures 22 and 23). Moreover, we also showed that the distribution of YL44 in mouse cecum was 
dependent on the microbiota context (Figure 22). Further investigations will be needed to understand the 
reasons of these different spatial distributions. These results highlight the importance of studying not only 
the gut microbiota composition, but also the bacterial population niches in the gut environment. Therefore, 
I am convinced that DAIME will be a powerful tool to study the behavior of single bacteria within the gut 
ecosystem. 
 
 How long do the Oligo-MM strains need to establish a stable microbial 6.1.4.4.
community in mouse gut? 
 It is known that colonization of the host with microbial community occurs in a dynamic way and 
depends on several parameters such as age and sex (Ge, Feng et al. 2006). However, very few studies 
analyzed the physiological changes induced by the microbiota after inoculation of GF animals. How long 
does a microbiota require to fulfil its functions in the mouse gut, to optimally interact with the host 
immune system or to strengthen the mucus layer? Recently, Johansson et al. reported that it takes seven to 
eight weeks for the colonic mucus to normalize and become impenetrable to microbial bacteria after 
conventionalization of GF mice. They also showed that colonizing microbiota undergoes dynamic changes 
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for three weeks post-colonization (Johansson, Jakobsson et al. 2015). In our study, we allowed the Oligo-
MM12 strains to stabilize for approximately 40 days before infection. Significant decrease of relative cecal 
weight at day 43 post-inoculation as compared to day 0 indicate that physiological changes occur even 
though microbiota composition remains quite stable from day 10 to 43 post-inoculation (Figures 9A and 
11B). However, we have not analyzed relative cecal weight correlated with microbiota dynamics further 
and it could be that 40 days may still not be enough for the microbiota to establish and completely 
normalize its host. Therefore, it would be interesting to study the metabolic dynamics post-inoculation 
into GF mice in order to analyze the time needed by the microbiota to fully protect the host against 
enteropathogens and to decipher the chronological events of mechanisms responsible for CR. 
 
 Culturomics as a tool to improve taxonomic calssification  6.1.4.5.
 Culturing of intestinal bacterial strains is one of the biggest limitations to study microbiota-host-
pathogen interactions, in particular regarding the human microbiome (Brown, de Vos et al. 2013). Since 
the development of sophisticated microbiome analysis techniques, molecular tools have supplanted culture 
techniques, as they are considered as time-consuming and challenging. In the early 21st century, some 
studies compared data obtained using 16S rRNA gene-based techniques with culturing approaches. In this 
way, it was shown that microbiota composition was slightly less complex as determined by culturing than 
by culture independent method such as by a 16S rRNA gene library (Wilson and Blitchington 1996). 
Moreover, Wilson et al. underlined the complementary use of both techniques, as half of species were 
only detected by 16S rRNA gene cloning while one third of species were only identified using culturing. 
Similarly, it was shown that Gram-negative bacteria are mostly underestimated using pyrosequencing, as 
compared to Gram staining and transmission electron microscopy (Hugon, Lagier et al. 2013). All 
together, these results highlight the need of using complementary techniques to analyze microbiota 
composition, as already noted above. It was estimated that only 60-80 % of fecal bacteria counted using 
microscopic techniques were uncultured (Langendijk, Schut et al. 1995, Hayashi, Sakamoto et al. 2002). 
More recently, Fodor et al. established a list of “most wanted” bacteria, which have less than 90 % 
identity to two major human-derived databases (i.e. GOLD-Human and Human Microbiome Project 
(HMP) databases), are present in at least 20 % of the samples from different human body sites and are still 
uncultured (Fodor, DeSantis et al. 2012). In order to isolate and cultivate these bacteria, efforts were made 
for examples to optimize growth media (Clavel, Henderson et al. 2006), generate novel culture methods 
such as synergistic growth and the use of gel microdroplets (Kaeberlein, Lewis et al. 2002, Zengler, 
Toledo et al. 2002, Rappe and Giovannoni 2003). One of the major advances made by the HMP and other 
sequencing projects was that about 5, 000 human-derived bacterial strains were isolated, cultured and their 
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genomes sequenced (Fodor, DeSantis et al. 2012). Several studies showed that cultivating a large 
repertoire of microbial OTUs was possible from few human donors (Goodman, Kallstrom et al. 2011). 
Increasing the number of culture conditions was termed as culturomics (Pfleiderer, Lagier et al. 2013, 
Lagier, Hugon et al. 2015). Development of culturomics is necessary not only to isolate novel bacteria, but 
also to improve the resolution of 16S rRNA amplicon and metagenomics studies as well as to ameliorate 
taxonomic classification and avoid misinterpretation of data (Fournier, Lagier et al. 2015, Lawson and 
Rainey 2015). Moreover, a complementation of public strain collections would facilitate standardization 
of gnotobiotic experiments, guarantee the availability of bacterial strains to the entire scientific 
community, enable the design of in vitro experiments to optimize the interpretation of “omics” datasets in 
combination with genome sequence databases (Bleich and Hansen 2012, Kim, Cho et al. 2012). Strain 
collections based on human isolates were readily implemented (e.g. to address clinically relevant 
questions). However, very few mouse-derived bacterial strains are currently available and fully sequenced. 
However, as explained before, the use of mouse-strains to colonize mouse gut is particularly important to 
study molecular and host-specific interactions between the commensals and their host. Therefore, efforts 
must also be made to isolate more mouse-derived strains, submit their genomes to sequencing and 
generate public genome databases and strain collections. Moreover, contrary to human pathogens, which 
have been extensively studied in the past, commensals have been poorly characterized. Thus, it appears 
essential to generate more commensal reference strains. In our study, we aimed at isolating and 
establishing culture methods of intestinal mouse-derived bacteria under anaerobic conditions. Our 
research lead us to isolate and characterize new genera such as KB18 (Ruminococcaceae; Incertae Sedis) 
and YL45 (Parasutterella spp.), which were taxonomically assigned using Silva database (Table 35). 
However, it is known that the Silva database contains sequences of unequal quality that can come from 
misidentified organisms and largely reflects uncultured taxa (Fodor, DeSantis et al. 2012, Ricker, Qian et 
al. 2012, Fournier, Lagier et al. 2015). Therefore, in order to better assign novel strains, we used another 
well-curated database, EzTaxon, which only contains sequences of type strains (i.e. cultured described 
species that are deposited in at least two recognized collections in two different countries) (Kim, Cho et al. 
2012). All sequences of this database were also subjected to phylogenetic analysis which leads to a 
complete hierarchical classification system. Therefore, we used 16S rRNA gene sequence alignment 
against EzTaxon database to identify novel species among Oligo-MM strains (i.e. with a match ≤ 97 % 
sequence identity to a type strain) (Table 37). This analysis revealed that the Oligo-MM12 consortium 
contains one novel species Bacteroides sp. nov. (I48), two members of a novel genus Clostridiales gen. 
nov. (KB18) and Sutterella_f gen. nov. (YL45), and one member of a novel family Barnesiella-like fam. 
nov. (YL27). Therefore, new names were proposed for these strains: Bacteroides caecimuris (I48), 
Acutalibacter muris (KB18), Turicimonas muris (YL45) and Muribaculum intestinalis (YL27) 
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(Lagkouvardos et al., submitted). By isolating novel strains, we aimed at exploring the potential of the so 
far uncultured majority of mouse intestinal bacteria. Up-to-date, we focused on members of the 
superkingdom Bacteria. However, it is known that members of the superkingdom Archaea such as 
Methanobrevibacter smithii and Methanosphaera stadtmanae can influence host immune homeostasis 
(Bang, Weidenbach et al. 2014). They have also been shown to interact with Bacteria members such as 
Bacteroides thetaiotaomicron which can modulate the metabolic landscape of the host (Samuel and 
Gordon 2006). In future experiments, it would be interesting to test whether Archaea representatives, 
alone or together with the Oligo-MM12, are also involved in CR. To my knowledge, it remains unknown. 
Table 37. Taxonomic assignment of the Oligo-MM strains using EzTaxon database 
Taxonomic  
classification 
Strain 
ID Taxonomic Identity Eztaxon besthit 
phylum Actinobacteria 
  class Actinobacteria 
    order Bifidobacteriales 
      family Bifidobacteriaceae 
 
 
 
YL2 
 
 
 
Bifidobacterium animalis 
 
phylum Bacteroidetes 
  class Bacteroidia 
    order Bacteroidales 
 
      family Bacteroidaceae 
 
 
YL27 
 
I48 
 
 
Barnesiella-like fam. nov. 
 
Bacteroides sp. nov. 
 
 
86.16 % Barnesiella 
intestinihominis 
96.86 % Bacteroides 
xylanisolvens 
phylum Proteobacteria 
  class Betaproteobacteria 
    order Burkholderiales 
      family Sutterellaceae 
 
 
 
YL45 
 
 
 
Sutterella_f gen. nov. 
 
 
 
93.92 % Parasutterella 
excrementihominis 
phylum Verrucomicrobia 
  class Verrucomicrobiae 
    order Verrucomicrobiales 
      family Verrucomicrobiaceae 
 
 
 
YL44 
 
 
 
Akkermansia muciniphila 
 
 
phylum Firmicutes 
  class Bacilli 
    order Lactobacillales 
      family Enterococcaceae 
      family Lactobacillaceae 
  class Clostridia 
    order Clostridiales 
      family Lachnospiraceae 
       
      family Ruminococcaceae 
   
class Erysipelotrichia 
    order Erysipelotrichales 
      family Erysipelotrichaceae 
 
 
 
KB1 
I49 
 
 
YL32 
YL58 
YL31 
KB18 
 
 
I46 
 
 
 
Enterococcus sp. 
Lactobacillus reuteri 
 
 
Clostridium clostridioforme 
Blautia sp.  
Flavonifractor plautii 
Clostridiales gen. nov. 
 
 
Clostridium innocuum 
 
 
 
 
 
 
 
 
 
 
92.09 % C. leptum 
Full length 16S rRNA gene sequences were aligned against the EzTaxon database. 
Discussion 
 
 
143 
 
 The AGR2ko mice: A mouse model to study the role of the mucus 6.2.
layer and the microbiota during S. Tm infection 
 Does mutation of AGR2 gene only affect the cecal mucus layer? 6.2.1.
 AGR2ko mice do not develop spontaneous colitis in contrast to other mucin-6.2.1.1.
deficient mouse models 
 In this study, the AGR2ko mouse model was used to study the role of the mucus layer during S. 
Tm infection as AGR2ko mice lack a functional intestinal mucus layer (Park, Zhen et al. 2009). Previous 
studies used other mucin-deficient mouse models to analyze the role of the mucus layer such as MUC2-
deficient, Winnie and Eeyore mice (Velcich, Yang et al. 2002, Heazlewood, Cook et al. 2008). Lack of an 
intestinal mucus layer allows the bacteria to come in direct contact with epithelial cells, penetrate into the 
normally sterile crypts and even into epithelial cells (Johansson, Phillipson et al. 2008). Therefore, these 
mice are known to develop spontaneous colitis and to be more susceptible to enteric infections and 
chemically induced colitis, although the colitis phenotype was also shown to vary depending on the mouse 
genetic background as well as housing hygiene conditions (Velcich, Yang et al. 2002, Van der Sluis, De 
Koning et al. 2006, Heazlewood, Cook et al. 2008, Bergstrom, Kissoon-Singh et al. 2010, Bao, Guo et al. 
2014). To my knowledge, AGR2ko mice have never been used to study the role of mucus layer during 
enteropathogen infection. In our study, AGR2ko mice did not develop spontaneous colitis when housed 
under SPF conditions. Surprisingly, they showed high mortality once rederived germfree. This is 
contradictory with other observations reporting that mucin-deficient mice generally do not develop colitis 
or high mortality when housed under germfree conditions (Sellon, Tonkonogy et al. 1998). The underlying 
reasons for this remain currently unknown. 
 
 AGR2ko and AGR2het mice exhibit differential phenotype and gene expression 6.2.1.2.
 It has been reported that AGR2ko mice exhibit other differences besides the absent mucus layer as 
compared to AGR2wt mice. In fact, mutation of AGR2 gene is also associated with body weight loss, 
premature death, intestinal morphologic abnormalities, dysregulation of immune responses, increased 
neutrophil infiltration in the intestinal epithelium and increased ER stress response (Gupta, Wodziak et al. 
2013). Moreover, dysregulation of AGR2 gene expression has also been associated with tumor growth and 
metastasis (Ramachandran, Arumugam et al. 2008, Hong, Wang et al. 2013, Sung, Choi et al. 2014). In 
this study, we focused on the mucus layer deficiency. However, we cannot exclude the possibility that 
Discussion 
 
 
144 
 
AGR2 gene mutation could also influence S. Tm infection by other mechanisms besides the mucus layer 
deficiency. 
 First, this is supported by the fact that AGR2 protein has been localized intracellularly and 
extracellularly (Bergstrom, Berg et al. 2014). Even though its functions remain unknown, we cannot 
exclude that AGR2 could exhibit an antimicrobial activity. Second, it is also supported by analyses of gene 
expression using DNA microarrays either on stomach or cecal tissues. In stomach tissues, 858 genes were 
found to show at least a 3-fold change in gene expression in AGR2ko vs AGRhet mice (Gupta, Wodziak et 
al. 2013). Among these genes, the authors highlighted the Reg family of genes such as RegIIIβ, which can 
kill Salmonella spp. (Stelter, Kappeli et al. 2011, van Ampting, Loonen et al. 2012). In agreement with this 
study, we found that gut epithelial gene expression varies for several gene sets between AGR2ko and 
AGRhet mice (Tables 49 and 50). Whereas few gene sets were found to be upregulated in AGR2ko mice 
(e.g. cholesterol biosynthesis), several gene sets were significantly downregulated in AGR2ko mice, as 
compared to AGR2het mice. Among them, we found genes involved in cell cycle, metabolism, damage 
response, cancer pathways and immune response (e.g. interleukin-2 signaling and immunoregulatory 
interactions between a lymphoid and a non-lymphoid cells). This suggests that AGR2ko mice exhibit 
decelerated epithelial turnover. In this thesis, we also showed that sm-treated AGR2ko mice exhibit 
attenuated susceptibility to S. Tm infection at d1 p.i. and decreased S. Tm numbers in cecal tissue (Figures 
26 and 27). Therefore, it would be reasonable to speculate that this protective effect against S. Tm-
induced inflammation could be due to a global downregulation of inflammatory immune responses or an 
upregulation of immune responses involved in S. Tm killing. Interestingly, several immune-related gene 
sets were found to be repressed in ileal epithelium of MUC2ko mice as compared to MUC2wt mice 
(Sovran, Loonen et al. 2015). Among these gene sets were found genes involved in Toll-like receptor-, 
immune- and chemokine-signaling. Genes involved in adaptive immune responses were also found to be 
downregulated in MUC2ko mice, although this downregulation depends also on mouse age. Therefore, due 
to the high complexity of regulation of immune responses, this hypothesis would require further 
investigation. Thus, the effects of differential gene expression remain unclear with respect to S. Tm 
infection between AGR2ko and AGRhet mice. 
  Furthermore, Sovran et al., also pointed out that MUC2het mice also exhibit differential gene 
expression as compared to MUC2wt mice. For instance, immune-related gene sets were upregulated in 
MUC2het mice as compared to MUC2wt mice (Sovran, Loonen et al. 2015). This differential gene 
expression suggests that heterozygous and wild-type mice may also exhibit different phenotypes. AGR2het 
and AGR2wt mice show a similar phenotype with respect to morphology of the mucus layer (Bergstrom, 
Berg et al. 2014). However, we did not investigate further neither the gene expression of AGR2wt 
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epithelial cells as compared to AGR2het cells, nor the response of AGR2wt mice to S. Tm infection. It could 
be that AGR2het mice exhibit a phenotype which is biased as compared to AGR2wt mice. Therefore, we 
would not have compared AGR2ko mice to mice harboring “normal” mucus layer and gene expression. 
This could have hampered the interpretation of the gene expression analysis, for example. 
 
 AGR2ko and AGR2het mice exhibit differential microbiota composition 6.2.1.3.
 In agreement with other studies we showed that mucin-deficient mice harbor different microbiota 
composition as compared to mice with an intact mucus layer (Figure 30) (Bel, Elkis et al. 2014, Sommer, 
Adam et al. 2014, Sovran, Loonen et al. 2015). This could be due to the fact that the mucus represents a 
potential ecological niche and nutrient source for bacteria (Li, Limenitakis et al. 2015). In 2014, Bel et al. 
showed that mice with altered mucus layer (i.e. mice harboring a thicker and more robust colonic mucus 
layer) had decreased susceptibility to chemically induced colitis and that this relative protection was 
transmissible using fecal transplantation (Bel, Elkis et al. 2014). In our study, we concluded that the gut 
microbiota of sm-treated AGR2ko mice conferred protection against S. Tm infection at early time-point 
(Figures 26 and 34). However, we did not analyze the transmissibility of this protection to AGR2het mice 
by transplantation of cecal content from sm-treated AGR2ko mice into AGR2het,GF mice, for example. Such 
an experiment would be important to confirm the protective role of the microbiota against S. Tm infection 
in AGR2ko mice. 
 Additionally, we used differential antibiotic treatment foregoing S. Tm infection to show that this 
protective effect could be due to bacterial taxa that are resistant to sm but not to amp. By applying 
indicator taxa analysis, we correlated this protective effect to the presence of bacterial members assigned 
to the phylum Deferribacteres (Figure 36). Up-to-date, this phylum has not been extensively investigated. 
On the one hand, some studies question whether it might play a deleterious role in periodontal diseases in 
humans (Hutter, Schlagenhauf et al. 2003, Kumar, Griffen et al. 2003, Saito, Leonardo Rde et al. 2006), in 
DSS-induced colitis in mice (Berry, Schwab et al. 2012) and during Citrobacter rodentium infection 
(Hoffmann, Hill et al. 2009) or whether it would be able to translocate from intestinal tract to hepatobilary 
system (Robertson, O'Rourke et al. 2005). On the other hand, the phylum Deferribacteres has also been 
associated with beneficial effects against DSS-induced colitis (Ooi, Li et al. 2013). Intriguingly, we had 
already correlated a bacterial member of this phylum (i.e. ASF457 assigned to Mucispirillum spp.) to 
increased CR against S. Tm due to a potential role of its T6SS in interfering with S. Tm growth (Figures 
19 and 20, block “D”). However, it remains unclear whether such a protective effect would also depend 
on the microbiota context. Moreover, bacterial taxa assigned to Ruminococcaceae and Clostridiales were 
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also found as enriched in sm-treated AGR2ko mice (Figure 36). It is reasonable to speculate that these taxa 
could also play a role in protection, as they have already been associated with recovery of colonization 
resistance against C. difficile and a vancomycin-resistant Enterococcus strain (Jump, Polinkovsky et al. 
2014). Thus, it would be interesting to test whether bacterial strains which are isolated from sm-treated 
AGR2ko mice would be protective against S. Tm-induced inflammation when inoculated to AGR2ko,GF 
mice alone or combined with the Oligo-MM12 consortium. 
 Finally, we also observed that microbiota of AGR2ko mice was less susceptible to antibiotic 
treatment than the microbiota of the other experimental groups (Figure 32B). It is known that the 
translocating activity of T3SS-1 is induced upon contact with epithelial cells (Zierler and Galan 1995). 
Thus, the residual sm-resistant microbiota might physically hamper S. Tm to reach the epithelial border. 
This hypothesis might deserve further investigation. 
  
 Which other mechanisms could protect sm-treated AGR2ko mice against S. 6.2.2.
Tm infection? 
 S. Tm exhibits reduced T3SS-1 expression in sm-treated AGR2ko mice 6.2.2.1.
 In order to invade epithelial cells and to trigger inflammation, S. Tm injects numerous effector 
proteins into the host cell via a T3SS encoded on SPI-1 and named as T3SS-1 (Kaiser, Diard et al. 2012). 
This T3SS-1 is essential for S. Tm internalization and to manipulate host-signaling pathways. Mechanisms 
involved in these processes have been well characterized (Fabrega and Vila 2013, LaRock, Chaudhary et 
al. 2015). In mouse gut lumen, it was shown that approximately 15 % of S. Tm cells expressed T3SS-1 
(Ackermann, Stecher et al. 2008). This was also confirmed in vitro (Hautefort, Proenca et al. 2003, 
Schlumberger, Muller et al. 2005). However, the mechanisms that regulate the bistable expression of 
T3SS-1 need to be further investigated. Several transcriptional regulators have been reported to modulate 
SPI-1 expression. For example, Fis is required for full activation of SPI-1 genes (Kelly, Goldberg et al. 
2004), whereas HilC and HilD can activate the transcription of HilA, which in turn activates the genes 
encoding for T3SS-1 as well as effector proteins (Bajaj, Hwang et al. 1995). Low oxygen levels found in 
the gut can also modulate SPI-1 gene expression as it influences DNA supercoiling topology. For 
example, relaxed DNA supercoiling can repress invA, a regulator encoded on SPI-1 (Galan and Curtiss 
1990) or activate hilC and hilD expression, which consequently can induce T3SS-1 expression (Cameron 
and Dorman 2012). Other environmental factors were found to repress T3SS-1 expression in vitro such as 
naringenin which is a citrus flavonoid (Vikram, Jesudhasan et al. 2011) and L-arabinose (Lopez-Garrido, 
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Puerta-Fernandez et al. 2015) as well as products released by the gut microbiota like SCFA (e.g. 
propionate and butyrate) and lactate (Durant, Corrier et al. 2000, Durant, Corrier et al. 2000, Lawhon, 
Maurer et al. 2002). Interestingly, lactic acid-producing bacteria were also found to alter SPI-1 expression 
in vivo but the mechanism remains unclear (Yang, Brisbin et al. 2014). 
 In this thesis, we showed that relative expression of T3SS-1 at epithelial border and in lumen of 
cecum of sm-treated AGR2ko mice was significantly reduced as compared to amp-treated AGR2ko mice 
(Figure 38A,B). Therefore, we reasoned that the gut microbiota might be able to influence T3SS-1 gene 
expression through mechanisms that remain to be determined. A reasonable approach to investigate these 
mechanisms in AGR2ko mice would be to test whether the effect is also recapitulated in gnotobiotic 
AGR2ko and AGR2het mice colonized with the Oligo-MM12 consortium. If yes, we could narrow down the 
bacterial isolates responsible for this effect and start deciphering the mechanism of interaction with S. Tm 
genes at a molecular level. If no, we could add different commensal strains isolated from sm-treated 
AGR2ko mice (e.g. bacterial strains assigned to the taxa Deferribacteres or Ruminococcaceae) and test 
their interaction with T3SS-1 expression in vitro and in vivo. It is tempting to speculate that the gut 
microbiota might be causal for the reduced T3SS-1 expression in S. Tm observed in sm-treated AGR2ko 
mice although other factors should also be considered. 
 
 Effects of antibiotic treatments on the host and on S. Tm   6.2.2.2.
 Not only can antibiotics severely damage the gut microbiota (Reikvam, Erofeev et al. 2011, 
Schubert, Sinani et al. 2015), but they can also have deleterious effects on the host. Long-term antibiotic-
induced dysbiosis has been associated with increased body adiposity, colitis, diarrhea and allergies (Hill, 
Siracusa et al. 2012, Liou and Turnbaugh 2012, Varughese, Vakil et al. 2013, Satokari, Fuentes et al. 
2014). Moreover, mice supplied with an antibiotic mixture (i.e. ampicillin, vancomycin, neomycin and 
metronidazole) can experience increased baseline morbidity and mortality depending on their genotype 
(Reikvam, Erofeev et al. 2011). Conversely, it was also reported that mice gavaged with a different 
mixture (i.e. vancomycin, neomycin, metronidazole and amphotericin-B) together with drinking water 
supplemented with ampicillin did not show distress or pain (Reikvam, Erofeev et al. 2011). The reason for 
this remains unclear. It could be due to the mode of antibiotic administration (i.e. continuously in drinking 
water or every 12 h by gavage), the duration of administration (i.e. seventeen days to several weeks) or 
other reasons such as genetic background, housing conditions, age, presence of opportunistic pathogens 
within the microbiota or microbiota composition (Ayres, Trinidad et al. 2012, Pham, Clare et al. 2014). 
The intestinal mucus layer was also shown to influence antibiotic permeation from gut lumen through 
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epithelial cells (Coghill, Hopwood et al. 1983, Goddard 1998). While ampicillin is known to be 
moderately well absorbed from the gut lumen, streptomycin is known not to be absorbed (Croswell, Amir 
et al. 2009). However, the effect of mucus deficiency on the absorption or the interactions of these 
antibiotics with epithelial cells remain unclear. Additionally, depletion of the gut microbiota by antibiotics 
can influence host gene expression and consequently, the host gut metabolic landscape (Lange, Buerger et 
al. 2016). In intestinal epithelial cells, 36 genes presenting at least a two-fold altered expression were 
upregulated in antibiotic treated mice (e.g. RegIIIβ) and 70 genes were downregulated (e.g. caspase 14) 
(Reikvam, Erofeev et al. 2011). Finally, the antibiotic novobiocin was shown to activate T3SS-1 genes 
expression by changing DNA topology (Cameron and Dorman 2012). Novobiocin is produced from the 
same bacterial genus as streptomycin (i.e. Streptomyces spp.) and belongs to the antibiotic class of 
aminocoumarins which are known to inhibit the DNA gyrase. Streptomycin is known to enhance 
susceptibility to infections by S. Tm and this effect was reported to be due to the depletion of microbiota 
by streptomycin (Ng, Ferreyra et al. 2013). However, the effects of sm on S. Tm virulence gene 
expression have never been studied in detail. In this thesis, the use of two antibiotics in AGR2ko mice 
allowed us to highlight the role of the microbiota in protection against S. Tm infection (Figures 26 & 34). 
However, we cannot rule out the possibility that antibiotics may influence S. Tm infection by modulating 
the gene expression and the physiology of AGR2ko mice (e.g. increased anti-inflammatory responses) or S. 
Tm. Thus, we could speculate that the protective effect observed against S. Tm in sm-treated AGR2ko 
mice could be due to interactions of sm with epithelial cells, which would be enhanced in AGR2ko due to 
the absence of a functional mucus layer. Moreover, in humans, the standard posology of sm and amp is 15 
mg/kg and 50-200 mg/kg, respectively. In mice, we used 25 mg/mouse, a much higher dose. This 
represents approximately 1250 mg/kg which is 6 to 83-fold more than in humans. Streptomycin is known 
to be more toxic (i.e. nephrotoxicity and ototoxicity, in humans) than ampicillin (Rybak, Abate et al. 
1999). Therefore, effects of sm and amp posology used for mouse experiment cannot be ignored although 
poorly characterized in mice. 
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 Appendix 7.
Table 38. Microbial composition of the Oligo-MM10 inoculum determined by qPCR 
 Strain ID Isol46 Isol49 YL58 YL31 YL32 YL44 KB1 YL2 YL45 Isol48 
Rel. abundance 0,00E+00 5,71E-03 3,78E-02 2,15E-01 1,51E-02 1,88E-01 9,57E-03 7,28E-03 2,45E-02 4,97E-01 
Amount of 16S rRNA gene copies per 5 ƞg fecal DNA are given as relative abundance and corresponding bar plots are presented in Figure 8B. 
 
Table 39. Microbial composition in feces determined by amplicon sequencing using the Silva database to assign taxonomy at the family level 
Days post-inoculation (d) d0 d0 d0 d0 d10 d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 224 227 228 222 223 227 228 224 225 230 231 
Microbiota ASF5 ASF5 + Oligo-MM10 
Taxon (Family level)             
Nocardiaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Microbacteriaceae 0,00E+00 5,50E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Promicromonosporaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 7,44E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroidaceae 1,17E-04 2,20E-04 5,64E-05 2,75E-04 1,32E-01 1,93E-01 1,23E-01 1,02E-01 1,99E-01 1,96E-01 2,99E-01 2,38E-01 
Porphyromonadaceae 9,09E-01 8,18E-01 9,14E-01 8,50E-01 1,81E-01 2,00E-01 1,72E-01 1,95E-01 2,41E-01 2,76E-01 2,23E-01 2,56E-01 
Prevotellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Rikenellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 6,75E-05 0,00E+00 0,00E+00 
S24-7 1,76E-04 5,50E-05 0,00E+00 5,50E-05 7,31E-05 0,00E+00 6,54E-05 0,00E+00 0,00E+00 0,00E+00 8,56E-05 7,48E-05 
Deferribacteraceae 5,69E-03 2,44E-02 6,10E-03 1,14E-02 7,31E-05 2,23E-04 0,00E+00 3,30E-04 1,42E-04 2,03E-04 4,28E-04 0,00E+00 
Lactobacillales;Other 3,99E-03 5,89E-03 4,01E-03 6,87E-03 0,00E+00 7,44E-05 0,00E+00 0,00E+00 0,00E+00 6,75E-05 8,56E-05 0,00E+00 
Enterococcaceae 0,00E+00 5,50E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,88E-04 1,98E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lactobacillaceae 8,06E-02 1,51E-01 7,59E-02 1,31E-01 3,66E-04 5,95E-04 0,00E+00 3,30E-04 3,54E-04 2,03E-04 3,42E-04 9,72E-04 
Lachnospiraceae 5,87E-05 2,75E-04 0,00E+00 3,85E-04 1,21E-01 1,48E-01 2,00E-01 3,13E-01 1,48E-01 2,01E-01 1,51E-01 1,65E-01 
Ruminococcaceae 5,87E-05 0,00E+00 0,00E+00 0,00E+00 2,34E-03 1,79E-03 4,57E-04 1,38E-03 3,19E-03 3,58E-03 1,11E-03 2,77E-03 
Clostridiales;__uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,85E-04 1,86E-03 6,54E-05 7,91E-04 4,25E-04 5,40E-04 3,42E-04 2,17E-03 
Rhizobiaceae 5,87E-05 5,50E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Alcaligenaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 3,66E-04 3,72E-04 5,88E-04 1,19E-03 7,79E-04 6,75E-04 6,85E-04 6,73E-04 
Comamonadaceae 5,87E-05 3,30E-04 0,00E+00 1,65E-04 0,00E+00 0,00E+00 0,00E+00 3,30E-04 1,42E-04 0,00E+00 0,00E+00 0,00E+00 
Desulfovibrionaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Verrucomicrobiaceae 5,87E-05 5,50E-05 5,64E-05 1,65E-04 5,62E-01 4,55E-01 5,03E-01 3,84E-01 4,08E-01 3,22E-01 3,24E-01 3,34E-01 
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Days post-inoculation (d) d22 d22 d22 d43 d43 d43 d43 d43 d43 
Mouse number 347 348 349 350 351 352 353 354 355 
Microbiota ASF5 + Oligo-MM10 ASF5 ASF5 + Oligo-MM10 
Taxon (Family level)          
Nocardiaceae 0,00E+00 0,00E+00 0,00E+00 5,80E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Microbacteriaceae 0,00E+00 0,00E+00 0,00E+00 5,80E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Promicromonosporaceae 0,00E+00 0,00E+00 0,00E+00 1,16E-04 0,00E+00 0,00E+00 8,39E-05 0,00E+00 0,00E+00 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 1,30E-04 0,00E+00 
Bacteroidaceae 3,85E-01 2,87E-01 3,54E-01 5,80E-05 1,38E-04 0,00E+00 4,18E-01 3,77E-01 4,01E-01 
Porphyromonadaceae 2,45E-01 2,50E-01 2,06E-01 9,25E-01 8,57E-01 8,42E-01 2,49E-01 2,66E-01 1,98E-01 
Prevotellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Rikenellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
S24-7 7,17E-05 4,88E-04 0,00E+00 5,80E-05 0,00E+00 0,00E+00 8,39E-05 0,00E+00 0,00E+00 
Deferribacteraceae 0,00E+00 1,63E-04 9,58E-05 1,36E-02 1,22E-02 1,51E-02 2,52E-03 3,90E-04 2,74E-04 
Lactobacillales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Enterococcaceae 1,43E-04 0,00E+00 0,00E+00 0,00E+00 6,91E-05 0,00E+00 0,00E+00 0,00E+00 2,74E-04 
Lactobacillaceae 5,74E-04 1,63E-04 9,58E-04 6,04E-02 1,29E-01 1,42E-01 5,87E-04 5,21E-04 1,92E-03 
Lachnospiraceae 6,74E-02 1,21E-01 1,96E-01 0,00E+00 2,07E-04 0,00E+00 1,80E-01 2,06E-01 1,53E-01 
Ruminococcaceae 3,87E-03 4,88E-04 1,63E-03 0,00E+00 0,00E+00 0,00E+00 4,11E-03 9,11E-04 1,92E-03 
Clostridiales;__uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae 1,65E-03 1,63E-04 6,71E-04 0,00E+00 0,00E+00 0,00E+00 8,39E-04 2,60E-04 9,14E-04 
Rhizobiaceae 0,00E+00 0,00E+00 0,00E+00 5,80E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Alcaligenaceae 1,48E-02 6,35E-03 6,61E-03 0,00E+00 0,00E+00 0,00E+00 8,98E-03 3,51E-03 6,67E-03 
Comamonadaceae 7,17E-05 0,00E+00 0,00E+00 1,16E-04 4,14E-04 8,44E-05 8,39E-05 0,00E+00 0,00E+00 
Desulfovibrionaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Verrucomicrobiaceae 2,81E-01 3,34E-01 2,34E-01 5,80E-05 9,67E-04 9,28E-04 1,36E-01 1,46E-01 2,36E-01 
Number of 16S amplicon sequencing reads is given as relative abundance and corresponding bar plots are presented in Figure 8C. 
 
Table 40. Microbial composition in small intestines determined by amplicon sequencing using the Silva database to assign taxonomy at the family level 
Days post-inoculation (d) d10 d10 d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 223 227 228 229 224 225 230 231 
Microbiota ASF5 + Oligo-MM10 
Taxon (Family level)          
Nocardiaceae 1,35E-04 2,01E-04 2,77E-04 2,52E-04 0,00E+00 0,00E+00 3,70E-03 1,53E-03 5,86E-03 
Microbacteriaceae 2,02E-04 5,35E-04 2,77E-04 1,89E-04 0,00E+00 5,61E-05 4,09E-03 2,11E-03 4,35E-03 
Promicromonosporaceae 0,00E+00 6,02E-04 2,08E-04 1,89E-04 6,25E-05 0,00E+00 1,16E-03 1,05E-03 2,73E-03 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroidaceae 1,35E-03 5,16E-02 6,24E-04 8,20E-04 5,62E-04 2,81E-04 6,79E-03 4,79E-04 3,34E-03 
Porphyromonadaceae 3,77E-03 5,47E-02 4,37E-03 3,22E-03 3,06E-03 4,66E-03 1,91E-02 1,53E-03 8,29E-03 
Prevotellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Rikenellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,61E-05 0,00E+00 0,00E+00 0,00E+00 
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Days post-inoculation (d) d10 d10 d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 223 227 228 229 224 225 230 231 
Microbiota ASF5 + Oligo-MM10 
Taxon (Family level)          
S24-7 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Deferribacteraceae 0,00E+00 6,68E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 1,54E-04 0,00E+00 0,00E+00 
Lactobacillales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Enterococcaceae 6,73E-05 3,61E-03 5,55E-04 4,42E-04 2,37E-03 0,00E+00 7,71E-05 9,58E-05 2,02E-04 
Lactobacillaceae 3,70E-03 5,27E-02 2,77E-04 8,83E-04 2,50E-04 1,07E-03 4,32E-03 9,77E-03 1,52E-03 
Lachnospiraceae 9,08E-03 1,37E-01 1,53E-02 1,10E-02 2,25E-03 1,51E-03 2,63E-02 1,55E-02 2,18E-02 
Ruminococcaceae 0,00E+00 2,67E-04 1,39E-04 3,15E-04 6,25E-05 4,49E-04 8,49E-04 1,63E-03 5,05E-04 
Clostridiales;__uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae 2,22E-03 3,74E-03 8,32E-04 2,14E-03 2,81E-03 9,54E-04 4,40E-03 1,15E-03 1,37E-02 
Rhizobiaceae 2,69E-04 4,68E-04 2,77E-04 1,89E-04 6,25E-05 5,61E-05 4,55E-03 2,87E-03 8,19E-03 
Alcaligenaceae 9,70E-02 2,43E-02 4,10E-02 4,98E-02 7,14E-02 2,91E-02 8,66E-02 1,15E-01 1,22E-01 
Comamonadaceae 2,15E-03 3,74E-03 2,08E-03 2,27E-03 3,12E-04 8,42E-04 3,24E-02 2,22E-02 5,31E-02 
Desulfovibrionaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Verrucomicrobiaceae 8,80E-01 6,67E-01 9,34E-01 9,28E-01 9,17E-01 9,61E-01 8,05E-01 8,25E-01 7,54E-01 
Number of 16S amplicon sequencing reads are given as relative abundance and corresponding bar plots are presented in Figure 8D. 
 
Table 41. Microbial composition in feces determined by amplicon sequencing using a custom sequence collection to assign taxonomy at the genus level  
Days post-inoculation (d) d0 d0 d0 d0 d10 d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 224 227 228 222 223 227 228 224 225 230 231 
Microbiota ASF5 ASF5 + Oligo-MM10 
Taxon (Genus level)             
Bifidobacterium 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 7,44E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroides 1,17E-04 2,20E-04 5,64E-05 2,75E-04 1,32E-01 1,93E-01 1,23E-01 1,02E-01 1,99E-01 1,96E-01 2,99E-01 2,38E-01 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 6,75E-05 0,00E+00 0,00E+00 
Parabacteroides 9,09E-01 8,18E-01 9,14E-01 8,50E-01 1,81E-01 2,00E-01 1,72E-01 1,95E-01 2,41E-01 2,76E-01 2,23E-01 2,56E-01 
Barnesiella 1,76E-04 5,50E-05 0,00E+00 5,50E-05 7,31E-05 0,00E+00 6,54E-05 0,00E+00 0,00E+00 0,00E+00 8,56E-05 7,48E-05 
Mucispirillum 5,69E-03 2,44E-02 6,10E-03 1,14E-02 7,31E-05 2,23E-04 0,00E+00 3,30E-04 1,42E-04 2,03E-04 4,28E-04 0,00E+00 
Enterococcus 0,00E+00 5,50E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,88E-04 1,98E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lactobacillus 8,46E-02 1,56E-01 7,99E-02 1,38E-01 3,66E-04 6,70E-04 0,00E+00 3,30E-04 3,54E-04 2,70E-04 4,28E-04 9,72E-04 
Blautia 0,00E+00 1,10E-04 0,00E+00 5,50E-05 7,31E-04 1,79E-03 7,84E-04 1,91E-03 8,50E-04 6,75E-04 1,37E-03 3,67E-03 
Lachnospiraceae;Incertae_Sedis 5,87E-05 1,65E-04 0,00E+00 3,30E-04 1,21E-01 1,46E-01 1,99E-01 3,12E-01 1,47E-01 2,00E-01 1,49E-01 1,62E-01 
Lachnospiraceae;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lachnospiraceae;uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 8,56E-05 0,00E+00 
Clostridiales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Flavonifractor 5,87E-05 0,00E+00 0,00E+00 0,00E+00 2,34E-03 1,79E-03 4,57E-04 1,38E-03 3,19E-03 3,58E-03 1,11E-03 2,77E-03 
Ruminococcaceae;Incertae_Sedis 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae;Incertae_Sedis 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,85E-04 1,86E-03 6,54E-05 7,91E-04 4,25E-04 5,40E-04 3,42E-04 2,17E-03 
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Days post-inoculation (d) d0 d0 d0 d0 d10 d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 224 227 228 222 223 227 228 224 225 230 231 
Microbiota ASF5 ASF5 + Oligo-MM10 
Taxon (Genus level)             
Bacteria;Other 5,87E-05 1,10E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Parasutterella 5,87E-05 3,30E-04 0,00E+00 1,65E-04 3,66E-04 3,72E-04 5,88E-04 1,52E-03 9,21E-04 6,75E-04 6,85E-04 6,73E-04 
Akkermansia 5,87E-05 5,50E-05 5,64E-05 1,65E-04 5,62E-01 4,55E-01 5,03E-01 3,84E-01 4,08E-01 3,22E-01 3,24E-01 3,34E-01 
 
Days post-inoculation (d) d22 d22 d22 d43 d43 d43 d43 d43 d43 
Mouse number 347 348 349 350 351 352 353 354 355 
Microbiota ASF5 + Oligo-MM10 ASF5 ASF5 + Oligo-MM10 
Taxon (Genus level)          
Bifidobacterium 0,00E+00 0,00E+00 0,00E+00 1,16E-04 0,00E+00 0,00E+00 8,39E-05 0,00E+00 0,00E+00 
Bacteroides 3,85E-01 2,87E-01 3,54E-01 5,80E-05 1,38E-04 0,00E+00 4,18E-01 3,77E-01 4,01E-01 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Parabacteroides 2,45E-01 2,50E-01 2,06E-01 9,25E-01 8,57E-01 8,42E-01 2,49E-01 2,66E-01 1,98E-01 
Barnesiella 7,17E-05 4,88E-04 0,00E+00 5,80E-05 0,00E+00 0,00E+00 8,39E-05 1,30E-04 0,00E+00 
Mucispirillum 0,00E+00 1,63E-04 9,58E-05 1,36E-02 1,22E-02 1,51E-02 2,52E-03 3,90E-04 2,74E-04 
Enterococcus 1,43E-04 0,00E+00 0,00E+00 0,00E+00 6,91E-05 0,00E+00 0,00E+00 0,00E+00 2,74E-04 
Lactobacillus 5,74E-04 1,63E-04 9,58E-04 6,04E-02 1,29E-01 1,42E-01 5,87E-04 5,21E-04 1,92E-03 
Blautia 1,08E-03 1,14E-03 3,83E-03 0,00E+00 0,00E+00 0,00E+00 1,51E-03 1,95E-03 3,38E-03 
Lachnospiraceae;Incertae_Sedis 6,64E-02 1,20E-01 1,92E-01 0,00E+00 2,07E-04 0,00E+00 1,79E-01 2,04E-01 1,50E-01 
Lachnospiraceae;Other 0,00E+00 1,63E-04 9,58E-05 0,00E+00 0,00E+00 0,00E+00 1,68E-04 2,60E-04 0,00E+00 
Lachnospiraceae;uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Clostridiales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Flavonifractor 3,87E-03 4,88E-04 1,63E-03 0,00E+00 0,00E+00 0,00E+00 4,11E-03 9,11E-04 1,92E-03 
Ruminococcaceae;Incertae_Sedis 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae;Incertae_Sedis 1,65E-03 1,63E-04 6,71E-04 0,00E+00 0,00E+00 0,00E+00 8,39E-04 2,60E-04 9,14E-04 
Bacteria;Other 0,00E+00 0,00E+00 0,00E+00 1,74E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Parasutterella 1,48E-02 6,35E-03 6,61E-03 1,16E-04 4,14E-04 8,44E-05 9,06E-03 3,51E-03 6,67E-03 
Akkermansia 2,81E-01 3,34E-01 2,34E-01 5,80E-05 9,67E-04 9,28E-04 1,36E-01 1,46E-01 2,36E-01 
Number of 16S amplicon sequencing reads are given as relative abundance and corresponding bar plots are presented in Figure 9A. 
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Table 42. Microbial composition in small intestines determined by amplicon sequencing using a custom sequence collection to assign taxonomy at the genus level 
Days post-inoculation (d) d10 d10 d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 223 227 228 229 224 225 230 231 
Microbiota ASF5 + Oligo-MM10 
Taxon (Genus level)          
Bifidobacterium 0,00E+00 6,02E-04 2,08E-04 1,89E-04 6,25E-05 0,00E+00 1,16E-03 1,05E-03 2,73E-03 
Bacteroides 1,35E-03 5,16E-02 6,24E-04 8,20E-04 5,62E-04 2,81E-04 6,79E-03 4,79E-04 3,34E-03 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,61E-05 0,00E+00 0,00E+00 0,00E+00 
Parabacteroides 3,77E-03 5,47E-02 4,37E-03 3,22E-03 3,06E-03 4,66E-03 1,91E-02 1,53E-03 8,29E-03 
Barnesiella 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Mucispirillum 0,00E+00 6,68E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 1,54E-04 0,00E+00 0,00E+00 
Enterococcus 6,73E-05 3,61E-03 5,55E-04 4,42E-04 2,37E-03 0,00E+00 7,71E-05 9,58E-05 2,02E-04 
Lactobacillus 3,70E-03 5,27E-02 2,77E-04 8,83E-04 2,50E-04 1,07E-03 4,32E-03 9,77E-03 1,52E-03 
Blautia 2,22E-03 5,62E-03 2,50E-03 2,40E-03 6,87E-04 7,29E-04 6,09E-03 4,69E-03 8,29E-03 
Lachnospiraceae;Incertae_Sedis 6,86E-03 1,31E-01 1,28E-02 8,58E-03 1,56E-03 7,86E-04 2,02E-02 1,08E-02 1,35E-02 
Lachnospiraceae;Other 0,00E+00 6,68E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lachnospiraceae;uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Clostridiales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Flavonifractor 0,00E+00 2,67E-04 1,39E-04 3,15E-04 6,25E-05 4,49E-04 8,49E-04 1,63E-03 5,05E-04 
Ruminococcaceae;Incertae_Sedis 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae;Incertae_Sedis 2,22E-03 3,74E-03 8,32E-04 2,14E-03 2,81E-03 9,54E-04 4,40E-03 1,15E-03 1,37E-02 
Bacteria;Other 6,05E-04 1,20E-03 8,32E-04 6,31E-04 6,25E-05 1,12E-04 1,23E-02 6,51E-03 1,84E-02 
Parasutterella 9,91E-02 2,81E-02 4,31E-02 5,21E-02 7,17E-02 2,99E-02 1,19E-01 1,37E-01 1,75E-01 
Akkermansia 8,80E-01 6,67E-01 9,34E-01 9,28E-01 9,17E-01 9,61E-01 8,05E-01 8,25E-01 7,54E-01 
Number of 16S amplicon sequencing reads are given as relative abundance and corresponding bar plots are presented in Figure 9B. 
 
Table 43. Microbial composition in the frozen inoculum determined by amplicon sequencing using a custom sequence collection to assign taxonomy at the genus 
level 
Taxon (Genus level) Inoculum 
Bifidobacterium 0,00E+00 
Bacteroides 4,54E-01 
Bacteroidales;Other 0,00E+00 
Parabacteroides 7,33E-04 
Barnesiella 0,00E+00 
Mucispirillum 0,00E+00 
Enterococcus 4,77E-02 
Lactobacillus 3,27E-03 
Blautia 1,21E-02 
Lachnospiraceae;Incertae_Sedis 9,26E-02 
Lachnospiraceae;Other 0,00E+00 
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Taxon (Genus level) Inoculum 
Lachnospiraceae;uncultured 0,00E+00 
Clostridiales;Other 0,00E+00 
Flavonifractor 4,11E-02 
Ruminococcaceae;Incertae_Sedis 0,00E+00 
Erysipelotrichaceae;Incertae_Sedis 3,79E-02 
Bacteria;Other 0,00E+00 
Parasutterella 6,00E-04 
Akkermansia 3,10E-01 
Number of 16S amplicon sequencing reads are given as relative abundance and corresponding bar plots are presented in Figure 9C. 
 
Table 44. Microbial composition in feces and cecal content determined by amplicon sequencing using a custom sequence collection to assign taxonomy at the genus 
level 
 Feces 
Days post-inoculation (d) d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 227 228 224 225 230 231 
Microbiota ASF5 + Oligo-MM10 
Taxon (Genus level)        
Bifidobacterium 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroides 1,32E-01 1,23E-01 1,02E-01 1,99E-01 1,96E-01 2,99E-01 2,38E-01 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 6,75E-05 0,00E+00 0,00E+00 
Parabacteroides 1,81E-01 1,72E-01 1,95E-01 2,41E-01 2,76E-01 2,23E-01 2,56E-01 
Barnesiella 7,31E-05 6,54E-05 0,00E+00 0,00E+00 0,00E+00 8,56E-05 7,48E-05 
Mucispirillum 7,31E-05 0,00E+00 3,30E-04 1,42E-04 2,03E-04 4,28E-04 0,00E+00 
Enterococcus 0,00E+00 5,88E-04 1,98E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lactobacillus 3,66E-04 0,00E+00 3,30E-04 3,54E-04 2,70E-04 4,28E-04 9,72E-04 
Blautia 7,31E-04 7,84E-04 1,91E-03 8,50E-04 6,75E-04 1,37E-03 3,67E-03 
Lachnospiraceae;Incertae_Sedis 1,21E-01 1,99E-01 3,12E-01 1,47E-01 2,00E-01 1,49E-01 1,62E-01 
Lachnospiraceae;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lachnospiraceae;uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 8,56E-05 0,00E+00 
Clostridiales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Flavonifractor 2,34E-03 4,57E-04 1,38E-03 3,19E-03 3,58E-03 1,11E-03 2,77E-03 
Ruminococcaceae;Incertae_Sedis 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae;Incertae_Sedis 5,85E-04 6,54E-05 7,91E-04 4,25E-04 5,40E-04 3,42E-04 2,17E-03 
Bacteria;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Parasutterella 3,66E-04 5,88E-04 1,52E-03 9,21E-04 6,75E-04 6,85E-04 6,73E-04 
Akkermansia 5,62E-01 5,03E-01 3,84E-01 4,08E-01 3,22E-01 3,24E-01 3,34E-01 
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 Cecal content 
Days post-inoculation (d) d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 227 228 224 225 230 231 
Microbiota ASF5 + Oligo-MM10 
Taxon (Genus level)        
Bifidobacterium 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroides 1,87E-01 1,42E-01 1,84E-01 2,29E-01 1,88E-01 2,23E-01 2,11E-01 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
 Cecal content 
Days post-inoculation (d) d10 d10 d10 d20 d20 d20 d20 
Mouse number 222 227 228 224 225 230 231 
Microbiota ASF5 + Oligo-MM10 
Taxon (Genus level)        
Parabacteroides 3,26E-01 3,09E-01 2,97E-01 2,88E-01 2,94E-01 2,80E-01 3,26E-01 
Barnesiella 6,77E-05 0,00E+00 9,53E-05 1,38E-04 5,77E-05 0,00E+00 0,00E+00 
Mucispirillum 4,74E-04 4,40E-04 1,24E-03 2,77E-04 2,31E-04 6,42E-04 7,15E-04 
Enterococcus 0,00E+00 3,52E-04 9,53E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Lactobacillus 4,74E-04 5,28E-04 9,53E-05 8,99E-04 3,46E-04 3,42E-04 1,02E-04 
Blautia 1,56E-03 1,41E-03 4,77E-04 1,04E-03 1,15E-03 1,80E-03 1,53E-03 
Lachnospiraceae;Incertae_Sedis 2,39E-01 3,79E-01 3,11E-01 2,30E-01 2,84E-01 3,13E-01 3,12E-01 
Lachnospiraceae;Other 6,77E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 1,02E-04 
Lachnospiraceae;uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Clostridiales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Flavonifractor 2,71E-03 7,04E-04 1,72E-03 3,25E-03 2,83E-03 2,35E-03 3,06E-03 
Ruminococcaceae;Incertae_Sedis 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae;Incertae_Sedis 5,41E-04 8,81E-05 8,58E-04 1,11E-03 6,35E-04 2,99E-04 8,17E-04 
Bacteria;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 1,02E-04 
Parasutterella 1,22E-03 4,40E-04 9,53E-04 8,30E-04 1,21E-03 7,70E-04 1,43E-03 
Akkermansia 2,41E-01 1,66E-01 2,03E-01 2,45E-01 2,27E-01 1,78E-01 1,43E-01 
Number of 16S amplicon sequencing reads are given as relative abundance and corresponding bar plots are presented in Figure 10. 
 
Table 45. Oligo-MM12 fecal composition over generations analyzed by qPCR 
Mouse 
generation Strain ID 
  I46 I49 YL58 YL27 YL31 YL32 KB18 YL44 KB1 YL2 YL45 I48 
F0 0,00E+00 4,24E-04 9,56E-03 1,19E-01 1,82E-02 9,01E-03 0,00E+00 3,70E-01 9,88E-04 0,00E+00 5,92E-02 4,14E-01 
F0 0,00E+00 4,52E-04 1,10E-02 1,33E-01 2,29E-02 9,83E-03 1,86E-03 2,03E-01 6,22E-04 0,00E+00 4,74E-02 5,70E-01 
             F1 0,00E+00 0,00E+00 6,49E-03 1,16E-01 2,40E-02 7,83E-03 0,00E+00 3,61E-01 3,92E-04 4,37E-06 4,35E-02 4,41E-01 
F1 0,00E+00 0,00E+00 7,01E-03 1,16E-01 1,45E-02 2,48E-02 0,00E+00 2,96E-01 5,52E-04 6,47E-06 4,49E-02 4,96E-01 
F1 0,00E+00 3,04E-04 8,82E-03 1,12E-01 2,29E-02 1,10E-02 3,19E-05 2,47E-01 8,53E-04 0,00E+00 4,18E-02 5,55E-01 
Mouse Strain ID 
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generation 
  I46 I49 YL58 YL27 YL31 YL32 KB18 YL44 KB1 YL2 YL45 I48 
F1 0,00E+00 1,90E-04 7,22E-03 1,11E-01 1,96E-02 6,99E-03 6,42E-04 2,58E-01 8,88E-04 0,00E+00 5,65E-02 5,38E-01 
F1 0,00E+00 1,04E-03 8,77E-03 8,91E-02 2,88E-02 1,28E-02 0,00E+00 2,57E-01 1,42E-03 0,00E+00 6,17E-02 5,40E-01 
             F2 0,00E+00 6,39E-04 2,32E-03 9,96E-02 1,90E-02 1,41E-02 0,00E+00 1,97E-01 0,00E+00 0,00E+00 2,95E-02 6,37E-01 
F2 0,00E+00 9,36E-04 4,31E-03 9,28E-02 2,43E-02 2,08E-02 9,65E-07 1,86E-01 6,45E-05 0,00E+00 3,01E-02 6,41E-01 
F2 0,00E+00 7,79E-04 5,05E-03 1,02E-01 2,17E-02 1,84E-02 0,00E+00 2,56E-01 5,17E-05 0,00E+00 3,42E-02 5,62E-01 
F2 0,00E+00 2,55E-03 8,85E-03 1,02E-01 2,40E-02 1,19E-02 0,00E+00 1,70E-01 5,51E-05 0,00E+00 3,62E-02 6,45E-01 
F2 0,00E+00 1,99E-03 4,19E-03 1,05E-01 2,11E-02 1,83E-02 1,04E-06 2,25E-01 4,29E-05 0,00E+00 3,80E-02 5,87E-01 
  I46 I49 YL58 YL27 YL31 YL32 KB18 YL44 KB1 YL2 YL45 I48 
F2 0,00E+00 1,04E-03 4,06E-03 7,92E-02 1,98E-02 1,73E-02 0,00E+00 2,32E-01 0,00E+00 0,00E+00 3,56E-02 6,11E-01 
F2 0,00E+00 8,02E-04 4,56E-03 9,01E-02 2,08E-02 2,34E-02 0,00E+00 2,53E-01 1,41E-04 0,00E+00 3,00E-02 5,78E-01 
F2 0,00E+00 9,07E-04 3,97E-03 7,99E-02 1,70E-02 1,21E-02 0,00E+00 1,51E-01 1,01E-04 0,00E+00 3,29E-02 7,02E-01 
F2 0,00E+00 6,64E-04 4,07E-03 8,08E-02 1,86E-02 1,95E-02 0,00E+00 2,33E-01 1,17E-04 0,00E+00 3,72E-02 6,06E-01 
F2 0,00E+00 6,76E-04 4,33E-03 8,79E-02 1,88E-02 1,36E-02 0,00E+00 2,27E-01 1,12E-04 0,00E+00 3,45E-02 6,13E-01 
F2 0,00E+00 9,04E-04 3,82E-03 8,82E-02 1,75E-02 1,41E-02 0,00E+00 2,00E-01 4,79E-05 0,00E+00 3,63E-02 6,39E-01 
             F3 0,00E+00 1,86E-03 9,68E-03 9,98E-02 2,19E-02 1,94E-02 0,00E+00 2,27E-01 3,11E-04 0,00E+00 2,37E-02 5,96E-01 
F3 0,00E+00 8,94E-04 1,28E-02 1,07E-01 2,45E-02 3,41E-02 0,00E+00 2,55E-01 6,37E-04 0,00E+00 2,77E-02 5,38E-01 
F3 0,00E+00 2,52E-03 7,98E-03 1,02E-01 2,04E-02 1,99E-02 0,00E+00 2,66E-01 4,98E-04 0,00E+00 2,74E-02 5,54E-01 
F3 0,00E+00 1,90E-03 8,22E-03 1,00E-01 2,35E-02 2,00E-02 0,00E+00 2,02E-01 3,11E-04 0,00E+00 2,38E-02 6,20E-01 
F3 0,00E+00 2,36E-03 7,55E-03 1,06E-01 2,26E-02 2,54E-02 0,00E+00 2,22E-01 4,91E-04 0,00E+00 3,40E-02 5,80E-01 
F3 0,00E+00 2,77E-03 5,62E-03 9,89E-02 2,22E-02 1,56E-02 0,00E+00 2,64E-01 6,73E-04 0,00E+00 3,33E-02 5,57E-01 
             F4 0,00E+00 0,00E+00 8,41E-03 1,25E-01 1,96E-02 1,03E-02 0,00E+00 1,71E-01 1,66E-04 8,12E-06 1,83E-02 6,47E-01 
F4 0,00E+00 6,16E-04 7,11E-03 1,08E-01 1,74E-02 1,07E-02 0,00E+00 2,11E-01 7,34E-05 0,00E+00 2,18E-02 6,23E-01 
F4 0,00E+00 1,04E-03 8,44E-03 9,69E-02 1,72E-02 7,39E-03 0,00E+00 1,50E-01 2,57E-04 3,80E-06 2,30E-02 6,96E-01 
F4 0,00E+00 6,89E-04 7,22E-03 9,43E-02 1,71E-02 1,16E-02 0,00E+00 1,55E-01 1,45E-04 4,49E-06 1,89E-02 6,95E-01 
F4 0,00E+00 5,59E-04 5,48E-03 9,82E-02 1,63E-02 9,75E-03 0,00E+00 1,43E-01 7,52E-05 0,00E+00 2,38E-02 7,03E-01 
F4 0,00E+00 7,48E-04 7,06E-03 8,79E-02 1,88E-02 9,40E-03 0,00E+00 1,75E-01 1,17E-04 0,00E+00 3,21E-02 6,69E-01 
Amount of 16S rRNA gene copies per 5 ƞg fecal DNA are given as relative abundance of total bacteria. Refer to Figure 12 for the corresponding bar plots. 
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Table 46. Microbial composition in feces determined by amplicon sequencing using the Silva database to assign taxonomy at the family level 
Days post-inoculation (d) d41 
Mouse number 381 382 383 384 385 386 387 388 390 
Microbiota ASF5 ASF5 + Oligo-MM12 
Taxon (Family level)          
Nocardiaceae 0,00E+00 0,00E+00 6,63E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Microbacteriaceae 1,09E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Promicromonosporaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Bacteroidales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 2,41E-03 2,60E-03 2,93E-03 3,04E-03 
Bacteroidaceae 5,47E-04 0,00E+00 6,63E-05 1,60E-04 2,54E-03 4,04E-01 3,54E-01 3,83E-01 3,71E-01 
Porphyromonadaceae 9,45E-01 9,72E-01 9,11E-01 9,43E-01 9,55E-01 2,32E-01 2,33E-01 2,82E-01 2,28E-01 
Prevotellaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 7,77E-05 0,00E+00 0,00E+00 4,47E-04 
Rikenellaceae 1,09E-04 0,00E+00 0,00E+00 5,32E-05 0,00E+00 0,00E+00 0,00E+00 8,37E-05 0,00E+00 
S24-7 0,00E+00 3,17E-04 0,00E+00 1,06E-04 2,95E-04 1,95E-02 2,24E-02 2,25E-02 1,32E-02 
Deferribacteraceae 5,14E-03 7,93E-04 5,63E-03 1,07E-02 9,10E-03 1,55E-04 4,88E-04 3,35E-04 1,07E-03 
Lactobacillales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Enterococcaceae 0,00E+00 0,00E+00 1,33E-04 0,00E+00 1,18E-04 0,00E+00 0,00E+00 0,00E+00 8,95E-05 
Lactobacillaceae 4,34E-02 1,46E-02 7,47E-02 4,62E-02 3,15E-02 2,64E-03 4,88E-04 3,35E-04 7,16E-04 
Lachnospiraceae 5,14E-03 1,05E-02 7,55E-03 5,32E-05 1,77E-04 6,93E-02 2,12E-01 9,06E-02 2,62E-01 
Ruminococcaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 2,41E-03 1,46E-03 3,93E-03 2,51E-03 
Clostridiales;__uncultured 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Erysipelotrichaceae 1,09E-04 0,00E+00 0,00E+00 0,00E+00 0,00E+00 1,32E-03 2,44E-04 1,17E-03 6,26E-04 
Rhizobiaceae 0,00E+00 3,17E-04 6,63E-05 0,00E+00 5,91E-05 7,77E-05 0,00E+00 0,00E+00 0,00E+00 
Alcaligenaceae 0,00E+00 0,00E+00 0,00E+00 0,00E+00 5,91E-05 8,55E-03 8,79E-03 8,03E-03 6,98E-03 
Comamonadaceae 0,00E+00 6,34E-04 2,65E-04 1,06E-04 5,91E-05 2,33E-04 0,00E+00 0,00E+00 8,95E-05 
Desulfovibrionaceae 0,00E+00 0,00E+00 6,63E-05 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Verrucomicrobiaceae 5,47E-04 6,34E-04 0,00E+00 0,00E+00 1,18E-03 2,57E-01 1,65E-01 2,05E-01 1,10E-01 
 
Days post-inoculation (d) d41 
Mouse number 391 392 393 394 395 
Microbiota ASF5 + CON 
Taxon (Family level)      
Nocardiaceae 1,12E-04 9,85E-05 0,00E+00 0,00E+00 2,30E-04 
Microbacteriaceae 1,12E-04 0,00E+00 2,11E-04 0,00E+00 0,00E+00 
Promicromonosporaceae 0,00E+00 0,00E+00 0,00E+00 4,63E-04 1,15E-04 
Bacteroidales;Other 4,49E-04 6,90E-04 2,32E-03 6,95E-04 8,05E-04 
Bacteroidaceae 5,37E-02 2,89E-02 4,60E-02 2,61E-02 2,31E-02 
Porphyromonadaceae 2,28E-02 1,57E-02 2,22E-02 1,57E-02 1,93E-02 
Prevotellaceae 9,67E-02 5,57E-02 1,27E-01 1,84E-02 1,91E-02 
Rikenellaceae 5,43E-02 4,62E-02 9,47E-02 6,07E-02 6,90E-02 
S24-7 6,06E-01 7,18E-01 4,84E-01 5,79E-01 6,39E-01 
Deferribacteraceae 4,49E-04 5,91E-04 2,11E-03 1,85E-03 8,05E-04 
Lactobacillales;Other 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
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Days post-inoculation (d) d41 
Mouse number 391 392 393 394 395 
Microbiota ASF5 + CON 
Taxon (Family level)      
Enterococcaceae 0,00E+00 1,97E-04 0,00E+00 1,16E-04 0,00E+00 
Lactobacillaceae 1,76E-02 2,72E-02 2,42E-02 2,44E-02 5,20E-02 
Lachnospiraceae 1,16E-01 7,94E-02 1,61E-01 2,44E-01 1,33E-01 
Ruminococcaceae 1,82E-02 1,22E-02 2,41E-02 1,25E-02 1,79E-02 
Clostridiales;__uncultured 2,02E-03 1,77E-03 2,74E-03 3,36E-03 5,98E-03 
Erysipelotrichaceae 7,85E-04 1,87E-03 4,22E-04 1,97E-03 4,26E-03 
Rhizobiaceae 0,00E+00 0,00E+00 0,00E+00 1,16E-04 0,00E+00 
Alcaligenaceae 6,62E-03 7,68E-03 5,17E-03 4,98E-03 7,25E-03 
Comamonadaceae 8,97E-04 1,97E-04 6,33E-04 1,16E-03 1,15E-04 
Desulfovibrionaceae 3,59E-03 4,04E-03 3,27E-03 5,33E-03 7,94E-03 
Verrucomicrobiaceae 0,00E+00 9,85E-05 1,06E-04 0,00E+00 0,00E+00 
Number of 16S amplicon sequencing reads are given as relative abundance and corresponding bar plots are presented in Figure 13C. 
 
Table 47. Microbial composition in feces of ASF and Oligo-MM strains before infection determined by qPCR 
Mouse 
number 381 382 383 384 385 386 387 388 389 390 
Microbiota ASF5 ASF5 ASF5 ASF5 ASF5 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
I46 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 I49 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 5,12E-05 NA 0,00E+00 YL58 0,00E+00 0,00E+00 0,00E+00   5,31E-03 3,63E-03 4,04E-03 NA 1,79E-03 YL27 0,00E+00 0,00E+00 0,00E+00   4,20E-02 4,01E-02 4,03E-02 NA 4,25E-02 YL31 7,92E-06 8,30E-05 1,76E-05   1,81E-02 1,35E-02 2,05E-02 NA 1,23E-02 YL32 0,00E+00 0,00E+00 0,00E+00   8,94E-03 2,46E-02 1,11E-02 NA 1,90E-02 KB18 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 YL44 0,00E+00 0,00E+00 0,00E+00   2,36E-01 2,22E-01 2,15E-01 NA 2,70E-01 KB1 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 2,55E-06 NA 4,06E-05 YL2 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 YL45 0,00E+00 0,00E+00 0,00E+00   2,66E-02 3,43E-02 3,01E-02 NA 4,23E-02 I48 0,00E+00 0,00E+00 0,00E+00   4,85E-01 4,60E-01 4,83E-01 NA 3,57E-01 ASF356 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 
ASF361 7,24E-02 2,55E-02 7,28E-02 4,26E-02 3,58E-02 1,37E-03 6,68E-04 8,96E-04 NA 5,66E-04 
ASF457 7,31E-02 3,28E-02 7,79E-02 7,64E-02 7,16E-02 9,06E-04 7,66E-04 3,56E-04 NA 4,67E-03 
ASF519 8,54E-01 9,42E-01 8,49E-01 8,81E-01 8,93E-01 1,75E-01 2,01E-01 1,95E-01 NA 2,50E-01 
ASF360 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 ASF502(SB2) 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 ASF500 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 NA 0,00E+00 
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Mouse 
number 381 382 383 384 385 386 387 388 389 390 
Microbiota ASF5 ASF5 ASF5 ASF5 ASF5 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
ASF5 + 
Oligo-
MM12 
S. Tmavir 0,00E+00 0,00E+00 0,00E+00   0,00E+00 0,00E+00 0,00E+00 NA  
Amount of 16S rRNA gene copies per 5 ƞg fecal DNA are given as relative abundance and corresponding bar plots are presented in Figure 14. Grey filling stays for 
values below detection limit. 
 
Table 48. Microbial composition in feces of ASF- and Oligo-MM-colonized mice before infection determined by qPCR 
Mouse  number 996 997 998 999 1000 1001 1002 1003 
Microbiota ASF4 ASF4 ASF4 ASF
4 + 
ASF7 
ASF4 + 
ASF7 
ASF4 + 
ASF7 
ASF4 + 
ASF7 
ASF4 + 
ASF7 
I46 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   I49 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL58 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL27 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL31 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL32 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   KB18 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL44 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   KB1 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL2 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   YL45 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   I48 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   ASF356 2,91E-02 2,18E-02 2,59E-02 1,12E-02 1,68E-02 1,77E-02 2,42E-02 2,35E-02 
ASF361 1,95E-01 1,21E-01 1,74E-01 2,00E-01 1,52E-01 1,43E-01 2,08E-01 2,14E-01 
ASF457 0,00E+00 0,00E+00 0,00E+00 8,74E-03 1,57E-02 1,22E-02 1,11E-02 1,35E-02 
ASF519 7,76E-01 8,57E-01 8,00E-01 7,80E-01 8,15E-01 8,27E-01 7,56E-01 7,49E-01 
ASF360 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 3,90E-05 0,00E+00 0,00E+00 
ASF502(SB2) 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 2,99E-06 0,00E+00 0,00E+00 
ASF500 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 2,42E-05 0,00E+00 1,26E-05 
S. Tmavir 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00   
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Mouse  number 942 943 944 945 946 947 948 949 950 951 952 953 
Microbiota Oligo-MM12 
Oligo-
MM12 
Oligo-
MM12 
Oligo-
MM12 
Oligo-
MM12 
Oligo-
MM12 
Oligo-
MM12 + 
ASF7 
Oligo-
MM12 + 
ASF7 
Oligo-
MM12 + 
ASF7 
Oligo-
MM12 + 
ASF7 
Oligo-
MM12 + 
ASF7 
Oligo-
MM12 + 
ASF7 
I46 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
I49 1,76E-03 8,15E-04 5,12E-04 4,49E-04 5,97E-04 3,25E-04 5,99E-04 1,48E-03 1,22E-03 2,15E-03 1,28E-03 3,48E-04 
YL58 1,49E-02 1,50E-02 1,78E-02 7,21E-03 5,31E-03 1,16E-02 1,14E-02 1,19E-02 1,50E-02 1,44E-02 1,33E-02 1,56E-02 
YL27 1,45E-01 1,33E-01 1,39E-01 1,80E-01 1,96E-01 2,22E-01 7,57E-02 9,79E-02 7,56E-02 6,45E-02 6,36E-02 5,00E-02 
YL31 2,20E-02 1,59E-02 1,44E-02 9,40E-03 1,03E-02 7,15E-03 1,87E-02 1,69E-02 1,17E-02 1,95E-02 2,25E-02 1,75E-02 
YL32 3,06E-02 3,07E-02 3,98E-02 4,58E-02 1,55E-02 4,43E-02 8,92E-02 3,89E-02 7,76E-02 4,21E-02 9,55E-02 1,09E-01 
KB18 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
YL44 2,90E-01 2,69E-01 1,91E-01 3,35E-01 2,70E-01 1,91E-01 1,86E-01 1,52E-01 1,31E-01 2,64E-01 1,78E-01 1,53E-01 
KB1 4,45E-05 5,35E-05 8,75E-05 6,72E-05 2,66E-05 4,30E-05 8,52E-05 7,96E-05 5,52E-05 4,32E-05 2,90E-05 8,16E-05 
YL2 0,00E+00 6,57E-06 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 4,57E-06 
YL45 3,63E-02 3,80E-02 4,77E-02 4,55E-02 3,89E-02 4,76E-02 3,12E-02 3,35E-02 3,59E-02 3,16E-02 3,04E-02 4,29E-02 
I48 4,60E-01 4,98E-01 5,49E-01 3,77E-01 4,64E-01 4,76E-01 4,65E-01 5,33E-01 5,20E-01 4,63E-01 4,43E-01 4,42E-01 
ASF356 0,00E+00 0,00E+00 0,00E+00    0,00E+00 0,00E+00 5,80E-03 7,63E-03 0,00E+00 0,00E+00 ASF361 0,00E+00 0,00E+00 0,00E+00    4,79E-03 3,08E-03 1,16E-05 0,00E+00 1,49E-03 1,96E-03 ASF457 0,00E+00 0,00E+00 0,00E+00    1,62E-02 7,93E-03 1,76E-02 5,66E-03 1,19E-02 1,16E-02 ASF519 0,00E+00 0,00E+00 0,00E+00    1,01E-01 1,03E-01 1,08E-01 8,56E-02 1,39E-01 1,57E-01 ASF360 0,00E+00 0,00E+00 0,00E+00    0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 ASF502(SB2) 0,00E+00 0,00E+00 0,00E+00    0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 ASF500 0,00E+00 0,00E+00 0,00E+00    0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 S. Tmavir 0,00E+00 0,00E+00 0,00E+00    0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 0,00E+00 
Amount of 16S rRNA gene copies per 5 ƞg fecal DNA are given as relative abundance and corresponding bar plots are presented in Figure 18B. Grey filling stays 
for analysis not performed. 
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Table 49. Gene sets upregulated in cecal epithelium of AGR2ko mice as compared to AGR2het littermates 
NAME SIZE NES FDR q-val 
REACT_CHOLESTEROL BIOSYNTHESIS 16 2,109206 0,025354 
NCI_ANTHRAXPATHWAY 17 1,882678 0,155662 
BIOC_HIVNEFPATHWAY 50 1,898674 0,19743 
Only the significant upregulated gene sets are shown here (FDR<0.25). 
 
Table 50. Gene sets downregulated in cecal epithelium of AGR2ko mice as compared to AGR2het littermates 
NAME SIZE NES FDR q-val 
REACT_MITOTIC M-M_G1 PHASES 132 -2,63888 0 
REACT_DNA REPLICATION 145 -2,61878 0 
WIP_MM_DNA_REPLICATION 39 -2,50171 0 
REACT_G1_S TRANSITION 70 -2,49978 0 
REACT_MITOTIC G1-G1_S PHASES 78 -2,49747 0 
REACT_S PHASE 82 -2,49701 0 
REACT_CELL CYCLE, MITOTIC 224 -2,46865 0 
REACT_SYNTHESIS OF DNA 69 -2,4529 0 
REACT_DNA STRAND ELONGATION 22 -2,44621 0 
NCI_AURORA_B_PATHWAY 34 -2,25125 4,89E-05 
REACT_ACTIVATION OF THE PRE-REPLICATIVE COMPLEX 21 -2,26184 5,12E-05 
REACT_ASSEMBLY OF THE PRE-REPLICATIVE COMPLEX 50 -2,26748 5,38E-05 
REACT_G2_M CHECKPOINTS 30 -2,26886 5,66E-05 
REACT_M PHASE 73 -2,27245 5,97E-05 
REACT_MITOTIC PROMETAPHASE 70 -2,28769 6,33E-05 
REACT_TELOMERE MAINTENANCE 25 -2,36994 6,72E-05 
REACT_CHROMOSOME MAINTENANCE 25 -2,3835 7,17E-05 
REACT_MEIOTIC RECOMBINATION (MOUSE) 58 -2,40668 7,68E-05 
KEGG_DNA REPLICATION 34 -2,4071 8,27E-05 
REACT_CELL CYCLE CHECKPOINTS 85 -2,41208 8,96E-05 
REACT_REGULATION OF DNA REPLICATION 55 -2,23133 9,09E-05 
REACT_M_G1 TRANSITION 59 -2,43479 9,78E-05 
REACT_DNA REPLICATION PRE-INITIATION 59 -2,44487 1,08E-04 
REACT_ORC1 REMOVAL FROM CHROMATIN 53 -2,18705 2,94E-04 
REACT_REMOVAL OF LICENSING FACTORS FROM ORIGINS 55 -2,19737 3,06E-04 
REACT_SWITCHING OF ORIGINS TO A POST-REPLICATIVE STATE 53 -2,17222 3,52E-04 
NCI_FANCONI_PATHWAY 44 -2,17796 3,66E-04 
KEGG_SYSTEMIC LUPUS ERYTHEMATOSUS 98 -2,14963 6,09E-04 
REACT_ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS 27 -2,12349 8,25E-04 
WIP_MM_G1_TO_S_CELL_CYCLE_CONTROL 60 -2,12509 8,53E-04 
REACT_MEIOTIC SYNAPSIS (MOUSE) 66 -2,11112 8,66E-04 
NCI_PLK1_PATHWAY 40 -2,12808 8,82E-04 
REACT_SCF(SKP2)-MEDIATED DEGRADATION OF P27_P21 43 -2,10127 0,001001 
REACT_MRNA SPLICING 72 -2,08338 0,001223 
REACT_G1_S DNA DAMAGE CHECKPOINTS 45 -2,07715 0,001311 
REACT_REGULATION OF INSULIN-LIKE GROWTH FACTOR (IGF) ACTIVITY BY INSULIN-
LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) 25 -2,06927 0,001394 
REACT_CYCLIN E ASSOCIATED EVENTS DURING G1_S TRANSITION 47 -2,05732 0,0015 
REACT_PROCESSING OF CAPPED INTRON-CONTAINING PRE-MRNA 75 -2,05544 0,001516 
KEGG_HOMOLOGOUS RECOMBINATION 25 -2,05037 0,001537 
KEGG_NUCLEOTIDE EXCISION REPAIR 43 -2,05189 0,001548 
REACT_P53-DEPENDENT G1_S DNA DAMAGE CHECKPOINT 43 -2,05356 0,00156 
REACT_CDT1 ASSOCIATION WITH THE CDC6_ORC_ORIGIN COMPLEX 44 -2,03157 0,001958 
REACT_AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 39 -2,02304 0,001997 
NCI_ATR_PATHWAY 37 -2,02674 0,002014 
REACT_MRNA SPLICING - MAJOR PATHWAY 72 -2,02518 0,002015 
REACT_P53-DEPENDENT G1 DNA DAMAGE RESPONSE 43 -2,02889 0,002037 
REACT_MRNA PROCESSING 90 -2,02392 0,002041 
WIP_MM_PROTEASOME_DEGRADATION 55 -2,01205 0,002272 
REACT_STABILIZATION OF P53 39 -2,00003 0,002515 
KEGG_CELL CYCLE 121 -2,00028 0,002566 
REACT_CYCLIN A_CDK2-ASSOCIATED EVENTS AT S PHASE ENTRY 48 -2,00287 0,002573 
REACT_MRNA SPLICING - MINOR PATHWAY 28 -1,97545 0,002993 
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NAME SIZE NES FDR q-val 
REACT_FORMATION OF A POOL OF FREE 40S SUBUNITS 54 -1,97385 0,003015 
REACT_UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D1 40 -1,97948 0,003048 
REACT_UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A 39 -1,97548 0,003048 
REACT_APC_C-MEDIATED DEGRADATION OF CELL CYCLE PROTEINS 62 -1,98028 0,003107 
WIP_MM_CELL_CYCLE 84 -1,96911 0,003184 
REACT_ACTIVATION OF APC_C AND APC_C_CDC20 MEDIATED DEGRADATION OF 
MITOTIC PROTEINS 52 -1,96525 0,00322 
REACT_DNA REPAIR 68 -1,96541 0,003276 
REACT_CDC20_PHOSPHO-APC_C MEDIATED DEGRADATION OF CYCLIN A 51 -1,95604 0,0034 
REACT_REGULATION OF MITOTIC CELL CYCLE 62 -1,9504 0,003544 
KEGG_PROTEASOME 43 -1,95087 0,00355 
KEGG_RNA TRANSPORT 144 -1,95232 0,003555 
REACT_P53-INDEPENDENT DNA DAMAGE RESPONSE 39 -1,94757 0,003606 
REACT_APC_C_CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC_C_CDH1 
TARGETED PROTEINS IN LATE MITOSIS_EARLY G1 53 -1,94627 0,003633 
NCI_BARD1PATHWAY 27 -1,94294 0,003692 
REACT_APC_C_CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS 51 -1,93892 0,003862 
REACT_UBIQUITIN-DEPENDENT DEGRADATION OF CYCLIN D 40 -1,93831 0,003885 
REACT_P53-INDEPENDENT G1_S DNA DAMAGE CHECKPOINT 39 -1,92998 0,004108 
REACT_CDK-MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 39 -1,90627 0,005406 
KEGG_PYRIMIDINE METABOLISM 93 -1,88722 0,006725 
REACT_EUKARYOTIC TRANSLATION ELONGATION 50 -1,88791 0,006789 
REACT_REGULATION OF APC_C ACTIVATORS BETWEEN G1_S AND EARLY ANAPHASE 58 -1,88209 0,006994 
REACT_FORMATION AND MATURATION OF MRNA TRANSCRIPT 105 -1,88091 0,006999 
KEGG_SPLICEOSOME 112 -1,88231 0,00709 
REACT_SCF-BETA-TRCP MEDIATED DEGRADATION OF EMI1 43 -1,8763 0,007257 
REACT_APC_C_CDC20 MEDIATED DEGRADATION OF SECURIN 49 -1,87253 0,0074 
REACT_AUTODEGRADATION OF CDH1 BY CDH1_APC_C 45 -1,86714 0,007507 
REACT_METABOLISM OF RNA 52 -1,86747 0,007589 
REACT_EUKARYOTIC TRANSLATION TERMINATION 47 -1,86815 0,00766 
REACT_METABOLISM OF PROTEINS 155 -1,85895 0,007742 
REACT_CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION 29 -1,85472 0,00778 
REACT_PROCESSING OF CAPPED INTRONLESS PRE-MRNA 19 -1,85761 0,007788 
REACT_POST-ELONGATION PROCESSING OF INTRONLESS PRE-MRNA 19 -1,85622 0,007821 
REACT_RNA POLYMERASE II TRANSCRIPTION TERMINATION 29 -1,85931 0,007823 
REACT_POST-ELONGATION PROCESSING OF THE TRANSCRIPT 29 -1,8522 0,007874 
KEGG_FANCONI ANEMIA PATHWAY 48 -1,85938 0,007905 
REACT_FORMATION OF THE TERNARY COMPLEX, AND SUBSEQUENTLY, THE 43S 
COMPLEX 26 -1,85979 0,007936 
REACT_TRANSLATION 74 -1,84872 0,00805 
WIP_MM_NUCLEOTIDE_METABOLISM 20 -1,84193 0,008685 
BIOC_AMIPATHWAY 18 -1,82941 0,009952 
REACT_REGULATION OF APOPTOSIS 47 -1,822 0,010711 
BIOC_CSKPATHWAY 18 -1,80562 0,012272 
KEGG_BASE EXCISION REPAIR 30 -1,80648 0,012324 
REACT_DEGRADATION OF BETA-CATENIN BY THE DESTRUCTION COMPLEX 48 -1,79582 0,013463 
REACT_REGULATION OF ORNITHINE DECARBOXYLASE (ODC) 39 -1,78143 0,014823 
NCI_FOXM1PATHWAY 38 -1,78206 0,014931 
REACT_L13A-MEDIATED TRANSLATIONAL SILENCING OF CERULOPLASMIN EXPRESSION 61 -1,78235 0,015087 
REACT_3 -UTR-MEDIATED TRANSLATIONAL REGULATION 61 -1,77266 0,016238 
REACT_GLOBAL GENOMIC NER (GG-NER) 21 -1,76667 0,016675 
REACT_GENE EXPRESSION 269 -1,76684 0,016819 
REACT_SIGNALING BY WNT 48 -1,76776 0,016868 
REACT_REGULATION OF ACTIVATED PAK-2P34 BY PROTEASOME MEDIATED 
DEGRADATION 38 -1,76081 0,017423 
KEGG_MISMATCH REPAIR 21 -1,75292 0,018473 
BIOC_MPRPATHWAY 19 -1,73406 0,022334 
REACT_PEPTIDE CHAIN ELONGATION 47 -1,70942 0,028406 
KEGG_MUCIN TYPE O-GLYCAN BIOSYNTHESIS 25 -1,70517 0,029303 
WIP_MM_CYTOPLASMIC_RIBOSOMAL_PROTEINS 40 -1,70072 0,030245 
REACT_TRANSCRIPTION 94 -1,69578 0,031367 
REACT_GTP HYDROLYSIS AND JOINING OF THE 60S RIBOSOMAL SUBUNIT 63 -1,69164 0,032061 
REACT_CAP-DEPENDENT TRANSLATION INITIATION 67 -1,68201 0,034675 
REACT_GLYCOLYSIS 20 -1,67923 0,035188 
BIOC_PROTEASOMEPATHWAY 19 -1,67813 0,035245 
KEGG_RNA DEGRADATION 69 -1,6728 0,036675 
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NAME SIZE NES FDR q-val 
NCI_MYC_ACTIVPATHWAY 69 -1,66482 0,038683 
REACT_REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN 19 -1,65724 0,040658 
REACT_DIABETES PATHWAYS 242 -1,6536 0,041503 
REACT_EUKARYOTIC TRANSLATION INITIATION 67 -1,64831 0,043037 
NCI_E2F_PATHWAY 70 -1,64553 0,043589 
REACT_RNA POLYMERASE II TRANSCRIPTION 66 -1,64173 0,044596 
BIOC_ATRBRCAPATHWAY 17 -1,63304 0,046842 
REACT_POST-TRANSLATIONAL PROTEIN MODIFICATION 46 -1,63401 0,046909 
REACT_POST-ELONGATION PROCESSING OF INTRON-CONTAINING PRE-MRNA 22 -1,62063 0,051481 
REACT_MRNA 3-END PROCESSING 22 -1,60823 0,056542 
NCI_IL2_STAT5PATHWAY 30 -1,60723 0,056543 
REACT_INSULIN SYNTHESIS AND PROCESSING 79 -1,60349 0,057755 
KEGG_RIBOSOME 52 -1,59794 0,059719 
WIP_MM_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS 20 -1,58851 0,063692 
REACT_DEADENYLATION-DEPENDENT MRNA DECAY 38 -1,58351 0,065925 
KEGG_RIBOSOME BIOGENESIS IN EUKARYOTES 75 -1,5795 0,067435 
NCI_BETACATENIN_NUC_PATHWAY 75 -1,575 0,068098 
REACT_NUCLEOTIDE EXCISION REPAIR 33 -1,57644 0,068487 
REACT_GLUCOSE TRANSPORT 25 -1,57508 0,068566 
REACT_LOSS OF PROTEINS REQUIRED FOR INTERPHASE MICROTUBULE 
ORGANIZATIONÂ FROM THE CENTROSOME 47 -1,57293 0,068769 
REACT_HEXOSE TRANSPORT 25 -1,56983 0,068919 
REACT_METABOLISM OF MRNA 38 -1,56994 0,069386 
WIP_MM_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION 31 -1,57075 0,069465 
REACT_METABOLISM OF AMINO ACIDS AND DERIVATIVES 143 -1,56706 0,069801 
NCI_IL2_PI3KPATHWAY 33 -1,56514 0,069807 
REACT_TRANSCRIPTION-COUPLED NER (TC-NER) 29 -1,56594 0,069856 
KEGG_PURINE METABOLISM 160 -1,56318 0,06992 
REACT_LOSS OF NLP FROM MITOTIC CENTROSOMES 47 -1,56399 0,069938 
REACT_METABOLISM OF CARBOHYDRATES 80 -1,55989 0,071042 
REACT_METABOLISM OF NUCLEOTIDES 48 -1,5477 0,076841 
NCI_AR_NONGENOMIC_PATHWAY 28 -1,54844 0,076942 
NCI_HIF1APATHWAY 16 -1,54586 0,077463 
NCI_TELOMERASEPATHWAY 62 -1,53903 0,080609 
REACT_RNA POLYMERASE I TRANSCRIPTION 19 -1,53105 0,084866 
BIOC_G2PATHWAY 20 -1,52354 0,088981 
REACT_INTERACTIONS OF THE IMMUNOGLOBULIN SUPERFAMILY (IGSF) MEMBER 
PROTEINS 22 -1,52007 0,090334 
REACT_SIGNALLING TO RAS 19 -1,51885 0,090515 
BIOC_G1PATHWAY 23 -1,52031 0,090774 
BIOC_CELLCYCLEPATHWAY 21 -1,51508 0,092355 
REACT_TRANSLATION INITIATION COMPLEX FORMATION 31 -1,50473 0,098421 
NCI_LKB1_PATHWAY 44 -1,50246 0,099352 
NCI_AURORA_A_PATHWAY 30 -1,50117 0,099488 
NCI_ATM_PATHWAY 32 -1,48536 0,110575 
REACT_RIBOSOMAL SCANNING AND START CODON RECOGNITION 32 -1,4811 0,113222 
KEGG_N-GLYCAN BIOSYNTHESIS 50 -1,4726 0,117979 
REACT_TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM 16 -1,47305 0,118412 
REACT_RNA POLYMERASE I, RNA POLYMERASE III, AND MITOCHONDRIAL 
TRANSCRIPTION 40 -1,47309 0,11913 
REACT_RNA POLYMERASE I PROMOTER CLEARANCE 17 -1,46947 0,119743 
REACT_RNA POLYMERASE I TRANSCRIPTION INITIATION 16 -1,46426 0,123388 
REACT_GLUCONEOGENESIS 26 -1,45628 0,129265 
REACT_PYRIMIDINE METABOLISM 20 -1,44924 0,134292 
KEGG_THYROID CANCER 28 -1,44971 0,13471 
KEGG_COMPLEMENT AND COAGULATION CASCADES 75 -1,44683 0,135605 
REACT_MITOTIC G2-G2_M PHASES 64 -1,43883 0,142173 
REACT_G2_M TRANSITION 61 -1,43666 0,142694 
REACT_POST-TRANSLATIONAL MODIFICATION_ SYNTHESIS OF GPI-ANCHORED 
PROTEINS 22 -1,4369 0,143316 
REACT_INTERLEUKIN-2 SIGNALING 15 -1,43147 0,147157 
REACT_CENTROSOME MATURATION 54 -1,41709 0,160883 
REACT_IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON-
LYMPHOID CELL 35 -1,4148 0,162398 
REACT_GLUCOSE METABOLISM 45 -1,41358 0,162611 
REACT_RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES 54 -1,40779 0,168082 
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NAME SIZE NES FDR q-val 
REACT_ASSOCIATION OF TRIC_CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS 17 -1,40679 0,1682 
BIOC_CK1PATHWAY 15 -1,39683 0,178182 
REACT_LYSOSOME VESICLE BIOGENESIS 20 -1,39552 0,178755 
REACT_LIPID DIGESTION, MOBILIZATION, AND TRANSPORT 24 -1,39208 0,181467 
NCI_S1P_META_PATHWAY 21 -1,38572 0,187576 
WIP_MM_TNF-ALPHA_NF-KB_SIGNALING_PATHWAY 176 -1,38332 0,189235 
BIOC_GSK3PATHWAY 26 -1,37926 0,192819 
REACT_CHAPERONIN-MEDIATED PROTEIN FOLDING 31 -1,37413 0,198061 
KEGG_P53 SIGNALING PATHWAY 66 -1,36862 0,201454 
REACT_ACTIVATION OF THE MRNA UPON BINDING OF THE CAP-BINDING COMPLEX AND 
EIFS, AND SUBSEQUENT BINDING TO 43S 32 -1,36879 0,202359 
KEGG_BASAL TRANSCRIPTION FACTORS 42 -1,36913 0,203069 
KEGG_PENTOSE PHOSPHATE PATHWAY 30 -1,36495 0,204813 
KEGG_ENDOCRINE AND OTHER FACTOR-REGULATED CALCIUM REABSORPTION 55 -1,36413 0,204835 
REACT_CA-DEPENDENT EVENTS 21 -1,35546 0,214695 
REACT_MRNA CAPPING 21 -1,34927 0,221686 
NCI_MYC_PATHWAY 20 -1,34382 0,227491 
NCI_ILK_PATHWAY 39 -1,34218 0,228471 
BIOC_NO2IL12PATHWAY 15 -1,3403 0,229787 
NCI_PI3KPLCTRKPATHWAY 32 -1,33914 0,23023 
REACT_FORMATION OF THE EARLY ELONGATION COMPLEX 21 -1,3278 0,244622 
REACT_COOPERATION OF PREFOLDIN AND TRIC_CCT  IN ACTIN AND TUBULIN FOLDING 21 -1,32529 0,247185 
Only the significant downregulated gene sets are shown here (FDR<0.25). 
 
 
 
 
Literature 
 
165 
 
 Literature 8.
Aagaard, K., J. Ma, K. M. Antony, R. Ganu, J. Petrosino and J. Versalovic (2014). "The placenta harbors 
a unique microbiome." Sci Transl Med 6(237): 237ra265. 
Aagaard, K. M. (2014). "Author response to comment on "the placenta harbors a unique microbiome"." 
Sci Transl Med 6(254): 254lr253. 
Ackermann, M., B. Stecher, N. E. Freed, P. Songhet, W. D. Hardt and M. Doebeli (2008). "Self-
destructive cooperation mediated by phenotypic noise." Nature 454(7207): 987-990. 
Adak, A., C. Maity, K. Ghosh and K. C. Mondal (2014). "Alteration of predominant gastrointestinal flora 
and oxidative damage of large intestine under simulated hypobaric hypoxia." Z Gastroenterol 52(2): 180-
186. 
Aguirre, M., A. Eck, P. H. Savelkoul, A. E. Budding and K. Venema (2015). "Diet drives quick changes 
in the metabolic activity and composition of human gut microbiota in a validated in vitro gut model." Res 
Microbiol. 
Alemka, A., M. Clyne, F. Shanahan, T. Tompkins, N. Corcionivoschi and B. Bourke (2010). "Probiotic 
colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni 
virulence properties." Infect Immun 78(6): 2812-2822. 
Allen, R. G., W. P. Lafuse, J. D. Galley, M. M. Ali, B. M. Ahmer and M. T. Bailey (2012). "The intestinal 
microbiota are necessary for stressor-induced enhancement of splenic macrophage microbicidal activity." 
Brain Behav Immun 26(3): 371-382. 
Allison, G. E., C. Fremaux and T. R. Klaenhammer (1994). "Expansion of bacteriocin activity and host 
range upon complementation of two peptides encoded within the lactacin F operon." J Bacteriol 176(8): 
2235-2241. 
Altschul, S. F., W. Gish, W. Miller, E. W. Myers and D. J. Lipman (1990). "Basic local alignment search 
tool." J Mol Biol 215(3): 403-410. 
Amann, R. I., B. J. Binder, R. J. Olson, S. W. Chisholm, R. Devereux and D. A. Stahl (1990). 
"Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed 
microbial populations." Appl Environ Microbiol 56(6): 1919-1925. 
Aranki, A. and R. Freter (1972). "Use of anaerobic glove boxes for the cultivation of strictly anaerobic 
bacteria." Am J Clin Nutr 25(12): 1329-1334. 
Aranki, A., S. A. Syed, E. B. Kenney and R. Freter (1969). "Isolation of anaerobic bacteria from human 
gingiva and mouse cecum by means of a simplified glove box procedure." Appl Microbiol 17(4): 568-576. 
Literature 
 
166 
 
Asker, N., M. A. Axelsson, S. O. Olofsson and G. C. Hansson (1998). "Dimerization of the human MUC2 
mucin in the endoplasmic reticulum is followed by a N-glycosylation-dependent transfer of the mono- and 
dimers to the Golgi apparatus." J Biol Chem 273(30): 18857-18863. 
Atarashi, K., J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, M. Onoue, H. Yagita, N. Ishii, R. 
Evans, K. Honda and K. Takeda (2008). "ATP drives lamina propria T(H)17 cell differentiation." Nature 
455(7214): 808-812. 
Atarashi, K., T. Tanoue, K. Oshima, W. Suda, Y. Nagano, H. Nishikawa, S. Fukuda, T. Saito, S. 
Narushima, K. Hase, S. Kim, J. V. Fritz, P. Wilmes, S. Ueha, K. Matsushima, H. Ohno, B. Olle, S. 
Sakaguchi, T. Taniguchi, H. Morita, M. Hattori and K. Honda (2013). "Treg induction by a rationally 
selected mixture of Clostridia strains from the human microbiota." Nature 500(7461): 232-236. 
Atarashi, K., T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose, G. Cheng, S. Yamasaki, T. 
Saito, Y. Ohba, T. Taniguchi, K. Takeda, S. Hori, Ivanov, II, Y. Umesaki, K. Itoh and K. Honda (2011). 
"Induction of colonic regulatory T cells by indigenous Clostridium species." Science 331(6015): 337-341. 
Ayres, J. S., N. J. Trinidad and R. E. Vance (2012). "Lethal inflammasome activation by a multidrug-
resistant pathobiont upon antibiotic disruption of the microbiota." Nat Med. 
Aziz, R. K., D. Bartels, A. A. Best, M. DeJongh, T. Disz, R. A. Edwards, K. Formsma, S. Gerdes, E. M. 
Glass, M. Kubal, F. Meyer, G. J. Olsen, R. Olson, A. L. Osterman, R. A. Overbeek, L. K. McNeil, D. 
Paarmann, T. Paczian, B. Parrello, G. D. Pusch, C. Reich, R. Stevens, O. Vassieva, V. Vonstein, A. Wilke 
and O. Zagnitko (2008). "The RAST Server: rapid annotations using subsystems technology." BMC 
Genomics 9: 75. 
Backhed, F. (2012). "Host responses to the human microbiome." Nutr Rev 70 Suppl 1: S14-17. 
Backhed, F., H. Ding, T. Wang, L. V. Hooper, G. Y. Koh, A. Nagy, C. F. Semenkovich and J. I. Gordon 
(2004). "The gut microbiota as an environmental factor that regulates fat storage." Proc Natl Acad Sci U S 
A 101(44): 15718-15723. 
Bajaj, V., C. Hwang and C. A. Lee (1995). "hilA is a novel ompR/toxR family member that activates the 
expression of Salmonella typhimurium invasion genes." Mol Microbiol 18(4): 715-727. 
Bang, C., K. Weidenbach, T. Gutsmann, H. Heine and R. A. Schmitz (2014). "The intestinal archaea 
Methanosphaera stadtmanae and Methanobrevibacter smithii activate human dendritic cells." PLoS One 
9(6): e99411. 
Bankevich, A., S. Nurk, D. Antipov, A. A. Gurevich, M. Dvorkin, A. S. Kulikov, V. M. Lesin, S. I. 
Nikolenko, S. Pham, A. D. Prjibelski, A. V. Pyshkin, A. V. Sirotkin, N. Vyahhi, G. Tesler, M. A. 
Alekseyev and P. A. Pevzner (2012). "SPAdes: a new genome assembly algorithm and its applications to 
single-cell sequencing." J Comput Biol 19(5): 455-477. 
Literature 
 
167 
 
Bao, Y., Y. Guo, Z. Li, W. Fang, Y. Yang, X. Li, Z. Li, B. Xiong, Z. Chen, J. Wang, K. Kang, D. Gou and 
W. Yang (2014). "MicroRNA profiling in Muc2 knockout mice of colitis-associated cancer model reveals 
epigenetic alterations during chronic colitis malignant transformation." PLoS One 9(6): e99132. 
Barthel, M., S. Hapfelmeier, L. Quintanilla-Martinez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. 
Russmann and W. D. Hardt (2003). "Pretreatment of mice with streptomycin provides a Salmonella 
enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host." Infect Immun 
71(5): 2839-2858. 
Becker, N., J. Kunath, G. Loh and M. Blaut (2011). "Human intestinal microbiota: characterization of a 
simplified and stable gnotobiotic rat model." Gut Microbes 2(1): 25-33. 
Bel, S., Y. Elkis, H. Elifantz, O. Koren, R. Ben-Hamo, T. Lerer-Goldshtein, R. Rahimi, S. Ben Horin, A. 
Nyska, S. Shpungin and U. Nir (2014). "Reprogrammed and transmissible intestinal microbiota confer 
diminished susceptibility to induced colitis in TMF-/- mice." Proc Natl Acad Sci U S A 111(13): 4964-
4969. 
Belzer, C., G. K. Gerber, G. Roeselers, M. Delaney, A. DuBois, Q. Liu, V. Belavusava, V. Yeliseyev, A. 
Houseman, A. Onderdonk, C. Cavanaugh and L. Bry (2014). "Dynamics of the microbiota in response to 
host infection." PLoS One 9(7): e95534. 
Berer, K., M. Mues, M. Koutrolos, Z. A. Rasbi, M. Boziki, C. Johner, H. Wekerle and G. Krishnamoorthy 
(2011). "Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination." 
Nature. 
Berg, R. D. (1996). "The indigenous gastrointestinal microflora." Trends Microbiol 4(11): 430-435. 
Bergstrom, J. H., K. A. Berg, A. M. Rodriguez-Pineiro, B. Stecher, M. E. Johansson and G. C. Hansson 
(2014). "AGR2, an endoplasmic reticulum protein, is secreted into the gastrointestinal mucus." PLoS One 
9(8): e104186. 
Bergstrom, K. S., V. Kissoon-Singh, D. L. Gibson, C. Ma, M. Montero, H. P. Sham, N. Ryz, T. Huang, A. 
Velcich, B. B. Finlay, K. Chadee and B. A. Vallance (2010). "Muc2 protects against lethal infectious 
colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa." PLoS Pathog 6(5): 
e1000902. 
Berry, D., C. Schwab, G. Milinovich, J. Reichert, K. Ben Mahfoudh, T. Decker, M. Engel, B. Hai, E. 
Hainzl, S. Heider, L. Kenner, M. Muller, I. Rauch, B. Strobl, M. Wagner, C. Schleper, T. Urich and A. 
Loy (2012). "Phylotype-level 16S rRNA analysis reveals new bacterial indicators of health state in acute 
murine colitis." ISME J 6(11): 2091-2106. 
Berry, D., B. Stecher, A. Schintlmeister, J. Reichert, S. Brugiroux, B. Wild, W. Wanek, A. Richter, I. 
Rauch, T. Decker, A. Loy and M. Wagner (2013). "Host-compound foraging by intestinal microbiota 
revealed by single-cell stable isotope probing." Proc Natl Acad Sci U S A 110(12): 4720-4725. 
Literature 
 
168 
 
Bibiloni, R. (2012). "Rodent models to study the relationships between mammals and their bacterial 
inhabitants." Gut Microbes 3(6): 536-543. 
Bleich, A. and A. K. Hansen (2012). "Time to include the gut microbiota in the hygienic standardisation 
of laboratory rodents." Comp Immunol Microbiol Infect Dis 35(2): 81-92. 
Boisvert, S., F. Raymond, E. Godzaridis, F. Laviolette and J. Corbeil (2012). "Ray Meta: scalable de novo 
metagenome assembly and profiling." Genome Biol 13(12): R122. 
Bouskra, D., C. Brezillon, M. Berard, C. Werts, R. Varona, I. G. Boneca and G. Eberl (2008). "Lymphoid 
tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis." Nature 
456(7221): 507-510. 
Brandl, K., G. Plitas, C. N. Mihu, C. Ubeda, T. Jia, M. Fleisher, B. Schnabl, R. P. DeMatteo and E. G. 
Pamer (2008). "Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits." 
Nature 455(7214): 804-807. 
Brown, J., W. M. de Vos, P. S. DiStefano, J. Dore, C. Huttenhower, R. Knight, T. D. Lawley, J. Raes and 
P. Turnbaugh (2013). "Translating the human microbiome." Nat Biotechnol 31(4): 304-308. 
Buffie, C. G., V. Bucci, R. R. Stein, P. T. McKenney, L. Ling, A. Gobourne, D. No, H. Liu, M. 
Kinnebrew, A. Viale, E. Littmann, M. R. van den Brink, R. R. Jenq, Y. Taur, C. Sander, J. R. Cross, N. C. 
Toussaint, J. B. Xavier and E. G. Pamer (2015). "Precision microbiome reconstitution restores bile acid 
mediated resistance to Clostridium difficile." Nature 517(7533): 205-208. 
Bultman, S. J. and C. Jobin (2014). "Microbial-derived butyrate: an oncometabolite or tumor-suppressive 
metabolite?" Cell Host Microbe 16(2): 143-145. 
Cameron, A. D. and C. J. Dorman (2012). "A fundamental regulatory mechanism operating through 
OmpR and DNA topology controls expression of Salmonella pathogenicity islands SPI-1 and SPI-2." 
PLoS Genet 8(3): e1002615. 
Caporaso, J. G., J. Kuczynski, J. Stombaugh, K. Bittinger, F. D. Bushman, E. K. Costello, N. Fierer, A. G. 
Pena, J. K. Goodrich, J. I. Gordon, G. A. Huttley, S. T. Kelley, D. Knights, J. E. Koenig, R. E. Ley, C. A. 
Lozupone, D. McDonald, B. D. Muegge, M. Pirrung, J. Reeder, J. R. Sevinsky, P. J. Turnbaugh, W. A. 
Walters, J. Widmann, T. Yatsunenko, J. Zaneveld and R. Knight (2010). "QIIME allows analysis of high-
throughput community sequencing data." Nat Methods 7(5): 335-336. 
Carmody, R. N., G. K. Gerber, J. M. Luevano, Jr., D. M. Gatti, L. Somes, K. L. Svenson and P. J. 
Turnbaugh (2015). "Diet dominates host genotype in shaping the murine gut microbiota." Cell Host 
Microbe 17(1): 72-84. 
Cash, H. L., C. V. Whitham, C. L. Behrendt and L. V. Hooper (2006). "Symbiotic bacteria direct 
expression of an intestinal bactericidal lectin." Science 313(5790): 1126-1130. 
Literature 
 
169 
 
Caspari, D. and J. M. Macy (1983). "The role of carbon dioxide in glucose metabolism of Bacteroides 
fragilis." Arch Microbiol 135(1): 16-24. 
Cha, H. R., S. Y. Chang, J. H. Chang, J. O. Kim, J. Y. Yang, C. H. Kim and M. N. Kweon (2010). 
"Downregulation of Th17 cells in the small intestine by disruption of gut flora in the absence of retinoic 
acid." J Immunol 184(12): 6799-6806. 
Chakravorty, S., D. Helb, M. Burday, N. Connell and D. Alland (2007). "A detailed analysis of 16S 
ribosomal RNA gene segments for the diagnosis of pathogenic bacteria." J Microbiol Methods 69(2): 330-
339. 
Cheng, H. and M. Bjerknes (1983). "Cell production in mouse intestinal epithelium measured by 
stathmokinetic flow cytometry and Coulter particle counting." Anat Rec 207(3): 427-434. 
Chung, H., S. J. Pamp, J. A. Hill, N. K. Surana, S. M. Edelman, E. B. Troy, N. C. Reading, E. J. 
Villablanca, S. Wang, J. R. Mora, Y. Umesaki, D. Mathis, C. Benoist, D. A. Relman and D. L. Kasper 
(2012). "Gut immune maturation depends on colonization with a host-specific microbiota." Cell 149(7): 
1578-1593. 
Clavel, T., G. Henderson, W. Engst, J. Dore and M. Blaut (2006). "Phylogeny of human intestinal bacteria 
that activate the dietary lignan secoisolariciresinol diglucoside." FEMS Microbiol Ecol 55(3): 471-478. 
Coghill, S. B., D. Hopwood, S. McPherson and S. Hislop (1983). "The ultrastructural localisation of De-
Nol (colloidal tripotassium dicitrato-bismuthate--TDB) in the upper gastrointestinal tract of man and 
rodents following oral and instrumental administration." J Pathol 139(2): 105-114. 
Connon, S. A. and S. J. Giovannoni (2002). "High-throughput methods for culturing microorganisms in 
very-low-nutrient media yield diverse new marine isolates." Appl Environ Microbiol 68(8): 3878-3885. 
Cordonnier, C., G. Le Bihan, J. G. Emond-Rheault, A. Garrivier, J. Harel and G. Jubelin (2016). "Vitamin 
B12 Uptake by the Gut Commensal Bacteria Bacteroides thetaiotaomicron Limits the Production of Shiga 
Toxin by Enterohemorrhagic Escherichia coli." Toxins (Basel) 8(1). 
Croswell, A., E. Amir, P. Teggatz, M. Barman and N. H. Salzman (2009). "Prolonged impact of 
antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection." Infect 
Immun 77(7): 2741-2753. 
Daims, H., A. Bruhl, R. Amann, K. H. Schleifer and M. Wagner (1999). "The domain-specific probe 
EUB338 is insufficient for the detection of all Bacteria: development and evaluation of a more 
comprehensive probe set." Syst Appl Microbiol 22(3): 434-444. 
Daims, H., S. Lucker and M. Wagner (2006). "daime, a novel image analysis program for microbial 
ecology and biofilm research." Environ Microbiol 8(2): 200-213. 
Daims, H., K. Stoecker and M. Wagner (2005). Advanced Methods in Molecular Microbial Ecology, eds 
Osborn A, Smith C: 213-239. 
Literature 
 
170 
 
Day, D. W., B. K. Mandal and B. C. Morson (1978). "The rectal biopsy appearances in Salmonella 
colitis." Histopathology 2(2): 117-131. 
Degnan, P. H., N. A. Barry, K. C. Mok, M. E. Taga and A. L. Goodman (2014). "Human gut microbes use 
multiple transporters to distinguish vitamin B(1)(2) analogs and compete in the gut." Cell Host Microbe 
15(1): 47-57. 
Demaneche, S., H. Sanguin, J. Pote, E. Navarro, D. Bernillon, P. Mavingui, W. Wildi, T. M. Vogel and P. 
Simonet (2008). "Antibiotic-resistant soil bacteria in transgenic plant fields." Proc Natl Acad Sci U S A 
105(10): 3957-3962. 
Deriu, E., J. Z. Liu, M. Pezeshki, R. A. Edwards, R. J. Ochoa, H. Contreras, S. J. Libby, F. C. Fang and 
M. Raffatellu (2013). "Probiotic bacteria reduce salmonella typhimurium intestinal colonization by 
competing for iron." Cell Host Microbe 14(1): 26-37. 
Derrien, M., M. C. Collado, K. Ben-Amor, S. Salminen and W. M. de Vos (2008). "The Mucin degrader 
Akkermansia muciniphila is an abundant resident of the human intestinal tract." Appl Environ Microbiol 
74(5): 1646-1648. 
Derrien, M., E. E. Vaughan, C. M. Plugge and W. M. de Vos (2004). "Akkermansia muciniphila gen. 
nov., sp. nov., a human intestinal mucin-degrading bacterium." Int J Syst Evol Microbiol 54(Pt 5): 1469-
1476. 
DeSantis, T. Z., I. Dubosarskiy, S. R. Murray and G. L. Andersen (2003). "Comprehensive aligned 
sequence construction for automated design of effective probes (CASCADE-P) using 16S rDNA." 
Bioinformatics 19(12): 1461-1468. 
Dewhirst, F. E., C. C. Chien, B. J. Paster, R. L. Ericson, R. P. Orcutt, D. B. Schauer and J. G. Fox (1999). 
"Phylogeny of the defined murine microbiota: altered Schaedler flora." Appl Environ Microbiol 65(8): 
3287-3292. 
Dominguez-Bello, M. G., E. K. Costello, M. Contreras, M. Magris, G. Hidalgo, N. Fierer and R. Knight 
(2010). "Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body 
habitats in newborns." Proc Natl Acad Sci U S A 107(26): 11971-11975. 
Donohoe, D. R., L. B. Collins, A. Wali, R. Bigler, W. Sun and S. J. Bultman (2012). "The Warburg effect 
dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation." Mol Cell 48(4): 
612-626. 
Donohoe, D. R., D. Holley, L. B. Collins, S. A. Montgomery, A. C. Whitmore, A. Hillhouse, K. P. Curry, 
S. W. Renner, A. Greenwalt, E. P. Ryan, V. Godfrey, M. T. Heise, D. S. Threadgill, A. Han, J. A. 
Swenberg, D. W. Threadgill and S. J. Bultman (2014). "A gnotobiotic mouse model demonstrates that 
dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner." 
Cancer Discov 4(12): 1387-1397. 
Literature 
 
171 
 
Durant, J. A., D. E. Corrier and S. C. Ricke (2000). "Short-chain volatile fatty acids modulate the 
expression of the hilA and invF genes of Salmonella typhimurium." J Food Prot 63(5): 573-578. 
Durant, J. A., D. E. Corrier, L. H. Stanker and S. C. Ricke (2000). "Expression of the hilA Salmonella 
typhimurium gene in a poultry Salm. enteritidis isolate in response to lactate and nutrients." J Appl 
Microbiol 89(1): 63-69. 
Earle, K. A., G. Billings, M. Sigal, J. S. Lichtman, G. C. Hansson, J. E. Elias, M. R. Amieva, K. C. Huang 
and J. L. Sonnenburg (2015). "Quantitative Imaging of Gut Microbiota Spatial Organization." Cell Host 
Microbe 18(4): 478-488. 
Eckburg, P. B., E. M. Bik, C. N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S. R. Gill, K. E. Nelson 
and D. A. Relman (2005). "Diversity of the human intestinal microbial flora." Science 308(5728): 1635-
1638. 
Edgar, R. C., B. J. Haas, J. C. Clemente, C. Quince and R. Knight (2011). "UCHIME improves sensitivity 
and speed of chimera detection." Bioinformatics 27(16): 2194-2200. 
Endt, K., B. Stecher, S. Chaffron, E. Slack, N. Tchitchek, A. Benecke, L. Van Maele, J. C. Sirard, A. J. 
Mueller, M. Heikenwalder, A. J. Macpherson, R. Strugnell, C. von Mering and W. D. Hardt (2010). "The 
microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea." 
PLoS Pathog 6(9). 
Eri, R. D., R. J. Adams, T. V. Tran, H. Tong, I. Das, D. K. Roche, I. Oancea, C. W. Png, P. L. Jeffery, G. 
L. Radford-Smith, M. C. Cook, T. H. Florin and M. A. McGuckin (2011). "An intestinal epithelial defect 
conferring ER stress results in inflammation involving both innate and adaptive immunity." Mucosal 
Immunol 4(3): 354-364. 
Fabrega, A. and J. Vila (2013). "Salmonella enterica serovar Typhimurium skills to succeed in the host: 
virulence and regulation." Clin Microbiol Rev 26(2): 308-341. 
Faith, J. J., P. P. Ahern, V. K. Ridaura, J. Cheng and J. I. Gordon (2014). "Identifying gut microbe-host 
phenotype relationships using combinatorial communities in gnotobiotic mice." Sci Transl Med 6(220): 
220ra211. 
Faith, J. J., N. P. McNulty, F. E. Rey and J. I. Gordon (2011). "Predicting a human gut microbiota's 
response to diet in gnotobiotic mice." Science 333(6038): 101-104. 
Falk, P. G., L. V. Hooper, T. Midtvedt and J. I. Gordon (1998). "Creating and maintaining the 
gastrointestinal ecosystem: what we know and need to know from gnotobiology." Microbiol Mol Biol Rev 
62(4): 1157-1170. 
Ferrand, J., K. Patron, C. Legrand-Frossi, J. P. Frippiat, C. Merlin, C. Alauzet and A. Lozniewski (2014). 
"Comparison of seven methods for extraction of bacterial DNA from fecal and cecal samples of mice." J 
Microbiol Methods 105C: 180-185. 
Literature 
 
172 
 
Figueira, R. and D. W. Holden (2012). "Functions of the Salmonella pathogenicity island 2 (SPI-2) type 
III secretion system effectors." Microbiology 158(Pt 5): 1147-1161. 
Flint, H. J. (2012). "Microbiology: Antibiotics and adiposity." Nature 488(7413): 601-602. 
Flint, H. J., K. P. Scott, S. H. Duncan, P. Louis and E. Forano (2012). "Microbial degradation of complex 
carbohydrates in the gut." Gut Microbes 3(4): 289-306. 
Fodor, A. A., T. Z. DeSantis, K. M. Wylie, J. H. Badger, Y. Ye, T. Hepburn, P. Hu, E. Sodergren, K. 
Liolios, H. Huot-Creasy, B. W. Birren and A. M. Earl (2012). "The "most wanted" taxa from the human 
microbiome for whole genome sequencing." PLoS One 7(7): e41294. 
Fournier, P. E., J. C. Lagier, G. Dubourg and D. Raoult (2015). "From culturomics to taxonomogenomics: 
A need to change the taxonomy of prokaryotes in clinical microbiology." Anaerobe 36: 73-78. 
Franzosa, E. A., X. C. Morgan, N. Segata, L. Waldron, J. Reyes, A. M. Earl, G. Giannoukos, M. R. 
Boylan, D. Ciulla, D. Gevers, J. Izard, W. S. Garrett, A. T. Chan and C. Huttenhower (2014). "Relating 
the metatranscriptome and metagenome of the human gut." Proc Natl Acad Sci U S A 111(22): E2329-
2338. 
Frese, S. A., A. K. Benson, G. W. Tannock, D. M. Loach, J. Kim, M. Zhang, P. L. Oh, N. C. Heng, P. B. 
Patil, N. Juge, D. A. Mackenzie, B. M. Pearson, A. Lapidus, E. Dalin, H. Tice, E. Goltsman, M. Land, L. 
Hauser, N. Ivanova, N. C. Kyrpides and J. Walter (2011). "The evolution of host specialization in the 
vertebrate gut symbiont Lactobacillus reuteri." PLoS Genet 7(2): e1001314. 
Freter, R., H. Brickner, J. Fekete, M. M. Vickerman and K. E. Carey (1983). "Survival and implantation 
of Escherichia coli in the intestinal tract." Infect Immun 39(2): 686-703. 
Fukuda, S., H. Toh, K. Hase, K. Oshima, Y. Nakanishi, K. Yoshimura, T. Tobe, J. M. Clarke, D. L. 
Topping, T. Suzuki, T. D. Taylor, K. Itoh, J. Kikuchi, H. Morita, M. Hattori and H. Ohno (2011). 
"Bifidobacteria can protect from enteropathogenic infection through production of acetate." Nature 
469(7331): 543-547. 
Gagnon, M., P. Savard, A. Riviere, G. LaPointe and D. Roy (2015). "Bioaccessible antioxidants in milk 
fermented by Bifidobacterium longum subsp. longum strains." Biomed Res Int 2015: 169381. 
Galan, J. E. and R. Curtiss, 3rd (1990). "Expression of Salmonella typhimurium genes required for 
invasion is regulated by changes in DNA supercoiling." Infect Immun 58(6): 1879-1885. 
Ganesh, B. P., R. Klopfleisch, G. Loh and M. Blaut (2013). "Commensal Akkermansia muciniphila 
exacerbates gut inflammation in Salmonella Typhimurium-infected gnotobiotic mice." PLoS One 8(9): 
e74963. 
Garcia-del Portillo, F., J. W. Foster, M. E. Maguire and B. B. Finlay (1992). "Characterization of the 
micro-environment of Salmonella typhimurium-containing vacuoles within MDCK epithelial cells." Mol 
Microbiol 6(22): 3289-3297. 
Literature 
 
173 
 
Garcia-del Portillo, F., M. B. Zwick, K. Y. Leung and B. B. Finlay (1993). "Salmonella induces the 
formation of filamentous structures containing lysosomal membrane glycoproteins in epithelial cells." 
Proc Natl Acad Sci U S A 90(22): 10544-10548. 
Garvis, S. G., C. R. Beuzon and D. W. Holden (2001). "A role for the PhoP/Q regulon in inhibition of 
fusion between lysosomes and Salmonella-containing vacuoles in macrophages." Cell Microbiol 3(11): 
731-744. 
Gaudier, E., A. Jarry, H. M. Blottiere, P. de Coppet, M. P. Buisine, J. P. Aubert, C. Laboisse, C. Cherbut 
and C. Hoebler (2004). "Butyrate specifically modulates MUC gene expression in intestinal epithelial 
goblet cells deprived of glucose." Am J Physiol Gastrointest Liver Physiol 287(6): G1168-1174. 
Gaudier, E., M. Rival, M. P. Buisine, I. Robineau and C. Hoebler (2009). "Butyrate enemas upregulate 
Muc genes expression but decrease adherent mucus thickness in mice colon." Physiol Res 58(1): 111-119. 
Ge, Z., Y. Feng, N. S. Taylor, M. Ohtani, M. F. Polz, D. B. Schauer and J. G. Fox (2006). "Colonization 
dynamics of altered Schaedler flora is influenced by gender, aging, and Helicobacter hepaticus infection in 
the intestines of Swiss Webster mice." Appl Environ Microbiol 72(7): 5100-5103. 
Gerlach, R. G., D. Jackel, N. Geymeier and M. Hensel (2007). "Salmonella pathogenicity island 4-
mediated adhesion is coregulated with invasion genes in Salmonella enterica." Infect Immun 75(10): 
4697-4709. 
Geuking, M. B., J. Cahenzli, M. A. Lawson, D. C. Ng, E. Slack, S. Hapfelmeier, K. D. McCoy and A. J. 
Macpherson (2011). "Intestinal bacterial colonization induces mutualistic regulatory T cell responses." 
Immunity 34(5): 794-806. 
Gill, S. R., M. Pop, R. T. Deboy, P. B. Eckburg, P. J. Turnbaugh, B. S. Samuel, J. I. Gordon, D. A. 
Relman, C. M. Fraser-Liggett and K. E. Nelson (2006). "Metagenomic analysis of the human distal gut 
microbiome." Science 312(5778): 1355-1359. 
Goddard, A. F. (1998). "Review article: factors influencing antibiotic transfer across the gastric mucosa." 
Aliment Pharmacol Ther 12(12): 1175-1184. 
Godl, K., M. E. Johansson, M. E. Lidell, M. Morgelin, H. Karlsson, F. J. Olson, J. R. Gum, Jr., Y. S. Kim 
and G. C. Hansson (2002). "The N terminus of the MUC2 mucin forms trimers that are held together 
within a trypsin-resistant core fragment." J Biol Chem 277(49): 47248-47256. 
Goodman, A. L., G. Kallstrom, J. J. Faith, A. Reyes, A. Moore, G. Dantas and J. I. Gordon (2011). "From 
the Cover: Extensive personal human gut microbiota culture collections characterized and manipulated in 
gnotobiotic mice." Proc Natl Acad Sci U S A 108(15): 6252-6257. 
Goodman, A. L., N. P. McNulty, Y. Zhao, D. Leip, R. D. Mitra, C. A. Lozupone, R. Knight and J. I. 
Gordon (2009). "Identifying genetic determinants needed to establish a human gut symbiont in its habitat." 
Cell Host Microbe 6(3): 279-289. 
Literature 
 
174 
 
Goodrich, J. K., J. L. Waters, A. C. Poole, J. L. Sutter, O. Koren, R. Blekhman, M. Beaumont, W. Van 
Treuren, R. Knight, J. T. Bell, T. D. Spector, A. G. Clark and R. E. Ley (2014). "Human genetics shape 
the gut microbiome." Cell 159(4): 789-799. 
Gradel, K. O., H. L. Nielsen, H. C. Schonheyder, T. Ejlertsen, B. Kristensen and H. Nielsen (2009). 
"Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter 
gastroenteritis." Gastroenterology 137(2): 495-501. 
Greene, J. D. and T. R. Klaenhammer (1994). "Factors involved in adherence of lactobacilli to human 
Caco-2 cells." Appl Environ Microbiol 60(12): 4487-4494. 
Gronbach, K., I. Flade, O. Holst, B. Lindner, H. J. Ruscheweyh, A. Wittmann, S. Menz, A. Schwiertz, P. 
Adam, B. Stecher, C. Josenhans, S. Suerbaum, A. D. Gruber, A. Kulik, D. Huson, I. B. Autenrieth and J. 
S. Frick (2014). "Endotoxicity of lipopolysaccharide as a determinant of T-cell-mediated colitis induction 
in mice." Gastroenterology 146(3): 765-775. 
Gum, J. R., Jr., J. W. Hicks, N. W. Toribara, B. Siddiki and Y. S. Kim (1994). "Molecular cloning of 
human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence 
similarity to prepro-von Willebrand factor." J Biol Chem 269(4): 2440-2446. 
Gupta, A., D. Wodziak, M. Tun, D. M. Bouley and A. W. Lowe (2013). "Loss of anterior gradient 2 
(Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach." J Biol 
Chem 288(6): 4321-4333. 
Gurevich, A., V. Saveliev, N. Vyahhi and G. Tesler (2013). "QUAST: quality assessment tool for genome 
assemblies." Bioinformatics 29(8): 1072-1075. 
Hagesaether, E., E. Christiansen, M. E. Due-Hansen and T. Ulven (2013). "Mucus can change the 
permeation rank order of drug candidates." Int J Pharm 452(1-2): 276-282. 
Hamer, H. M., D. M. Jonkers, I. B. Renes, S. A. Vanhoutvin, A. Kodde, F. J. Troost, K. Venema and R. J. 
Brummer (2010). "Butyrate enemas do not affect human colonic MUC2 and TFF3 expression." Eur J 
Gastroenterol Hepatol 22(9): 1134-1140. 
Hansson, G. C. (2012). "Role of mucus layers in gut infection and inflammation." Curr Opin Microbiol 
15(1): 57-62. 
Hapfelmeier, S., K. Ehrbar, B. Stecher, M. Barthel, M. Kremer and W. D. Hardt (2004). "Role of the 
Salmonella pathogenicity island 1 effector proteins SipA, SopB, SopE, and SopE2 in Salmonella enterica 
subspecies 1 serovar Typhimurium colitis in streptomycin-pretreated mice." Infect Immun 72(2): 795-809. 
Hapfelmeier, S. and W. D. Hardt (2005). "A mouse model for S. typhimurium-induced enterocolitis." 
Trends Microbiol 13(10): 497-503. 
Hapfelmeier, S., M. A. Lawson, E. Slack, J. K. Kirundi, M. Stoel, M. Heikenwalder, J. Cahenzli, Y. 
Velykoredko, M. L. Balmer, K. Endt, M. B. Geuking, R. Curtiss, 3rd, K. D. McCoy and A. J. Macpherson 
Literature 
 
175 
 
(2010). "Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune 
responses." Science 328(5986): 1705-1709. 
Hapfelmeier, S., B. Stecher, M. Barthel, M. Kremer, A. J. Muller, M. Heikenwalder, T. Stallmach, M. 
Hensel, K. Pfeffer, S. Akira and W. D. Hardt (2005). "The Salmonella pathogenicity island (SPI)-2 and 
SPI-1 type III secretion systems allow Salmonella serovar typhimurium to trigger colitis via MyD88-
dependent and MyD88-independent mechanisms." J Immunol 174(3): 1675-1685. 
Harmsen, H. J., G. R. Gibson, P. Elfferich, G. C. Raangs, A. C. Wildeboer-Veloo, A. Argaiz, M. B. 
Roberfroid and G. W. Welling (2000). "Comparison of viable cell counts and fluorescence in situ 
hybridization using specific rRNA-based probes for the quantification of human fecal bacteria." FEMS 
Microbiol Lett 183(1): 125-129. 
Harris, N. R., P. R. Carter, A. S. Yadav, M. N. Watts, S. Zhang, M. Kosloski-Davidson and M. B. 
Grisham (2011). "Relationship between inflammation and tissue hypoxia in a mouse model of chronic 
colitis." Inflamm Bowel Dis 17(3): 742-746. 
Hasegawa, M., N. Kamada, Y. Jiao, M. Z. Liu, G. Nunez and N. Inohara (2012). "Protective role of 
commensals against Clostridium difficile infection via an IL-1beta-mediated positive-feedback loop." J 
Immunol 189(6): 3085-3091. 
Hautefort, I., M. J. Proenca and J. C. Hinton (2003). "Single-copy green fluorescent protein gene fusions 
allow accurate measurement of Salmonella gene expression in vitro and during infection of mammalian 
cells." Appl Environ Microbiol 69(12): 7480-7491. 
Hayashi, H., M. Sakamoto and Y. Benno (2002). "Phylogenetic analysis of the human gut microbiota 
using 16S rDNA clone libraries and strictly anaerobic culture-based methods." Microbiol Immunol 46(8): 
535-548. 
Heazlewood, C. K., M. C. Cook, R. Eri, G. R. Price, S. B. Tauro, D. Taupin, D. J. Thornton, C. W. Png, T. 
L. Crockford, R. J. Cornall, R. Adams, M. Kato, K. A. Nelms, N. A. Hong, T. H. Florin, C. C. Goodnow 
and M. A. McGuckin (2008). "Aberrant mucin assembly in mice causes endoplasmic reticulum stress and 
spontaneous inflammation resembling ulcerative colitis." PLoS Med 5(3): e54. 
Helaine, S., A. M. Cheverton, K. G. Watson, L. M. Faure, S. A. Matthews and D. W. Holden (2014). 
"Internalization of Salmonella by macrophages induces formation of nonreplicating persisters." Science 
343(6167): 204-208. 
Higa, A., A. Mulot, F. Delom, M. Bouchecareilh, D. T. Nguyen, D. Boismenu, M. J. Wise and E. Chevet 
(2011). "Role of pro-oncogenic protein disulfide isomerase (PDI) family member anterior gradient 2 
(AGR2) in the control of endoplasmic reticulum homeostasis." J Biol Chem 286(52): 44855-44868. 
Hill, D. A., M. C. Siracusa, M. C. Abt, B. S. Kim, D. Kobuley, M. Kubo, T. Kambayashi, D. F. Larosa, E. 
D. Renner, J. S. Orange, F. D. Bushman and D. Artis (2012). "Commensal bacteria-derived signals 
regulate basophil hematopoiesis and allergic inflammation." Nat Med 18(4): 538-546. 
Literature 
 
176 
 
Hoffmann, C., D. A. Hill, N. Minkah, T. Kirn, A. Troy, D. Artis and F. Bushman (2009). "Community-
wide response of the gut microbiota to enteropathogenic Citrobacter rodentium infection revealed by deep 
sequencing." Infect Immun 77(10): 4668-4678. 
Hoiseth, S. K. and B. A. Stocker (1981). "Aromatic-dependent Salmonella typhimurium are non-virulent 
and effective as live vaccines." Nature 291(5812): 238-239. 
Hong, X. Y., J. Wang and Z. Li (2013). "AGR2 expression is regulated by HIF-1 and contributes to 
growth and angiogenesis of glioblastoma." Cell Biochem Biophys 67(3): 1487-1495. 
Hooper, L. V., J. Xu, P. G. Falk, T. Midtvedt and J. I. Gordon (1999). "A molecular sensor that allows a 
gut commensal to control its nutrient foundation in a competitive ecosystem." Proc Natl Acad Sci U S A 
96(17): 9833-9838. 
Hoskins, L. C., M. Agustines, W. B. McKee, E. T. Boulding, M. Kriaris and G. Niedermeyer (1985). 
"Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade 
ABH blood group antigens and oligosaccharides from mucin glycoproteins." J Clin Invest 75(3): 944-953. 
Hsiao, A., A. M. Ahmed, S. Subramanian, N. W. Griffin, L. L. Drewry, W. A. Petri, R. Haque, T. Ahmed 
and J. I. Gordon (2014). "Members of the human gut microbiota involved in recovery from Vibrio 
cholerae infection." Nature 515(7527): 423-426. 
Huang, J. Y., S. M. Lee and S. K. Mazmanian (2011). "The human commensal Bacteroides fragilis binds 
intestinal mucin." Anaerobe. 
Hudault, S., J. Guignot and A. L. Servin (2001). "Escherichia coli strains colonising the gastrointestinal 
tract protect germfree mice against Salmonella typhimurium infection." Gut 49(1): 47-55. 
Hugon, P., J. C. Lagier, C. Robert, C. Lepolard, L. Papazian, D. Musso, B. Vialettes and D. Raoult (2013). 
"Molecular studies neglect apparently gram-negative populations in the human gut microbiota." J Clin 
Microbiol 51(10): 3286-3293. 
Hutter, G., U. Schlagenhauf, G. Valenza, M. Horn, S. Burgemeister, H. Claus and U. Vogel (2003). 
"Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and 
putative pathogens." Microbiology 149(Pt 1): 67-75. 
Hyatt, D., G. L. Chen, P. F. Locascio, M. L. Land, F. W. Larimer and L. J. Hauser (2010). "Prodigal: 
prokaryotic gene recognition and translation initiation site identification." BMC Bioinformatics 11: 119. 
Hyatt, D., P. F. LoCascio, L. J. Hauser and E. C. Uberbacher (2012). "Gene and translation initiation site 
prediction in metagenomic sequences." Bioinformatics 28(17): 2223-2230. 
Inagaki, H., T. Suzuki, K. Nomoto and Y. Yoshikai (1996). "Increased susceptibility to primary infection 
with Listeria monocytogenes in germfree mice may be due to lack of accumulation of L-selectin+ CD44+ 
T cells in sites of inflammation." Infect Immun 64(8): 3280-3287. 
Literature 
 
177 
 
Itoh, K. and R. Freter (1989). "Control of Escherichia coli populations by a combination of indigenous 
clostridia and lactobacilli in gnotobiotic mice and continuous-flow cultures." Infect Immun 57(2): 559-
565. 
Itoh, K. and T. Mitsuoka (1985). "Characterization of clostridia isolated from faeces of limited flora mice 
and their effect on caecal size when associated with germ-free mice." Lab Anim 19(2): 111-118. 
Jakobsson, H. E., A. M. Rodriguez-Pineiro, A. Schutte, A. Ermund, P. Boysen, M. Bemark, F. Sommer, F. 
Backhed, G. C. Hansson and M. E. Johansson (2015). "The composition of the gut microbiota shapes the 
colon mucus barrier." EMBO Rep 16(2): 164-177. 
JCVI (2013). "ENA: Experiment SRX313003. [Online] Available at: 
http://www.ebi.ac.uk/ena/data/view/SRX313003 [Accessed October 2014].". 
Johansson, M. E., D. Ambort, T. Pelaseyed, A. Schutte, J. K. Gustafsson, A. Ermund, D. B. Subramani, J. 
M. Holmen-Larsson, K. A. Thomsson, J. H. Bergstrom, S. van der Post, A. M. Rodriguez-Pineiro, H. 
Sjovall, M. Backstrom and G. C. Hansson (2011). "Composition and functional role of the mucus layers in 
the intestine." Cell Mol Life Sci 68(22): 3635-3641. 
Johansson, M. E., J. K. Gustafsson, K. E. Sjoberg, J. Petersson, L. Holm, H. Sjovall and G. C. Hansson 
(2010). "Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis 
model." PLoS One 5(8): e12238. 
Johansson, M. E. and G. C. Hansson (2012). "Preservation of mucus in histological sections, 
immunostaining of mucins in fixed tissue, and localization of bacteria with FISH." Methods Mol Biol 842: 
229-235. 
Johansson, M. E., H. E. Jakobsson, J. Holmen-Larsson, A. Schutte, A. Ermund, A. M. Rodriguez-Pineiro, 
L. Arike, C. Wising, F. Svensson, F. Backhed and G. C. Hansson (2015). "Normalization of Host 
Intestinal Mucus Layers Requires Long-Term Microbial Colonization." Cell Host Microbe 18(5): 582-
592. 
Johansson, M. E., J. M. Larsson and G. C. Hansson (2011). "The two mucus layers of colon are organized 
by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions." Proc Natl 
Acad Sci U S A 108 Suppl 1: 4659-4665. 
Johansson, M. E., M. Phillipson, J. Petersson, A. Velcich, L. Holm and G. C. Hansson (2008). "The inner 
of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria." Proc Natl Acad Sci U S A 
105(39): 15064-15069. 
Johansson, M. E., K. A. Thomsson and G. C. Hansson (2009). "Proteomic analyses of the two mucus 
layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the 
Fcgbp protein." J Proteome Res 8(7): 3549-3557. 
Literature 
 
178 
 
Jump, R. L., A. Polinkovsky, K. Hurless, B. Sitzlar, K. Eckart, M. Tomas, A. Deshpande, M. M. 
Nerandzic and C. J. Donskey (2014). "Metabolomics analysis identifies intestinal microbiota-derived 
biomarkers of colonization resistance in clindamycin-treated mice." PLoS One 9(7): e101267. 
Kaeberlein, T., K. Lewis and S. S. Epstein (2002). "Isolating "uncultivable" microorganisms in pure 
culture in a simulated natural environment." Science 296(5570): 1127-1129. 
Kaiser, P., M. Diard, B. Stecher and W. D. Hardt (2012). "The streptomycin mouse model for Salmonella 
diarrhea: functional analysis of the microbiota, the pathogen's virulence factors, and the host's mucosal 
immune response." Immunol Rev 245(1): 56-83. 
Kamada, N., Y. G. Kim, H. P. Sham, B. A. Vallance, J. L. Puente, E. C. Martens and G. Nunez (2012). 
"Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota." Science. 
Kanehisa, M., S. Goto, Y. Sato, M. Kawashima, M. Furumichi and M. Tanabe (2014). "Data, information, 
knowledge and principle: back to metabolism in KEGG." Nucleic Acids Res 42(Database issue): D199-
205. 
Keeney, K. M. and B. B. Finlay (2013). "Microbiology: EHEC Downregulates Virulence in Response to 
Intestinal Fucose." Curr Biol 23(3): R108-110. 
Kelly, A., M. D. Goldberg, R. K. Carroll, V. Danino, J. C. Hinton and C. J. Dorman (2004). "A global role 
for Fis in the transcriptional control of metabolism and type III secretion in Salmonella enterica serovar 
Typhimurium." Microbiology 150(Pt 7): 2037-2053. 
Kero, J., M. Gissler, M. M. Gronlund, P. Kero, P. Koskinen, E. Hemminki and E. Isolauri (2002). "Mode 
of delivery and asthma -- is there a connection?" Pediatr Res 52(1): 6-11. 
Kim, O. S., Y. J. Cho, K. Lee, S. H. Yoon, M. Kim, H. Na, S. C. Park, Y. S. Jeon, J. H. Lee, H. Yi, S. 
Won and J. Chun (2012). "Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with 
phylotypes that represent uncultured species." Int J Syst Evol Microbiol 62(Pt 3): 716-721. 
Kittler, J., J. Illingworth and J. Föglein (1985). "Threshold selection based on a simple image statistic." 
Comp. Vis. Graph. Image Proc.(30): 125-147. 
Koenig, J. E., A. Spor, N. Scalfone, A. D. Fricker, J. Stombaugh, R. Knight, L. T. Angenent and R. E. Ley 
(2011). "Succession of microbial consortia in the developing infant gut microbiome." Proc Natl Acad Sci 
U S A 108 Suppl 1: 4578-4585. 
Konturek, P. C., D. Haziri, T. Brzozowski, T. Hess, S. Heyman, S. Kwiecien, S. J. Konturek and J. Koziel 
(2015). "Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-
gastrointestinal diseases." J Physiol Pharmacol 66(4): 483-491. 
Koopman, J. P., H. M. Kennis, J. W. Mullink, R. A. Prins, A. M. Stadhouders, H. De Boer and M. P. 
Hectors (1984). "'Normalization' of germfree mice with anaerobically cultured caecal flora of 'normal' 
mice." Lab Anim 18(2): 188-194. 
Literature 
 
179 
 
Koren, O., J. K. Goodrich, T. C. Cullender, A. Spor, K. Laitinen, H. K. Backhed, A. Gonzalez, J. J. 
Werner, L. T. Angenent, R. Knight, F. Backhed, E. Isolauri, S. Salminen and R. E. Ley (2012). "Host 
remodeling of the gut microbiome and metabolic changes during pregnancy." Cell 150(3): 470-480. 
Koren, O., D. Knights, A. Gonzalez, L. Waldron, N. Segata, R. Knight, C. Huttenhower and R. E. Ley 
(2013). "A guide to enterotypes across the human body: meta-analysis of microbial community structures 
in human microbiome datasets." PLoS Comput Biol 9(1): e1002863. 
Kovalev, L. I., S. S. Shishkin, P. Z. Khasigov, N. K. Dzeranov, A. V. Kazachenko, I. Toropygin and S. V. 
Mamykina (2006). "[Identification of AGR2 protein, a novel potential cancer marker, using proteomics 
technologies]." Prikl Biokhim Mikrobiol 42(4): 480-484. 
Krych, L., C. H. Hansen, A. K. Hansen, F. W. van den Berg and D. S. Nielsen (2013). "Quantitatively 
different, yet qualitatively alike: a meta-analysis of the mouse core gut microbiome with a view towards 
the human gut microbiome." PLoS One 8(5): e62578. 
Krzanowski, W. J. (2000). "Principles of multivariate analysis. A user´s perspective." Oxford University 
Press, Oxford, United Kingdom. 
Kumar, P. S., A. L. Griffen, J. A. Barton, B. J. Paster, M. L. Moeschberger and E. J. Leys (2003). "New 
bacterial species associated with chronic periodontitis." J Dent Res 82(5): 338-344. 
Lagier, J. C., P. Hugon, S. Khelaifia, P. E. Fournier, B. La Scola and D. Raoult (2015). "The rebirth of 
culture in microbiology through the example of culturomics to study human gut microbiota." Clin 
Microbiol Rev 28(1): 237-264. 
Lam, L. H. and D. M. Monack (2014). "Intraspecies competition for niches in the distal gut dictate 
transmission during persistent Salmonella infection." PLoS Pathog 10(12): e1004527. 
Lane, D. J., E. Stackebrandt and M. Goodfellow (1991). "16S/23S rRNA sequencing." Nucleic acid 
techniques in bacterial systematics: 115-175. 
Lange, K., M. Buerger, A. Stallmach and T. Bruns (2016). "Effects of Antibiotics on Gut Microbiota." 
Dig Dis 34(3): 260-268. 
Langendijk, P. S., F. Schut, G. J. Jansen, G. C. Raangs, G. R. Kamphuis, M. H. Wilkinson and G. W. 
Welling (1995). "Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-
specific 16S rRNA-targeted probes and its application in fecal samples." Appl Environ Microbiol 61(8): 
3069-3075. 
LaRock, D. L., A. Chaudhary and S. I. Miller (2015). "Salmonellae interactions with host processes." Nat 
Rev Microbiol 13(4): 191-205. 
Laukens, D., B. M. Brinkman, J. Raes, M. De Vos and P. Vandenabeele (2015). "Heterogeneity of the gut 
microbiome in mice: guidelines for optimizing experimental design." FEMS Microbiol Rev. 
Literature 
 
180 
 
Lawhon, S. D., R. Maurer, M. Suyemoto and C. Altier (2002). "Intestinal short-chain fatty acids alter 
Salmonella typhimurium invasion gene expression and virulence through BarA/SirA." Mol Microbiol 
46(5): 1451-1464. 
Lawley, T. D., K. Chan, L. J. Thompson, C. C. Kim, G. R. Govoni and D. M. Monack (2006). "Genome-
wide screen for Salmonella genes required for long-term systemic infection of the mouse." PLoS Pathog 
2(2): e11. 
Lawley, T. D., S. Clare, A. W. Walker, M. D. Stares, T. R. Connor, C. Raisen, D. Goulding, R. Rad, F. 
Schreiber, C. Brandt, L. J. Deakin, D. J. Pickard, S. H. Duncan, H. J. Flint, T. G. Clark, J. Parkhill and G. 
Dougan (2012). "Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy 
resolves relapsing Clostridium difficile disease in mice." PLoS Pathog 8(10): e1002995. 
Lawson, P. A. and F. A. Rainey (2015). "Proposal to restrict the genus Clostridium (Prazmowski) to 
Clostridium butyricum and related species." Int J Syst Evol Microbiol. 
Lee, S. M., G. P. Donaldson, Z. Mikulski, S. Boyajian, K. Ley and S. K. Mazmanian (2013). "Bacterial 
colonization factors control specificity and stability of the gut microbiota." Nature 501(7467): 426-429. 
Ley, R. E., F. Backhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight and J. I. Gordon (2005). "Obesity 
alters gut microbial ecology." Proc Natl Acad Sci U S A 102(31): 11070-11075. 
Ley, R. E., M. Hamady, C. Lozupone, P. J. Turnbaugh, R. R. Ramey, J. S. Bircher, M. L. Schlegel, T. A. 
Tucker, M. D. Schrenzel, R. Knight and J. I. Gordon (2008). "Evolution of mammals and their gut 
microbes." Science 320(5883): 1647-1651. 
Ley, R. E., C. A. Lozupone, M. Hamady, R. Knight and J. I. Gordon (2008). "Worlds within worlds: 
evolution of the vertebrate gut microbiota." Nat Rev Microbiol 6(10): 776-788. 
Li, H., J. P. Limenitakis, T. Fuhrer, M. B. Geuking, M. A. Lawson, M. Wyss, S. Brugiroux, I. Keller, J. A. 
Macpherson, S. Rupp, B. Stolp, J. V. Stein, B. Stecher, U. Sauer, K. D. McCoy and A. J. Macpherson 
(2015). "The outer mucus layer hosts a distinct intestinal microbial niche." Nat Commun 6: 8292. 
Li, Z., Z. Wu, H. Chen, Q. Zhu, G. Gao, L. Hu, H. Negi, S. Kamle and D. Li (2015). "Induction of anterior 
gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell 
proliferation and migration." Med Oncol 32(6): 577. 
Linnenbrink, M., J. Wang, E. A. Hardouin, S. Kunzel, D. Metzler and J. F. Baines (2013). "The role of 
biogeography in shaping diversity of the intestinal microbiota in house mice." Mol Ecol 22(7): 1904-1916. 
Liou, A. P. and P. J. Turnbaugh (2012). "Antibiotic exposure promotes fat gain." Cell Metab 16(4): 408-
410. 
Liu, J. Z., S. Jellbauer, A. J. Poe, V. Ton, M. Pesciaroli, T. E. Kehl-Fie, N. A. Restrepo, M. P. Hosking, R. 
A. Edwards, A. Battistoni, P. Pasquali, T. E. Lane, W. J. Chazin, T. Vogl, J. Roth, E. P. Skaar and M. 
Literature 
 
181 
 
Raffatellu (2012). "Zinc sequestration by the neutrophil protein calprotectin enhances salmonella growth 
in the inflamed gut." Cell Host Microbe 11(3): 227-239. 
Loetscher, Y., A. Wieser, J. Lengefeld, P. Kaiser, S. Schubert, M. Heikenwalder, W. D. Hardt and B. 
Stecher (2012). "Salmonella transiently reside in luminal neutrophils in the inflamed gut." PLoS One 7(4): 
e34812. 
Lopez-Garrido, J., E. Puerta-Fernandez, I. Cota and J. Casadesus (2015). "Virulence Gene Regulation by 
L-Arabinose in Salmonella enterica." Genetics 200(3): 807-819. 
Lotz, M., D. Gutle, S. Walther, S. Menard, C. Bogdan and M. W. Hornef (2006). "Postnatal acquisition of 
endotoxin tolerance in intestinal epithelial cells." J Exp Med 203(4): 973-984. 
Ma, B. W., N. A. Bokulich, P. A. Castillo, A. Kananurak, M. A. Underwood, D. A. Mills and C. L. Bevins 
(2012). "Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in 
laboratory mice." PLoS One 7(10): e47416. 
MacIntyre, D. L., S. T. Miyata, M. Kitaoka and S. Pukatzki (2010). "The Vibrio cholerae type VI 
secretion system displays antimicrobial properties." Proc Natl Acad Sci U S A 107(45): 19520-19524. 
Macpherson, A. J. and T. Uhr (2004). "Induction of protective IgA by intestinal dendritic cells carrying 
commensal bacteria." Science 303(5664): 1662-1665. 
Maier, L., R. Vyas, C. D. Cordova, H. Lindsay, T. S. Schmidt, S. Brugiroux, B. Periaswamy, R. Bauer, A. 
Sturm, F. Schreiber, C. von Mering, M. D. Robinson, B. Stecher and W. D. Hardt (2013). "Microbiota-
derived hydrogen fuels salmonella typhimurium invasion of the gut ecosystem." Cell Host Microbe 14(6): 
641-651. 
Marchesi, J. and F. Shanahan (2007). "The normal intestinal microbiota." Curr Opin Infect Dis 20(5): 508-
513. 
Marcobal, A., A. M. Southwick, K. A. Earle and J. L. Sonnenburg (2013). "A refined palate: Bacterial 
consumption of host glycans in the gut." Glycobiology 23(9): 1038-1046. 
Maukonen, J., C. Simoes and M. Saarela (2012). "The currently used commercial DNA-extraction 
methods give different results of clostridial and actinobacterial populations derived from human fecal 
samples." FEMS Microbiol Ecol 79(3): 697-708. 
Maurice, C. F., H. J. Haiser and P. J. Turnbaugh (2013). "Xenobiotics shape the physiology and gene 
expression of the active human gut microbiome." Cell 152(1-2): 39-50. 
Milani, C., A. Hevia, E. Foroni, S. Duranti, F. Turroni, G. A. Lugli, B. Sanchez, R. Martin, M. 
Gueimonde, D. van Sinderen, A. Margolles and M. Ventura (2013). "Assessing the fecal microbiota: an 
optimized ion torrent 16S rRNA gene-based analysis protocol." PLoS One 8(7): e68739. 
Literature 
 
182 
 
Milk, K. (2014). "ENA: Experiment DRX013306. [Online] Available at: 
http://www.ebi.ac.uk/ena/data/view/DRX013306 [Accessed October 2014].". 
Miller, C. P., M. Bohnhoff and D. Rifkind (1956). "The effect of an antibiotic on the susceptibility of the 
mouse's intestinal tract to Salmonella infection." Trans Am Clin Climatol Assoc 68: 51-55; discussion 55-
58. 
Monack, D. M., D. M. Bouley and S. Falkow (2004). "Salmonella typhimurium persists within 
macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be 
reactivated by IFNgamma neutralization." J Exp Med 199(2): 231-241. 
Monack, D. M., B. Raupach, A. E. Hromockyj and S. Falkow (1996). "Salmonella typhimurium invasion 
induces apoptosis in infected macrophages." Proc Natl Acad Sci U S A 93(18): 9833-9838. 
Morgan, X. C., T. L. Tickle, H. Sokol, D. Gevers, K. L. Devaney, D. V. Ward, J. A. Reyes, S. A. Shah, N. 
LeLeiko, S. B. Snapper, A. Bousvaros, J. Korzenik, B. E. Sands, R. J. Xavier and C. Huttenhower (2012). 
"Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment." Genome Biol 
13(9): R79. 
Muller, A. J., C. Hoffmann, M. Galle, A. Van Den Broeke, M. Heikenwalder, L. Falter, B. Misselwitz, M. 
Kremer, R. Beyaert and W. D. Hardt (2009). "The S. Typhimurium effector SopE induces caspase-1 
activation in stromal cells to initiate gut inflammation." Cell Host Microbe 6(2): 125-136. 
Nanjing University, C. (2013). "ENA: Experiment ERX166941. [Online] Available at: 
http://www.ebi.ac.uk/ena/data/view/ERX166941 [Accessed October 2014].". 
Nedialkova, L. P., R. Denzler, M. B. Koeppel, M. Diehl, D. Ring, T. Wille, R. G. Gerlach and B. Stecher 
(2014). "Inflammation fuels colicin Ib-dependent competition of Salmonella serovar Typhimurium and E. 
coli in enterobacterial blooms." PLoS Pathog 10(1): e1003844. 
Ng, K. M., J. A. Ferreyra, S. K. Higginbottom, J. B. Lynch, P. C. Kashyap, S. Gopinath, N. Naidu, B. 
Choudhury, B. C. Weimer, D. M. Monack and J. L. Sonnenburg (2013). "Microbiota-liberated host sugars 
facilitate post-antibiotic expansion of enteric pathogens." Nature. 
Nguyen, T. L., S. Vieira-Silva, A. Liston and J. Raes (2015). "How informative is the mouse for human 
gut microbiota research?" Dis Model Mech 8(1): 1-16. 
Nicholson, J. K., E. Holmes, J. Kinross, R. Burcelin, G. Gibson, W. Jia and S. Pettersson (2012). "Host-
gut microbiota metabolic interactions." Science 336(6086): 1262-1267. 
Nicholson, J. K., E. Holmes and I. D. Wilson (2005). "Gut microorganisms, mammalian metabolism and 
personalized health care." Nat Rev Microbiol 3(5): 431-438. 
Norin, E. and T. Midtvedt (2010). "Intestinal microflora functions in laboratory mice claimed to harbor a 
"normal" intestinal microflora. Is the SPF concept running out of date?" Anaerobe 16(3): 311-313. 
Literature 
 
183 
 
Ogata, H., S. Goto, K. Sato, W. Fujibuchi, H. Bono and M. Kanehisa (1999). "KEGG: Kyoto 
Encyclopedia of Genes and Genomes." Nucleic Acids Res 27(1): 29-34. 
Ohland, C. L. and C. Jobin (2015). "Microbial activities and intestinal Homeostasis: A delicate balance 
between health and disease." Cell Mol Gastroenterol Hepatol 1(1): 28-40. 
Ooi, J. H., Y. Li, C. J. Rogers and M. T. Cantorna (2013). "Vitamin D regulates the gut microbiome and 
protects mice from dextran sodium sulfate-induced colitis." J Nutr 143(10): 1679-1686. 
Orcutt, R. P., F. J. Giannim and R. J. Judge (1987). "Development of an "altered Schaedler flora" for NCI 
gnotobiotic rodents." Microecol Ther 17: 59. 
Pacheco, A. R., M. M. Curtis, J. M. Ritchie, D. Munera, M. K. Waldor, C. G. Moreira and V. Sperandio 
(2012). "Fucose sensing regulates bacterial intestinal colonization." Nature. 
Paesold, G., D. G. Guiney, L. Eckmann and M. F. Kagnoff (2002). "Genes in the Salmonella 
pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced 
apoptosis in intestinal epithelial cells." Cell Microbiol 4(11): 771-781. 
Paliy, O., H. Kenche, F. Abernathy and S. Michail (2009). "High-throughput quantitative analysis of the 
human intestinal microbiota with a phylogenetic microarray." Appl Environ Microbiol 75(11): 3572-3579. 
Papavasileiou, K., E. Papavasileiou, A. Tseleni-Kotsovili, S. Bersimis, C. Nicolaou, A. Ioannidis and S. 
Chatzipanagiotou (2010). "Comparative antimicrobial susceptibility of biofilm versus planktonic forms of 
Salmonella enterica strains isolated from children with gastroenteritis." Eur J Clin Microbiol Infect Dis 
29(11): 1401-1405. 
Park, S. W., G. Zhen, C. Verhaeghe, Y. Nakagami, L. T. Nguyenvu, A. J. Barczak, N. Killeen and D. J. 
Erle (2009). "The protein disulfide isomerase AGR2 is essential for production of intestinal mucus." Proc 
Natl Acad Sci U S A 106(17): 6950-6955. 
Patel, J. C. and J. E. Galan (2005). "Manipulation of the host actin cytoskeleton by Salmonella--all in the 
name of entry." Curr Opin Microbiol 8(1): 10-15. 
Patel, S. and B. A. McCormick (2014). "Mucosal Inflammatory Response to Salmonella typhimurium 
Infection." Front Immunol 5: 311. 
Penders, J., C. Thijs, C. Vink, F. F. Stelma, B. Snijders, I. Kummeling, P. A. van den Brandt and E. E. 
Stobberingh (2006). "Factors influencing the composition of the intestinal microbiota in early infancy." 
Pediatrics 118(2): 511-521. 
Pernthaler, A., C. M. Preston, J. Pernthaler, E. F. DeLong and R. Amann (2002). "Comparison of 
fluorescently labeled oligonucleotide and polynucleotide probes for the detection of pelagic marine 
bacteria and archaea." Appl Environ Microbiol 68(2): 661-667. 
Literature 
 
184 
 
Persson, S., M. Rosenquist, B. Knoblach, R. Khosravi-Far, M. Sommarin and M. Michalak (2005). 
"Diversity of the protein disulfide isomerase family: identification of breast tumor induced Hag2 and 
Hag3 as novel members of the protein family." Mol Phylogenet Evol 36(3): 734-740. 
Pfleiderer, A., J. C. Lagier, F. Armougom, C. Robert, B. Vialettes and D. Raoult (2013). "Culturomics 
identified 11 new bacterial species from a single anorexia nervosa stool sample." Eur J Clin Microbiol 
Infect Dis. 
Pham, T. A., S. Clare, D. Goulding, J. M. Arasteh, M. D. Stares, H. P. Browne, J. A. Keane, A. J. Page, N. 
Kumasaka, L. Kane, L. Mottram, K. Harcourt, C. Hale, M. J. Arends, D. J. Gaffney, P. Sanger Mouse 
Genetics, G. Dougan and T. D. Lawley (2014). "Epithelial IL-22RA1-Mediated Fucosylation Promotes 
Intestinal Colonization Resistance to an Opportunistic Pathogen." Cell Host Microbe 16(4): 504-516. 
Ploger, S., F. Stumpff, G. B. Penner, J. D. Schulzke, G. Gabel, H. Martens, Z. Shen, D. Gunzel and J. R. 
Aschenbach (2012). "Microbial butyrate and its role for barrier function in the gastrointestinal tract." Ann 
N Y Acad Sci 1258: 52-59. 
Png, C. W., S. K. Linden, K. S. Gilshenan, E. G. Zoetendal, C. S. McSweeney, L. I. Sly, M. A. McGuckin 
and T. H. Florin (2010). "Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro 
utilization of mucin by other bacteria." Am J Gastroenterol 105(11): 2420-2428. 
Pongpech, P., D. J. Hentges, W. W. Marsh and M. E. Eberle (1989). "Effect of streptomycin 
administration on association of enteric pathogens with cecal tissue of mice." Infect Immun 57(7): 2092-
2097. 
Price, M. N., P. S. Dehal and A. P. Arkin (2009). "FastTree: computing large minimum evolution trees 
with profiles instead of a distance matrix." Mol Biol Evol 26(7): 1641-1650. 
Quast, C., E. Pruesse, P. Yilmaz, J. Gerken, T. Schweer, P. Yarza, J. Peplies and F. O. Glockner (2013). 
"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools." 
Nucleic Acids Res 41(Database issue): D590-596. 
Raffatellu, M., M. D. George, Y. Akiyama, M. J. Hornsby, S. P. Nuccio, T. A. Paixao, B. P. Butler, H. 
Chu, R. L. Santos, T. Berger, T. W. Mak, R. M. Tsolis, C. L. Bevins, J. V. Solnick, S. Dandekar and A. J. 
Baumler (2009). "Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype 
Typhimurium for growth and survival in the inflamed intestine." Cell Host Microbe 5(5): 476-486. 
Raghunathan, A., J. Reed, S. Shin, B. Palsson and S. Daefler (2009). "Constraint-based analysis of 
metabolic capacity of Salmonella typhimurium during host-pathogen interaction." BMC Syst Biol 3: 38. 
Ramachandran, V., T. Arumugam, H. Wang and C. D. Logsdon (2008). "Anterior gradient 2 is expressed 
and secreted during the development of pancreatic cancer and promotes cancer cell survival." Cancer Res 
68(19): 7811-7818. 
Rappe, M. S. and S. J. Giovannoni (2003). "The uncultured microbial majority." Annu Rev Microbiol 57: 
369-394. 
Literature 
 
185 
 
Rausch, P., N. Steck, A. Suwandi, J. A. Seidel, S. Kunzel, K. Bhullar, M. Basic, A. Bleich, J. M. Johnsen, 
B. A. Vallance, J. F. Baines and G. A. Grassl (2015). "Expression of the Blood-Group-Related Gene 
B4galnt2 Alters Susceptibility to Salmonella Infection." PLoS Pathog 11(7): e1005008. 
Reed, S., H. Neuman, S. Moscovich, R. P. Glahn, O. Koren and E. Tako (2015). "Chronic Zinc Deficiency 
Alters Chick Gut Microbiota Composition and Function." Nutrients 7(12): 9768-9784. 
Reeves, A. E., M. J. Koenigsknecht, I. L. Bergin and V. B. Young (2012). "Suppression of Clostridium 
difficile in the Gastrointestinal Tract of Germ-Free Mice Inoculated with a Murine Lachnospiraceae 
Isolate." Infect Immun. 
Reikvam, D. H., A. Erofeev, A. Sandvik, V. Grcic, F. L. Jahnsen, P. Gaustad, K. D. McCoy, A. J. 
Macpherson, L. A. Meza-Zepeda and F. E. Johansen (2011). "Depletion of murine intestinal microbiota: 
effects on gut mucosa and epithelial gene expression." PLoS One 6(3): e17996. 
Ren, D., C. Li, Y. Qin, R. Yin, X. Li, M. Tian, S. Du, H. Guo, C. Liu, N. Zhu, D. Sun, Y. Li and N. Jin 
(2012). "Inhibition of Staphylococcus aureus adherence to Caco-2 cells by lactobacilli and cell surface 
properties that influence attachment." Anaerobe 18(5): 508-515. 
Rescigno, M., G. Rotta, B. Valzasina and P. Ricciardi-Castagnoli (2001). "Dendritic cells shuttle microbes 
across gut epithelial monolayers." Immunobiology 204(5): 572-581. 
Rhee, S. J., W. A. Walker and B. J. Cherayil (2005). "Developmentally regulated intestinal expression of 
IFN-gamma and its target genes and the age-specific response to enteric Salmonella infection." J Immunol 
175(2): 1127-1136. 
Ricker, N., H. Qian and R. R. Fulthorpe (2012). "The limitations of draft assemblies for understanding 
prokaryotic adaptation and evolution." Genomics 100(3): 167-175. 
Rivera-Chavez, F., S. E. Winter, C. A. Lopez, M. N. Xavier, M. G. Winter, S. P. Nuccio, J. M. Russell, R. 
C. Laughlin, S. D. Lawhon, T. Sterzenbach, C. L. Bevins, R. M. Tsolis, R. Harshey, L. G. Adams and A. 
J. Baumler (2013). "Salmonella uses energy taxis to benefit from intestinal inflammation." PLoS Pathog 
9(4): e1003267. 
Robertson, B. R., J. L. O'Rourke, B. A. Neilan, P. Vandamme, S. L. On, J. G. Fox and A. Lee (2005). 
"Mucispirillum schaedleri gen. nov., sp. nov., a spiral-shaped bacterium colonizing the mucus layer of the 
gastrointestinal tract of laboratory rodents." Int J Syst Evol Microbiol 55(Pt 3): 1199-1204. 
Rogers, G. B., J. Kozlowska, J. Keeble, K. Metcalfe, M. Fao, S. E. Dowd, A. J. Mason, M. A. McGuckin 
and K. D. Bruce (2014). "Functional divergence in gastrointestinal microbiota in physically-separated 
genetically identical mice." Sci Rep 4: 5437. 
Rojo, D., M. J. Gosalbes, R. Ferrari, A. E. Perez-Cobas, E. Hernandez, R. Oltra, J. Buesa, A. Latorre, C. 
Barbas, M. Ferrer and A. Moya (2015). "Clostridium difficile heterogeneously impacts intestinal 
community architecture but drives stable metabolome responses." ISME J 9(10): 2206-2220. 
Literature 
 
186 
 
Round, J. L. and S. K. Mazmanian (2009). "The gut microbiota shapes intestinal immune responses during 
health and disease." Nat Rev Immunol 9(5): 313-323. 
Russell, A. B., A. G. Wexler, B. N. Harding, J. C. Whitney, A. J. Bohn, Y. A. Goo, B. Q. Tran, N. A. 
Barry, H. Zheng, S. B. Peterson, S. Chou, T. Gonen, D. R. Goodlett, A. L. Goodman and J. D. Mougous 
(2014). "A Type VI Secretion-Related Pathway in Bacteroidetes Mediates Interbacterial Antagonism." 
Cell Host Microbe. 
Rybak, M. J., B. J. Abate, S. L. Kang, M. J. Ruffing, S. A. Lerner and G. L. Drusano (1999). "Prospective 
evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and 
ototoxicity." Antimicrob Agents Chemother 43(7): 1549-1555. 
Rydstrom, A. and M. J. Wick (2007). "Monocyte recruitment, activation, and function in the gut-
associated lymphoid tissue during oral Salmonella infection." J Immunol 178(9): 5789-5801. 
Saito, D., T. Leonardo Rde, J. L. Rodrigues, S. M. Tsai, J. F. Hofling and R. B. Goncalves (2006). 
"Identification of bacteria in endodontic infections by sequence analysis of 16S rDNA clone libraries." J 
Med Microbiol 55(Pt 1): 101-107. 
Salonen, A., J. Nikkila, J. Jalanka-Tuovinen, O. Immonen, M. Rajilic-Stojanovic, R. A. Kekkonen, A. 
Palva and W. M. de Vos (2010). "Comparative analysis of fecal DNA extraction methods with 
phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis." J 
Microbiol Methods 81(2): 127-134. 
Samuel, B. S. and J. I. Gordon (2006). "A humanized gnotobiotic mouse model of host-archaeal-bacterial 
mutualism." Proc Natl Acad Sci U S A 103(26): 10011-10016. 
Sarma-Rupavtarm, R. B., Z. Ge, D. B. Schauer, J. G. Fox and M. F. Polz (2004). "Spatial distribution and 
stability of the eight microbial species of the altered schaedler flora in the mouse gastrointestinal tract." 
Appl Environ Microbiol 70(5): 2791-2800. 
Sassone-Corsi, M. and M. Raffatellu (2015). "No vacancy: how beneficial microbes cooperate with 
immunity to provide colonization resistance to pathogens." J Immunol 194(9): 4081-4087. 
Satoh-Takayama, N., C. A. Vosshenrich, S. Lesjean-Pottier, S. Sawa, M. Lochner, F. Rattis, J. J. Mention, 
K. Thiam, N. Cerf-Bensussan, O. Mandelboim, G. Eberl and J. P. Di Santo (2008). "Microbial flora drives 
interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense." 
Immunity 29(6): 958-970. 
Satokari, R., S. Fuentes, E. Mattila, J. Jalanka, W. M. de Vos and P. Arkkila (2014). "Fecal transplantation 
treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up." Case Rep Med 
2014: 913867. 
Schaedler, R. W., R. Dubs and R. Costello (1965). "Association of Germfree Mice with Bacteria Isolated 
from Normal Mice." J Exp Med 122: 77-82. 
Literature 
 
187 
 
Schillinger, C., A. Petrich, R. Lux, B. Riep, J. Kikhney, A. Friedmann, L. E. Wolinsky, U. B. Gobel, H. 
Daims and A. Moter (2012). "Co-localized or randomly distributed? Pair cross correlation of in vivo 
grown subgingival biofilm bacteria quantified by digital image analysis." PLoS One 7(5): e37583. 
Schlumberger, M. C., A. J. Muller, K. Ehrbar, B. Winnen, I. Duss, B. Stecher and W. D. Hardt (2005). 
"Real-time imaging of type III secretion: Salmonella SipA injection into host cells." Proc Natl Acad Sci U 
S A 102(35): 12548-12553. 
Schmidt, T. S., J. F. Matias Rodrigues and C. von Mering (2015). "Limits to robustness and 
reproducibility in the demarcation of operational taxonomic units." Environ Microbiol 17(5): 1689-1706. 
Schubert, A. M., H. Sinani and P. D. Schloss (2015). "Antibiotic-Induced Alterations of the Murine Gut 
Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile." MBio 6(4): 
e00974. 
Schwab, C., D. Berry, I. Rauch, I. Rennisch, J. Ramesmayer, E. Hainzl, S. Heider, T. Decker, L. Kenner, 
M. Muller, B. Strobl, M. Wagner, C. Schleper, A. Loy and T. Urich (2014). "Longitudinal study of murine 
microbiota activity and interactions with the host during acute inflammation and recovery." ISME J. 
Seedorf, H., N. W. Griffin, V. K. Ridaura, A. Reyes, J. Cheng, F. E. Rey, M. I. Smith, G. M. Simon, R. H. 
Scheffrahn, D. Woebken, A. M. Spormann, W. Van Treuren, L. K. Ursell, M. Pirrung, A. Robbins-Pianka, 
B. L. Cantarel, V. Lombard, B. Henrissat, R. Knight and J. I. Gordon (2014). "Bacteria from diverse 
habitats colonize and compete in the mouse gut." Cell 159(2): 253-266. 
Segata, N., J. Izard, L. Waldron, D. Gevers, L. Miropolsky, W. S. Garrett and C. Huttenhower (2011). 
"Metagenomic biomarker discovery and explanation." Genome Biol 12(6): R60. 
Sellin, M. E., A. A. Muller, B. Felmy, T. Dolowschiak, M. Diard, A. Tardivel, K. M. Maslowski and W. 
D. Hardt (2014). "Epithelium-Intrinsic NAIP/NLRC4 Inflammasome Drives Infected Enterocyte 
Expulsion to Restrict Salmonella Replication in the Intestinal Mucosa." Cell Host Microbe 16(2): 237-
248. 
Sellon, R. K., S. Tonkonogy, M. Schultz, L. A. Dieleman, W. Grenther, E. Balish, D. M. Rennick and R. 
B. Sartor (1998). "Resident enteric bacteria are necessary for development of spontaneous colitis and 
immune system activation in interleukin-10-deficient mice." Infect Immun 66(11): 5224-5231. 
Shankar, V., M. J. Hamilton, A. Khoruts, A. Kilburn, T. Unno, O. Paliy and M. J. Sadowsky (2014). 
"Species and genus level resolution analysis of gut microbiota in Clostridium difficile patients following 
fecal microbiota transplantation." Microbiome 2: 13. 
Shimotoyodome, A., S. Meguro, T. Hase, I. Tokimitsu and T. Sakata (2000). "Short chain fatty acids but 
not lactate or succinate stimulate mucus release in the rat colon." Comp Biochem Physiol A Mol Integr 
Physiol 125(4): 525-531. 
Literature 
 
188 
 
Slezak, K., Z. Krupova, S. Rabot, G. Loh, F. Levenez, A. Descamps, P. Lepage, J. Dore, S. Bellier and M. 
Blaut (2014). "Association of germ-free mice with a simplified human intestinal microbiota results in a 
shortened intestine." Gut Microbes 5(2): 176-182. 
Smith, P. M., M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, Y. M. Bohlooly, J. N. Glickman and 
W. S. Garrett (2013). "The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell 
homeostasis." Science 341(6145): 569-573. 
Sogin, M. L., H. G. Morrison, J. A. Huber, D. Mark Welch, S. M. Huse, P. R. Neal, J. M. Arrieta and G. J. 
Herndl (2006). "Microbial diversity in the deep sea and the underexplored "rare biosphere"." Proc Natl 
Acad Sci U S A 103(32): 12115-12120. 
Sommer, F., N. Adam, M. E. Johansson, L. Xia, G. C. Hansson and F. Backhed (2014). "Altered mucus 
glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal 
architecture." PLoS One 9(1): e85254. 
Sommer, M. O., G. Dantas and G. M. Church (2009). "Functional characterization of the antibiotic 
resistance reservoir in the human microflora." Science 325(5944): 1128-1131. 
Sovran, B., L. M. Loonen, P. Lu, F. Hugenholtz, C. Belzer, E. H. Stolte, M. V. Boekschoten, P. van 
Baarlen, M. Kleerebezem, P. de Vos, J. Dekker, I. B. Renes and J. M. Wells (2015). "IL-22-STAT3 
pathway plays a key role in the maintenance of ileal homeostasis in mice lacking secreted mucus barrier." 
Inflamm Bowel Dis 21(3): 531-542. 
Stecher, B., M. Barthel, M. C. Schlumberger, L. Haberli, W. Rabsch, M. Kremer and W. D. Hardt (2008). 
"Motility allows S. Typhimurium to benefit from the mucosal defence." Cell Microbiol 10(5): 1166-1180. 
Stecher, B., S. Chaffron, R. Kappeli, S. Hapfelmeier, S. Freedrich, T. C. Weber, J. Kirundi, M. Suar, K. D. 
McCoy, C. von Mering, A. J. Macpherson and W. D. Hardt (2010). "Like will to like: abundances of 
closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal 
bacteria." PLoS Pathog 6(1): e1000711. 
Stecher, B., R. Denzler, L. Maier, F. Bernet, M. J. Sanders, D. J. Pickard, M. Barthel, A. M. Westendorf, 
K. A. Krogfelt, A. W. Walker, M. Ackermann, U. Dobrindt, N. R. Thomson and W. D. Hardt (2012). "Gut 
inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae." 
Proc Natl Acad Sci U S A 109(4): 1269-1274. 
Stecher, B., S. Hapfelmeier, C. Muller, M. Kremer, T. Stallmach and W. D. Hardt (2004). "Flagella and 
chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in 
streptomycin-pretreated mice." Infect Immun 72(7): 4138-4150. 
Stecher, B., A. J. Macpherson, S. Hapfelmeier, M. Kremer, T. Stallmach and W. D. Hardt (2005). 
"Comparison of Salmonella enterica serovar Typhimurium colitis in germfree mice and mice pretreated 
with streptomycin." Infect Immun 73(6): 3228-3241. 
Literature 
 
189 
 
Stecher, B., R. Robbiani, A. W. Walker, A. M. Westendorf, M. Barthel, M. Kremer, S. Chaffron, A. J. 
Macpherson, J. Buer, J. Parkhill, G. Dougan, C. von Mering and W. D. Hardt (2007). "Salmonella enterica 
serovar typhimurium exploits inflammation to compete with the intestinal microbiota." PLoS Biol 5(10): 
2177-2189. 
Stefka, A. T., T. Feehley, P. Tripathi, J. Qiu, K. McCoy, S. K. Mazmanian, M. Y. Tjota, G. Y. Seo, S. 
Cao, B. R. Theriault, D. A. Antonopoulos, L. Zhou, E. B. Chang, Y. X. Fu and C. R. Nagler (2014). 
"Commensal bacteria protect against food allergen sensitization." Proc Natl Acad Sci U S A 111(36): 
13145-13150. 
Stelter, C., R. Kappeli, C. Konig, A. Krah, W. D. Hardt, B. Stecher and D. Bumann (2011). "Salmonella-
Induced Mucosal Lectin RegIIIbeta Kills Competing Gut Microbiota." PLoS One 6(6): e20749. 
Struss, A. K., P. Pasini, D. Flomenhoft, H. Shashidhar and S. Daunert (2012). "Investigating the effect of 
antibiotics on quorum sensing with whole-cell biosensing systems." Anal Bioanal Chem 402(10): 3227-
3236. 
Subramani, D. B., M. E. Johansson, G. Dahlen and G. C. Hansson (2010). "Lactobacillus and 
Bifidobacterium species do not secrete protease that cleaves the MUC2 mucin which organises the colon 
mucus." Benef Microbes 1(4): 343-350. 
Subramanian, A., P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, A. Paulovich, S. L. 
Pomeroy, T. R. Golub, E. S. Lander and J. P. Mesirov (2005). "Gene set enrichment analysis: a 
knowledge-based approach for interpreting genome-wide expression profiles." Proc Natl Acad Sci U S A 
102(43): 15545-15550. 
Suez, J., T. Korem, D. Zeevi, G. Zilberman-Schapira, C. A. Thaiss, O. Maza, D. Israeli, N. Zmora, S. 
Gilad, A. Weinberger, Y. Kuperman, A. Harmelin, I. Kolodkin-Gal, H. Shapiro, Z. Halpern, E. Segal and 
E. Elinav (2014). "Artificial sweeteners induce glucose intolerance by altering the gut microbiota." Nature 
514(7521): 181-186. 
Sung, H. Y., E. N. Choi, D. Lyu, A. K. Park, W. Ju and J. H. Ahn (2014). "Aberrant hypomethylation-
mediated AGR2 overexpression induces an aggressive phenotype in ovarian cancer cells." Oncol Rep 
32(2): 815-820. 
Thiel, R. and M. Blaut (2005). "An improved method for the automated enumeration of fluorescently 
labelled bacteria in human faeces." J Microbiol Methods 61(3): 369-379. 
Thiennimitr, P., S. E. Winter and A. J. Baumler (2012). "Salmonella, the host and its microbiota." Curr 
Opin Microbiol 15(1): 108-114. 
Thijm, H. A. and D. van der Waaij (1979). "The effect of three frequently applied antibiotics on the 
colonization resistance of the digestive tract of mice." J Hyg (Lond) 82(3): 397-405. 
Ubeda, C., V. Bucci, S. Caballero, A. Djukovic, N. C. Toussaint, M. Equinda, L. Lipuma, L. Ling, A. 
Gobourne, D. No, Y. Taur, R. R. Jenq, M. R. van den Brink, J. B. Xavier and E. G. Pamer (2013). 
Literature 
 
190 
 
"Intestinal Microbiota Containing Barnesiella Species Cures Vancomycin-Resistant Enterococcus faecium 
Colonization." Infect Immun 81(3): 965-973. 
Uchiya, K., M. A. Barbieri, K. Funato, A. H. Shah, P. D. Stahl and E. A. Groisman (1999). "A Salmonella 
virulence protein that inhibits cellular trafficking." EMBO J 18(14): 3924-3933. 
Vaishnava, S., C. L. Behrendt, A. S. Ismail, L. Eckmann and L. V. Hooper (2008). "Paneth cells directly 
sense gut commensals and maintain homeostasis at the intestinal host-microbial interface." Proc Natl Acad 
Sci U S A 105(52): 20858-20863. 
van Ampting, M. T., L. M. Loonen, A. J. Schonewille, I. Konings, C. Vink, J. Iovanna, M. Chamaillard, J. 
Dekker, R. van der Meer, J. M. Wells and I. M. Bovee-Oudenhoven (2012). "Intestinally secreted C-type 
lectin Reg3b attenuates salmonellosis but not listeriosis in mice." Infect Immun 80(3): 1115-1120. 
Van der Sluis, M., B. A. De Koning, A. C. De Bruijn, A. Velcich, J. P. Meijerink, J. B. Van Goudoever, 
H. A. Buller, J. Dekker, I. Van Seuningen, I. B. Renes and A. W. Einerhand (2006). "Muc2-deficient mice 
spontaneously develop colitis, indicating that MUC2 is critical for colonic protection." Gastroenterology 
131(1): 117-129. 
van der Waaij, D., J. M. Berghuis-de Vries and L.-v. Lekkerkerk (1971). "Colonization resistance of the 
digestive tract in conventional and antibiotic-treated mice." J Hyg (Lond) 69(3): 405-411. 
van Meer, G., D. R. Voelker and G. W. Feigenson (2008). "Membrane lipids: where they are and how 
they behave." Nat Rev Mol Cell Biol 9(2): 112-124. 
Vanhoutvin, S. A., F. J. Troost, H. M. Hamer, P. J. Lindsey, G. H. Koek, D. M. Jonkers, A. Kodde, K. 
Venema and R. J. Brummer (2009). "Butyrate-induced transcriptional changes in human colonic mucosa." 
PLoS One 4(8): e6759. 
Varughese, C. A., N. H. Vakil and K. M. Phillips (2013). "Antibiotic-associated diarrhea: a refresher on 
causes and possible prevention with probiotics--continuing education article." J Pharm Pract 26(5): 476-
482. 
Velcich, A., W. Yang, J. Heyer, A. Fragale, C. Nicholas, S. Viani, R. Kucherlapati, M. Lipkin, K. Yang 
and L. Augenlicht (2002). "Colorectal cancer in mice genetically deficient in the mucin Muc2." Science 
295(5560): 1726-1729. 
Velge, P., A. Wiedemann, M. Rosselin, N. Abed, Z. Boumart, A. M. Chausse, O. Grepinet, F. Namdari, S. 
M. Roche, A. Rossignol and I. Virlogeux-Payant (2012). "Multiplicity of Salmonella entry mechanisms, a 
new paradigm for Salmonella pathogenesis." Microbiologyopen 1(3): 243-258. 
Verberkmoes, N. C., A. L. Russell, M. Shah, A. Godzik, M. Rosenquist, J. Halfvarson, M. G. Lefsrud, J. 
Apajalahti, C. Tysk, R. L. Hettich and J. K. Jansson (2009). "Shotgun metaproteomics of the human distal 
gut microbiota." ISME J 3(2): 179-189. 
Literature 
 
191 
 
Vieira-Pinto, M. O., M., F. Bernardo and C. Martins (2007). "Rapid detection of Salmonella sp. in pork 
samples using fluorescent in situ hybridization: a comparison with VIDAS-SLM system and ISO 6579 
cultural method." Arq. Bras. Med. Vet. Zootec. 59(6): 1388-1393. 
Vikram, A., P. R. Jesudhasan, G. K. Jayaprakasha, S. D. Pillai, A. Jayaraman and B. S. Patil (2011). 
"Citrus flavonoid represses Salmonella pathogenicity island 1 and motility in S. Typhimurium LT2." Int J 
Food Microbiol 145(1): 28-36. 
Wang, J., M. Linnenbrink, S. Kunzel, R. Fernandes, M. J. Nadeau, P. Rosenstiel and J. F. Baines (2014). 
"Dietary history contributes to enterotype-like clustering and functional metagenomic content in the 
intestinal microbiome of wild mice." Proc Natl Acad Sci U S A 111(26): E2703-2710. 
Wang, Q., G. M. Garrity, J. M. Tiedje and J. R. Cole (2007). "Naive Bayesian classifier for rapid 
assignment of rRNA sequences into the new bacterial taxonomy." Appl Environ Microbiol 73(16): 5261-
5267. 
Wang, R. F. and S. R. Kushner (1991). "Construction of versatile low-copy-number vectors for cloning, 
sequencing and gene expression in Escherichia coli." Gene 100: 195-199. 
Wang, Z., Y. Hao and A. W. Lowe (2008). "The adenocarcinoma-associated antigen, AGR2, promotes 
tumor growth, cell migration, and cellular transformation." Cancer Res 68(2): 492-497. 
Wannemuehler, M. J., A. M. Overstreet, D. V. Ward and G. J. Phillips (2014). "Draft genome sequences 
of the altered schaedler flora, a defined bacterial community from gnotobiotic mice." Genome Announc 
2(2). 
Watanabe, M., H. Kojima and M. Fukui (2013). "Desulfotomaculum intricatum sp. nov., a sulfate reducer 
isolated from freshwater lake sediment." Int J Syst Evol Microbiol 63(Pt 10): 3574-3578. 
Wei, Y., J. Gong, W. Zhu, D. Guo, L. Gu, N. Li and J. Li (2015). "Fecal microbiota transplantation 
restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis." BMC Infect 
Dis 15: 265. 
Weisburg, W. G., S. M. Barns, D. A. Pelletier and D. J. Lane (1991). "16S ribosomal DNA amplification 
for phylogenetic study." J Bacteriol 173(2): 697-703. 
Wenzel, U. A., M. K. Magnusson, A. Rydstrom, C. Jonstrand, J. Hengst, M. E. Johansson, A. Velcich, L. 
Ohman, H. Strid, H. Sjovall, G. C. Hansson and M. J. Wick (2014). "Spontaneous colitis in muc2-
deficient mice reflects clinical and cellular features of active ulcerative colitis." PLoS One 9(6): e100217. 
Wichmann, A., A. Allahyar, T. U. Greiner, H. Plovier, G. O. Lunden, T. Larsson, D. J. Drucker, N. M. 
Delzenne, P. D. Cani and F. Backhed (2013). "Microbial modulation of energy availability in the colon 
regulates intestinal transit." Cell Host Microbe 14(5): 582-590. 
Willing, B. P., A. Vacharaksa, M. Croxen, T. Thanachayanont and B. B. Finlay (2011). "Altering Host 
Resistance to Infections through Microbial Transplantation." PLoS One 6(10): e26988. 
Literature 
 
192 
 
Wilson, K. H. and R. B. Blitchington (1996). "Human colonic biota studied by ribosomal DNA sequence 
analysis." Appl Environ Microbiol 62(7): 2273-2278. 
Winter, S. E., P. Thiennimitr, M. G. Winter, B. P. Butler, D. L. Huseby, R. W. Crawford, J. M. Russell, C. 
L. Bevins, L. G. Adams, R. M. Tsolis, J. R. Roth and A. J. Baumler (2010). "Gut inflammation provides a 
respiratory electron acceptor for Salmonella." Nature 467(7314): 426-429. 
Wlodarska, M., B. Willing, K. M. Keeney, A. Menendez, K. S. Bergstrom, N. Gill, S. L. Russell, B. A. 
Vallance and B. B. Finlay (2011). "Antibiotic treatment alters the colonic mucus layer and predisposes the 
host to exacerbated Citrobacter rodentium-induced colitis." Infect Immun 79(4): 1536-1545. 
Woting, A., N. Pfeiffer, L. Hanske, G. Loh, S. Klaus and M. Blaut (2015). "Alleviation of high fat diet-
induced obesity by oligofructose in gnotobiotic mice is independent of presence of Bifidobacterium 
longum." Mol Nutr Food Res 59(11): 2267-2278. 
Woting, A., N. Pfeiffer, G. Loh, S. Klaus and M. Blaut (2014). "Clostridium ramosum promotes high-fat 
diet-induced obesity in gnotobiotic mouse models." MBio 5(5): e01530-01514. 
Wrzosek, L., S. Miquel, M. L. Noordine, S. Bouet, M. Joncquel Chevalier-Curt, V. Robert, C. Philippe, C. 
Bridonneau, C. Cherbuy, C. Robbe-Masselot, P. Langella and M. Thomas (2013). "Bacteroides 
thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the 
development of goblet cells in the colonic epithelium of a gnotobiotic model rodent." BMC Biol 11: 61. 
Wymore Brand, M., M. J. Wannemuehler, G. J. Phillips, A. Proctor, A. M. Overstreet, A. E. Jergens, R. P. 
Orcutt and J. G. Fox (2015). "The Altered Schaedler Flora: Continued Applications of a Defined Murine 
Microbial Community." ILAR J 56(2): 169-178. 
Xiong, X., D. N. Frank, C. E. Robertson, S. S. Hung, J. Markle, A. J. Canty, K. D. McCoy, A. J. 
Macpherson, P. Poussier, J. S. Danska and J. Parkinson (2012). "Generation and analysis of a mouse 
intestinal metatranscriptome through Illumina based RNA-sequencing." PLoS One 7(4): e36009. 
Xue, Y., H. Zhang, H. Wang, J. Hu, M. Du and M. J. Zhu (2014). "Host inflammatory response inhibits 
Escherichia coli O157:H7 adhesion to gut epithelium through augmentation of mucin expression." Infect 
Immun 82(5): 1921-1930. 
Yang, X., J. Brisbin, H. Yu, Q. Wang, F. Yin, Y. Zhang, P. Sabour, S. Sharif and J. Gong (2014). 
"Selected lactic acid-producing bacterial isolates with the capacity to reduce Salmonella translocation and 
virulence gene expression in chickens." PLoS One 9(4): e93022. 
Yatsunenko, T., F. E. Rey, M. J. Manary, I. Trehan, M. G. Dominguez-Bello, M. Contreras, M. Magris, G. 
Hidalgo, R. N. Baldassano, A. P. Anokhin, A. C. Heath, B. Warner, J. Reeder, J. Kuczynski, J. G. 
Caporaso, C. A. Lozupone, C. Lauber, J. C. Clemente, D. Knights, R. Knight and J. I. Gordon (2012). 
"Human gut microbiome viewed across age and geography." Nature 486(7402): 222-227. 
Ye, Y., J. H. Choi and H. Tang (2011). "RAPSearch: a fast protein similarity search tool for short reads." 
BMC Bioinformatics 12: 159. 
Literature 
 
193 
 
Zarepour, M., K. Bhullar, M. Montero, C. Ma, T. Huang, A. Velcich, L. Xia and B. A. Vallance (2013). 
"The Mucin Muc2 Limits Pathogen Burdens and Epithelial Barrier Dysfunction during Salmonella 
enterica Serovar Typhimurium Colitis." Infect Immun 81(10): 3672-3683. 
Zengler, K., G. Toledo, M. Rappe, J. Elkins, E. J. Mathur, J. M. Short and M. Keller (2002). "Cultivating 
the uncultured." Proc Natl Acad Sci U S A 99(24): 15681-15686. 
Zhang, Z., J. Geng, X. Tang, H. Fan, J. Xu, X. Wen, Z. S. Ma and P. Shi (2014). "Spatial heterogeneity 
and co-occurrence patterns of human mucosal-associated intestinal microbiota." ISME J 8(4): 881-893. 
Zhao, F., R. Edwards, D. Dizon, K. Afrasiabi, J. R. Mastroianni, M. Geyfman, A. J. Ouellette, B. 
Andersen and S. M. Lipkin (2010). "Disruption of Paneth and goblet cell homeostasis and increased 
endoplasmic reticulum stress in Agr2-/- mice." Dev Biol 338(2): 270-279. 
Zhao, Y., H. Tang and Y. Ye (2012). "RAPSearch2: a fast and memory-efficient protein similarity search 
tool for next-generation sequencing data." Bioinformatics 28(1): 125-126. 
Zheng, X., G. Xie, A. Zhao, L. Zhao, C. Yao, N. H. Chiu, Z. Zhou, Y. Bao, W. Jia, J. K. Nicholson and 
W. Jia (2011). "The footprints of gut microbial-mammalian co-metabolism." J Proteome Res 10(12): 
5512-5522. 
Zierler, M. K. and J. E. Galan (1995). "Contact with cultured epithelial cells stimulates secretion of 
Salmonella typhimurium invasion protein InvJ." Infect Immun 63(10): 4024-4028. 
 
 
 
 
194 
 
 Acknowledgments 9.
 There is an enormous amount of people I would like to thank for their help, support, 
understanding and contribution. From active scientific discussions to more personal support, passing by 
technical help, specific teaching or even general conversation, each of the following persons has 
contributed, in its way, to the achievements of this PhD thesis. 
 
 Supervisors. 
 First of all, I would like to thank the people without whom this adventure will not have been 
possible starting with Prof. Dr. Dr. Jürgen Heesemann, Prof. Dr. Bärbel Stecher. Prof. Heesemann, thank 
you so much for your support and brilliant scientific discussions, you are definitely an inexhaustible 
source of ideas and exiting theories. You made the Max-von-Pettenkofer (MvP) Institute a place with an 
inspiring and friendly atmosphere, where personal and professional success can meet. I guess this is one of 
your secrets, which makes you being such a great leader! And talking about great leadership, a wonderful 
and devoted supervisor: Prof. Bärbel Stecher. Bärbel, I remember the first time I met Yvonne and Lisa, 
they both told me how “lucky I was” and, not that I doubted it, but I realized pretty quickly how right they 
were. These five years spent by your side are just unforgettable. You have definitely been one of my 
strongest driving forces and an amazing mentor not only for the work-related questions but also at a 
private life level. On the first evening of my interview, you have asked me to think overnight about my 
decision to join you in your freshly starting group. My choice was in fact made the morning we had met 
and, even though I am having a hard time writing everything up ;-), I have never regretted it! Thank you 
so much for being so devoted, kind, fair, enthusiastic, eternal optimistic, trustful, …, well, for being who 
you are. You changed my life, sharpened my scientific skills and helped me being (I hope) a better 
researcher. 
 
 Family. 
 Secondly, I would like to thank my family who, even though being really happy for me, are quite 
impatient to have me back. Alain & Mathilde, alias papa & maman, un immense merci pour votre 
inestimable soutien, nos nombreuses discussions, vos efforts pour comprendre mes projets de thèse et 
votre confiance même lorsque je n’ai cessé de répéter “je suis sur la fin” durant des mois! Avec un peu de 
chance, il y aura bientôt un second docteur dans la famille sauf que le nouveau aura tué des souris au lieu 
Acknowledgments 
  
195 
 
de sauver des humains. Merci aussi à vous deux pour l’éducation que vous m’avez apporté, la confiance 
que vous m’avez toujours témoignée, l’équilibre et l’amour que j’ai reçu et dont un enfant pourrait rêver. 
Jérémie & Audrey, malgré la distance nous avons su rester une fratrie. Un grand merci pour l’intérêt que 
vous avez témoigné à ce travail doctoral ainsi que pour votre soutien. J’ai enfin fini…à nous les vacances 
et les folies!! Mamie Elfriede, mamie Marie & papy Salomon, je souhaiterais vous remercier du fond du 
cœur pour m’avoir soutenu et encourager dans cette aventure un peu folle. Ne vous en faites pas, je 
reviendrai…un jour peut-être ! ;-) 
 
 Mentors. 
 In the third part, I would like to thank my mentors who supported me during this PhD work, most 
of the time without even noticing it. Dr. Robert Zumbihl, alias Robert, you were definitely the one who 
guided me into the wonderful MvP Institute journey. I cannot find the right words to express how grateful 
I am. You have been an inspiration (yes, I mean it!) during three years of microbiological classes and I 
will always remember the day you introduced me to the MvP Institute and how supportive you have been 
in many ways. As you have seen, I signed in for the Munich “adventure” and have not regretted it a single 
day. Dr. Ombeline Rossier and Dr. David Berry, thank you so much for our rewarding discussions, your 
technical assistance and great support. You have been a priceless help to me. 
 
 Friends. 
 The fourth part is dedicated to my friends who, for most of them, still do not realize how much 
they mean to me. I am sure I will forget some people and I do hope they won’t be too upset about it. Let’s 
say, it is because of work! Mickaël, alias Mikado Borracho, I know that you have improved your English 
enough to understand the few following words. Thank you for being such a devoted and close friend. I 
know that I should call you more often but it is not my fault; phones are not allowed in the mouse house ;-
). I also know I should visit Montpellier more often too but how could I when I am such a work-
alcoholic…and there are no regular direct flights from Munich to Montpellier. However, I do know that 
despite the distance, I can count on you and you, on me. Thanks for standing by me in the good moments 
and even more in the bad ones! Lubov, thanks a lot for being such an amazing friend. I cannot believe five 
years are already gone since we met. Starting the entire lab and doing our PhD thesis together have been 
the craziest things I have ever done; dancing in the lab over the weekend (sorry boss…and thanks for the 
radio-CD post! ;-)), having lunch …diners together in front of our computers, co-organizing the Christmas 
Acknowledgments 
  
196 
 
party (ok, you have done most of it by yourself but I have had a lot of fun watching you dealing with 
western blots and Christmas tree decorations), helping each other to translate German formularies, 
winning despite of all expectations the MvP kicker tournament, nicely explaining to the new colleagues 
how bad it is not to participate in the common lab-work, …. , and I should probably thank you in advance 
for the time you are going to spend on my thesis corrections. I wish you all the best you do deserve in the 
career path you will chose. Audrey V., my dear Audrey, we met quite roughly eight years ago and to my 
surprise, and probably yours too, we coped so well together! I am sure one day, we will find a way to 
work in the same lab and that day is going to be legen … wait for it … dary! Thanks a lot Copine for 
being such a close and good friend. I promise to do my best to come back to France … if Flamby promises 
to resign! Debora & Lukas, my two favorite kicker players, thanks a lot for the good mood you spread 
around as an Ebola pandemic. And Lukas, thank you so much for having introduced me to the “Whatever” 
American philosophy, you changed my life that day! P.S. Sorry for the salt into the coffee … but it was 
really meant to help you smile! Debora, your Italian enthusiasm and optimism is just awesome. You are 
able to light up a rainy day in a heartbeat, do not change anything!! Halina, thank you for sharing your 
research experience so often, for supporting me so many times during tough moments and providing 
advices such as “stop over-working!”. I should have listened to you more carefully. Louise, you were 
definitely one of the triggering events, who brought me where I am today. I will always be grateful to you 
for your unconditional support and unwavering optimism from the BCPST-prepa in Versailles to the final 
step of this PhD work. 
 Jérôme Lafare, alias mon homme. Certes tu n’as pas connu l’intégralité des cinq années de thèse 
mais tu es entré dans ma vie au meilleur moment. Le moment où j’étais physiquement et mentalement 
épuisée. Je te remercie du fond du cœur de m’avoir encouragé, soutenu de toutes tes forces et donné 
l’énergie nécessaire dont j’avais besoin pour clore ce chapitre. Ce ne sont ici que des mots, et j’espère un 
jour pouvoir te le montrer, mais je te suis à jamais reconnaissante d’avoir été à mes côtés pour la dernière 
ligne droite, l’ultime sprint, d’un certain 3 octobre 2014 jusqu’au bout du tunnel. 
 
 Colleagues. 
 This fifth part is dedicated to my colleagues whom I have had the pleasure to get to know and to 
work with. Dear colleagues, I thank you for all the moments we have shared during these last years. All 
the discussions we have had, all the candies and cakes we have shared, the good mood spread in the 
offices as well as in the lab, the cocktail evenings, … Thank you very much. All of you contributed to 
change these five years into an amazing journey, full of enriching human and professional experiences. 
Acknowledgments 
  
197 
 
 Diana Kaiser, thank you so much for your very professional help and German lessons, I do use 
“Schnäppchen” in daily life. Steffi Spriewald, talking about German lessons, sorry that I will never be able 
to pronounce “Eichhörnchen” properly and thank you very much for your support, especially during the 
writing process. Markus Beutler, thank you so much for your high contribution to this work. You are 
definitely doing an amazing work with developing further the Oligo-MM stories and I am sure that you 
will be even more successful than I am now! Have a lot of fun with the mouse models and keep your 
enthusiasm, it is awesome! Simone Herp, we still do not know each other so well, but I am sure you are 
already having a lot of fun working with the ASF mice and Mucispirillum! Manuel Diehl, thanks a lot for 
your great help during the establishment of the gnotobiotic facilities…and the famous MvP kicker 
tournaments! Jana Glaser, thank you so much for your very helpful advices starting with “you should 
more take care of you”. I swear I have been working on this one a lot! I would also like to thank Aline 
Kessler, Christopher Harrison, Lisa Maier, Luisa Fernanda Jimenez Soto, Maximilian Frömberg, Ute 
Breithaupt, Carina Pfann and Eva Rath. Many thanks for your great conversations, your support and your 
enthusiasm, sometimes awesomely funny! 
 I would also like to thank the animal care-takers who made an awesome work and were always 
free to talk and help. Without such a good team, this work would have been like hell. You made my days, 
especially you, Saib Hussain. Saib, you cannot imagine how grateful I am that we got to know each other 
so well. Thousand thanks for your incredible help within the mouse facilities, our amazing “point of 
views” sharing sessions and your endless support in every case for me. 
 
 The last but not the least! 
 Finally, I would like to thank the germfree, ASF, Oligo-MM, AGR2 and MUC2 mice without 
whom none of this work would have been possible. I hope your sacrifice have not been fully useless and 
that, somehow, the scientific community will use the data and models, you and I have been working on so 
hard in order to better understand the interactions between “us”, our gut microbiota and our pathogens. 
 
 
198 
 
  Curriculum Vitae       10.
Brugiroux Sandrine               
French, English, German (read, written, spoken)              
Date of birth: 14.05.1986                  
Place of birth: Firminy, France                   
sandrine.brugiroux@yahoo.fr  
                         Skills 
Work with gnotobiotic mice 
Performed animal infections 
Anaerobic bacterial cultures 
Fluorescence in situ hybridization 
Immunofluorescence staining 
Confocal & epifluorescence microscopy 
Cell tissue culture  
RNA extraction for microarray analysis
Molecular biology (clonings, Western blottings, qPCR, RT-PCR, 454 amplicon-sequencing) 
Softwares: statistical analysis (GraphPad Prism 5); sequence analysis (CLC DNA Workbench 6, 
MaGe); image analysis (DAIME, EndNote) and figure processing (Adobe Illustrator CS5) 
 
Education 
 
Ph.D. student in Microbiology, Max von Pettenkofer Institute (Ludwig Maximilian   Oct. 2010-now 
University of Munich, Germany). Advisor: Prof. B. Stecher 
Thesis Research: Establishment of a gnotobiotic mouse model to study colonization 
resistance against Salmonella enterica serovar Typhimurium and its first applications. 
M.Sc.2. in Biology & Health Research: Host-pathogen Interactions & Mechanisms                    2010
 of Defense, University of Montpellier 2 (France). Advisor: Prof. C. Braun-Breton 
 Thesis Research: Studies on the role of multigene families PfEFP-1, -3 and -4 during  
 invasion of red blood cells by Plasmodium falciparum, causative agent of malaria. (8 months) 
M.Sc.1. student in Biology & Health Research, University of Montpellier 2 (France)        2009 
 Advisors: Dr. J.P. Leonetti & Dr. M. Gualtieri 
 Thesis Research: Identification and phylogenic characterization of UV-resistant
Curriculum Vitae 
 
199 
 
environmental bacterial strains and studies of their antimicrobial potential. (6 months)  
             
B.Sc. student in Microbiology, University of Montpellier 2 (France). Advisor: Dr. A. Givaudan         2008 
 Research topic: Study of the haemolytic activity of a Photorhabdus asymbiotica toxin. (2 months) 
 
BCPST1. Preparatory school in Biology, Chemistry, Physics & Geology, Lycée Hoche            June 2005 
 (Versailles, France) 
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Microbiol. (Accepted for publication) 
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ISME. (Submitted) 
Studer N, Desharnais L, Beutler M, Brugiroux S, Terrazos M, Menin L, McCoy KD, Kuehne S, Minton 
N, Stecher B, Bernier-Latmani R, Hapfelmeier S. Functional intestinal microbial secondary bile acid 
production by 7-alpha-dehydroxylating Clostridium scindens in a gnotobiotic mouse model. Front Cell 
Infect Microbiol. (Submitted) 
Uchimura Y, Wyss M, Brugiroux S, Limenitakis J, Stecher B, McCoy KD, and Macpherson AJ. (2016) 
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Hornef MW, Baines JF, Smidt H, Walter J, Kristiansen K, Nielsen HB, Haller D, Overmann J, Stecher B, 
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JA, Rupp S, Stolp B, Stein JV, Stecher B, Sauer U, McCoy KD, Macpherson AJ. (2015) The outer mucus 
layer hosts a distinct intestinal microbial niche. Nat Commun. 6:8292. 
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Decker T, Loy A, Wagner M. (2013) Host-compound foraging by intestinal microbiota revealed by single-
cell stable isotope probing. Proc Natl Acad Sci U S A. 110(12):4720-5. 
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     Main Academic Conferences 
VAAM. Annual Conference of the Association for General and Applied Microbiology,        March 2015 
Marburg, Germany. Poster                              
7th Seeon Conference “Microbiota, Probiota and Host”, Chiemsee, Germany. Poster            July 2014 
FEMS. 5th Congress of European Microbiologists, Leipzig, Germany. Poster              July 2013 
6th Seeon Conference “Microbiota, Probiota and Host”, Chiemsee, Germany.            June 2013 
Poster and oral presentation (two different projects presented)   
International Yakult Symposium, London, England. Poster             April 2013 
DGHM. 64th Annual meeting of German Society for Hygiene and Microbiology,      Sept-Oct 2012 
Hamburg, Germany. Poster                  
5th Seeon Conference “Microbiota, Probiota and Host”, Chiemsee, Germany.             June 2012 
Oral  presentation          
4th Seeon Conference “Microbiota, Probiota and Host”, Chiemsee, Germany. Poster          April 2011 
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                 Poster prizes 
 
“Generation of gnotobiotic mice to investigate the role of the intestinal microbiota in Salmonella 
enterica spp. I serovar Typhimurium colitis in AGR2-deficient mice”    
(8th Seeon Conference, July 2015), Chiemsee, Germany. 
“Why are Agr2-deficient mice resistant against Salmonella-induced colitis?”    
 (6th Seeon Conference, June 2013), Chiemsee, Germany. 
“An Oligo-mouse microbiota protective against Salmonella Typhimurium infection”   
 (DGHM, Sept-Oct 2012), Hamburg, Germany.  
 
    Teaching activities 
 
“Cultivating obligate anaerobic bacteria: from the bench to the anaerobic chamber” 
“Using fluorescence in situ hybridization to detect and quantify single cells” 
Private teachings from 1-3 days with 1-6 participants depending on the needs. 
 
